(16201,32528,'microvillus organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a microvillus, a thin cylindrical membrane-covered projection on the surface of a cell.','2013-10-27','NSRP'),(16202,32529,'follicle cell microvillus organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a microvillus on a follicle cell. A microvillus is a thin cylindrical membrane-covered projection on the surface of an animal cell containing a core bundle of actin filaments.','2013-10-27','NSRP'),(16203,32530,'regulation of microvillus organization','P','Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a microvillus.','2013-10-27','NSRP'),(16204,32531,'regulation of follicle cell microvillus organization','P','Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a microvillus on a follicle cell.','2013-10-27','NSRP'),(16205,32532,'regulation of microvillus length','P','A process that modulates the length of a microvillus.','2013-10-27','NSRP'),(16206,32533,'regulation of follicle cell microvillus length','P','A process that modulates the length of a microvillus on a follicle cell.','2013-10-27','NSRP'),(16207,32534,'regulation of microvillus assembly','P','A process that modulates the formation of a microvillus.','2013-10-27','NSRP'),(16208,32535,'regulation of cellular component size','P','A process that modulates the size of a cellular component.','2013-10-27','NSRP'),(16209,32536,'regulation of cell projection size','P','A process that modulates the size of a cell projection.','2013-10-27','NSRP'),(16210,32537,'host-seeking behavior','P','The specific behavior of an organism that are associated with finding a host organism; may include behavioral responses to light, temperature, or chemical emanations from the prospective host.','2013-10-27','NSRP'),(16211,32538,'regulation of host-seeking behavior','P','Any process that modulates the frequency, rate or extent of any behavior associated with finding a host organism.','2013-10-27','NSRP'),(16212,32539,'negative regulation of host-seeking behavior','P','Any process that stops, prevents, or reduces the frequency, rate or extent of any behavior associated with finding a host organism.','2013-10-27','NSRP'),(16213,32540,'positive regulation of host-seeking behavior','P','Any process that activates or increases the frequency, rate or extent of any behavior associated with finding a host organism.','2013-10-27','NSRP'),(16214,32541,'cortical endoplasmic reticulum','C','A cortical network of highly dynamic tubules that are juxtaposed to the plasma membrane and undergo ring closure and tubule-branching movements.','2013-10-27','NSRP'),(16215,32542,'sulfiredoxin activity','F','Catalysis of the reaction: peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 R-SH = peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + R-S-S-R.','2013-10-27','NSRP'),(16216,32543,'mitochondrial translation','P','The chemical reactions and pathways resulting in the formation of a protein in a mitochondrion. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein; the mitochondrion has its own ribosomes and transfer RNAs, and uses a genetic code that differs from the nuclear code.','2013-10-27','NSRP'),(16217,32544,'plastid translation','P','The chemical reactions and pathways resulting in the formation of a protein in a plastid. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein; the plastid has its own ribosomes and transfer RNAs, and uses a genetic code that differs from the nuclear code.','2013-10-27','NSRP'),(16218,32545,'CURI complex','C','A protein complex that is involved in the transcription of ribosomal genes. In Saccharomyces this complex consists of Ckb2p, Utp22p, Rrp7p andIfh1p.','2013-10-27','NSRP'),(16219,32546,'deoxyribonucleoside binding','F','Interacting selectively and non-covalently with a deoxyribonucleoside, a compound consisting of a purine or pyrimidine nitrogenous base linked to deoxyribose.','2013-10-27','NSRP'),(16220,32547,'purine deoxyribonucleoside binding','F','Interacting selectively and non-covalently with a purine deoxyribonucleoside, a compound consisting of a purine base linked to deoxyribose.','2013-10-27','NSRP'),(16221,32548,'pyrimidine deoxyribonucleoside binding','F','Interacting selectively and non-covalently with a pyrimidine deoxyribonucleoside, a compound consisting of a pyrimidine base linked to deoxyribose.','2013-10-27','NSRP'),(16222,32549,'ribonucleoside binding','F','Interacting selectively and non-covalently with a ribonucleoside, a compound consisting of a purine or pyrimidine nitrogenous base linked to ribose.','2013-10-27','NSRP'),(16223,32550,'purine ribonucleoside binding','F','Interacting selectively and non-covalently with a purine ribonucleoside, a compound consisting of a purine base linked to ribose.','2013-10-27','NSRP'),(16224,32551,'pyrimidine ribonucleoside binding','F','Interacting selectively and non-covalently with a pyrimidine ribonucleoside, a compound consisting of a pyrimidine base linked to ribose.','2013-10-27','NSRP'),(16225,32552,'deoxyribonucleotide binding','F','Interacting selectively and non-covalently with a deoxyribonucleotide, any compound consisting of a deoxyribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the deoxyribose moiety.','2013-10-27','NSRP'),(16226,32553,'ribonucleotide binding','F','Interacting selectively and non-covalently with a ribonucleotide, any compound consisting of a ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.','2013-10-27','NSRP'),(16227,32554,'purine deoxyribonucleotide binding','F','Interacting selectively and non-covalently with a purine deoxyribonucleotide, any compound consisting of a purine deoxyribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the deoxyribose moiety.','2013-10-27','NSRP'),(16228,32555,'purine ribonucleotide binding','F','Interacting selectively and non-covalently with a purine ribonucleotide, any compound consisting of a purine ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.','2013-10-27','NSRP'),(16229,32556,'pyrimidine deoxyribonucleotide binding','F','Interacting selectively and non-covalently with a pyrimidine deoxyribonucleotide, any compound consisting of a pyrimidine deoxyribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the deoxyribose moiety.','2013-10-27','NSRP'),(16230,32557,'pyrimidine ribonucleotide binding','F','Interacting selectively and non-covalently with a pyrimidine ribonucleotide, any compound consisting of a pyrimidine ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.','2013-10-27','NSRP'),(16231,32558,'adenyl deoxyribonucleotide binding','F','Interacting selectively and non-covalently with an adenyl deoxyribonucleotide, any compound consisting of adenosine esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the deoxyribose moiety.','2013-10-27','NSRP'),(16232,32559,'adenyl ribonucleotide binding','F','Interacting selectively and non-covalently with an adenyl ribonucleotide, any compound consisting of adenosine esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.','2013-10-27','NSRP'),(16233,32560,'guanyl deoxyribonucleotide binding','F','Interacting selectively and non-covalently with a guanyl deoxyribonucleotide, any compound consisting of guanosine esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the deoxyribose moiety.','2013-10-27','NSRP'),(16234,32561,'guanyl ribonucleotide binding','F','Interacting selectively and non-covalently with a guanyl ribonucleotide, any compound consisting of guanosine esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety.','2013-10-27','NSRP'),(16235,32562,'dAMP binding','F','Interacting selectively and non-covalently with dAMP, deoxyadenosine monophosphate.','2013-10-27','NSRP'),(16236,32563,'dADP binding','F','Interacting selectively and non-covalently with dADP, deoxyadenosine diphosphate.','2013-10-27','NSRP'),(16237,32564,'dATP binding','F','Interacting selectively and non-covalently with dATP, deoxyadenosine triphosphate.','2013-10-27','NSRP'),(16238,32565,'dGMP binding','F','Interacting selectively and non-covalently with dGMP, deoxyguanosine monophosphate.','2013-10-27','NSRP'),(16239,32566,'dGDP binding','F','Interacting selectively and non-covalently with dGDP, deoxyguanosine diphosphate.','2013-10-27','NSRP'),(16240,32567,'dGTP binding','F','Interacting selectively and non-covalently with dGTP, deoxyguanosine triphosphate.','2013-10-27','NSRP'),(16241,32570,'response to progesterone stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.','2013-10-27','NSRP'),(16242,32571,'response to vitamin K','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin K stimulus.','2013-10-27','NSRP'),(16243,32572,'response to menaquinone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a menaquinone (vitamin K2) stimulus.','2013-10-27','NSRP'),(16244,32573,'response to phylloquinone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a phylloquinone (vitamin K1) stimulus.','2013-10-27','NSRP'),(16245,32574,'5\'-3\' RNA helicase activity','F','Catalysis of the unwinding of an RNA helix in the direction 5\' to 3\'.','2013-10-27','NSRP'),(16246,32575,'ATP-dependent 5\'-3\' RNA helicase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of an RNA helix in the direction 5\' to 3\'.','2013-10-27','NSRP'),(16247,32576,'O-linoleoyltransferase activity','F','Catalysis of the transfer of a linoleoyl ((9Z,12Z)-octadeca-9,12-dienoyl) group to an oxygen atom on the acceptor molecule.','2013-10-27','NSRP'),(16248,32577,'phosphatidylcholine:cardiolipin O-linoleoyltransferase activity','F','Catalysis of the transfer of a linoleoyl ((9Z,12Z)-octadeca-9,12-dienoyl) group from phosphatidylcholine to an oxygen atom on a cardiolipin molecule.','2013-10-27','NSRP'),(16249,32578,'aleurone grain membrane','C','The lipid bilayer surrounding an aleurone grain.','2013-10-27','NSRP'),(16250,32579,'apical lamina of hyaline layer','C','A fibrous network that is part of the hyalin layer extracellular matrix. The apical lamina is thought to be principally composed of the glycoproteins fibropellins. This matrix has been found in echinoderms.','2013-10-27','NSRP'),(16251,32580,'Golgi cisterna membrane','C','The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex.','2013-10-27','NSRP'),(16252,32581,'ER-dependent peroxisome organization','P','A process of peroxisome organization in which assembly or arrangement of constituent parts takes place in the endoplasmic reticulum.','2013-10-27','NSRP'),(16253,32584,'growth cone membrane','C','The portion of the plasma membrane surrounding a growth cone.','2013-10-27','NSRP'),(16254,32585,'multivesicular body membrane','C','The lipid bilayer surrounding a multivesicular body.','2013-10-27','NSRP'),(16255,32586,'protein storage vacuole membrane','C','The lipid bilayer surrounding a protein storage vacuole.','2013-10-27','NSRP'),(16256,32587,'ruffle membrane','C','The portion of the plasma membrane surrounding a ruffle.','2013-10-27','NSRP'),(16257,32588,'trans-Golgi network membrane','C','The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network.','2013-10-27','NSRP'),(16258,32589,'neuron projection membrane','C','The portion of the plasma membrane surrounding a neuron projection.','2013-10-27','NSRP'),(16259,32590,'dendrite membrane','C','The portion of the plasma membrane surrounding a dendrite.','2013-10-27','NSRP'),(16260,32591,'dendritic spine membrane','C','The portion of the plasma membrane surrounding a dendritic spine.','2013-10-27','NSRP'),(16261,32592,'integral to mitochondrial membrane','C','Located such that some or all of the gene product itself penetrates at least one phospholipid bilayer of a mitochondrial membrane. May also refer to the state of being buried in the bilayer with no exposure outside the bilayer.','2013-10-27','NSRP'),(16262,32593,'insulin-responsive compartment','C','A small membrane-bounded vesicle that releases its contents by exocytosis in response to insulin stimulation; the contents are enriched in GLUT4, IRAP and VAMP2.','2013-10-27','NSRP'),(16263,32594,'protein transport within lipid bilayer','P','The directed movement of a protein from one location to another within a lipid bilayer.','2013-10-27','NSRP'),(16264,32595,'B cell receptor transport within lipid bilayer','P','The directed movement of a B cell receptor within a lipid bilayer.','2013-10-27','NSRP'),(16265,32596,'protein transport into membrane raft','P','The directed movement of a protein into a membrane raft. Membrane rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes.','2013-10-27','NSRP'),(16266,32597,'B cell receptor transport into membrane raft','P','The directed movement of a B cell receptor into a membrane raft.','2013-10-27','NSRP'),(16267,32598,'B cell receptor transport into immunological synapse','P','The directed movement of a B cell receptor into an immunological synapse.','2013-10-27','NSRP'),(16268,32599,'protein transport out of membrane raft','P','The directed movement of a protein out of a membrane raft. Membrane rafts are small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes.','2013-10-27','NSRP'),(16269,32600,'chemokine receptor transport out of membrane raft','P','The directed movement of a chemokine receptor out of a membrane raft.','2013-10-27','NSRP'),(16270,32601,'connective tissue growth factor production','P','The appearance of connective tissue growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16271,32602,'chemokine production','P','The appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16272,32603,'fractalkine production','P','The appearance of fractalkine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16273,32604,'granulocyte macrophage colony-stimulating factor production','P','The appearance of granulocyte macrophage colony-stimulating factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16274,32605,'hepatocyte growth factor production','P','The appearance of hepatocyte growth factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16275,32606,'type I interferon production','P','The appearance of type I interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.','2013-10-27','NSRP'),(16276,32607,'interferon-alpha production','P','The appearance of interferon-alpha due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16277,32608,'interferon-beta production','P','The appearance of interferon-beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16278,32609,'interferon-gamma production','P','The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon.','2013-10-27','NSRP'),(16279,32610,'interleukin-1 alpha production','P','The appearance of interleukin-1 alpha due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16280,32611,'interleukin-1 beta production','P','The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16281,32612,'interleukin-1 production','P','The appearance of interleukin-1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16282,32613,'interleukin-10 production','P','The appearance of interleukin-10 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16283,32614,'interleukin-11 production','P','The appearance of interleukin-11 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16284,32615,'interleukin-12 production','P','The appearance of interleukin-12 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16285,32616,'interleukin-13 production','P','The appearance of interleukin-13 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16286,32617,'interleukin-14 production','P','The appearance of interleukin-14 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16287,32618,'interleukin-15 production','P','The appearance of interleukin-15 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16288,32619,'interleukin-16 production','P','The appearance of interleukin-16 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16289,32620,'interleukin-17 production','P','The appearance of any member of the interleukin-17 family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16290,32621,'interleukin-18 production','P','The appearance of interleukin-18 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16291,32622,'interleukin-19 production','P','The appearance of interleukin-19 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16292,32623,'interleukin-2 production','P','The appearance of interleukin-2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16293,32624,'interleukin-20 production','P','The appearance of interleukin-20 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16294,32625,'interleukin-21 production','P','The appearance of interleukin-21 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16295,32626,'interleukin-22 production','P','The appearance of interleukin-22 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16296,32627,'interleukin-23 production','P','The appearance of interleukin-23 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16297,32628,'interleukin-24 production','P','The appearance of interleukin-24 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16298,32629,'interleukin-25 production','P','The appearance of interleukin-25 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16299,32630,'interleukin-26 production','P','The appearance of interleukin-26 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16300,32631,'interleukin-27 production','P','The appearance of interleukin-27 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16301,32632,'interleukin-3 production','P','The appearance of interleukin-3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16302,32633,'interleukin-4 production','P','The appearance of interleukin-4 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16303,32634,'interleukin-5 production','P','The appearance of interleukin-5 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16304,32635,'interleukin-6 production','P','The appearance of interleukin-6 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16305,32636,'interleukin-7 production','P','The appearance of interleukin-7 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16306,32637,'interleukin-8 production','P','The appearance of interleukin-8 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16307,32638,'interleukin-9 production','P','The appearance of interleukin-9 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16308,32639,'TRAIL production','P','The appearance of TRAIL due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16309,32640,'tumor necrosis factor production','P','The appearance of tumor necrosis factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16310,32641,'lymphotoxin A production','P','The appearance of lymphotoxin A due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16311,32642,'regulation of chemokine production','P','Any process that modulates the frequency, rate, or extent of chemokine production.','2013-10-27','NSRP'),(16312,32643,'regulation of connective tissue growth factor production','P','Any process that modulates the frequency, rate, or extent of connective tissue growth factor production.','2013-10-27','NSRP'),(16313,32644,'regulation of fractalkine production','P','Any process that modulates the frequency, rate, or extent of fractalkine production.','2013-10-27','NSRP'),(16314,32645,'regulation of granulocyte macrophage colony-stimulating factor production','P','Any process that modulates the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.','2013-10-27','NSRP'),(16315,32646,'regulation of hepatocyte growth factor production','P','Any process that modulates the frequency, rate, or extent of hepatocyte growth factor production.','2013-10-27','NSRP'),(16316,32647,'regulation of interferon-alpha production','P','Any process that modulates the frequency, rate, or extent of interferon-alpha production.','2013-10-27','NSRP'),(16317,32648,'regulation of interferon-beta production','P','Any process that modulates the frequency, rate, or extent of interferon-beta production.','2013-10-27','NSRP'),(16318,32649,'regulation of interferon-gamma production','P','Any process that modulates the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.','2013-10-27','NSRP'),(16319,32650,'regulation of interleukin-1 alpha production','P','Any process that modulates the frequency, rate, or extent of interleukin-1 alpha production.','2013-10-27','NSRP'),(16320,32651,'regulation of interleukin-1 beta production','P','Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.','2013-10-27','NSRP'),(16321,32652,'regulation of interleukin-1 production','P','Any process that modulates the frequency, rate, or extent of interleukin-1 production.','2013-10-27','NSRP'),(16322,32653,'regulation of interleukin-10 production','P','Any process that modulates the frequency, rate, or extent of interleukin-10 production.','2013-10-27','NSRP'),(16323,32654,'regulation of interleukin-11 production','P','Any process that modulates the frequency, rate, or extent of interleukin-11 production.','2013-10-27','NSRP'),(16324,32655,'regulation of interleukin-12 production','P','Any process that modulates the frequency, rate, or extent of interleukin-12 production.','2013-10-27','NSRP'),(16325,32656,'regulation of interleukin-13 production','P','Any process that modulates the frequency, rate, or extent of interleukin-13 production.','2013-10-27','NSRP'),(16326,32657,'regulation of interleukin-14 production','P','Any process that modulates the frequency, rate, or extent of interleukin-14 production.','2013-10-27','NSRP'),(16327,32658,'regulation of interleukin-15 production','P','Any process that modulates the frequency, rate, or extent of interleukin-15 production.','2013-10-27','NSRP'),(16328,32659,'regulation of interleukin-16 production','P','Any process that modulates the frequency, rate, or extent of interleukin-16 production.','2013-10-27','NSRP'),(16329,32660,'regulation of interleukin-17 production','P','Any process that modulates the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.','2013-10-27','NSRP'),(16330,32661,'regulation of interleukin-18 production','P','Any process that modulates the frequency, rate, or extent of interleukin-18 production.','2013-10-27','NSRP'),(16331,32662,'regulation of interleukin-19 production','P','Any process that modulates the frequency, rate, or extent of interleukin-19 production.','2013-10-27','NSRP'),(16332,32663,'regulation of interleukin-2 production','P','Any process that modulates the frequency, rate, or extent of interleukin-2 production.','2013-10-27','NSRP'),(16333,32664,'regulation of interleukin-20 production','P','Any process that modulates the frequency, rate, or extent of interleukin-20 production.','2013-10-27','NSRP'),(16334,32665,'regulation of interleukin-21 production','P','Any process that modulates the frequency, rate, or extent of interleukin-21 production.','2013-10-27','NSRP'),(16335,32666,'regulation of interleukin-22 production','P','Any process that modulates the frequency, rate, or extent of interleukin-22 production.','2013-10-27','NSRP'),(16336,32667,'regulation of interleukin-23 production','P','Any process that modulates the frequency, rate, or extent of interleukin-23 production.','2013-10-27','NSRP'),(16337,32668,'regulation of interleukin-24 production','P','Any process that modulates the frequency, rate, or extent of interleukin-24 production.','2013-10-27','NSRP'),(16338,32669,'regulation of interleukin-25 production','P','Any process that modulates the frequency, rate, or extent of interleukin-25 production.','2013-10-27','NSRP'),(16339,32670,'regulation of interleukin-26 production','P','Any process that modulates the frequency, rate, or extent of interleukin-26 production.','2013-10-27','NSRP'),(16340,32671,'regulation of interleukin-27 production','P','Any process that modulates the frequency, rate, or extent of interleukin-27 production.','2013-10-27','NSRP'),(16341,32672,'regulation of interleukin-3 production','P','Any process that modulates the frequency, rate, or extent of interleukin-3 production.','2013-10-27','NSRP'),(16342,32673,'regulation of interleukin-4 production','P','Any process that modulates the frequency, rate, or extent of interleukin-4 production.','2013-10-27','NSRP'),(16343,32674,'regulation of interleukin-5 production','P','Any process that modulates the frequency, rate, or extent of interleukin-5 production.','2013-10-27','NSRP'),(16344,32675,'regulation of interleukin-6 production','P','Any process that modulates the frequency, rate, or extent of interleukin-6 production.','2013-10-27','NSRP'),(16345,32676,'regulation of interleukin-7 production','P','Any process that modulates the frequency, rate, or extent of interleukin-7 production.','2013-10-27','NSRP'),(16346,32677,'regulation of interleukin-8 production','P','Any process that modulates the frequency, rate, or extent of interleukin-8 production.','2013-10-27','NSRP'),(16347,32678,'regulation of interleukin-9 production','P','Any process that modulates the frequency, rate, or extent of interleukin-9 production.','2013-10-27','NSRP'),(16348,32679,'regulation of TRAIL production','P','Any process that modulates the frequency, rate, or extent of TRAIL production.','2013-10-27','NSRP'),(16349,32680,'regulation of tumor necrosis factor production','P','Any process that modulates the frequency, rate, or extent of tumor necrosis factor production.','2013-10-27','NSRP'),(16350,32681,'regulation of lymphotoxin A production','P','Any process that modulates the frequency, rate, or extent of lymphotoxin A production.','2013-10-27','NSRP'),(16351,32682,'negative regulation of chemokine production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of chemokine production.','2013-10-27','NSRP'),(16352,32683,'negative regulation of connective tissue growth factor production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of connective tissue growth factor production.','2013-10-27','NSRP'),(16353,32684,'negative regulation of fractalkine production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of fractalkine production.','2013-10-27','NSRP'),(16354,32685,'negative regulation of granulocyte macrophage colony-stimulating factor production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.','2013-10-27','NSRP'),(16355,32686,'negative regulation of hepatocyte growth factor production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of hepatocyte growth factor production.','2013-10-27','NSRP'),(16356,32687,'negative regulation of interferon-alpha production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-alpha production.','2013-10-27','NSRP'),(16357,32688,'negative regulation of interferon-beta production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-beta production.','2013-10-27','NSRP'),(16358,32689,'negative regulation of interferon-gamma production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.','2013-10-27','NSRP'),(16359,32690,'negative regulation of interleukin-1 alpha production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha production.','2013-10-27','NSRP'),(16360,32691,'negative regulation of interleukin-1 beta production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.','2013-10-27','NSRP'),(16361,32692,'negative regulation of interleukin-1 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 production.','2013-10-27','NSRP'),(16362,32693,'negative regulation of interleukin-10 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production.','2013-10-27','NSRP'),(16363,32694,'negative regulation of interleukin-11 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-11 production.','2013-10-27','NSRP'),(16364,32695,'negative regulation of interleukin-12 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.','2013-10-27','NSRP'),(16365,32696,'negative regulation of interleukin-13 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-13 production.','2013-10-27','NSRP'),(16366,32697,'negative regulation of interleukin-14 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-14 production.','2013-10-27','NSRP'),(16367,32698,'negative regulation of interleukin-15 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-15 production.','2013-10-27','NSRP'),(16368,32699,'negative regulation of interleukin-16 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 production.','2013-10-27','NSRP'),(16369,32700,'negative regulation of interleukin-17 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.','2013-10-27','NSRP'),(16370,32701,'negative regulation of interleukin-18 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-18 production.','2013-10-27','NSRP'),(16371,32702,'negative regulation of interleukin-19 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-19 production.','2013-10-27','NSRP'),(16372,32703,'negative regulation of interleukin-2 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-2 production.','2013-10-27','NSRP'),(16373,32704,'negative regulation of interleukin-20 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-20 production.','2013-10-27','NSRP'),(16374,32705,'negative regulation of interleukin-21 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-21 production.','2013-10-27','NSRP'),(16375,32706,'negative regulation of interleukin-22 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-22 production.','2013-10-27','NSRP'),(16376,32707,'negative regulation of interleukin-23 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-23 production.','2013-10-27','NSRP'),(16377,32708,'negative regulation of interleukin-24 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-24 production.','2013-10-27','NSRP'),(16378,32709,'negative regulation of interleukin-25 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-25 production.','2013-10-27','NSRP'),(16379,32710,'negative regulation of interleukin-26 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-26 production.','2013-10-27','NSRP'),(16380,32711,'negative regulation of interleukin-27 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-27 production.','2013-10-27','NSRP'),(16381,32712,'negative regulation of interleukin-3 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-3 production.','2013-10-27','NSRP'),(16382,32713,'negative regulation of interleukin-4 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-4 production.','2013-10-27','NSRP'),(16383,32714,'negative regulation of interleukin-5 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-5 production.','2013-10-27','NSRP'),(16384,32715,'negative regulation of interleukin-6 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.','2013-10-27','NSRP'),(16385,32716,'negative regulation of interleukin-7 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-7 production.','2013-10-27','NSRP'),(16386,32717,'negative regulation of interleukin-8 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production.','2013-10-27','NSRP'),(16387,32718,'negative regulation of interleukin-9 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-9 production.','2013-10-27','NSRP'),(16388,32719,'negative regulation of TRAIL production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of TRAIL production.','2013-10-27','NSRP'),(16389,32720,'negative regulation of tumor necrosis factor production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.','2013-10-27','NSRP'),(16390,32721,'negative regulation of lymphotoxin A production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of lymphotoxin A production.','2013-10-27','NSRP'),(16391,32722,'positive regulation of chemokine production','P','Any process that activates or increases the frequency, rate, or extent of chemokine production.','2013-10-27','NSRP'),(16392,32723,'positive regulation of connective tissue growth factor production','P','Any process that activates or increases the frequency, rate, or extent of connective tissue growth factor production.','2013-10-27','NSRP'),(16393,32724,'positive regulation of fractalkine production','P','Any process that activates or increases the frequency, rate, or extent of fractalkine production.','2013-10-27','NSRP'),(16394,32725,'positive regulation of granulocyte macrophage colony-stimulating factor production','P','Any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.','2013-10-27','NSRP'),(16395,32726,'positive regulation of hepatocyte growth factor production','P','Any process that activates or increases the frequency, rate, or extent of hepatocyte growth factor production.','2013-10-27','NSRP'),(16396,32727,'positive regulation of interferon-alpha production','P','Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.','2013-10-27','NSRP'),(16397,32728,'positive regulation of interferon-beta production','P','Any process that activates or increases the frequency, rate, or extent of interferon-beta production.','2013-10-27','NSRP'),(16398,32729,'positive regulation of interferon-gamma production','P','Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.','2013-10-27','NSRP'),(16399,32730,'positive regulation of interleukin-1 alpha production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-1 alpha production.','2013-10-27','NSRP'),(16400,32731,'positive regulation of interleukin-1 beta production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production.','2013-10-27','NSRP'),(16401,32732,'positive regulation of interleukin-1 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-1 production.','2013-10-27','NSRP'),(16402,32733,'positive regulation of interleukin-10 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.','2013-10-27','NSRP'),(16403,32734,'positive regulation of interleukin-11 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-11 production.','2013-10-27','NSRP'),(16404,32735,'positive regulation of interleukin-12 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.','2013-10-27','NSRP'),(16405,32736,'positive regulation of interleukin-13 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.','2013-10-27','NSRP'),(16406,32737,'positive regulation of interleukin-14 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-14 production.','2013-10-27','NSRP'),(16407,32738,'positive regulation of interleukin-15 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-15 production.','2013-10-27','NSRP'),(16408,32739,'positive regulation of interleukin-16 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-16 production.','2013-10-27','NSRP'),(16409,32740,'positive regulation of interleukin-17 production','P','Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.','2013-10-27','NSRP'),(16410,32741,'positive regulation of interleukin-18 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-18 production.','2013-10-27','NSRP'),(16411,32742,'positive regulation of interleukin-19 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-19 production.','2013-10-27','NSRP'),(16412,32743,'positive regulation of interleukin-2 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.','2013-10-27','NSRP'),(16413,32744,'positive regulation of interleukin-20 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-20 production.','2013-10-27','NSRP'),(16414,32745,'positive regulation of interleukin-21 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-21 production.','2013-10-27','NSRP'),(16415,32746,'positive regulation of interleukin-22 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-22 production.','2013-10-27','NSRP'),(16416,32747,'positive regulation of interleukin-23 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-23 production.','2013-10-27','NSRP'),(16417,32748,'positive regulation of interleukin-24 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-24 production.','2013-10-27','NSRP'),(16418,32749,'positive regulation of interleukin-25 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-25 production.','2013-10-27','NSRP'),(16419,32750,'positive regulation of interleukin-26 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-26 production.','2013-10-27','NSRP'),(16420,32751,'positive regulation of interleukin-27 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-27 production.','2013-10-27','NSRP'),(16421,32752,'positive regulation of interleukin-3 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-3 production.','2013-10-27','NSRP'),(16422,32753,'positive regulation of interleukin-4 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.','2013-10-27','NSRP'),(16423,32754,'positive regulation of interleukin-5 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.','2013-10-27','NSRP'),(16424,32755,'positive regulation of interleukin-6 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.','2013-10-27','NSRP'),(16425,32756,'positive regulation of interleukin-7 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-7 production.','2013-10-27','NSRP'),(16426,32757,'positive regulation of interleukin-8 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.','2013-10-27','NSRP'),(16427,32758,'positive regulation of interleukin-9 production','P','Any process that activates or increases the frequency, rate, or extent of interleukin-9 production.','2013-10-27','NSRP'),(16428,32759,'positive regulation of TRAIL production','P','Any process that activates or increases the frequency, rate, or extent of TRAIL production.','2013-10-27','NSRP'),(16429,32760,'positive regulation of tumor necrosis factor production','P','Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.','2013-10-27','NSRP'),(16430,32761,'positive regulation of lymphotoxin A production','P','Any process that activates or increases the frequency, rate, or extent of lymphotoxin A production.','2013-10-27','NSRP'),(16431,32762,'mast cell cytokine production','P','Any process that contributes to cytokine production by a mast cell.','2013-10-27','NSRP'),(16432,32763,'regulation of mast cell cytokine production','P','Any process that modulates the frequency, rate, or extent of mast cell cytokine production.','2013-10-27','NSRP'),(16433,32764,'negative regulation of mast cell cytokine production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell cytokine production.','2013-10-27','NSRP'),(16434,32765,'positive regulation of mast cell cytokine production','P','Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production.','2013-10-27','NSRP'),(16435,32766,'NHE3/E3KARP/ACTN4 complex','C','A heterotrimeric protein complex formed by the association of NHE3, E3KARP and alpha-actinin upon an increase in calcium ion concentration; found in clusters localized on plasma membrane and in intracellular compartments.','2013-10-27','NSRP'),(16436,32767,'copper-dependent protein binding','F','Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules), in the presence of copper.','2013-10-27','NSRP'),(16437,32768,'regulation of monooxygenase activity','P','Any process that modulates the activity of a monooxygenase.','2013-10-27','NSRP'),(16438,32769,'negative regulation of monooxygenase activity','P','Any process that stops or reduces the activity of a monooxygenase.','2013-10-27','NSRP'),(16439,32770,'positive regulation of monooxygenase activity','P','Any process that activates or increases the activity of a monooxygenase.','2013-10-27','NSRP'),(16440,32771,'regulation of monophenol monooxygenase activity','P','Any process that modulates the activity of the enzyme monophenol monooxygenase. Monophenol monooxygenase catalyzes the reaction: L-tyrosine + L-DOPA + O2 = L-DOPA + DOPAquinone + H2O.','2013-10-27','NSRP'),(16441,32772,'negative regulation of monophenol monooxygenase activity','P','Any process that stops or reduces the activity of the enzyme monophenol monooxygenase. Monophenol monooxygenase catalyzes the reaction: L-tyrosine + L-DOPA + O2 = L-DOPA + DOPAquinone + H2O.','2013-10-27','NSRP'),(16442,32773,'positive regulation of monophenol monooxygenase activity','P','Any process that activates or increases the activity of the enzyme monophenol oxygenase. Monophenol monooxygenase catalyzes the reaction: L-tyrosine + L-DOPA + O2 = L-DOPA + DOPAquinone + H2O.','2013-10-27','NSRP'),(16443,32774,'RNA biosynthetic process','P','The chemical reactions and pathways resulting in the formation of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3\',5\'-phosphodiester linkage. Includes polymerization of ribonucleotide monomers.','2013-10-27','NSRP'),(16444,32775,'DNA methylation on adenine','P','The covalent transfer of a methyl group to N-6 of adenine in a DNA molecule.','2013-10-27','NSRP'),(16445,32776,'DNA methylation on cytosine','P','The covalent transfer of a methyl group to C-5 or N-4 of cytosine in a DNA molecule.','2013-10-27','NSRP'),(16446,32777,'Piccolo NuA4 histone acetyltransferase complex','C','A heterotrimeric H4/H2A histone acetyltransferase complex with a substrate preference of chromatin over free histones. It contains a subset of the proteins found in the larger NuA4 histone acetyltransferase complex; for example, the S. cerevisiae complex contains Esa1p, Yng2p, and Epl1p.','2013-10-27','NSRP'),(16447,32778,'cobalt-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + cobalt(out) = ADP + phosphate + cobalt(in).','2013-10-27','NSRP'),(16448,32779,'copper-induced intracellular protein transport','P','The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell, induced by an increase in copper ion concentration.','2012-03-14','NSRP'),(16449,32780,'negative regulation of ATPase activity','P','Any process that stops or reduces the rate of ATP hydrolysis by an ATPase.','2013-10-27','NSRP'),(16450,32781,'positive regulation of ATPase activity','P','Any process that activates or increases the rate of ATP hydrolysis by an ATPase.','2013-10-27','NSRP'),(16451,32782,'bile acid secretion','P','The regulated release of bile acid, composed of any of a group of steroid carboxylic acids occurring in bile, by a cell or a tissue.','2013-10-27','NSRP'),(16452,32783,'ELL-EAF complex','C','A heterodimeric protein complex that acts as an RNA polymerase II elongation factor; the complex is conserved from yeast to humans, and is present in S. pombe, but absent from S. cerevisiae.','2013-10-27','NSRP'),(16453,32784,'regulation of DNA-dependent transcription, elongation','P','Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.','2013-10-27','NSRP'),(16454,32785,'negative regulation of DNA-dependent transcription, elongation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.','2013-10-27','NSRP'),(16455,32786,'positive regulation of DNA-dependent transcription, elongation','P','Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.','2013-10-27','NSRP'),(16456,32787,'monocarboxylic acid metabolic process','P','The chemical reactions and pathways involving monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-).','2013-10-27','NSRP'),(16457,32788,'saturated monocarboxylic acid metabolic process','P','The chemical reactions and pathways involving saturated monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-) and fully saturated C-C bonds.','2013-10-27','NSRP'),(16458,32789,'unsaturated monocarboxylic acid metabolic process','P','The chemical reactions and pathways involving unsaturated monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-) and one or more unsaturated C-C bonds.','2013-10-27','NSRP'),(16459,32790,'ribosome disassembly','P','The disaggregation of a ribosome into its constituent components; includes the dissociation of ribosomal subunits.','2013-10-27','NSRP'),(16460,32791,'lead ion binding','F','Interacting selectively and non-covalently with lead (Pb) ions.','2013-10-27','NSRP'),(16461,32792,'negative regulation of CREB transcription factor activity','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor CREB.','2013-10-27','NSRP'),(16462,32793,'positive regulation of CREB transcription factor activity','P','Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.','2013-10-27','NSRP'),(16463,32794,'GTPase activating protein binding','F','Interacting selectively and non-covalently with a GTPase activating protein.','2013-10-27','NSRP'),(16464,32795,'heterotrimeric G-protein binding','F','Interacting selectively and non-covalently with a heterotrimeric G-protein.','2013-10-27','NSRP'),(16465,32796,'uropod organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a uropod, a rigid membrane projection with related cytoskeletal components at the trailing edge of a lymphocyte or other cell in the process of migrating or being activated.','2013-10-27','NSRP'),(16466,32797,'SMN complex','C','A protein complex that contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and Unrip proteins; the complex is found in the cytoplasm and in nuclear Gems, and is involved in spliceosomal snRNP assembly in the cytoplasm and in pre-mRNA splicing in the nucleus.','2013-10-27','NSRP'),(16467,32798,'Swi5-Sfr1 complex','C','A conserved DNA recombinase mediator complex that contains two Swi5 monomers and one Sfr1 monomer in Schizosaccharomyces, or orthologs thereof (e.g. Sae3p and Mei5p in Saccharomyces).','2013-10-27','NSRP'),(16468,32799,'low-density lipoprotein receptor particle metabolic process','P','The chemical reactions and pathways involving low-density lipoprotein receptors.','2013-10-27','NSRP'),(16469,32800,'receptor biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.','2013-10-27','NSRP'),(16470,32801,'receptor catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.','2013-10-27','NSRP'),(16471,32802,'low-density lipoprotein particle receptor catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.','2013-10-27','NSRP'),(16472,32803,'regulation of low-density lipoprotein particle receptor catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.','2013-10-27','NSRP'),(16473,32804,'negative regulation of low-density lipoprotein particle receptor catabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein receptors.','2013-10-27','NSRP'),(16474,32805,'positive regulation of low-density lipoprotein particle receptor catabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.','2013-10-27','NSRP'),(16475,32806,'carboxy-terminal domain protein kinase complex','C','A protein complex that phosphorylates amino acid residues of RNA polymerase II C-terminal domain repeats; phosphorylation occurs mainly on Ser2 and Ser5.','2013-10-27','NSRP'),(16476,32807,'DNA ligase IV complex','C','A eukaryotically conserved protein complex that contains DNA ligase IV and is involved in DNA repair by non-homologous end joining; in addition to the ligase, the complex also contains XRCC4 or a homolog, e.g. Saccharomyces Lif1p.','2013-10-27','NSRP'),(16477,32808,'lacrimal gland development','P','The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.','2013-10-27','NSRP'),(16478,32809,'neuronal cell body membrane','C','The plasma membrane of a neuron cell body - excludes the plasma membrane of cell projections such as axons and dendrites.','2013-10-27','NSRP'),(16479,32810,'sterol response element binding','F','Interacting selectively and non-covalently with the sterol response element (SRE), a nonpalindromic sequence found in the promoters of genes involved in lipid metabolism.','2013-10-27','NSRP'),(16480,32811,'negative regulation of epinephrine secretion','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.','2013-10-27','NSRP'),(16481,32812,'positive regulation of epinephrine secretion','P','Any process that activates or increases the frequency, rate or extent of the regulated release of epinephrine.','2013-10-27','NSRP'),(16482,32813,'tumor necrosis factor receptor superfamily binding','F','Interacting selectively and non-covalently with any member of the tumor necrosis factor receptor superfamily.','2013-10-27','NSRP'),(16483,32814,'regulation of natural killer cell activation','P','Any process that modulates the frequency, rate or extent of natural killer cell activation.','2013-10-27','NSRP'),(16484,32815,'negative regulation of natural killer cell activation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation.','2013-10-27','NSRP'),(16485,32816,'positive regulation of natural killer cell activation','P','Any process that activates or increases the frequency, rate or extent of natural killer cell activation.','2013-10-27','NSRP'),(16486,32817,'regulation of natural killer cell proliferation','P','Any process that modulates the frequency, rate or extent of natural killer cell proliferation.','2013-10-27','NSRP'),(16487,32818,'negative regulation of natural killer cell proliferation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell proliferation.','2013-10-27','NSRP'),(16488,32819,'positive regulation of natural killer cell proliferation','P','Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.','2013-10-27','NSRP'),(16489,32820,'regulation of natural killer cell proliferation involved in immune response','P','Any process that modulates the frequency, rate or extent of natural killer cell proliferation as part of an immune response.','2013-10-27','NSRP'),(16490,32821,'negative regulation of natural killer cell proliferation involved in immune response','P','Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell proliferation as part of an immune response.','2013-10-27','NSRP'),(16491,32822,'positive regulation of natural killer cell proliferation involved in immune response','P','Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation as part of an immune response.','2013-10-27','NSRP'),(16492,32823,'regulation of natural killer cell differentiation','P','Any process that modulates the frequency, rate or extent of natural killer cell differentiation.','2013-10-27','NSRP'),(16493,32824,'negative regulation of natural killer cell differentiation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell differentiation.','2013-10-27','NSRP'),(16494,32825,'positive regulation of natural killer cell differentiation','P','Any process that activates or increases the frequency, rate or extent of natural killer cell differentiation.','2013-10-27','NSRP'),(16495,32826,'regulation of natural killer cell differentiation involved in immune response','P','Any process that modulates the frequency, rate or extent of natural killer cell differentiation as part of an immune response.','2013-10-27','NSRP'),(16496,32827,'negative regulation of natural killer cell differentiation involved in immune response','P','Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell differentiation as part of an immune response.','2013-10-27','NSRP'),(16497,32828,'positive regulation of natural killer cell differentiation involved in immune response','P','Any process that activates or increases the frequency, rate or extent of natural killer cell differentiation as part of an immune response.','2013-10-27','NSRP'),(16498,32829,'regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation','P','Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.','2013-10-27','NSRP'),(16499,32830,'negative regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.','2013-10-27','NSRP'),(16500,32831,'positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation','P','Any process that activates or increases the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.','2013-10-27','NSRP'),(16501,32832,'regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response','P','Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells as part of an immune response.','2013-10-27','NSRP'),(16502,32833,'negative regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response','P','Any process that stops, prevents, or reduces the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells as part of an immune response.','2013-10-27','NSRP'),(16503,32834,'positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response','P','Any process that activates or increases the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells as part of an immune response.','2013-10-27','NSRP'),(16504,32835,'glomerulus development','P','The progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft which forms a close network with the visceral epithelium (podocytes) and the mesangium to form the filtration barrier and is surrounded by Bowman\'s capsule in nephrons of the vertebrate kidney. The glomerulus is part of the nephron and is restricted to one body segment.','2013-10-27','NSRP'),(16505,32836,'glomerular basement membrane development','P','The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.','2013-10-27','NSRP'),(16506,32837,'distributive segregation','P','The cell cycle process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets during a normally chiasmate meiosis under the condition that chiasma have not occurred between a particular pair of homologs. Distributive segregation is a \"backup\" mechanism to ensure the segregation of homologs that have failed to cross over - either as a consequence of mutation or not, as, for example, the 4th chromosome of Drosophila melanogaster (which never exchanges, presumably due to its small size) - but nevertheless segregate normally.','2013-10-27','NSRP'),(16507,32838,'cell projection cytoplasm','C','All of the contents of a cell projection, excluding the plasma membrane surrounding the projection.','2013-10-27','NSRP'),(16508,32839,'dendrite cytoplasm','C','All of the contents of a dendrite, excluding the surrounding plasma membrane.','2013-10-27','NSRP'),(16509,32840,'intramolecular proline-rich ligand binding','F','Interacting selectively and non-covalently with a proline-rich region within the same polypeptide.','2013-10-27','NSRP'),(16510,32841,'calcitonin binding','F','Interacting selectively and non-covalently with calcitonin, a peptide hormone responsible for reducing serum calcium levels by inhibiting osteoclastic bone reabsorption and promoting renal calcium excretion. It is synthesized and released by the C cells of the thyroid.','2013-10-27','NSRP'),(16511,32843,'hydroperoxide reductase activity','F','Catalysis of the reaction: 2 RSH + ROOH = RSSR + ROH + H2O. This reaction is the thiol-dependent conversion of an organic hydroperoxide to the corresponding alcohol.','2013-10-27','NSRP'),(16512,32844,'regulation of homeostatic process','P','Any process that modulates the frequency, rate, or extent of a homeostatic process.','2013-10-27','NSRP'),(16513,32845,'negative regulation of homeostatic process','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of a homeostatic process.','2013-10-27','NSRP'),(16514,32846,'positive regulation of homeostatic process','P','Any process that activates or increases the frequency, rate, or extent of a homeostatic process.','2013-10-27','NSRP'),(16515,32847,'regulation of cellular pH reduction','P','Any process that modulates the frequency, rate, or extent of a process that reduces the internal pH of a cell.','2013-10-27','NSRP'),(16516,32848,'negative regulation of cellular pH reduction','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of a process that reduces the internal pH of a cell.','2013-10-27','NSRP'),(16517,32849,'positive regulation of cellular pH reduction','P','Any process that activates or increases the frequency, rate, or extent of a process that reduces the internal pH of a cell.','2013-10-27','NSRP'),(16518,32850,'positive regulation of ARF GTPase activity','P','Any process that activates or increases the activity of the GTPase ARF.','2013-10-27','NSRP'),(16519,32851,'positive regulation of Rab GTPase activity','P','Any process that activates or increases the activity of a GTPase of the Rab family.','2013-10-27','NSRP'),(16520,32852,'positive regulation of Ral GTPase activity','P','Any process that activates or increases the activity of a GTPase of the Ral family.','2013-10-27','NSRP'),(16521,32853,'positive regulation of Ran GTPase activity','P','Any process that activates or increases the activity of a GTPase of the Ran family.','2013-10-27','NSRP'),(16522,32854,'positive regulation of Rap GTPase activity','P','Any process that activates or increases the activity of a GTPase of the Rap family.','2013-10-27','NSRP'),(16523,32855,'positive regulation of Rac GTPase activity','P','Any process that activates or increases the activity of a GTPase of the Rac family.','2013-10-27','NSRP'),(16524,32856,'activation of Ras GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Ras superfamily through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16525,32857,'activation of ARF GTPase activity','P','Any process that initiates the activity of the inactive enzyme ARF GTPase through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16526,32858,'activation of Rab GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Rab family through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16527,32859,'activation of Ral GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Ral family through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16528,32860,'activation of Ran GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Ran family through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16529,32861,'activation of Rap GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Rap family through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16530,32862,'activation of Rho GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Rho family through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16531,32863,'activation of Rac GTPase activity','P','Any process that initiates the activity of an inactive GTPase of the Rac family through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16532,32864,'activation of Cdc42 GTPase activity','P','Any process that initiates the activity of the inactive GTPase Cdc42 through the replacement of GDP by GTP.','2013-10-27','NSRP'),(16533,32865,'ERMES complex','C','A protein complex that links the endoplasmic reticulum with mitochondria and may have a role in promoting exchange of calcium and phospholipids between the two organelles. The complex is also associated with actively replicating mitochondrial DNA nucleoids, and may further coordinate mitochondrial genome replication and membrane growth.','2013-10-27','NSRP'),(16534,32866,'D-xylose:NADP reductase activity','F','Catalysis of the reaction: D-xylitol + NADP+ = D-xylose + NADPH + H+.','2013-10-27','NSRP'),(16535,32867,'L-arabinose:NADP reductase activity','F','Catalysis of the reaction: L-arabitol + NADP+ = L-arabinose + NADPH + H+.','2013-10-27','NSRP'),(16536,32868,'response to insulin stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.','2013-10-27','NSRP'),(16537,32869,'cellular response to insulin stimulus','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.','2013-10-27','NSRP'),(16538,32870,'cellular response to hormone stimulus','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.','2013-10-27','NSRP'),(16539,32871,'regulation of karyogamy','P','Any process that modulates the frequency, rate or extent of karyogamy, the creation of a single nucleus from multiple nuclei as a result of membrane fusion.','2013-10-27','NSRP'),(16540,32872,'regulation of stress-activated MAPK cascade','P','Any process that modulates the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.','2013-10-27','NSRP'),(16541,32873,'negative regulation of stress-activated MAPK cascade','P','Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.','2013-10-27','NSRP'),(16542,32874,'positive regulation of stress-activated MAPK cascade','P','Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.','2013-10-27','NSRP'),(16543,32875,'regulation of DNA endoreduplication','P','Any process that modulates the frequency, rate or extent of DNA endoreduplication.','2013-10-27','NSRP'),(16544,32876,'negative regulation of DNA endoreduplication','P','Any process that stops, prevents, or reduces the frequency, rate or extent of DNA endoreduplication.','2013-10-27','NSRP'),(16545,32877,'positive regulation of DNA endoreduplication','P','Any process that activates or increases the frequency, rate or extent of DNA endoreduplication.','2013-10-27','NSRP'),(16546,32878,'regulation of establishment or maintenance of cell polarity','P','Any process that modulates the frequency, rate or extent of the specification, formation or maintenance of anisotropic intracellular organization or cell growth patterns.','2013-10-27','NSRP'),(16547,32879,'regulation of localization','P','Any process that modulates the frequency, rate or extent of any process in which a cell, a substance, or a cellular entity is transported to, or maintained in, a specific location.','2013-10-27','NSRP'),(16548,32880,'regulation of protein localization','P','Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location.','2013-10-27','NSRP'),(16549,32881,'regulation of polysaccharide metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving polysaccharides.','2013-10-27','NSRP'),(16550,32882,'regulation of chitin metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving chitin.','2013-10-27','NSRP'),(16551,32883,'regulation of chitin biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chitin.','2013-10-27','NSRP'),(16552,32884,'regulation of cell wall chitin biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cell wall chitin.','2013-10-27','NSRP'),(16553,32885,'regulation of polysaccharide biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides.','2013-10-27','NSRP'),(16554,32886,'regulation of microtubule-based process','P','Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the microtubule cytoskeleton.','2013-10-27','NSRP'),(16555,32887,'regulation of spindle elongation','P','Any process that modulates the frequency, rate or extent of the cell cycle process in which the distance is lengthened between poles of the spindle.','2013-10-27','NSRP'),(16556,32888,'regulation of mitotic spindle elongation','P','Any process that modulates the frequency, rate or extent of the cell cycle process in which the distance is lengthened between poles of the mitotic spindle.','2013-10-27','NSRP'),(16557,32889,'regulation of vacuole fusion, non-autophagic','P','Any process that modulates the frequency, rate or extent of the fusion of two vacuole membranes to form a single vacuole.','2013-10-27','NSRP'),(16558,32890,'regulation of organic acid transport','P','Any process that modulates the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16559,32891,'negative regulation of organic acid transport','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16560,32892,'positive regulation of organic acid transport','P','Any process that activates or increases the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16561,32893,'regulation of gluconate transport','P','Any process that modulates the frequency, rate or extent of the directed movement of gluconate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16562,32894,'negative regulation of gluconate transport','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of gluconate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16563,32895,'positive regulation of gluconate transport','P','Any process that activates or increases the frequency, rate or extent of the directed movement of gluconate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16564,32896,'palmitoyl-CoA 9-desaturase activity','F','Catalysis of the reaction: palmitoyl-CoA + AH2 + O2 = palmitoleic acid (16:1delta9) + A + 2 H2O.','2013-10-27','NSRP'),(16565,32897,'negative regulation of viral transcription','P','Any process that stops, prevents, or reduces the frequency, rate or extent of viral transcription.','2013-10-27','NSRP'),(16566,32898,'neurotrophin production','P','The appearance of a neurotrophin due to biosynthesis or secretion by cells in a neuron\'s target field, resulting in an increase in its intracellular or extracellular levels. A neurotrophin is any of a family of growth factors that prevent apoptosis in neurons and promote nerve growth.','2013-10-27','NSRP'),(16567,32899,'regulation of neurotrophin production','P','Any process that modulates the frequency, rate, or extent of production of a neurotrophin.','2013-10-27','NSRP'),(16568,32900,'negative regulation of neurotrophin production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of production of a neurotrophin.','2013-10-27','NSRP'),(16569,32901,'positive regulation of neurotrophin production','P','Any process that activates or increases the frequency, rate, or extent of production of a neurotrophin.','2013-10-27','NSRP'),(16570,32902,'nerve growth factor production','P','The appearance of nerve growth factor (NGF) due to biosynthesis or secretion by cells in a neuron\'s target field, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16571,32903,'regulation of nerve growth factor production','P','Any process that modulates the frequency, rate, or extent of production of nerve growth factor (NGF).','2013-10-27','NSRP'),(16572,32904,'negative regulation of nerve growth factor production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of production of nerve growth factor (NGF).','2013-10-27','NSRP'),(16573,32905,'transforming growth factor beta1 production','P','The appearance of transforming growth factor-beta1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16574,32906,'transforming growth factor beta2 production','P','The appearance of transforming growth factor-beta2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16575,32907,'transforming growth factor beta3 production','P','The appearance of transforming growth factor-beta3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.','2013-10-27','NSRP'),(16576,32908,'regulation of transforming growth factor beta1 production','P','Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta1.','2013-10-27','NSRP'),(16577,32909,'regulation of transforming growth factor beta2 production','P','Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta2.','2013-10-27','NSRP'),(16578,32910,'regulation of transforming growth factor beta3 production','P','Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta3.','2013-10-27','NSRP'),(16579,32911,'negative regulation of transforming growth factor beta1 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.','2013-10-27','NSRP'),(16580,32912,'negative regulation of transforming growth factor beta2 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta2.','2013-10-27','NSRP'),(16581,32913,'negative regulation of transforming growth factor beta3 production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta3.','2013-10-27','NSRP'),(16582,32914,'positive regulation of transforming growth factor beta1 production','P','Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta1.','2013-10-27','NSRP'),(16583,32915,'positive regulation of transforming growth factor beta2 production','P','Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta2.','2013-10-27','NSRP'),(16584,32916,'positive regulation of transforming growth factor beta3 production','P','Any process that activates or increases the frequency, rate, or extent of production of transforming growth factor-beta3.','2013-10-27','NSRP'),(16585,32917,'polyamine acetylation','P','The modification of polyamines by addition of acetyl groups.','2013-10-27','NSRP'),(16586,32918,'spermidine acetylation','P','The modification of spermidine by addition of acetyl groups.','2013-10-27','NSRP'),(16587,32919,'spermine acetylation','P','The modification of spermine by addition of acetyl groups.','2013-10-27','NSRP'),(16588,32920,'putrescine acetylation','P','The modification of putrescine by addition of acetyl groups.','2013-10-27','NSRP'),(16589,32921,'sarcosine oxidase complex','C','A complex consisting of 4 protein subunits as a heterotetramer, that possesses sarcosine oxidase activity.','2013-10-27','NSRP'),(16590,32922,'circadian regulation of gene expression','P','Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours.','2013-10-27','NSRP'),(16591,32923,'organic phosphonate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of phosphonates, any organic compound containing one or more C-PO(OH)2 or C-PO(OR)2 (with R=alkyl, aryl) groups. Synthesis of phosphonic acid itself, an inorganic compound without the biochemically relevant C-P bond, is not included.','2013-10-27','NSRP'),(16592,32924,'activin receptor signaling pathway','P','A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.','2013-10-27','NSRP'),(16593,32925,'regulation of activin receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of the activity of any activin receptor signaling pathway.','2013-10-27','NSRP'),(16594,32926,'negative regulation of activin receptor signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.','2013-10-27','NSRP'),(16595,32927,'positive regulation of activin receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.','2013-10-27','NSRP'),(16596,32928,'regulation of superoxide anion generation','P','Any process that modulates the frequency, rate or extent of enzymatic generation of superoxide by a cell.','2013-10-27','NSRP'),(16597,32929,'negative regulation of superoxide anion generation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of enzymatic generation of superoxide by a cell.','2013-10-27','NSRP'),(16598,32930,'positive regulation of superoxide anion generation','P','Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.','2013-10-27','NSRP'),(16599,32931,'histone acetyltransferase activity (H3-K56 specific)','F','Catalysis of the reaction: acetyl-CoA + histone H3 L-lysine (position 56) = CoA + histone H3 N6-acetyl-L-lysine (position 56).','2013-10-27','NSRP'),(16600,32932,'negative regulation of astral microtubule depolymerization','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the depolymerization of astral microtubules.','2013-10-27','NSRP'),(16601,32933,'SREBP signaling pathway','P','A series of molecular signals from the endoplasmic reticulum to the nucleus generated as a consequence of decreased levels of one or more sterols (and in some yeast, changes in oxygen levels) and which proceeds through activation of a sterol response element binding transcription factor (SREBP) to result in up-regulation of target gene transcription.','2013-10-27','NSRP'),(16602,32934,'sterol binding','F','Interacting selectively and non-covalently with a sterol, any steroid containing a hydroxy group in the 3 position, closely related to cholestan-3-ol.','2013-10-27','NSRP'),(16603,32935,'sterol sensor activity','F','Interacting selectively and non-covalently with and responding, e.g. by conformational change, to changes in the cellular level of a sterol.','2013-10-27','NSRP'),(16604,32936,'SREBP-SCAP complex','C','A protein complex formed by the association of sterol regulatory element binding protein (SREBP) and SREBP-cleavage-activating protein (SCAP) in the ER membrane; in the absence of sterols, the SREBP-SCAP complex is packaged into COPII vesicles and travels to the Golgi apparatus to be processed.','2013-10-27','NSRP'),(16605,32937,'SREBP-SCAP-Insig complex','C','A protein complex formed by the association of sterol regulatory element binding protein (SREBP), SREBP-cleavage-activating protein (SCAP), and an Insig protein (Insig-1 or Insig-2) in the ER membrane.','2013-10-27','NSRP'),(16606,32938,'negative regulation of translation in response to oxidative stress','P','Any process that stops, prevents, or reduces the frequency, rate or extent of translation as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.','2013-10-27','NSRP'),(16607,32939,'positive regulation of translation in response to oxidative stress','P','Any process that activates or increases the frequency, rate or extent of translation as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.','2013-10-27','NSRP'),(16608,32940,'secretion by cell','P','The controlled release of a substance by a cell.','2013-10-27','NSRP'),(16609,32941,'secretion by tissue','P','The controlled release of a substance by a tissue.','2013-10-27','NSRP'),(16610,32942,'inositol tetrakisphosphate 2-kinase activity','F','Catalysis of the reaction: 1D-myo-inositol tetrakisphosphate + ATP = 1D-myo-inositol pentakisphosphate (containing 2-phosphate) + ADP.','2013-10-27','NSRP'),(16611,32943,'mononuclear cell proliferation','P','The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.','2013-10-27','NSRP'),(16612,32944,'regulation of mononuclear cell proliferation','P','Any process that modulates the frequency, rate or extent of mononuclear cell proliferation.','2013-10-27','NSRP'),(16613,32945,'negative regulation of mononuclear cell proliferation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of mononuclear cell proliferation.','2013-10-27','NSRP'),(16614,32946,'positive regulation of mononuclear cell proliferation','P','Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation.','2013-10-27','NSRP'),(16615,32947,'protein complex scaffold','F','Functions to provide a physical support for the assembly of a multiprotein complex.','2013-10-27','NSRP'),(16616,32948,'regulation of alpha-glucan metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving alpha-glucans.','2013-10-27','NSRP'),(16617,32949,'regulation of alpha-glucan biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways relusting in the formation of alpha-glucans.','2013-10-27','NSRP'),(16618,32950,'regulation of beta-glucan metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving beta-glucans.','2013-10-27','NSRP'),(16619,32951,'regulation of beta-glucan biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways relusting in the formation of beta-glucans.','2013-10-27','NSRP'),(16620,32952,'regulation of (1->3)-beta-D-glucan metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving (1->3)-beta-D-glucans.','2013-10-27','NSRP'),(16621,32953,'regulation of (1->3)-beta-D-glucan biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.','2013-10-27','NSRP'),(16622,32954,'regulation of cytokinetic process','P','Any process that modulates the frequency, rate or extent of a cytokinetic process.','2013-10-27','NSRP'),(16623,32955,'regulation of barrier septum assembly','P','Any process that modulates the frequency, rate or extent of barrier septum formation. Barrier septum formation is the assembly and arrangement of a septum that spans the plasma membrane interface between progeny cells following cytokinesis.','2013-10-27','NSRP'),(16624,32956,'regulation of actin cytoskeleton organization','P','Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins.','2013-10-27','NSRP'),(16625,32957,'inositol trisphosphate metabolic process','P','The chemical reactions and pathways involving myo-inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached.','2013-10-27','NSRP'),(16626,32958,'inositol phosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.','2013-10-27','NSRP'),(16627,32959,'inositol trisphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of inositol trisphosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached.','2013-10-27','NSRP'),(16628,32960,'regulation of inositol trisphosphate biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.','2013-10-27','NSRP'),(16629,32961,'negative regulation of inositol trisphosphate biosynthetic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.','2013-10-27','NSRP'),(16630,32962,'positive regulation of inositol trisphosphate biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.','2013-10-27','NSRP'),(16631,32963,'collagen metabolic process','P','The chemical reactions and pathways involving collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).','2013-10-27','NSRP'),(16632,32964,'collagen biosynthetic process','P','The chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. Collagen is highly enriched in glycine (some regions are 33% glycine) and proline, occurring predominantly as 3-hydroxyproline (about 20%).','2013-10-27','NSRP'),(16633,32965,'regulation of collagen biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.','2013-10-27','NSRP'),(16634,32966,'negative regulation of collagen biosynthetic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.','2013-10-27','NSRP'),(16635,32967,'positive regulation of collagen biosynthetic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.','2013-10-27','NSRP'),(16636,32968,'positive regulation of transcription elongation from RNA polymerase II promoter','P','Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.','2013-10-27','NSRP'),(16637,32969,'endosomal scaffold complex','C','A protein complex that contains MAPKSP1 (MP1, Map2k1ip1) and ROBLD3 (p14, Mapbpip), is anchored to late endosomes, and is involved in selective activation of the ERK1 in ERK/MAPK signaling.','2013-10-27','NSRP'),(16638,32970,'regulation of actin filament-based process','P','Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the actin cytoskeleton.','2013-10-27','NSRP'),(16639,32971,'regulation of muscle filament sliding','P','Any process that modulates the frequency, rate or extent of muscle filament sliding.','2013-10-27','NSRP'),(16640,32972,'regulation of muscle filament sliding speed','P','Any process that modulates the velocity of muscle filament sliding.','2013-10-27','NSRP'),(16641,32973,'amino acid export','P','The directed movement of amino acids out of a cell or organelle.','2013-10-27','NSRP'),(16642,32974,'amino acid transmembrane export from vacuole','P','The directed movement of amino acids out of the vacuole, across the vacuolar membrane.','2013-10-27','NSRP'),(16643,32975,'amino acid transmembrane import into vacuole','P','The directed movement of amino acids into the vacuole across the vacuolar membrane.','2013-10-27','NSRP'),(16644,32976,'release of matrix enzymes from mitochondria','P','The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol, as part of the apoptotic process.','2013-10-27','NSRP'),(16645,32977,'membrane insertase activity','F','Mediates the integration of proteins into a membrane from the inner side of the membrane. Membrane insertases are highly conserved and include the bacterial YidC family, the plant chloroplast Alb3 family, and the fungal and animal mitochondrial Oxa1/Cox18 family.','2013-10-27','NSRP'),(16646,32978,'protein insertion into membrane from inner side','P','The process in which a protein is incorporated into a lipid bilayer, e.g., the prokaryotic, mitochondrial, or chloroplast inner membrane, from the inner side.','2013-10-27','NSRP'),(16647,32979,'protein insertion into mitochondrial membrane from inner side','P','The process in which a protein is incorporated into the mitochondrial membrane from the inner side. This includes membrane insertion of newly synthesized mitochondrially-encoded proteins, and insertion of nuclear-encoded proteins after their import into the mitochondrial matrix.','2013-10-27','NSRP'),(16648,32980,'keratinocyte activation','P','A change in the morphology or behavior of a keratinocyte resulting from exposure to an activating factor such as a cellular or soluble ligand. Upon activation, keratinocytes become migratory and hyperproliferative, and produce growth factors and cytokines.','2013-10-27','NSRP'),(16649,32981,'mitochondrial respiratory chain complex I assembly','P','The aggregation, arrangement and bonding together of a set of components to form mitochondrial respiratory chain complex I.','2013-10-27','NSRP'),(16650,32982,'myosin filament','C','A protein complex containing myosin heavy chains, plus associated light chains and other proteins, in which the myosin heavy chains are arranged into a filament.','2013-10-27','NSRP'),(16651,32983,'kainate selective glutamate receptor complex','C','An assembly of four or five subunits which form a structure with an extracellular N-terminus and a large loop that together form the ligand binding domain. The C-terminus is intracellular. The ionotropic glutamate receptor complex itself acts as a ligand gated ion channel; on binding glutamate, charged ions pass through a channel in the center of the receptor complex. Kainate receptors are multimeric assemblies of GluR5-7 and KA-1/2 subunits.','2013-10-27','NSRP'),(16652,32984,'macromolecular complex disassembly','P','The disaggregation of a macromolecular complex into its constituent components.','2013-10-27','NSRP'),(16653,32985,'protein-carbohydrate complex disassembly','P','The disaggregation of a protein-carbohydrate complex into its constituent components.','2013-10-27','NSRP'),(16654,32986,'protein-DNA complex disassembly','P','The disaggregation of a protein-DNA complex into its constituent components.','2013-10-27','NSRP'),(16655,32987,'protein-lipid complex disassembly','P','The disaggregation of a protein-lipid complex into its constituent components.','2013-10-27','NSRP'),(16656,32988,'ribonucleoprotein complex disassembly','P','The disaggregation of a protein-RNA complex into its constituent components.','2013-10-27','NSRP'),(16657,32989,'cellular component morphogenesis','P','The process in which cellular structures, including whole cells or cell parts, are generated and organized.','2013-10-27','NSRP'),(16658,32990,'cell part morphogenesis','P','The process in which the anatomical structures of a cell part are generated and organized.','2013-10-27','NSRP'),(16659,32991,'macromolecular complex','C','A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which the constituent parts function together.','2013-10-27','NSRP'),(16660,32992,'protein-carbohydrate complex','C','A macromolecular complex containing both protein and carbohydrate molecules.','2013-10-27','NSRP'),(16661,32993,'protein-DNA complex','C','A macromolecular complex containing both protein and DNA molecules.','2013-10-27','NSRP'),(16662,32994,'protein-lipid complex','C','A macromolecular complex containing both protein and lipid molecules.','2013-10-27','NSRP'),(16663,32995,'regulation of fungal-type cell wall biogenesis','P','Any process that modulates the process in which a cell wall is synthesized, aggregates, and bonds together. The fungal-type cell wall contains beta-glucan and may contain chitin.','2013-10-27','NSRP'),(16664,32996,'Bcl3-Bcl10 complex','C','A protein complex containing Bcl3 and Bcl10, which forms when Akt1 is activated by TNF-alpha to phosphorylate Bcl10; the Bcl3-Bcl10 complex is translocated to the nucleus.','2013-10-27','NSRP'),(16665,32997,'Fc receptor complex','C','A protein complex composed of a subunit or subunits capable of binding the Fc portion of an immunoglobulin with additional signaling components. The complex functions as a receptor for immunoglobulin.','2013-10-27','NSRP'),(16666,32998,'Fc-epsilon receptor I complex','C','A protein complex composed of an Fc-epsilon RI alpha chain and an Fc-epsilon RI gamma chain dimer with or without an Fc-episilon RI beta chain and additional signaling components. The complex functions primarily as an activating receptor for IgE.','2013-10-27','NSRP'),(16667,32999,'Fc-alpha receptor I complex','C','A protein complex composed of an Fc-alpha R alpha chain and an Fc-epsilon RI gamma chain dimer with or without additional signaling components. The complex functions primarily as an activating receptor for IgA.','2013-10-27','NSRP'),(16668,33000,'Fc-gamma receptor I complex','C','A protein complex composed of an Fc-gamma RI alpha chain and an Fc-epsilon RI gamma chain dimer with or without additional signaling components. The complex functions primarily as an activating receptor for IgG.','2013-10-27','NSRP'),(16669,33001,'Fc-gamma receptor III complex','C','A protein complex composed of an Fc-gamma RIII alpha chain and an Fc-epsilon RI gamma chain dimer with or without an Fc-epsilon RI beta chain and additional signaling components. The complex functions primarily as an activating receptor for IgG.','2013-10-27','NSRP'),(16670,33002,'muscle cell proliferation','P','The expansion of a muscle cell population by cell division.','2013-10-27','NSRP'),(16671,33003,'regulation of mast cell activation','P','Any process that modulates the frequency, rate, or extent of mast cell activation.','2013-10-27','NSRP'),(16672,33004,'negative regulation of mast cell activation','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation.','2013-10-27','NSRP'),(16673,33005,'positive regulation of mast cell activation','P','Any process that activates or increases the frequency, rate, or extent of mast cell activation.','2013-10-27','NSRP'),(16674,33006,'regulation of mast cell activation involved in immune response','P','Any process that modulates the frequency, rate, or extent of mast cell activation as part of an immune response.','2013-10-27','NSRP'),(16675,33007,'negative regulation of mast cell activation involved in immune response','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell activation as part of an immune response.','2013-10-27','NSRP'),(16676,33008,'positive regulation of mast cell activation involved in immune response','P','Any process that activates or increases the frequency, rate, or extent of mast cell activation as part of an immune response.','2013-10-27','NSRP'),(16677,33009,'nucleomorph','C','A small, vestigial nucleus found in some plastids that derive from a eukaryotic endosymbiont. Observed in chlorarachniophytes and cryptomonads, which acquired their plastids from a green and red alga respectively.','2013-10-27','NSRP'),(16678,33010,'paranodal junction','C','A highly specialized cell-cell junction found in vertebrates, which forms between a neuron and a glial cell, and has structural similarity to Drosophila septate junctions. It flanks the node of Ranvier in myelinated nerve and electrically isolates the myelinated from unmyelinated nerve segments and physically separates the voltage-gated sodium channels at the node from the cluster of potassium channels underneath the myelin sheath.','2013-10-27','NSRP'),(16679,33011,'perinuclear theca','C','A condensed cytoplasmic structure that covers the nucleus of mammalian spermatozoa except for a narrow zone around the insertion of the tail. It shows two distinct regions, a subacrosomal layer and, continuing caudally beyond the acrosomic system, the postacrosomal sheath. The perinuclear theca has been considered a cytoskeletal scaffold responsible for maintaining the overall architecture of the mature sperm head; however, recent studies indicate that the bulk of its constituent proteins are not traditional cytoskeletal proteins but rather a variety of cytosolic proteins.','2013-10-27','NSRP'),(16680,33012,'porosome','C','A permanent cup-shaped structure at the cell plasma membrane in secretory cells. Following a secretory stimulus, secretory vesicles transiently dock and fuse at the base of porosomes and release intravesicular contents dictated by the turgor pressure generated from the swelling of secretory vesicles.','2013-10-27','NSRP'),(16681,33013,'tetrapyrrole metabolic process','P','The chemical reactions and pathways involving tetrapyrroles, natural pigments containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.','2013-10-27','NSRP'),(16682,33014,'tetrapyrrole biosynthetic process','P','The chemical reactions and pathways leading to the formation of tetrapyrroles, natural pigments containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.','2013-10-27','NSRP'),(16683,33015,'tetrapyrrole catabolic process','P','The chemical reactions and pathways leading to the breakdown of tetrapyrroles, natural pigments containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next.','2013-10-27','NSRP'),(16684,33016,'rhoptry membrane','C','The lipid bilayer surrounding a rhoptry.','2013-10-27','NSRP'),(16685,33017,'sarcoplasmic reticulum membrane','C','The lipid bilayer surrounding the sarcoplasmic reticulum.','2013-10-27','NSRP'),(16686,33018,'sarcoplasmic reticulum lumen','C','The volume enclosed by the membranes of the sarcoplasmic reticulum.','2013-10-27','NSRP'),(16687,33019,'5-hydroxyvalerate dehydrogenase activity','F','Catalysis of the reaction: 5-hydroxyvalerate + NAD+ = 5-oxovalerate + NADH.','2013-10-27','NSRP'),(16688,33020,'cyclopentanol metabolic process','P','The chemical reactions and pathways involving cyclopentanol.','2013-10-27','NSRP'),(16689,33021,'cyclopentanol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cyclopentanol.','2013-10-27','NSRP'),(16690,33022,'cyclopentanol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of cyclopentanol.','2013-10-27','NSRP'),(16691,33023,'mast cell homeostasis','P','The process of regulating the proliferation and elimination of mast cells such that the total number of mast cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.','2013-10-27','NSRP'),(16692,33024,'mast cell apoptotic process','P','Any apoptotic process in a mast cell, a cell that is found in almost all tissues containing numerous basophilic granules and capable of releasing large amounts of histamine and heparin upon activation.','2013-10-27','NSRP'),(16693,33025,'regulation of mast cell apoptotic process','P','Any process that modulates the frequency, rate, or extent of mast cell apoptotic process.','2013-10-27','NSRP'),(16694,33026,'negative regulation of mast cell apoptotic process','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell apoptotic process.','2013-10-27','NSRP'),(16695,33027,'positive regulation of mast cell apoptotic process','P','Any process that activates or increases the frequency, rate, or extent of mast cell apoptotic process.','2013-10-27','NSRP'),(16696,33028,'myeloid cell apoptotic process','P','Any apoptotic process in a myeloid cell, a cell of the monocyte, granulocyte, mast cell, megakaryocyte, or erythroid lineage.','2013-10-27','NSRP'),(16697,33029,'regulation of neutrophil apoptotic process','P','Any process that modulates the frequency, rate, or extent of neutrophil apoptotic process.','2013-10-27','NSRP'),(16698,33030,'negative regulation of neutrophil apoptotic process','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of neutrophil apoptotic process.','2013-10-27','NSRP'),(16699,33031,'positive regulation of neutrophil apoptotic process','P','Any process that activates or increases the frequency, rate, or extent of neutrophil apoptotic process.','2013-10-27','NSRP'),(16700,33032,'regulation of myeloid cell apoptotic process','P','Any process that modulates the frequency, rate, or extent of myeloid cell apoptotic process.','2013-10-27','NSRP'),(16701,33033,'negative regulation of myeloid cell apoptotic process','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of a myeloid cell apoptotic process.','2013-10-27','NSRP'),(16702,33034,'positive regulation of myeloid cell apoptotic process','P','Any process that activates or increases the frequency, rate, or extent of myeloid cell apoptotic process.','2013-10-27','NSRP'),(16703,33036,'macromolecule localization','P','Any process in which a macromolecule is transported to, or maintained in, a specific location.','2013-10-27','NSRP'),(16704,33037,'polysaccharide localization','P','Any process in which a polysaccharide is transported to, or maintained in, a specific location.','2013-10-27','NSRP'),(16705,33038,'bitter taste receptor activity','F','Combining with soluble bitter compounds to initiate a change in cell activity. These receptors are responsible for the sense of bitter taste.','2013-10-27','NSRP'),(16706,33039,'salty taste receptor activity','F','Combining with soluble salty compounds to initiate a change in cell activity. These receptors are responsible for the sense of salty taste.','2013-10-27','NSRP'),(16707,33040,'sour taste receptor activity','F','Combining with soluble sour compounds to initiate a change in cell activity. These receptors are responsible for the sense of sour taste.','2013-10-27','NSRP'),(16708,33041,'sweet taste receptor activity','F','Combining with soluble sweet compounds to initiate a change in cell activity. These receptors are responsible for the sense of sweet taste.','2013-10-27','NSRP'),(16709,33042,'umami taste receptor activity','F','Combining with soluble umami compounds to initiate a change in cell activity. These receptors are responsible for the sense of umami taste, the savory taste of meats and other foods that are rich in glutamates.','2013-10-27','NSRP'),(16710,33043,'regulation of organelle organization','P','Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of an organelle.','2013-10-27','NSRP'),(16711,33044,'regulation of chromosome organization','P','Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of a chromosome.','2013-10-27','NSRP'),(16712,33045,'regulation of sister chromatid segregation','P','Any process that modulates the frequency, rate or extent of sister chromatid segregation.','2013-10-27','NSRP'),(16713,33046,'negative regulation of sister chromatid segregation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation.','2013-10-27','NSRP'),(16714,33047,'regulation of mitotic sister chromatid segregation','P','Any process that modulates the frequency, rate or extent of sister chromatid segregation during mitosis.','2013-10-27','NSRP'),(16715,33048,'negative regulation of mitotic sister chromatid segregation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of sister chromatid segregation during mitosis.','2013-10-27','NSRP'),(16716,33049,'clavulanic acid metabolic process','P','The chemical reactions and pathways involving clavulanic acid, (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.','2013-10-27','NSRP'),(16717,33050,'clavulanic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of clavulanic acid, (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid.','2013-10-27','NSRP'),(16718,33051,'aminophosphonate metabolic process','P','The chemical reactions and pathways involving aminophosphonates, phosphonic acid derivatives that contain an amino group.','2013-10-27','NSRP'),(16719,33052,'cyanoamino acid metabolic process','P','The chemical reactions and pathways involving cyanoamino acids, amino acid derivatives that contain a cyanide group.','2013-10-27','NSRP'),(16720,33053,'D-glutamine metabolic process','P','The chemical reactions and pathways involving D-glutamine, the D-enantiomer of the amino acid glutamine, i.e. (2R)-2,5-diamino-5-oxopentanoic acid.','2013-10-27','NSRP'),(16721,33054,'D-glutamate metabolic process','P','The chemical reactions and pathways involving D-glutamate, the D-enantiomer of the amino acid glutamate, i.e. (2R)-2-aminopentanedioic acid.','2013-10-27','NSRP'),(16722,33055,'D-arginine metabolic process','P','The chemical reactions and pathways involving D-arginine, the D-enantiomer of the amino acid arginine, i.e. (2R)-2-amino-5-(carbamimidamido)pentanoic acid.','2013-10-27','NSRP'),(16723,33056,'D-ornithine metabolic process','P','The chemical reactions and pathways involving D-ornithine, the D-enantiomer of the amino acid ornithine, i.e. (2R)-2,5-diaminopentanoic acid.','2013-10-27','NSRP'),(16724,33057,'multicellular organismal reproductive behavior','P','The specific behavior of an organism that is associated with reproduction in a multicellular organism.','2013-10-27','NSRP'),(16725,33058,'directional locomotion','P','Self-propelled movement of a cell or organism from one location to another along an axis.','2013-10-27','NSRP'),(16726,33059,'cellular pigmentation','P','The deposition or aggregation of coloring matter in a cell.','2013-10-27','NSRP'),(16727,33060,'ocellus pigmentation','P','The deposition or aggregation of coloring matter in an ocellus, a minute simple eye found in many invertebrates.','2013-10-27','NSRP'),(16728,33061,'DNA recombinase mediator complex','C','A protein complex containing accessory proteins which bind a recombinase (e.g. Rad51) and bind single-stranded DNA (ssDNA), and promote nucleation of the recombinase onto ssDNA.','2013-10-27','NSRP'),(16729,33062,'Rhp55-Rhp57 complex','C','A conserved heterodimeric DNA recombinase mediator complex that contains the RecA family proteins Rhp55p and Rph57 in Schizosaccharomyces, or orthologs thereof (e.g. Rad55p and Rad57p in Saccharomyces).','2013-10-27','NSRP'),(16730,33063,'Rad51B-Rad51C-Rad51D-XRCC2 complex','C','A DNA recombinase mediator complex that contains the Rad51 paralogs RAD51B, RAD51C, RAD51D, and XRCC2, or orthologs thereof.','2013-10-27','NSRP'),(16731,33064,'XRCC2-RAD51D complex','C','A heterodimeric DNA recombinase mediator complex that contains the Rad51 paralogs RAD51D and XRCC2, or orthologs thereof; conserved from fission yeast to human but absent from budding yeast.','2013-10-27','NSRP'),(16732,33065,'Rad51C-XRCC3 complex','C','A DNA recombinase mediator complex that contains the Rad51 paralogs RAD51C and XRCC3, or orthologs thereof.','2013-10-27','NSRP'),(16733,33066,'Rad51B-Rad51C complex','C','A DNA recombinase mediator complex that contains the Rad51 paralogs RAD51B and RAD51C, or orthologs thereof.','2013-10-27','NSRP'),(16734,33067,'macrolide metabolic process','P','The chemical reactions and pathways involving macrolides, any of a large group of polyketide compounds that contain a large lactone ring with few or no double bonds and no nitrogen atoms, linked glycosidically to one or more sugar groups. The macrolides include the carbomycins, the erythromycins, oleandomycin, oligomycins, and the spiramycins, and act as antibiotics, mainly against Gram-positive bacteria.','2013-10-27','NSRP'),(16735,33068,'macrolide biosynthetic process','P','The chemical reactions and pathways leading to the formation of macrolides, any of a large group of polyketide compounds that contain a large lactone ring with few or no double bonds and no nitrogen atoms, linked glycosidically to one or more sugar groups. The macrolides include the carbomycins, the erythromycins, oleandomycin, oligomycins, and the spiramycins, and act as antibiotics, mainly against Gram-positive bacteria.','2013-10-27','NSRP'),(16736,33069,'ansamycin metabolic process','P','The chemical reactions and pathways involving ansamycins, any of a group of complex macrolactam compounds characterized by a cyclic structure in which an aliphatic ansa chain forms a bridge between two non-adjacent positions of a cyclic p-system; many exhibit antibacterial, antifungal or antitumor activity.','2013-10-27','NSRP'),(16737,33070,'ansamycin biosynthetic process','P','The chemical reactions and pathways leading to the formation of ansamycins, any of a group of complex macrolactam compounds characterized by a cyclic structure in which an aliphatic ansa chain forms a bridge between two non-adjacent positions of a cyclic p-system; many exhibit antibacterial, antifungal or antitumor activity.','2013-10-27','NSRP'),(16738,33071,'vancomycin metabolic process','P','The chemical reactions and pathways involving vancomycin, (3S,6R,7R,11R,23S,26S,30aS,36R,38aR)-44-[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-(N-methyl-D-leucyl)-2,5,24,38,39-pentaoxo-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid, a complex glycopeptide from Streptomyces orientalis that inhibits a specific step in the synthesis of the peptidoglycan layer in Gram-positive bacteria.','2013-10-27','NSRP'),(16739,33072,'vancomycin biosynthetic process','P','The chemical reactions and pathways leading to the formation of vancomycin, (3S,6R,7R,11R,23S,26S,30aS,36R,38aR)-44-[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-(N-methyl-D-leucyl)-2,5,24,38,39-pentaoxo-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid, a complex glycopeptide from Streptomyces orientalis that inhibits a specific step in the synthesis of the peptidoglycan layer in Gram-positive bacteria.','2013-10-27','NSRP'),(16740,33073,'pinene metabolic process','P','The chemical reactions and pathways involving the monoterpenoid pinene; alpha-pinene is (1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene, and beta-pinene is (1S,5S)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane.','2013-10-27','NSRP'),(16741,33074,'pinene catabolic process','P','The chemical reactions and pathways leading to the breakdown of the monoterpenoid pinene; alpha-pinene is (1S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-2-ene, and beta-pinene is (1S,5S)-6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane.','2013-10-27','NSRP'),(16742,33075,'isoquinoline alkaloid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of isoquinoline alkaloids, alkaloid compounds that contain bicyclic N-containing aromatic rings and are derived from a 3,4-dihydroxytyramine (dopamine) precursor that undergoes a Schiff base addition with aldehydes of different origin.','2013-10-27','NSRP'),(16743,33076,'isoquinoline alkaloid metabolic process','P','The chemical reactions and pathways involving isoquinoline alkaloids, alkaloid compounds that contain bicyclic N-containing aromatic rings and are derived from a 3,4-dihydroxytyramine (dopamine) precursor that undergoes a Schiff base addition with aldehydes of different origin.','2013-10-27','NSRP'),(16744,33077,'T cell differentiation in thymus','P','The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.','2013-10-27','NSRP'),(16745,33078,'extrathymic T cell differentiation','P','The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway independent of the thymus.','2013-10-27','NSRP'),(16746,33079,'immature T cell proliferation','P','The expansion of an immature T cell population by cell division.','2013-10-27','NSRP'),(16747,33080,'immature T cell proliferation in thymus','P','The expansion of an immature T cell population by cell division in the thymus.','2013-10-27','NSRP'),(16748,33081,'regulation of T cell differentiation in thymus','P','Any process that modulates the frequency, rate or extent of T cell differentiation in the thymus.','2013-10-27','NSRP'),(16749,33082,'regulation of extrathymic T cell differentiation','P','Any process that modulates the frequency, rate or extent of extrathymic T cell differentiation.','2013-10-27','NSRP'),(16750,33083,'regulation of immature T cell proliferation','P','Any process that modulates the frequency, rate or extent of immature T cell proliferation.','2013-10-27','NSRP'),(16751,33084,'regulation of immature T cell proliferation in thymus','P','Any process that modulates the frequency, rate or extent of immature T cell proliferation in the thymus.','2013-10-27','NSRP'),(16752,33085,'negative regulation of T cell differentiation in thymus','P','Any process that stops, prevents, or reduces the frequency, rate or extent of T cell differentiation in the thymus.','2013-10-27','NSRP'),(16753,33086,'negative regulation of extrathymic T cell differentiation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of extrathymic T cell differentiation.','2013-10-27','NSRP'),(16754,33087,'negative regulation of immature T cell proliferation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation.','2013-10-27','NSRP'),(16755,33088,'negative regulation of immature T cell proliferation in thymus','P','Any process that stops, prevents, or reduces the frequency, rate or extent of immature T cell proliferation in the thymus.','2013-10-27','NSRP'),(16756,33089,'positive regulation of T cell differentiation in thymus','P','Any process that activates or increases the frequency, rate or extent of T cell differentiation in the thymus.','2013-10-27','NSRP'),(16757,33090,'positive regulation of extrathymic T cell differentiation','P','Any process that activates or increases the frequency, rate or extent of extrathymic T cell differentiation.','2013-10-27','NSRP'),(16758,33091,'positive regulation of immature T cell proliferation','P','Any process that activates or increases the frequency, rate or extent of immature T cell proliferation.','2013-10-27','NSRP'),(16759,33092,'positive regulation of immature T cell proliferation in thymus','P','Any process that activates or increases the frequency, rate or extent of immature T cell proliferation in the thymus.','2013-10-27','NSRP'),(16760,33093,'Weibel-Palade body','C','A large, elongated, rod-shaped secretory granule characteristic of vascular endothelial cells that contain a number of structurally and functionally distinct proteins, of which the best characterized are von Willebrand factor (VWF) and P-selectin. Weibel-Palade bodies are formed from the trans-Golgi network in a process that depends on VWF, which is densely packed in a highly organized manner, and on coat proteins that remain associated with the granules. Upon cell stimulation, regulated exocytosis releases the contained proteins to the cell surface, where they act in the recruitment of platelets and leukocytes and in inflammatory and vasoactive responses.','2013-10-27','NSRP'),(16761,33094,'butane-1,4-diamine:2-oxoglutarate aminotransferase activity','F','Catalysis of the reaction: putrescine + 2-oxoglutarate = L-glutamate + 1-pyrroline + H2O.','2013-10-27','NSRP'),(16762,33095,'aleurone grain','C','A membrane-bounded storage granule found in cells of the aleurone layer in plants; contains either a protein matrix, protein-carbohydrate bodies and/or globoids. Aleurone grains are formed by the vacuole, rough endoplasmic reticulum and dictyosomes.','2013-10-27','NSRP'),(16763,33096,'amyloplast envelope','C','The double lipid bilayer enclosing the amyloplast and separating its contents from the rest of the cytoplasm; includes the intermembrane space.','2013-10-27','NSRP'),(16764,33097,'amyloplast membrane','C','Either of the lipid bilayers that surround an amyloplast and form the amyloplast envelope.','2013-10-27','NSRP'),(16765,33098,'amyloplast inner membrane','C','The inner, i.e. lumen-facing, lipid bilayer of the amyloplast envelope; also faces the amyloplast stroma.','2013-10-27','NSRP'),(16766,33099,'attachment organelle','C','A membrane-bounded extension of the cell, originally characterized in Mycoplasma species, that contains an electron-dense core that is part of the cytoskeleton and is oriented lengthwise and ends distally in a bulbous knob (terminal button). Required for adherence to host cells and involved in gliding motility and cell division.','2013-10-27','NSRP'),(16767,33100,'NuA3 histone acetyltransferase complex','C','A Gcn5-independent multisubunit complex that catalyzes the acetylation of histone H3. The budding yeast complex includes Sas3p, Taf30p, and Yng1p.','2013-10-27','NSRP'),(16768,33101,'cellular bud membrane','C','The portion of the plasma membrane surrounding a cellular bud.','2013-10-27','NSRP'),(16769,33102,'acidocalcisome membrane','C','The lipid bilayer surrounding an acidocalcisome.','2013-10-27','NSRP'),(16770,33103,'protein secretion by the type VI secretion system','P','The process in which proteins are transferred into the extracellular milieu or directly into host cells by the type VI secretion system. Proteins secreted by this system do not require an N-terminal signal sequence.','2013-10-27','NSRP'),(16771,33104,'type VI protein secretion system complex','C','A complex of proteins that permits the transfer of proteins into the extracellular milieu or directly into host cells via the type VI secretion system. Proteins secreted by this complex do not require an N-terminal signal sequence.','2013-10-27','NSRP'),(16772,33105,'chlorosome envelope','C','The structure, composed of a monolayer of glycolipids with embedded proteins, that encloses the pigments and other contents of the chlorosome.','2013-10-27','NSRP'),(16773,33106,'cis-Golgi network membrane','C','The lipid bilayer surrounding any of the compartments that make up the cis-Golgi network.','2013-10-27','NSRP'),(16774,33107,'CVT vesicle','C','A cytosolic vesicle that is enclosed by a double membrane and is implicated in the cytoplasm to vacuole targeting pathway. These vesicles are found in the yeast S. cerevisiae, and contain vacuolar hydrolases, aminopeptidase I (Ape1p) and alpha-mannosidase (Ams1p).','2013-10-27','NSRP'),(16775,33108,'mitochondrial respiratory chain complex assembly','P','The aggregation, arrangement and bonding together of a set of components to form a mitochondrial respiratory chain complex.','2013-10-27','NSRP'),(16776,33109,'cortical actin cytoskeleton stabilization','P','The process in which the assembly and arrangement of cytoskeletal structures in the actin cortex with respect to the plasma membrane is maintained.','2013-10-27','NSRP'),(16777,33110,'Cvt vesicle membrane','C','The double lipid bilayer surrounding a Cvt vesicle, a vesicle that functions in the cytoplasm-to-vacuole targeting (Cvt) pathway.','2013-10-27','NSRP'),(16778,33111,'attachment organelle membrane','C','The lipid bilayer surrounding an attachment organelle.','2013-10-27','NSRP'),(16779,33112,'cyanelle envelope','C','The double lipid bilayer enclosing the cyanelle and separating its contents from the rest of the cytoplasm; includes the intermembrane space.','2013-10-27','NSRP'),(16780,33113,'cyanelle membrane','C','Either of the lipid bilayers that surround a cyanelle and form the cyanelle envelope.','2013-10-27','NSRP'),(16781,33114,'cyanelle thylakoid lumen','C','The volume enclosed by a cyanelle thylakoid membrane.','2013-10-27','NSRP'),(16782,33115,'cyanelle thylakoid membrane','C','The lipid bilayer membrane of any thylakoid within a cyanelle.','2013-10-27','NSRP'),(16783,33116,'endoplasmic reticulum-Golgi intermediate compartment membrane','C','The lipid bilayer surrounding any of the compartments of the endoplasmic reticulum (ER)-Golgi intermediate compartment system.','2013-10-27','NSRP'),(16784,33117,'esterosome','C','A vesicle filled with crystalline protein that shows sequence similarities with various esterases.','2013-10-27','NSRP'),(16785,33118,'esterosome membrane','C','The lipid bilayer surrounding an esterosome. This membrane has characteristics of rough endoplasmic reticulum (RER) membranes.','2013-10-27','NSRP'),(16786,33119,'negative regulation of RNA splicing','P','Any process that stops, prevents, or reduces the frequency, rate or extent of RNA splicing.','2013-10-27','NSRP'),(16787,33120,'positive regulation of RNA splicing','P','Any process that activates or increases the frequency, rate or extent of RNA splicing.','2013-10-27','NSRP'),(16788,33121,'regulation of purine nucleotide catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.','2013-10-27','NSRP'),(16789,33122,'negative regulation of purine nucleotide catabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.','2013-10-27','NSRP'),(16790,33123,'positive regulation of purine nucleotide catabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.','2013-10-27','NSRP'),(16791,33124,'regulation of GTP catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of GTP, guanosine triphosphate.','2013-10-27','NSRP'),(16792,33125,'negative regulation of GTP catabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of GTP, guanosine triphosphate.','2013-10-27','NSRP'),(16793,33126,'positive regulation of GTP catabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of GTP, guanosine triphosphate.','2013-10-27','NSRP'),(16794,33127,'regulation of histone phosphorylation','P','Any process that modulates the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.','2013-10-27','NSRP'),(16795,33128,'negative regulation of histone phosphorylation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.','2013-10-27','NSRP'),(16796,33129,'positive regulation of histone phosphorylation','P','Any process that activates or increases the frequency, rate or extent of the addition of one or more phosphate groups to a histone protein.','2013-10-27','NSRP'),(16797,33130,'acetylcholine receptor binding','F','Interacting selectively and non-covalently with an acetylcholine receptor.','2013-10-27','NSRP'),(16798,33131,'regulation of glucokinase activity','P','Any process that modulates the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.','2013-10-27','NSRP'),(16799,33132,'negative regulation of glucokinase activity','P','Any process that stops, prevents, or reduces the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.','2013-10-27','NSRP'),(16800,33133,'positive regulation of glucokinase activity','P','Any process that activates or increases the frequency, rate or extent of glucokinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a glucose molecule.','2013-10-27','NSRP'),(16801,33134,'ubiquitin activating enzyme binding','F','Interacting selectively and non-covalently with a ubiquitin activating enzyme, any of the E1 proteins.','2013-10-27','NSRP'),(16802,33135,'regulation of peptidyl-serine phosphorylation','P','Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-serine.','2013-10-27','NSRP'),(16803,33136,'serine phosphorylation of STAT3 protein','P','The process of introducing a phosphate group to a serine residue of the STAT3 protein.','2013-10-27','NSRP'),(16804,33137,'negative regulation of peptidyl-serine phosphorylation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine.','2013-10-27','NSRP'),(16805,33138,'positive regulation of peptidyl-serine phosphorylation','P','Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.','2013-10-27','NSRP'),(16806,33139,'regulation of peptidyl-serine phosphorylation of STAT protein','P','Any process that modulates the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein.','2013-10-27','NSRP'),(16807,33140,'negative regulation of peptidyl-serine phosphorylation of STAT protein','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein.','2013-10-27','NSRP'),(16808,33141,'positive regulation of peptidyl-serine phosphorylation of STAT protein','P','Any process that activates or increases the frequency, rate or extent of the phosphorylation of a serine residue of a STAT (Signal Transducer and Activator of Transcription) protein.','2013-10-27','NSRP'),(16809,33142,'progesterone receptor binding','F','Interacting selectively and non-covalently with a progesterone receptor.','2013-10-27','NSRP'),(16810,33143,'regulation of intracellular steroid hormone receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.','2013-10-27','NSRP'),(16811,33144,'negative regulation of intracellular steroid hormone receptor signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.','2013-10-27','NSRP'),(16812,33145,'positive regulation of intracellular steroid hormone receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of the activity of any intracellular steroid hormone receptor signaling pathway.','2013-10-27','NSRP'),(16813,33146,'regulation of intracellular estrogen receptor signaling pathway','P','Any process that modulates the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.','2013-10-27','NSRP'),(16814,33147,'negative regulation of intracellular estrogen receptor signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.','2013-10-27','NSRP'),(16815,33148,'positive regulation of intracellular estrogen receptor signaling pathway','P','Any process that activates or increases the frequency, rate or extent of the activity of an intracellular estrogen receptor signaling pathway.','2013-10-27','NSRP'),(16816,33149,'FFAT motif binding','F','Interacting selectively and non-covalently with the FFAT motif, a short motif containing diphenylalanine in an acidic tract that targets proteins to the cytosolic surface of the ER and to the nuclear membrane by binding directly to members of the VAP (VAMP-associated protein) protein family.','2013-10-27','NSRP'),(16817,33150,'cytoskeletal calyx','C','A large cytoskeletal structure located at the posterior end of the perinuclear theca of a mammalian sperm head. The nucleus is tightly associated with the calyx, which contains calicin and basic cylicin proteins.','2013-10-27','NSRP'),(16818,33151,'V(D)J recombination','P','The process in which immune receptor V, D, and J, or V and J gene segments, depending on the specific receptor, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).','2013-10-27','NSRP'),(16819,33152,'immunoglobulin V(D)J recombination','P','The process in which immunoglobulin gene segments are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS). For immunoglobulin heavy chains V, D, and J gene segments are joined, and for immunoglobulin light chains V and J gene segments are joined.','2013-10-27','NSRP'),(16820,33153,'T cell receptor V(D)J recombination','P','The process in which T cell receptor V, D, and J, or V and J gene segments, depending on the specific locus, are recombined within a single locus utilizing the conserved heptamer and nonomer recombination signal sequences (RSS).','2013-10-27','NSRP'),(16821,33154,'oligogalacturonide transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + oligogalacturonide(out) = ADP + phosphate + oligogalacturonide(in).','2013-10-27','NSRP'),(16822,33155,'oligogalacturonide transmembrane transporter activity','F','Catalysis of the transfer of oligogalacturonide from one side of the membrane to the other.','2013-10-27','NSRP'),(16823,33156,'oligogalacturonide transport','P','The directed movement of oligogalacturonides into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16824,33157,'regulation of intracellular protein transport','P','Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.','2013-10-27','NSRP'),(16825,33158,'regulation of protein import into nucleus, translocation','P','Any process that modulates the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.','2013-10-27','NSRP'),(16826,33159,'negative regulation of protein import into nucleus, translocation','P','Any process that stops, prevents or reduces the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.','2013-10-27','NSRP'),(16827,33160,'positive regulation of protein import into nucleus, translocation','P','Any process that activates or increases the vectorial transfer of a protein from the cytoplasm into the nucleus, across the nuclear membrane.','2013-10-27','NSRP'),(16828,33161,'mitogen-activated protein kinase kinase kinase kinase binding','F','Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase kinase kinase, any protein that can phosphorylate a MAP kinase kinase kinase.','2013-10-27','NSRP'),(16829,33162,'melanosome membrane','C','The lipid bilayer surrounding a melanosome.','2013-10-27','NSRP'),(16830,33163,'microneme membrane','C','The lipid bilayer surrounding a microneme.','2013-10-27','NSRP'),(16831,33164,'glycolipid 6-alpha-mannosyltransferase activity','F','Catalysis of the transfer of an alpha-D-mannosyl residue from GDP-mannose into lipid-linked oligosaccharide, forming an alpha-(1->6)-D-mannosyl-D-mannose linkage.','2013-10-27','NSRP'),(16832,33165,'interphotoreceptor matrix','C','A specialized extracellularc matrix that surrounds the photoreceptors of the retina and lies between them and the apical surface of the retinal pigment epithelium. The IPM has been implicated in several important activities required for photoreceptor function and maintenance.','2013-10-27','NSRP'),(16833,33166,'hyaline layer','C','A multilayered extraembryonic matrix that functions as a substrate for cell adhesion through early development. It is thought to protect and lubricate the embryo, stabilize the blastomeres during morphogenesis, and regulate nutrient intake. The major constituent of the hyaline layer is the protein hyalin. This matrix has been found in echinoderms.','2013-10-27','NSRP'),(16834,33167,'ARC complex','C','A ribonucleoprotein complex that contains members of the Argonaute family of proteins, additional protein subunits, and duplex siRNA; required for heterochromatin assembly and siRNA generation. Possibly involved in the conversion of ds siRNA to ss siRNA.','2013-10-27','NSRP'),(16835,33168,'conversion of ds siRNA to ss siRNA involved in RNA interference','P','The process in which double-stranded siRNA molecules are converted to single-stranded siRNAs; required for the formation of a mature RITS complex during RNA interference.','2013-10-27','NSRP'),(16836,33169,'histone H3-K9 demethylation','P','The modification of histone H3 by the removal of a methyl group from lysine at position 9 of the histone.','2013-10-27','NSRP'),(16837,33170,'protein-DNA loading ATPase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate, to drive the assembly of a protein or protein complex onto a DNA molecule.','2013-10-27','NSRP'),(16838,33171,'nucleoprotein filament-forming ATPase activity','F','OBSOLETE. Catalysis of the reaction: ATP + H2O = ADP + phosphate to drive the assembly of proteins such as Rad51p onto single-stranded (ss) DNA to form a helical nucleoprotein filament.','2013-10-27','NSRP'),(16839,33172,'gas vesicle shell','C','The proteinaceous structure surrounding a gas vesicle.','2013-10-27','NSRP'),(16840,33173,'calcineurin-NFAT signaling cascade','P','Any intracellular signal transduction in which the signal is passed on within the by activation of a member of the NFAT protein family as a consequence of NFAT dephosphorylation by Ca(2+)-activated calcineurin. The cascade begins with calcium-dependent activation of the phosphatase calcineurin. Calcineurin dephosphorylates multiple phosphoserine residues on NFAT, resulting in the translocation of NFAT to the nucleus. The cascade ends with regulation of transcription by NFAT. The calcineurin-NFAT cascade lies downstream of many cell surface receptors, including G-protein coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs) that signal to mobilize calcium ions (Ca2+).','2013-10-27','NSRP'),(16841,33174,'chloroplast proton-transporting ATP synthase complex, catalytic core CF(1)','C','The catalytic sector of the mitochondrial hydrogen-transporting ATP synthase; it comprises the catalytic core and central stalk, and is peripherally associated with the chloroplast thylakoid membrane when the entire ATP synthase is assembled. The chloroplast F0 domain contains three alpha, three beta, one gamma, one delta, and one epsilon subunits.','2013-10-27','NSRP'),(16842,33175,'chloroplast proton-transporting ATP synthase complex, coupling factor CF(o)','C','All non-F1 subunits of the chloroplast hydrogen-transporting ATP synthase, including integral and peripheral chloroplast thylakoid membrane proteins.','2013-10-27','NSRP'),(16843,33176,'proton-transporting V-type ATPase complex','C','A proton-transporting two-sector ATPase complex that couples ATP hydrolysis to the transport of protons across a concentration gradient. The resulting transmembrane electrochemical potential of H+ is used to drive a variety of (i) secondary active transport systems via H+-dependent symporters and antiporters and (ii) channel-mediated transport systems. The complex comprises a membrane sector (V0) that carries out proton transport and a cytoplasmic compartment sector (V1) that catalyzes ATP hydrolysis. V-type ATPases are found in the membranes of organelles such as vacuoles, endosomes, and lysosomes, and in the plasma membrane.','2013-10-27','NSRP'),(16844,33177,'proton-transporting two-sector ATPase complex, proton-transporting domain','C','A protein complex that forms part of a proton-transporting two-sector ATPase complex and carries out proton transport across a membrane. The proton-transporting domain (F0, V0, or A0) includes integral and peripheral membrane proteins.','2013-10-27','NSRP'),(16845,33178,'proton-transporting two-sector ATPase complex, catalytic domain','C','A protein complex that forms part of a proton-transporting two-sector ATPase complex and catalyzes ATP hydrolysis or synthesis. The catalytic domain (F1, V1, or A1) comprises a hexameric catalytic core and a central stalk, and is peripherally associated with the membrane when the two-sector ATPase is assembled.','2013-10-27','NSRP'),(16846,33179,'proton-transporting V-type ATPase, V0 domain','C','A protein complex that forms part of a proton-transporting V-type ATPase and mediates proton transport across a membrane. The V0 complex consists of at least four different subunits (a,c,d and e); six or more c subunits form a proton-binding rotor ring.','2013-10-27','NSRP'),(16847,33180,'proton-transporting V-type ATPase, V1 domain','C','A protein complex that forms part of a proton-transporting V-type ATPase and catalyzes ATP hydrolysis. The V1 complex consists of: (1) a globular headpiece with three alternating copies of subunits A and B that form a ring, (2) a central rotational stalk composed of single copies of subunits D and F, and (3) a peripheral stalk made of subunits C, E, G and H. Subunits A and B mediate the hydrolysis of ATP at three reaction sites associated with subunit A.','2013-10-27','NSRP'),(16848,33181,'plasma membrane proton-transporting V-type ATPase complex','C','A proton-transporting two-sector ATPase complex found in the plasma membrane.','2013-10-27','NSRP'),(16849,33182,'regulation of histone ubiquitination','P','Any process that modulates the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.','2013-10-27','NSRP'),(16850,33183,'negative regulation of histone ubiquitination','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.','2013-10-27','NSRP'),(16851,33184,'positive regulation of histone ubiquitination','P','Any process that activates or increases the frequency, rate or extent of the addition of a ubiquitin group to a histone protein.','2013-10-27','NSRP'),(16852,33185,'dolichol-phosphate-mannose synthase complex','C','A protein complex that possesses dolichyl-phosphate beta-D-mannosyltransferase activity; contains a catalytic subunit, a regulatory subunit, and a third subunit that stabilizes the complex. In human and several other metazoa, the subunits are named DPM1, DPM2 and DPM3, respectively.','2013-10-27','NSRP'),(16853,33186,'CAF-1 complex','C','A conserved heterotrimeric protein complex that promotes histone H3 and H4 deposition onto newly synthesized DNA during replication or DNA repair; specifically facilitates replication-dependent nucleosome assembly with the major histone H3 (H3.1). In many species the CAF-1 subunits are designated p150, p60, and p48.','2013-10-27','NSRP'),(16854,33187,'inositol hexakisphosphate 4-kinase or 6-kinase activity','F','OBSOLETE. Catalysis of the reaction: ATP + 1D-myo-inositol hexakisphosphate = ADP + 4-diphospho-1D-myo-inositol (1,2,3,5,6)pentakisphosphate, and ATP + 1D-myo-inositol hexakisphosphate = ADP + 6-diphospho-1D-myo-inositol (1,2,3,4,5)pentakisphosphate.','2013-10-27','NSRP'),(16855,33188,'sphingomyelin synthase activity','F','Catalysis of the reaction: 1,2-diacyl-sn-glycero-3-phosphocholine + ceramide = 1,2-diacyl-sn-glycerol + sphingomyelin.','2013-10-27','NSRP'),(16856,33189,'response to vitamin A','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus.','2013-10-27','NSRP'),(16857,33190,'solanapyrone synthase activity','F','Catalysis of the cyclization of double bonds in prosolanapyrone II to form (-)-solanapyrone A.','2013-10-27','NSRP'),(16858,33191,'macrophomate synthase activity','F','Catalysis of the reaction: a 2-pyrone + oxalacetate = macrophomate.','2013-10-27','NSRP'),(16859,33192,'calmodulin-dependent protein phosphatase activity','F','Catalysis of the reaction: protein serine/threonine phosphate + H2O = protein serine/threonine + phosphate, dependent on the presence of calcium-bound calmodulin.','2013-10-27','NSRP'),(16860,33193,'Lsd1/2 complex','C','A nucleosome-binding protein complex that comprises two SWIRM domain histone demethylases and two PHD finger proteins. The complex is involved in transcriptional regulation via heterochromatic silencing and the regulation of chromatin boundary formation, and was first identified in fission yeast.','2013-10-27','NSRP'),(16861,33194,'response to hydroperoxide','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroperoxide stimulus. Hydroperoxides are monosubstitution products of hydrogen peroxide, HOOH.','2013-10-27','NSRP'),(16862,33195,'response to alkyl hydroperoxide','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkyl hydroperoxide stimulus. Alkyl hydroperoxides are monosubstitution products of hydrogen peroxide, HOOH, where the substituent is an alkyl group.','2013-10-27','NSRP'),(16863,33196,'tryparedoxin peroxidase activity','F','Catalysis of the reaction: tryparedoxin + hydrogen peroxide = tryparedoxin disulfide + H2O.','2013-10-27','NSRP'),(16864,33197,'response to vitamin E','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin E stimulus.','2013-10-27','NSRP'),(16865,33198,'response to ATP','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ATP (adenosine 5\'-triphosphate) stimulus.','2013-10-27','NSRP');
INSERT INTO `GO` VALUES (16866,33199,'inositol heptakisphosphate 4-kinase or 6-kinase activity','F','OBSOLETE. Catalysis of the reaction: ATP + 5-diphospho-1D-myo-inositol (1,2,3,4,6)pentakisphosphate = 4,5-bisdiphosphoinositol-1D-myoinositol (1,2,3,6)tetrakisphosphate, and ATP + 5-diphospho-1D-myo-inositol (1,2,3,4,6)pentakisphosphate = 5,6-bisdiphosphoinositol-1D-myoinositol (1,2,3,4)tetrakisphosphate.','2013-10-27','NSRP'),(16867,33200,'inositol heptakisphosphate 5-kinase activity','F','Catalysis of the reaction: ATP + 4-diphospho-1D-myo-inositol (1,2,3,5,6)pentakisphosphate = 4,5-bisdiphosphoinositol-1D-myoinositol (1,2,3,6)tetrakisphosphate, and ATP + 6-diphospho-1D-myo-inositol (1,2,3,4,5)pentakisphosphate = 5,6-bisdiphosphoinositol-1D-myoinositol (1,2,3,4)tetrakisphosphate.','2013-10-27','NSRP'),(16868,33201,'alpha-1,4-glucan synthase activity','F','Catalysis of the reaction: RDP-glucose + [alpha-D-glucosyl-(1,4)]n = RDP + [alpha-D-glucosyl-(1,4)]n+1, where RDP is ADP or UDP.','2013-10-27','NSRP'),(16869,33202,'DNA helicase complex','C','A protein complex that possesses DNA helicase activity.','2013-10-27','NSRP'),(16870,33203,'DNA helicase A complex','C','A homohexameric protein complex that possesses DNA helicase activity; associates with DNA polymerase alpha-primase and translocates in the 5\' to 3\' direction.','2013-10-27','NSRP'),(16871,33204,'ribonuclease P RNA binding','F','Interacting selectively and non-covalently with the RNA subunit of ribonuclease P.','2013-10-27','NSRP'),(16872,33205,'cell cycle cytokinesis','P','Cytokinesis that occurs in the context of cell cycle progression and results in the division of the cytoplasm of a cell and its separation into two daughter cells.','2013-04-22','NSRP'),(16873,33206,'meiotic cytokinesis','P','A cell cycle process that results in the division of the cytoplasm of a cell after meiosis, resulting in the separation of the original cell into two daughter cells.','2013-10-27','NSRP'),(16874,33207,'beta-1,4-N-acetylgalactosaminyltransferase activity','F','Catalysis of the transfer of an N-acetylgalactosaminyl residue from UDP-N-acetyl-galactosamine to an acceptor molecule, forming a beta-1,4 linkage.','2013-10-27','NSRP'),(16875,33208,'UDP-N-acetylgalactosamine:N-acetylneuraminyl-alpha-2,3-galactosyl-beta-R 1,4-N-acetylgalactosaminyltransferase activity','F','Catalysis of the reaction: UDP-N-acetylgalactosamine + N-acetylneuraminyl-alpha-2,3-galactosyl-beta-oligosaccharide = UDP + N-acetylgalactosaminyl-N-acetylneuraminyl-alpha-2,3-galactosyl-beta-oligosaccharide.','2013-10-27','NSRP'),(16876,33209,'tumor necrosis factor-mediated signaling pathway','P','A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.','2013-10-27','NSRP'),(16877,33210,'leptin-mediated signaling pathway','P','A series of molecular signals initiated by the binding of leptin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Leptin is a hormone manufactured primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body.','2013-10-27','NSRP'),(16878,33211,'adiponectin-mediated signaling pathway','P','A series of molecular signals initiated by the binding of adiponectin to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.','2013-10-27','NSRP'),(16879,33212,'iron assimilation','P','A process in which iron is solubilized and transported into a cell.','2013-10-27','NSRP'),(16880,33213,'iron assimilation by capture and transport','P','A process in which iron (Fe3+) is solubilized by binding to a receptor or transport protein and transported into a cell.','2013-10-27','NSRP'),(16881,33214,'iron assimilation by chelation and transport','P','A process in which iron (Fe3+) is solubilized by ferric iron-specific chelators, known as siderophores, excreted by a cell; the iron-siderophore complex is then transported into the cell by specific cell surface receptors.','2013-10-27','NSRP'),(16882,33215,'iron assimilation by reduction and transport','P','A process in which iron is solubilized by reduction from Fe3+ to Fe2+ via a cell surface reductase and subsequent transport of the iron across the membrane by iron uptake proteins.','2013-10-27','NSRP'),(16883,33216,'ferric iron import','P','The directed movement of ferric iron (Fe(III) or Fe3+) ions into a cell or organelle.','2013-10-27','NSRP'),(16884,33217,'regulation of transcription from RNA polymerase II promoter in response to iron ion starvation','P','Modulation of the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of deprivation of iron ions.','2013-10-27','NSRP'),(16885,33218,'amide binding','F','Interacting selectively and non-covalently with an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group.','2013-10-27','NSRP'),(16886,33219,'urea binding','F','Interacting selectively and non-covalently with urea, a water-soluble carboxamide with the structure H2N-CO-NH2.','2013-10-27','NSRP'),(16887,33220,'amide-transporting ATPase activity','F','Catalysis of the reaction: ATP + H2O + amide(out) = ADP + phosphate + amide(in).','2013-10-27','NSRP'),(16888,33221,'urea-transporting ATPase activity','F','Catalysis of the reaction: ATP + H2O + urea(out) = ADP + phosphate + urea(in).','2013-10-27','NSRP'),(16889,33222,'xylose binding','F','Interacting selectively and non-covalently with the D- or L-enantiomer of xylose.','2013-10-27','NSRP'),(16890,33223,'2-aminoethylphosphonate transport','P','The directed movement of 2-aminoethylphosphonate, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16891,33224,'2-aminoethylphosphonate transmembrane transporter activity','F','Enables the directed movement of 2-aminoethylphosphonate into, out of or within a cell, or between cells.','2013-10-27','NSRP'),(16892,33225,'2-aminoethylphosphonate transporting ATPase activity','F','Catalysis of the reaction: ATP + H2O + 2-aminoethylphosphonate(out) = ADP + phosphate + 2-aminoethylphosphonate(in).','2013-10-27','NSRP'),(16893,33226,'2-aminoethylphosphonate binding','F','Interacting selectively and non-covalently with 2-aminoethylphosphonate.','2013-10-27','NSRP'),(16894,33227,'dsRNA transport','P','The directed movement of dsRNA, double-stranded ribonucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16895,33228,'cysteine export','P','The directed movement of cysteine out of a cell or organelle.','2013-10-27','NSRP'),(16896,33229,'cysteine transmembrane transporter activity','F','Catalysis of the transfer of cysteine from one side of the membrane to the other.','2013-10-27','NSRP'),(16897,33230,'cysteine-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + cysteine(out/in) = ADP + phosphate + cysteine(in/out).','2013-10-27','NSRP'),(16898,33231,'carbohydrate export','P','The directed movement of carbohydrates out of a cell or organelle.','2013-10-27','NSRP'),(16899,33232,'D-methionine-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + D-methionine(out/in) = ADP + phosphate + D-methionine(in/out).','2013-10-27','NSRP'),(16900,33233,'regulation of protein sumoylation','P','Any process that modulates the frequency, rate or extent of the addition of SUMO groups to a protein.','2013-10-27','NSRP'),(16901,33234,'negative regulation of protein sumoylation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of SUMO groups to a protein.','2013-10-27','NSRP'),(16902,33235,'positive regulation of protein sumoylation','P','Any process that activates or increases the frequency, rate or extent of the addition of SUMO groups to a protein.','2013-10-27','NSRP'),(16903,33236,'11-beta-hydroxysteroid dehydrogenase (NAD+) activity','F','OBSOLETE. Catalysis of the reaction: an 11-beta-hydroxysteroid + NAD+ = an 11-oxosteroid + NADH + H+.','2013-10-27','NSRP'),(16904,33237,'11-beta-hydroxysteroid dehydrogenase (NADP+) activity','F','OBSOLETE. Catalysis of the reaction: an 11-beta-hydroxysteroid + NADP+ = an 11-oxosteroid + NADPH + H+.','2013-10-27','NSRP'),(16905,33238,'regulation of cellular amine metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform amines.','2013-10-27','NSRP'),(16906,33239,'negative regulation of cellular amine metabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving amines.','2013-10-27','NSRP'),(16907,33240,'positive regulation of cellular amine metabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amines.','2013-10-27','NSRP'),(16908,33241,'regulation of cellular amine catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of amines.','2013-10-27','NSRP'),(16909,33242,'negative regulation of cellular amine catabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of amines.','2013-10-27','NSRP'),(16910,33243,'positive regulation of cellular amine catabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of amines.','2013-10-27','NSRP'),(16911,33244,'regulation of penicillin metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving any antibiotic that contains the condensed beta-lactamthiazolidine ring system.','2013-10-27','NSRP'),(16912,33245,'negative regulation of penicillin metabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving any antibiotic that contains the condensed beta-lactamthiazolidine ring system.','2013-10-27','NSRP'),(16913,33246,'positive regulation of penicillin metabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving any antibiotic that contains the condensed beta-lactamthiazolidine ring system.','2013-10-27','NSRP'),(16914,33247,'regulation of penicillin catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.','2013-10-27','NSRP'),(16915,33248,'negative regulation of penicillin catabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.','2013-10-27','NSRP'),(16916,33249,'positive regulation of penicillin catabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways leading to the breakdown of any antibiotic that contains the condensed beta-lactamthiazolidine ring system.','2013-10-27','NSRP'),(16917,33250,'penicillinase activity','F','Catalysis of the reaction: a penicillin + H2O = a substituted beta-amino acid derivative of the penicillin.','2013-10-27','NSRP'),(16918,33251,'cephalosporinase activity','F','Catalysis of the reaction: a cephalosporin + H2O = a substituted beta-amino acid derivative of the cephalosporin.','2013-10-27','NSRP'),(16919,33252,'regulation of beta-lactamase activity','P','Any process that modulates the frequency, rate or extent of beta-lactamase activity, the hydrolysis of a beta-lactam to yield a substituted beta-amino acid.','2013-10-27','NSRP'),(16920,33253,'regulation of penicillinase activity','P','Any process that modulates the frequency, rate or extent of nuclease activity, the hydrolysis of a penicillin to yield a substituted beta-amino acid derivative.','2013-10-27','NSRP'),(16921,33254,'vacuolar transporter chaperone complex','C','A protein complex that contains four related proteins that have been implicated in several membrane-related processes, such as sorting of H+-translocating ATPases, endocytosis, ER-Golgi trafficking, vacuole fusion, vacuolar polyphosphate homeostasis and the microautophagic scission of vesicles into the vacuolar lumen. The complex is enriched at the vacuolar membrane, but also found in other cellular compartments, including the ER and the cell periphery. In Saccharomyces, the subunits are Vtc1p, Vtc2p, Vtc3p and Vtc4p.','2013-10-27','NSRP'),(16922,33255,'SAS acetyltransferase complex','C','A protein complex that possesses histone acetyltransferase activity and links histone acetylation to the assembly of transcriptionally silent chromatin. In vitro, the complex acetylates lysine 16 of histone H4 and lysine 14 of histone H3, although the latter may not be relevant in vivo. The complex contains a catalytic subunit and at least two other subunits; in Saccharomyces, the catalytic subunit is Sas2p and additional subunits are Sas4p and Sas5p.','2013-10-27','NSRP'),(16923,33256,'I-kappaB/NF-kappaB complex','C','A protein complex containing an inhibitory-kappaB (I-kappaB/IKB) protein and one or more copies of an NF-kappaB protein. In the resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm.','2013-10-27','NSRP'),(16924,33257,'Bcl3/NF-kappaB2 complex','C','A protein complex containing one Bcl protein and one or more copies of NF-kappaB2; formation of complexes of different stoichiometry depends on the Bcl3:NF-kappaB2 ratio, and allow Bcl3 to exert different regulatory effects on NF-kappaB2-dependent transcription.','2013-10-27','NSRP'),(16925,33258,'plastid DNA metabolic process','P','The chemical reactions and pathways involving plastid DNA.','2013-10-27','NSRP'),(16926,33259,'plastid DNA replication','P','The process in which new strands of DNA are synthesized in a plastid.','2013-10-27','NSRP'),(16927,33260,'nuclear cell cycle DNA replication','P','The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.','2013-10-27','NSRP'),(16928,33261,'regulation of S phase','P','OBSOLETE. A cell cycle process that modulates the rate or extent of the progression through the S phase of the cell cycle.','2013-10-27','NSRP'),(16929,33262,'regulation of nuclear cell cycle DNA replication','P','Any process that modulates the frequency, rate or extent of The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle.','2013-10-27','NSRP'),(16930,33263,'CORVET complex','C','A multimeric protein complex that acts as an endosomal tethering complex (CORVET = class C core vacuole/endosome tethering) by cooperating with Rab GTPases to capture endosomal vesicles and trap them prior to the action of SNAREs; the complex is involved in endo-lysosomal biogenesis and required for transport between endosome and vacuole. The Saccharomyces cerevisiae complex contains Vps8p, Vps3p, Pep5p, Vps16p, Pep3p, and Vps33p.','2013-10-27','NSRP'),(16931,33264,'bontoxilysin activity','F','OBSOLETE. Catalysis of limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.','2013-10-27','NSRP'),(16932,33265,'choline binding','F','Interacting selectively and non-covalently with choline, the amine 2-hydroxy-N,N,N-trimethylethanaminium.','2013-10-27','NSRP'),(16933,33266,'choline-transporting ATPase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate, to directly drive the transport of choline across a membrane.','2013-10-27','NSRP'),(16934,33267,'axon part','C','A part of an axon, a cell projection of a neuron.','2013-10-27','NSRP'),(16935,33268,'node of Ranvier','C','An axon part that is a gap in the myelin where voltage-gated sodium channels cluster and saltatory conduction is executed.','2013-10-27','NSRP'),(16936,33269,'internode region of axon','C','An axon part that is located between the nodes of Ranvier and surrounded by compact myelin sheath.','2013-10-27','NSRP'),(16937,33270,'paranode region of axon','C','An axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath.','2013-10-27','NSRP'),(16938,33271,'myo-inositol phosphate transport','P','The directed movement of any phosphorylated myo-inositol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16939,33272,'myo-inositol hexakisphosphate transport','P','The directed movement of myo-inositol hexakisphosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16940,33273,'response to vitamin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin stimulus.','2013-10-27','NSRP'),(16941,33274,'response to vitamin B2','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B2 stimulus.','2013-10-27','NSRP'),(16942,33275,'actin-myosin filament sliding','P','The sliding movement of actin thin filaments and myosin thick filaments past each other.','2013-10-27','NSRP'),(16943,33276,'transcription factor TFTC complex','C','A protein complex that does not contain either a TATA-binding protein (TBP) or a TBP-like factor, but is composed of several TAFIIs and other proteins, including a histone acetyltransferase. This complex is able to nucleate transcription initiation by RNA polymerase II, can mediate transcriptional activation, and has histone acetyltransferase activity.','2013-10-27','NSRP'),(16944,33277,'abortive mitotic cell cycle','P','A cell cycle in which mitosis is begun and progresses normally through the end of anaphase, but not completed, resulting in a cell with increased ploidy.','2013-10-27','NSRP'),(16945,33278,'cell proliferation in midbrain','P','The multiplication or reproduction of cells, resulting in the expansion of a cell population in the midbrain.','2013-10-27','NSRP'),(16946,33280,'response to vitamin D','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.','2013-10-27','NSRP'),(16947,33281,'TAT protein transport complex','C','A complex of three proteins integral to the cytoplasmic membrane of bacteria and membranes of organelles derived from bacteria (chloroplasts and mitochondria) involved in membrane transport of folded proteins.','2013-10-27','NSRP'),(16948,33282,'protein C inhibitor-acrosin complex','C','A heterodimeric protein complex of protein C inhibitor (SERPINA5) and acrosin; formation of the complex inhibits the protease activity of acrosin.','2013-10-27','NSRP'),(16949,33283,'organic acid-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + organic acid(out/in) = ADP + phosphate + organic acid(in/out).','2013-10-27','NSRP'),(16950,33284,'carboxylic acid-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + carboxylic acid(out/in) = ADP + phosphate + carboxylic acid(in/out).','2013-10-27','NSRP'),(16951,33285,'monocarboxylic acid-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + monocarboxylic acid(out/in) = ADP + phosphate + monocarboxylic acid(in/out).','2013-10-27','NSRP'),(16952,33286,'ectoine-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + ectoine(out/in) = ADP + phosphate + ectoine(in/out).','2013-10-27','NSRP'),(16953,33287,'hydroxyectoine transmembrane transporter activity','F','Catalysis of the transfer of hydroxyectoine from one side of the membrane to the other.','2013-10-27','NSRP'),(16954,33288,'hydroxyectoine-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + hydroxyectoine(out/in) = ADP + phosphate + hydroxyectoine(in/out).','2013-10-27','NSRP'),(16955,33289,'intraconoid microtubule','C','A microtubule located such that it threads through the conoid and projects through the polar ring.','2013-10-27','NSRP'),(16956,33290,'eukaryotic 48S preinitiation complex','C','A protein complex composed of the small ribosomal subunit, eIF3, eIF1A, methionyl-initiatior methionine and a capped mRNA. The complex is initially positioned at the 5\'-end of the capped mRNA.','2013-10-27','NSRP'),(16957,33291,'eukaryotic 80S initiation complex','C','A protein complex composed of the large and small ribosomal subunits, methionyl-initiatior tRNA, and the capped mRNA. The initiator tRNA is positioned at the ribosomal P site at the AUG codon corresponding to the beginning of the coding region.','2013-10-27','NSRP'),(16958,33292,'T-tubule organization','P','A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of the T-tubule. A T-tubule is an invagination of the plasma membrane of a muscle cell that extends inward from the cell surface around each myofibril.','2013-10-27','NSRP'),(16959,33293,'monocarboxylic acid binding','F','Interacting selectively and non-covalently with a monocarboxylic acid, any organic acid containing one carboxyl (COOH) group or anion (COO-).','2013-10-27','NSRP'),(16960,33294,'ectoine binding','F','Interacting selectively and non-covalently with ectoine, 1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid.','2013-10-27','NSRP'),(16961,33295,'hydroxyectoine binding','F','Interacting selectively and non-covalently with hydroxyectoine.','2013-10-27','NSRP'),(16962,33296,'rhamnose binding','F','Interacting selectively and non-covalently with the D- or L-enantiomer of rhamnose.','2013-10-27','NSRP'),(16963,33297,'rhamnose-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + rhamnose(out/in) = ADP + phosphate + rhamnose(in/out).','2013-10-27','NSRP'),(16964,33298,'contractile vacuole organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a contractile vacuole. A specialized vacuole that fills with water from the cytoplasm and then discharges this externally by the opening of contractile vacuole pores.','2013-10-27','NSRP'),(16965,33299,'secretion of lysosomal enzymes','P','The controlled release of lysosomal enzymes by a cell.','2013-10-27','NSRP'),(16966,33300,'dehydroascorbic acid transporter activity','F','Enables the directed movement of dehydroascorbate, 5-(1,2-dihydroxyethyl)furan-2,3,4(5H)-trione, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16967,33301,'cell cycle comprising mitosis without cytokinesis','P','A mitotic cell cycle in which mitosis is completed but cytokinesis does not occur, resulting in a cell containing multiple nuclei each with a chromosomal complement of the original ploidy (usually 2N).','2013-10-27','NSRP'),(16968,33302,'quercetin O-glucoside metabolic process','P','The chemical reactions and pathways involving O-glucosylated derivatives of quercetin.','2013-10-27','NSRP'),(16969,33303,'quercetin O-glucoside biosynthetic process','P','The chemical reactions and pathways leading to the formation of O-glucosylated derivatives of quercetin.','2013-10-27','NSRP'),(16970,33304,'chlorophyll a metabolic process','P','The chemical reactions and pathways involving chlorophyll a.','2013-10-27','NSRP'),(16971,33305,'chlorophyll a biosynthetic process','P','The chemical reactions and pathways leading to the formation of chlorophyll a.','2013-10-27','NSRP'),(16972,33306,'phytol metabolic process','P','The chemical reactions and pathways involving phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol.','2013-10-27','NSRP'),(16973,33307,'phytol salvage','P','A process that generates phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol, from derivatives of it without de novo synthesis.','2013-10-27','NSRP'),(16974,33308,'hydroxyectoine transport','P','The directed movement of hydroxyectoine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(16975,33309,'SBF transcription complex','C','A protein complex that binds to the Swi4/6 cell cycle box (SCB) promoter element, consensus sequence CRCGAAA, and activates transcription during the G1/S transition of the cell cycle. In Saccharomyces, the complex contains a heterodimer of the DNA binding protein Swi6p and the activator Swi4p, and is associated with additional proteins known as Whi5p and Msa1p.','2013-10-27','NSRP'),(16976,33310,'chlorophyll a catabolic process','P','The chemical reactions and pathways leading to the breakdown of chlorophyll a.','2013-10-27','NSRP'),(16977,33311,'chlorophyll a biosynthetic process via phytyl diphosphate','P','The chemical reactions and pathways leading to the formation of chlorophyll a, via the intermediate phytyl diphosphate.','2013-10-27','NSRP'),(16978,33312,'chlorophyll a biosynthetic process via geranylgeranyl-chlorophyll a','P','The chemical reactions and pathways leading to the formation of chlorophyll a, via the intermediate geranylgeranyl-chlorophyll a.','2013-10-27','NSRP'),(16979,33313,'meiotic cell cycle checkpoint','P','A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a meiotic cell cycle until conditions are suitable for the cell to proceed to the next stage.','2013-10-27','NSRP'),(16980,33314,'mitotic DNA replication checkpoint','P','A cell cycle checkpoint that acts during a mitotic cell cycle and prevents the initiation of mitosis until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the genome.','2013-10-27','NSRP'),(16981,33315,'meiotic DNA replication checkpoint','P','A cell cycle checkpoint that acts during a meiotic cell cycle and prevents the initiation of cell division until DNA replication is complete, thereby ensuring that progeny inherit a full complement of the haploid genome.','2013-10-27','NSRP'),(16982,33316,'meiotic spindle assembly checkpoint','P','A cell cycle checkpoint that delays the metaphase/anaphase transition of a meiotic cell cycle until the spindle is correctly assembled and chromosomes are attached to the spindle.','2013-10-27','NSRP'),(16983,33317,'pantothenate biosynthetic process from valine','P','The chemical reactions and pathways resulting in the formation of pantothenate, the anion of pantothenic acid, from other compounds, including valine.','2013-10-27','NSRP'),(16984,33318,'pantothenate biosynthetic process from 2-dehydropantolactone','P','The chemical reactions and pathways resulting in the formation of pantothenate, the anion of pantothenic acid, from other compounds, including 2-dehydropantolactone.','2013-10-27','NSRP'),(16985,33319,'UDP-D-xylose metabolic process','P','The chemical reactions and pathways involving UDP-D-xylose, uridinediphosphoxylose, a substance composed of xylose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(16986,33320,'UDP-D-xylose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of UDP-D-xylose, uridinediphosphoxylose, a substance composed of xylose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(16987,33321,'homomethionine metabolic process','P','The chemical reactions and pathways involving homomethionine, a non-protein amino acid synthesized from methionine via chain elongation.','2013-10-27','NSRP'),(16988,33322,'homomethionine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of homomethionine, a non-protein amino acid synthesized from methionine via chain elongation.','2013-10-27','NSRP'),(16989,33323,'choline biosynthetic process via CDP-choline','P','The chemical reactions and pathways resulting in the formation of choline (2-hydroxyethyltrimethylammonium), via the intermediate CDP-choline.','2013-10-27','NSRP'),(16990,33324,'choline biosynthetic process via N-monomethylethanolamine','P','The chemical reactions and pathways resulting in the formation of choline (2-hydroxyethyltrimethylammonium), via the intermediate N-monomethylethanolamine.','2013-10-27','NSRP'),(16991,33325,'choline biosynthetic process via phosphoryl-ethanolamine','P','The chemical reactions and pathways resulting in the formation of choline (2-hydroxyethyltrimethylammonium), via the intermediate phosphoryl-ethanolamine.','2013-10-27','NSRP'),(16992,33326,'cerebrospinal fluid secretion','P','The regulated release of cerebrospinal fluid (CSF) from the choroid plexus of the lateral, third and fourth ventricles. The cerebrospinal fluid is a clear liquid that located within the ventricles, spinal canal, and subarachnoid spaces.','2013-10-27','NSRP'),(16993,33327,'Leydig cell differentiation','P','The process in which a relatively unspecialized cell acquires specialized structural and/or functional features of a Leydig cell. A Leydig cell is a testosterone-secreting cell in the interstitial area, between the seminiferous tubules, in the testis.','2013-10-27','NSRP'),(16994,33328,'peroxisome membrane targeting sequence binding','F','Interacting selectively and non-covalently with a peroxisomal membrane targeting sequence, any of several sequences of amino acids within a protein that can act as a signal for the localization of the protein into the peroxisome membrane.','2013-10-27','NSRP'),(16995,33329,'kaempferol O-glucoside metabolic process','P','The chemical reactions and pathways involving O-glucosylated derivatives of kaempferol.','2013-10-27','NSRP'),(16996,33330,'kaempferol O-glucoside biosynthetic process','P','The chemical reactions and pathways leading to the formation of O-glucosylated derivatives of kaempferol.','2013-10-27','NSRP'),(16997,33331,'ent-kaurene metabolic process','P','The chemical reactions and pathways involving ent-kaur-16-ene. Ent-kaurene is a tetracyclic diterpenoid that is a precursor of several plant isoprenoids, including gibberellins.','2013-10-27','NSRP'),(16998,33332,'ent-kaurene biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ent-kaurene. Ent-kaurene is a tetracyclic diterpenoid that is a precursor of several plant isoprenoids, including gibberellins.','2013-10-27','NSRP'),(16999,33333,'fin development','P','The process whose specific outcome is the progression of a fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17000,33334,'fin morphogenesis','P','The process in which the anatomical structures of a fin are generated and organized.','2013-10-27','NSRP'),(17001,33335,'anal fin development','P','The process whose specific outcome is the progression of the anal fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17002,33336,'caudal fin development','P','The process whose specific outcome is the progression of the caudal fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17003,33337,'dorsal fin development','P','The process whose specific outcome is the progression of the dorsal fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17004,33338,'medial fin development','P','The process whose specific outcome is the progression of a medial fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17005,33339,'pectoral fin development','P','The process whose specific outcome is the progression of the pectoral fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17006,33340,'pelvic fin development','P','The process whose specific outcome is the progression of the pelvic fin over time, from its formation to the mature structure.','2013-10-27','NSRP'),(17007,33341,'regulation of collagen binding','P','Any process that modulates the frequency, rate or extent of collagen binding.','2013-10-27','NSRP'),(17008,33342,'negative regulation of collagen binding','P','Any process that stops, prevents, or reduces the frequency, rate or extent of collagen binding.','2013-10-27','NSRP'),(17009,33343,'positive regulation of collagen binding','P','Any process that activates or increases the frequency, rate or extent of collagen binding.','2013-10-27','NSRP'),(17010,33344,'cholesterol efflux','P','The directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.','2013-10-27','NSRP'),(17011,33345,'asparagine catabolic process via L-aspartate','P','The chemical reactions and pathways resulting in the breakdown of glutamate, via the intermediate L-aspartate.','2013-10-27','NSRP'),(17012,33346,'asparagine catabolic process via 2-oxosuccinamate','P','The chemical reactions and pathways resulting in the breakdown of glutamate, via the intermediate 2-oxosuccinamate.','2013-10-27','NSRP'),(17013,33347,'tetrose metabolic process','P','The chemical reactions and pathways involving a tetrose, any monosaccharide with a chain of four carbon atoms in the molecule.','2013-10-27','NSRP'),(17014,33348,'tetrose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a tetrose, any monosaccharide with a chain of four carbon atoms in the molecule.','2013-10-27','NSRP'),(17015,33349,'apiose metabolic process','P','The chemical reactions and pathways involving apiose, the branched tetrose 3-C-(hydroxymethyl)-D-glycero-tetrose.','2013-10-27','NSRP'),(17016,33350,'apiose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of apiose, the branched tetrose 3-C-(hydroxymethyl)-D-glycero-tetrose.','2013-10-27','NSRP'),(17017,33351,'UDP-D-apiose metabolic process','P','The chemical reactions and pathways involving UDP-D-apiose, uridinediphosphoapiose, a substance composed of apiose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17018,33352,'UDP-D-apiose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of UDP-D-apiose, uridinediphosphoapicose, a substance composed of apiose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17019,33353,'S-adenosylmethionine cycle','P','A cyclic series of interconversions involving S-adenosylmethionine, S-adenosyl-L-homocysteine, L-cysteine, and L-methionine. Couples utilization of the methyl group of SAM with recycling of the homocysteinyl group and regeneration of methionine.','2013-10-27','NSRP'),(17020,33354,'chlorophyll cycle','P','A cyclic series of interconversions involving chlorophyll a, chlorophyll b and several chlorophyllide intermediates.','2013-10-27','NSRP'),(17021,33355,'ascorbate glutathione cycle','P','A cyclic series of interconversions involving L-ascorbate and glutathione that scavenges hydrogen peroxide and reduces it to water, with concomitant oxidation of NADPH.','2013-10-27','NSRP'),(17022,33356,'UDP-L-arabinose metabolic process','P','The chemical reactions and pathways involving UDP-L-arabinose, uridinediphosphoarabinose, a substance composed of arabinose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17023,33357,'L-arabinose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of L-arabinose, arabino-pentose.','2013-10-27','NSRP'),(17024,33358,'UDP-L-arabinose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of UDP-L-arabinose, uridinediphosphoarabinose, a substance composed of arabinose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17025,33359,'lysine biosynthetic process via diaminopimelate and N-succinyl-2-amino-6-ketopimelate','P','The chemical reactions and pathways resulting in the formation of lysine, via the intermediates diaminopimelate and N-succinyl-2-amino-6-ketopimelate; in this pathway tetrahydrodipicolinate is converted to meso-diaminopimelate in four enzymatic steps.','2013-10-27','NSRP'),(17026,33360,'lysine biosynthetic process via diaminopimelate and L-2-acetamido-6-oxoheptanedioate','P','The chemical reactions and pathways resulting in the formation of lysine, via the intermediates diaminopimelate and L-2-acetamido-6-oxoheptanedioate; in this pathway tetrahydrodipicolinate is converted to meso-diaminopimelate in four enzymatic steps.','2013-10-27','NSRP'),(17027,33361,'lysine biosynthetic process via diaminopimelate, dehydrogenase pathway','P','The chemical reactions and pathways resulting in the formation of lysine, via the intermediate diaminopimelate; in this pathway tetrahydrodipicolinate is converted to meso-diaminopimelate in a single enzymatic step.','2013-10-27','NSRP'),(17028,33362,'lysine biosynthetic process via diaminopimelate, diaminopimelate-aminotransferase pathway','P','The chemical reactions and pathways resulting in the formation of lysine, via the intermediate diaminopimelate; in this pathway tetrahydrodipicolinate is converted to meso-diaminopimelate in two enzymatic steps.','2013-10-27','NSRP'),(17029,33363,'secretory granule organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.','2013-10-27','NSRP'),(17030,33364,'mast cell secretory granule organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule in a mast cell. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.','2013-10-27','NSRP'),(17031,33365,'protein localization to organelle','P','A process in which a protein is transported to, or maintained in, a location within an organelle.','2013-10-27','NSRP'),(17032,33366,'protein localization to secretory granule','P','A process in which a protein is transported to, or maintained in, a location within a secretory granule.','2013-10-27','NSRP'),(17033,33367,'protein localization to mast cell secretory granule','P','A process in which a protein is transported to, or maintained in, a location within a secretory granule in a mast cell.','2013-10-27','NSRP'),(17034,33368,'protease localization to mast cell secretory granule','P','Any process in which a protease is transported to, or maintained in, a location within a secretory granule in a mast cell.','2013-10-27','NSRP'),(17035,33369,'establishment of protein localization to mast cell secretory granule','P','The directed movement of a protein to a location within a secretory granule in a mast cell.','2013-10-27','NSRP'),(17036,33370,'maintenance of protein location in mast cell secretory granule','P','A process in which a protein is maintained in a secretory granule in a mast cell and prevented from moving elsewhere.','2013-10-27','NSRP'),(17037,33371,'T cell secretory granule organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a secretory granule in a T cell. A secretory granule is a small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion.','2013-10-27','NSRP'),(17038,33372,'establishment of protease localization to mast cell secretory granule','P','The directed movement of a protease to a location within a secretory granule in a mast cell.','2013-10-27','NSRP'),(17039,33373,'maintenance of protease location in mast cell secretory granule','P','A process in which a protease is maintained in a secretory granule in a mast cell and prevented from moving elsewhere.','2013-10-27','NSRP'),(17040,33374,'protein localization to T cell secretory granule','P','A process in which a protein is transported to, or maintained in, a location within a secretory granule in a T cell.','2013-10-27','NSRP'),(17041,33375,'protease localization to T cell secretory granule','P','Any process in which a protease is transported to, or maintained in, a location within a secretory granule in a T cell.','2013-10-27','NSRP'),(17042,33376,'establishment of protein localization to T cell secretory granule','P','The directed movement of a protein to a location within a secretory granule in a T cell.','2013-10-27','NSRP'),(17043,33377,'maintenance of protein location in T cell secretory granule','P','A process in which a protein is maintained in a secretory granule in a T cell and prevented from moving elsewhere.','2013-10-27','NSRP'),(17044,33378,'establishment of protease localization to T cell secretory granule','P','The directed movement of a protease to a location within a secretory granule in a T cell.','2013-10-27','NSRP'),(17045,33379,'maintenance of protease location in T cell secretory granule','P','A process in which a protease is maintained in a secretory granule in a T cell and prevented from moving elsewhere.','2013-10-27','NSRP'),(17046,33380,'granzyme B localization to T cell secretory granule','P','Any process in which the protease granzyme B is transported to, or maintained in, a location within a secretory granule in a T cell.','2013-10-27','NSRP'),(17047,33381,'establishment of granzyme B localization to T cell secretory granule','P','The directed movement of the protease granzyme B to a location within a secretory granule in a T cell.','2013-10-27','NSRP'),(17048,33382,'maintenance of granzyme B location in T cell secretory granule','P','A process in which the protease granyme B is maintained in a secretory granule in a T cell and prevented from moving elsewhere.','2013-10-27','NSRP'),(17049,33383,'geranyl diphosphate metabolic process','P','The chemical reactions and pathways involving geranyl diphosphate, the universal precursor of the monoterpenes.','2013-10-27','NSRP'),(17050,33384,'geranyl diphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of geranyl diphosphate.','2013-10-27','NSRP'),(17051,33385,'geranylgeranyl diphosphate metabolic process','P','The chemical reactions and pathways involving geranylgeranyl diphosphate, a polyprenol compound involved in the biosynthesis of a variety of terpenoids including chlorophylls, carotenoids, tocopherols, plastoquinones, and the plant hormones gibberellins.','2013-10-27','NSRP'),(17052,33386,'geranylgeranyl diphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of geranylgeranyl diphosphate.','2013-10-27','NSRP'),(17053,33387,'putrescine biosynthetic process from ornithine','P','The chemical reactions and pathways resulting in the formation of putrescine, 1,4-diaminobutane by decarboxylation of ornithine.','2013-10-27','NSRP'),(17054,33388,'putrescine biosynthetic process from arginine','P','The chemical reactions and pathways resulting in the formation of putrescine, 1,4-diaminobutane, from other compounds, including arginine.','2013-10-27','NSRP'),(17055,33389,'putrescine biosynthetic process from arginine, using agmatinase','P','The chemical reactions and pathways resulting in the formation of putrescine, 1,4-diaminobutane, from other compounds, including arginine; in this pathway, arginine is converted to agmatine, and agmatine is converted to putrescine in a single enzymatic step.','2013-10-27','NSRP'),(17056,33390,'putrescine biosynthetic process from arginine via N-carbamoylputrescine','P','The chemical reactions and pathways resulting in the formation of putrescine, 1,4-diaminobutane, from other compounds, including arginine, via the intermediate N-carbamoylputrescine; in this pathway, arginine is converted to agmatine, and agmatine is converted to putrescine in two single enzymatic steps.','2013-10-27','NSRP'),(17057,33391,'chromatoid body','C','A ribonucleoprotein complex found in the cytoplasm of male germ cells, composed of exceedingly thin filaments that are consolidated into a compact mass or into dense strands of varying thickness that branch to form an irregular network. Contains mRNAs, miRNAs, and protein components involved in miRNA processing (such as Argonaute proteins and the endonuclease Dicer) and in RNA decay (such as the decapping enzyme DCP1a and GW182).','2013-10-27','NSRP'),(17058,33392,'actin homodimerization activity','F','Interacting selectively and non-covalently with an identical actin monomer to form a homodimer.','2013-10-27','NSRP'),(17059,33393,'homogalacturonan catabolic process','P','The chemical reactions and pathways resulting in the breakdown of homogalacturonan, a pectidic polymer, characterized by a backbone of 1,4-linked alpha-D-GalpA residues that can be methyl-esterified at C-6 and carry acetyl groups on O-2 and O-3.','2013-10-27','NSRP'),(17060,33394,'beta-alanine biosynthetic process via 1,3 diaminopropane','P','The chemical reactions and pathways resulting in the formation of beta-alanine via the intermediate 1,3 diaminopropane.','2013-10-27','NSRP'),(17061,33395,'beta-alanine biosynthetic process via 3-hydroxypropionate','P','The chemical reactions and pathways resulting in the formation of beta-alanine via the intermediate 3-hydroxypropionate.','2013-10-27','NSRP'),(17062,33396,'beta-alanine biosynthetic process via 3-ureidopropionate','P','The chemical reactions and pathways resulting in the formation of beta-alanine via the intermediate 3-ureidopropionate.','2013-10-27','NSRP'),(17063,33397,'zeatin metabolic process','P','The chemical reactions and pathways involving zeatin, 2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol.','2013-10-27','NSRP'),(17064,33398,'zeatin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of zeatin, 2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol.','2013-10-27','NSRP'),(17065,33399,'cis-zeatin metabolic process','P','The chemical reactions and pathways involving cis-zeatin, (2Z)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol.','2013-10-27','NSRP'),(17066,33400,'trans-zeatin metabolic process','P','The chemical reactions and pathways involving trans-zeatin, (2E)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol.','2013-10-27','NSRP'),(17067,33401,'UUU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UUU codon.','2013-10-27','NSRP'),(17068,33402,'UUC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UUC codon.','2013-10-27','NSRP'),(17069,33403,'UUA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UUA codon.','2013-10-27','NSRP'),(17070,33404,'UUG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UUG codon.','2013-10-27','NSRP'),(17071,33405,'UCU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UCU codon.','2013-10-27','NSRP'),(17072,33406,'UCC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UCC codon.','2013-10-27','NSRP'),(17073,33407,'UCA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UCA codon.','2013-10-27','NSRP'),(17074,33408,'UCG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UCG codon.','2013-10-27','NSRP'),(17075,33409,'UAU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UAU codon.','2013-10-27','NSRP'),(17076,33410,'UAC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UAC codon.','2013-10-27','NSRP'),(17077,33411,'UAA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UAA codon.','2013-10-27','NSRP'),(17078,33412,'UAG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UAG codon.','2013-10-27','NSRP'),(17079,33413,'UGU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UGU codon.','2013-10-27','NSRP'),(17080,33414,'UGC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UGC codon.','2013-10-27','NSRP'),(17081,33415,'UGA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UGA codon.','2013-10-27','NSRP'),(17082,33416,'UGG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a UGG codon.','2013-10-27','NSRP'),(17083,33417,'CUU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CUU codon.','2013-10-27','NSRP'),(17084,33418,'CUC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CUC codon.','2013-10-27','NSRP'),(17085,33419,'CUA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CUA codon.','2013-10-27','NSRP'),(17086,33420,'CUG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CUG codon.','2013-10-27','NSRP'),(17087,33421,'CCU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CCU codon.','2013-10-27','NSRP'),(17088,33422,'CCC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CCC codon.','2013-10-27','NSRP'),(17089,33423,'CCA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CCA codon.','2013-10-27','NSRP'),(17090,33424,'CCG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CCG codon.','2013-10-27','NSRP'),(17091,33425,'CAU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CAU codon.','2013-10-27','NSRP'),(17092,33426,'CAC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CAC codon.','2013-10-27','NSRP'),(17093,33427,'CAA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CAA codon.','2013-10-27','NSRP'),(17094,33428,'CAG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CAG codon.','2013-10-27','NSRP'),(17095,33429,'CGU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CGU codon.','2013-10-27','NSRP'),(17096,33430,'CGC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CGC codon.','2013-10-27','NSRP'),(17097,33431,'CGA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CGA codon.','2013-10-27','NSRP'),(17098,33432,'CGG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a CGG codon.','2013-10-27','NSRP'),(17099,33433,'AUU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AUU codon.','2013-10-27','NSRP'),(17100,33434,'AUC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AUC codon.','2013-10-27','NSRP'),(17101,33435,'AUA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AUA codon.','2013-10-27','NSRP'),(17102,33436,'AUG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AUG codon.','2013-10-27','NSRP'),(17103,33437,'ACU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an ACU codon.','2013-10-27','NSRP'),(17104,33438,'ACC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an ACC codon.','2013-10-27','NSRP'),(17105,33439,'ACA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an ACA codon.','2013-10-27','NSRP'),(17106,33440,'ACG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an ACG codon.','2013-10-27','NSRP'),(17107,33441,'AAU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AAU codon.','2013-10-27','NSRP'),(17108,33442,'AAC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AAC codon.','2013-10-27','NSRP'),(17109,33443,'AAA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AAA codon.','2013-10-27','NSRP'),(17110,33444,'AAG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AAG codon.','2013-10-27','NSRP'),(17111,33445,'AGU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AGU codon.','2013-10-27','NSRP'),(17112,33446,'AGC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AGC codon.','2013-10-27','NSRP'),(17113,33447,'AGA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AGA codon.','2013-10-27','NSRP'),(17114,33448,'AGG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes an AGG codon.','2013-10-27','NSRP'),(17115,33449,'GUU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GUU codon.','2013-10-27','NSRP'),(17116,33450,'GUC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GUC codon.','2013-10-27','NSRP'),(17117,33451,'GUA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GUA codon.','2013-10-27','NSRP'),(17118,33452,'GUG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GUG codon.','2013-10-27','NSRP'),(17119,33453,'GCU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GCU codon.','2013-10-27','NSRP'),(17120,33454,'GCC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GCC codon.','2013-10-27','NSRP'),(17121,33455,'GCA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GCA codon.','2013-10-27','NSRP'),(17122,33456,'GCG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GCG codon.','2013-10-27','NSRP'),(17123,33457,'GAU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GAU codon.','2013-10-27','NSRP'),(17124,33458,'GAC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GAC codon.','2013-10-27','NSRP'),(17125,33459,'GAA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GAA codon.','2013-10-27','NSRP'),(17126,33460,'GAG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GAG codon.','2013-10-27','NSRP'),(17127,33461,'GGU codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GGU codon.','2013-10-27','NSRP'),(17128,33462,'GGC codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GGC codon.','2013-10-27','NSRP'),(17129,33463,'GGA codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GGA codon.','2013-10-27','NSRP'),(17130,33464,'GGG codon-amino acid adaptor activity','F','A triplet codon-amino acid adaptor activity that recognizes a GGG codon.','2013-10-27','NSRP'),(17131,33465,'cis-zeatin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cis-zeatin, (2Z)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol.','2013-10-27','NSRP'),(17132,33466,'trans-zeatin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of trans-zeatin, (2E)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol.','2013-10-27','NSRP'),(17133,33467,'CMP-keto-3-deoxy-D-manno-octulosonic acid metabolic process','P','The chemical reactions and pathways involving CMP-keto-3-deoxy-D-manno-octulosonic acid, a substance composed of the acidic sugar 3-deoxy-D-manno-octulosonic acid in glycosidic linkage with cytidine monophosphate.','2013-10-27','NSRP'),(17134,33468,'CMP-keto-3-deoxy-D-manno-octulosonic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of CMP-keto-3-deoxy-D-manno-octulosonic acid, a substance composed of the acidic sugar 3-deoxy-D-manno-octulosonic acid in glycosidic linkage with cytidine monophosphate.','2013-10-27','NSRP'),(17135,33469,'gibberellin 12 metabolic process','P','The chemical reactions and pathways involving gibberellin 12, (1R,2S,3S,4R,8S,9S,12R)-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4-dicarboxylic acid 1meta,4a-dimethyl-8-methylidene-4aalpha,4bbeta-gibbane-1alpha,10beta-dicarboxylic acid.','2013-10-27','NSRP'),(17136,33470,'gibberellin 12 biosynthetic process','P','The chemical reactions and pathways resulting in the formation of gibberellin 12, (1R,2S,3S,4R,8S,9S,12R)-4,8-dimethyl-13-methylidenetetracyclo[10.2.1.01,9.03,8]pentadecane-2,4-dicarboxylic acid 1meta,4a-dimethyl-8-methylidene-4aalpha,4bbeta-gibbane-1alpha,10beta-dicarboxylic acid.','2013-10-27','NSRP'),(17137,33471,'GDP-L-galactose metabolic process','P','The chemical reactions and pathways involving GDP-L-galactose, a substance composed of L-galactose in glycosidic linkage with guanosine diphosphate.','2013-10-27','NSRP'),(17138,33472,'GDP-L-galactose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of GDP-L-galactose, a substance composed of L-galactose in glycosidic linkage with guanosine diphosphate.','2013-10-27','NSRP'),(17139,33473,'indoleacetic acid conjugate metabolic process','P','The chemical reactions and pathways involving any indole-3-acetic acid conjugate, a form of indoleacetic acid covalently bound to another molecule.','2013-10-27','NSRP'),(17140,33474,'indoleacetic acid conjugate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an indole-3-acetic acid conjugate, a form of indoleacetic acid covalently bound to another molecule.','2013-10-27','NSRP'),(17141,33475,'indoleacetic acid amide conjugate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an indole-3-acetic acid amide conjugate, a form of indoleacetic acid covalently bound to an amino acid or polypeptide through an amide bond.','2013-10-27','NSRP'),(17142,33476,'indoleacetic acid ester conjugate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of an indole-3-acetic acid amide conjugate, a form of indoleacetic acid covalently bound to an a sugar or polyol through an ester bond.','2013-10-27','NSRP'),(17143,33477,'S-methylmethionine metabolic process','P','The chemical reactions and pathways involving S-methyl-methionine (SMM). SMM can be converted to methionine by donating a methyl group to homocysteine, and concurrent operation of this reaction and that mediated by MMT sets up the SMM cycle.','2013-10-27','NSRP'),(17144,33478,'UDP-rhamnose metabolic process','P','The chemical reactions and pathways involving UDP-L-rhamnose, a substance composed of rhamnose in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17145,33479,'UDP-D-galacturonate metabolic process','P','The chemical reactions and pathways involving UDP-D-galacturonate, a substance composed of galacturonic acid in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17146,33480,'UDP-D-galacturonate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of UDP-D-galacturonate, a substance composed of galacturonic acid in glycosidic linkage with uridine diphosphate.','2013-10-27','NSRP'),(17147,33481,'galacturonate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of galacturonate, the anion of galacturonic acid.','2013-10-27','NSRP'),(17148,33482,'D-galacturonate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of D-galacturonate, the D-enantiomer of galacturonate, the anion of galacturonic acid.','2013-10-27','NSRP'),(17149,33483,'gas homeostasis','P','A homeostatic process involved in the maintenance of an internal steady state of a gas within an organism or cell.','2013-10-27','NSRP'),(17150,33484,'nitric oxide homeostasis','P','A homeostatic process involved in the maintenance of an internal steady state of nitric oxide within an organism or cell.','2013-10-27','NSRP'),(17151,33485,'cyanidin 3-O-glucoside biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cyanidin 3-O-glucoside, a basic anthocyanin responsible for red to magenta coloration of flowers and fruits.','2013-10-27','NSRP'),(17152,33486,'delphinidin 3-O-glucoside biosynthetic process','P','The chemical reactions and pathways resulting in the formation of delphinidin 3-O-glucoside, a basic, water-soluble anthocyanin responsible for blue coloration of flowers and fruits.','2013-10-27','NSRP'),(17153,33487,'pelargonidin 3-O-glucoside biosynthetic process','P','The chemical reactions and pathways resulting in the formation of pelargonidin 3-O-glucoside, a basic anthocyanin responsible for red to magenta coloration of flowers and fruits.','2013-10-27','NSRP'),(17154,33488,'cholesterol biosynthetic process via 24,25-dihydrolanosterol','P','The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, via the intermediate 24,25-dihydrolanosterol.','2013-10-27','NSRP'),(17155,33489,'cholesterol biosynthetic process via desmosterol','P','The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, via the intermediate desmosterol.','2013-10-27','NSRP'),(17156,33490,'cholesterol biosynthetic process via lathosterol','P','The chemical reactions and pathways resulting in the formation of cholesterol, cholest-5-en-3 beta-ol, via the intermediate lathosterol.','2013-10-27','NSRP'),(17157,33491,'coniferin metabolic process','P','The chemical reactions and pathways involving coniferin, 4-(3-hydroxyprop-1-en-1-yl)-2-methoxyphenyl beta-D-glucopyranoside.','2013-10-27','NSRP'),(17158,33492,'esculetin metabolic process','P','The chemical reactions and pathways involving esculetin, 6,7-dihydroxycoumarin.','2013-10-27','NSRP'),(17159,33493,'esculetin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of esculetin, 6,7-dihydroxycoumarin.','2013-10-27','NSRP'),(17160,33494,'ferulate metabolic process','P','The chemical reactions and pathways involving ferulate, (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate.','2013-10-27','NSRP'),(17161,33495,'ferulate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ferulate, (2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate.','2013-10-27','NSRP'),(17162,33496,'sinapate metabolic process','P','The chemical reactions and pathways involving sinapate, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate.','2013-10-27','NSRP'),(17163,33497,'sinapate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of sinapate, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate.','2013-10-27','NSRP'),(17164,33498,'galactose catabolic process via D-galactonate','P','The chemical reactions and pathways resulting in the breakdown of galactose, via the intermediate D-galactonate.','2013-10-27','NSRP'),(17165,33499,'galactose catabolic process via UDP-galactose','P','The chemical reactions and pathways resulting in the breakdown of galactose, via the intermediate UDP-galactose.','2013-10-27','NSRP'),(17166,33500,'carbohydrate homeostasis','P','A homeostatic process involved in the maintenance of an internal steady state of a carbohydrate within an organism or cell.','2013-10-27','NSRP'),(17167,33501,'galactose homeostasis','P','A homeostatic process involved in the maintenance of an internal steady state of galactose within an organism or cell.','2013-10-27','NSRP'),(17168,33502,'cellular galactose homeostasis','P','A cellular homeostatic process involved in the maintenance of an internal steady state of galactose within a cell or between a cell and its external environment.','2013-10-27','NSRP'),(17169,33503,'HULC complex','C','A ubiquitin-conjugating enzyme complex that contains two RING finger proteins, which have ubiquitin ligase activity, in addition to a protein with ubiquitin-conjugating enzyme activity; catalyzes the ubiquitination of histone H2B at lysine 119 (or the equivalent residue). In Schizosaccharomyces the subunits are Rhp1, Brl2/Rfp1 and Brl1/Rfp2.','2013-10-27','NSRP'),(17170,33504,'floor plate development','P','The progression of the floor plate over time from its initial formation until its mature state.','2013-10-27','NSRP'),(17171,33505,'floor plate morphogenesis','P','The process in which the anatomical structure of the floor plate is generated and organized.','2013-10-27','NSRP'),(17172,33506,'glucosinolate biosynthetic process from homomethionine','P','The chemical reactions and pathways resulting in the formation of glucosinolates from other compounds including homomethionine.','2013-10-27','NSRP'),(17173,33507,'glucosinolate biosynthetic process from phenylalanine','P','The chemical reactions and pathways resulting in the formation of glucosinolates from other compounds including phenylalanine.','2013-10-27','NSRP'),(17174,33508,'glutamate catabolic process to butyrate','P','The chemical reactions and pathways resulting in the breakdown of glutamate into other compounds, including butyrate.','2013-10-27','NSRP'),(17175,33509,'glutamate catabolic process to propionate','P','The chemical reactions and pathways resulting in the breakdown of glutamate into other compounds, including propionate.','2013-10-27','NSRP'),(17176,33510,'luteolin metabolic process','P','The chemical reactions and pathways involving luteolin, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one.','2013-10-27','NSRP'),(17177,33511,'luteolin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of luteolin, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one.','2013-10-27','NSRP'),(17178,33512,'L-lysine catabolic process to acetyl-CoA via saccharopine','P','The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including acetyl-CoA, via the intermediate saccharopine.','2013-10-27','NSRP'),(17179,33513,'L-lysine catabolic process to acetyl-CoA via 5-aminopentanamide','P','The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including acetyl-CoA, via the intermediate 5-aminopentanamide.','2013-10-27','NSRP'),(17180,33514,'L-lysine catabolic process to acetyl-CoA via L-pipecolate','P','The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including acetyl-CoA, via the intermediate L-pipecolate.','2013-10-27','NSRP'),(17181,33515,'L-lysine catabolic process using lysine 6-aminotransferase','P','The chemical reactions and pathways resulting in the breakdown of L-lysine into other compounds, including alpha-aminoadipate; in this pathway, L-lysine is converted to 2-aminoadipate-6-semialdehyde by lysine 6-aminotransferase.','2013-10-27','NSRP'),(17182,33516,'L-methionine biosynthetic process from homoserine via O-phospho-L-homoserine and cystathionine','P','The chemical reactions and pathways resulting in the formation of L-methionine from other compounds, including homoserine, via the intermediates O-phospho-L-homoserine and cystathionine.','2013-10-27','NSRP'),(17183,33517,'myo-inositol hexakisphosphate metabolic process','P','The chemical reactions and pathways involving phytic acid, myo-inositol hexakisphosphate, a regulator of intracellular signaling, a highly abundant animal anti-nutrient and a phosphate and mineral storage compound in plant seeds.','2013-10-27','NSRP'),(17184,33518,'myo-inositol hexakisphosphate dephosphorylation','P','The process of removing one or more phosphate group from myo-inositol hexakisphosphate.','2013-10-27','NSRP'),(17185,33519,'phytyl diphosphate metabolic process','P','The chemical reactions and pathways involving phytyl diphosphate, (2E)-3,7,11,15-tetramethylhexadec-2-en-1-yl trihydrogen diphosphate.','2013-10-27','NSRP'),(17186,33520,'phytol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of phytol, (2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol.','2013-10-27','NSRP'),(17187,33521,'phytyl diphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of phytyl diphosphate, (2E)-3,7,11,15-tetramethylhexadec-2-en-1-yl trihydrogen diphosphate.','2013-10-27','NSRP'),(17188,33522,'histone H2A ubiquitination','P','The modification of histone H2A by addition of one or more ubiquitin groups.','2013-10-27','NSRP'),(17189,33523,'histone H2B ubiquitination','P','The modification of histone H2B by addition of ubiquitin groups.','2013-10-27','NSRP'),(17190,33524,'sinapate ester metabolic process','P','The chemical reactions and pathways involving ester derivatives of sinapate, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate.','2013-10-27','NSRP'),(17191,33525,'sinapate ester biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ester derivates of sinapate, (2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate.','2013-10-27','NSRP'),(17192,33526,'tetrapyrrole biosynthetic process from glutamate','P','The chemical reactions and pathways leading to the formation of tetrapyrroles, natural pigments containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next, from other compounds, including L-glutamate.','2013-10-27','NSRP'),(17193,33527,'tetrapyrrole biosynthetic process from glycine and succinyl-CoA','P','The chemical reactions and pathways leading to the formation of tetrapyrroles, natural pigments containing four pyrrole rings joined by one-carbon units linking position 2 of one pyrrole ring to position 5 of the next, from other compounds, including glycine and succinyl-CoA.','2013-10-27','NSRP'),(17194,33528,'S-methylmethionine cycle','P','A cyclic series of interconversions involving S-methyl-L-methionine, S-adenosyl-L-homocysteine, S-adenosyl-L-methionine, L-homocysteine, and L-methionine. Converts the methionine group of adenosylmethionine back to free methionine, and may serve regulate the cellular adenosylmethionine level.','2013-10-27','NSRP'),(17195,33529,'raffinose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of raffinose, the trisaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17196,33530,'raffinose metabolic process','P','The chemical reactions and pathways involving raffinose, the trisaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17197,33531,'stachyose metabolic process','P','The chemical reactions and pathways involving stachyose, the tetrasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17198,33532,'stachyose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of stachyose, the tetrasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17199,33533,'verbascose metabolic process','P','The chemical reactions and pathways involving verbascose, the pentasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17200,33534,'verbascose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of verbascose, the pentasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17201,33535,'ajugose metabolic process','P','The chemical reactions and pathways involving ajugose, the hexasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17202,33536,'ajugose biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ajugose, the hexasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(17203,33537,'ajugose biosynthetic process using galactinol:raffinose galactosyltransferase','P','The chemical reactions and pathways resulting in the formation of ajugose, the hexasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside, by a pathway in which galactinol:raffinose galactosyltransferase catalyzes chain elongation by transferring the alpha-galactosyl residue of galactinol to the oligosaccharide.','2013-10-27','NSRP'),(17204,33538,'ajugose biosynthetic process using galactan:galactan galactosyltransferase','P','The chemical reactions and pathways resulting in the formation of ajugose, the hexasaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside, by a pathway in which galactan:galactan galactosyltransferase catalyzes chain elongation by transferring the alpha-galactosyl residue of one raffinose-family oligosaccharide to another.','2013-10-27','NSRP'),(17205,33539,'fatty acid beta-oxidation using acyl-CoA dehydrogenase','P','A fatty acid beta-oxidation pathway in which the initial step of each oxidation cycle, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA dehydrogenase; the electrons removed by oxidation pass through the respiratory chain to oxygen and leave H2O as the product. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).','2013-10-27','NSRP'),(17206,33540,'fatty acid beta-oxidation using acyl-CoA oxidase','P','A fatty acid beta-oxidation pathway in which the initial step, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA oxidase; the electrons removed by oxidation pass directly to oxygen and produce hydrogen peroxide, which is cleaved by peroxisomal catalases. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).','2013-10-27','NSRP'),(17207,33541,'fatty acid beta-oxidation, unsaturated, odd number','P','A fatty acid beta-oxidation pathway by which fatty acids having cis-double bonds on odd-numbered carbons are degraded. In this pathway, a cis-3-enoyl-CoA is generated by the core beta-oxidation pathway, and then converted to a trans-2-enoyl-CoA, which can return to the core beta-oxidation pathway for complete degradation. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).','2013-10-27','NSRP'),(17208,33542,'fatty acid beta-oxidation, unsaturated, even number','P','A fatty acid beta-oxidation pathway by which fatty acids having cis-double bonds on even-numbered carbons are degraded. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).','2013-10-27','NSRP'),(17209,33543,'fatty acid beta-oxidation, unsaturated, even number, reductase/isomerase pathway','P','A fatty acid beta-oxidation pathway by which fatty acids having cis-double bonds on even-numbered carbons are degraded. In this pathway, the intermediate 2,4-dienoyl-CoA is converted to trans-2-enoyl-CoA by 2,4-dienoyl-CoA reductase and delta3-delta2-enoyl-CoA isomerase; trans-2-enoyl-CoA returns to the core beta-oxidation pathway for further degradation. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).','2013-10-27','NSRP'),(17210,33544,'fatty acid beta-oxidation, unsaturated, even number, epimerase pathway','P','A fatty acid beta-oxidation pathway by which fatty acids having cis-double bonds on even-numbered carbons are degraded. In this pathway, the intermediate 2,4-dienoyl-CoA is converted to cis-2-enoyl-CoA through one more cycle of the core beta-oxidation pathway. Cis-2-enoyl-CoA cannot be completely degraded via the core beta-oxidation pathway because hydratation of cis-2-enoyl-CoA yields D-3-hydroxyacyl-CoA, which is not a substrate for 3-hydroxylacyl-CoA dehydrogenase. Cis-2-enoyl-CoA must enter the so-called epimerase pathway, which involves converting D-3-hydroxyacyl-CoA to L-3-hydroxyacyl-CoA by 3-hydroxylacyl-CoA epimerase or by two stereo-specific enoyl-CoA hydratases. L-3-hydroxyacyl-CoA then returns to the core beta-oxidation pathway. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).','2013-10-27','NSRP'),(17211,33545,'myo-inositol hexakisphosphate biosynthetic process, lipid-dependent','P','The chemical reactions and pathways resulting in the formation of 1D-myo-inositol 1,2,3,4,5,6-hexakisphosphate, phytate, by a pathway using inositol 1,4,5-trisphosphate produced from phosphatidylinositol 4,5-biphosphate hydrolysis by phospholipase C.','2013-10-27','NSRP'),(17212,33546,'myo-inositol hexakisphosphate biosynthetic process, via inositol 1,3,4-trisphosphate','P','The chemical reactions and pathways resulting in the formation of 1D-myo-inositol 1,2,3,4,5,6-hexakisphosphate, phytate, by a pathway using inositol 1,4,5-trisphosphate produced from phosphatidylinositol 4,5-biphosphate hydrolysis by phospholipase C; in this pathway, inositol 1,4,5-trisphosphate is first converted to inositol 1,3,4-trisphosphate, and then phosphorylated further.','2013-10-27','NSRP'),(17213,33547,'myo-inositol hexakisphosphate biosynthetic process, via direct phosphorylation of inositol 1,4,5-trisphosphate','P','OBSOLETE. The chemical reactions and pathways resulting in the formation of 1D myo-inositol 1,2,3,4,5,6-hexakisphosphate, phytate, by a pathway using inositol 1,4,5-trisphosphate produced from phosphatidylinositol 4,5-biphosphate hydrolysis by phospholipase C; in this pathway, inositol 1,4,5-trisphosphate is successively phosphorylated to yield inositol hexakisphosphate.','2013-10-27','NSRP'),(17214,33548,'myo-inositol hexakisphosphate biosynthetic process, lipid-independent','P','The chemical reactions and pathways resulting in the formation of phytic acid, myo-inositol hexakisphosphate, by the successively phosphorylation of myo-inositol or an inositol trisphosphate; the inositol trisphosphates that may be used by this pathway are inositol 3,4,5-trisphosphate and inositol 3,4,6trisphosphate.','2013-10-27','NSRP'),(17215,33549,'MAP kinase phosphatase activity','F','Catalysis of the reaction: a phosphorylated MAP kinase + H2O = a MAP kinase + phosphate.','2013-10-27','NSRP'),(17216,33550,'MAP kinase tyrosine phosphatase activity','F','Catalysis of the reaction: MAP kinase tyrosine phosphate + H2O = MAP kinase tyrosine + phosphate.','2013-10-27','NSRP'),(17217,33551,'monopolin complex','C','A protein complex required for clamping microtubule binding sites, ensuring orientation of sister kinetochores to the same pole (mono-orientation) during meiosis I. In the yeast S. cerevisiae this complex consists of Csm1p, Lrs4p, Hrr25p and Mam1p; in S. pombe Psc1 and Mde4 have been identified as subunits.','2013-10-27','NSRP'),(17218,33552,'response to vitamin B3','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B3 stimulus.','2013-10-27','NSRP'),(17219,33553,'rDNA heterochromatin','C','A region of heterochromatin located at the rDNA repeats in a chromosome.','2013-10-27','NSRP'),(17220,33554,'cellular response to stress','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).','2013-10-27','NSRP'),(17221,33555,'multicellular organismal response to stress','P','Any process that results in a change in state or activity of a multicellular organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).','2013-10-27','NSRP'),(17222,33556,'dolichyl pyrophosphate Man7GlcNAc2 alpha-1,3-glucosyltransferase activity','F','Catalysis of the addition of a glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation; the transfer of glucose from dolichyl phosphate glucose (Dol-P-Glc) on to the lipid-linked oligosaccharide Man(7)GlcNAc(2)-PP-Dol.','2013-10-27','NSRP'),(17223,33557,'Slx1-Slx4 complex','C','A heterodimeric protein complex that possesses an endonuclease activity that specifically cleaves certain types of branched DNA structures; because such structures often form during the replication ribosomal DNA (rDNA) repeats, the complex plays a role in the maintenance of rDNA. The subunits are known as Slx1 and Slx 4 in budding and fission yeasts, and are conserved in eukaryotes.','2013-10-27','NSRP'),(17224,33558,'protein deacetylase activity','F','Catalysis of the hydrolysis of an acetyl group or groups from a protein substrate.','2013-10-27','NSRP'),(17225,33559,'unsaturated fatty acid metabolic process','P','The chemical reactions and pathways involving an unsaturated fatty acid, any fatty acid containing one or more double bonds between carbon atoms.','2013-10-27','NSRP'),(17226,33560,'folate reductase activity','F','Catalysis of the reaction: 7,8-dihydrofolate + NADP+ = folate + NADPH + H+.','2013-10-27','NSRP'),(17227,33561,'regulation of water loss via skin','P','A process that modulates the rate or extent of water loss from an organism via the skin.','2013-10-27','NSRP'),(17228,33562,'co-transcriptional gene silencing by RNA interference machinery','P','A process in which the RNAi machinery mediates the degradation of nascent transcripts in association with chromatin.','2013-10-27','NSRP'),(17229,33563,'dorsal/ventral axon guidance','P','The process in which the migration of an axon growth cone is directed to a specific target site along the dorsal-ventral body axis in response to a combination of attractive and repulsive cues. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.','2013-10-27','NSRP'),(17230,33564,'anterior/posterior axon guidance','P','The process in which the migration of an axon growth cone is directed to a specific target site along the anterior-posterior body axis in response to a combination of attractive and repulsive cues. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.','2013-10-27','NSRP'),(17231,33565,'ESCRT-0 complex','C','A protein complex required for the recycling of Golgi proteins, formation of lumenal membranes and sorting of ubiquitinated proteins into those membranes. This complex includes Vps1p and Hse1p in yeast and the Hrs and STAM proteins in mammals.','2013-10-27','NSRP'),(17232,33566,'gamma-tubulin complex localization','P','Any process in which a gamma-tubulin complex is transported to, or maintained in, a specific location.','2013-10-27','NSRP'),(17233,33567,'DNA replication, Okazaki fragment processing','P','The DNA metabolic process, occurring during lagging strand synthesis, by which RNA primers are removed from Okazaki fragments, the resulting gaps filled by DNA polymerization, and the ends ligated to form a continuous strand.','2013-10-27','NSRP'),(17234,33568,'lactoferrin receptor activity','F','Combining with lactoferrin and delivering lactoferrin into the cell via endocytosis. Lactoferrin is an iron-binding glycoprotein which binds ferric iron most efficiently at low pH.','2013-10-27','NSRP'),(17235,33569,'lactoferrin transmembrane transporter activity','F','Catalysis of the transfer of lactoferrin from one side of a membrane to the other.','2013-10-27','NSRP'),(17236,33570,'transferrin transmembrane transporter activity','F','Catalysis of the transfer of transferrin from one side of a membrane to the other.','2013-10-27','NSRP'),(17237,33571,'lactoferrin transport','P','The directed movement of lactoferrin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(17238,33572,'transferrin transport','P','The directed movement of transferrin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(17239,33573,'high affinity iron permease complex','C','A protein complex composed of a multicopper ferroxidase that oxidizes Fe(II) to Fe(III), and a ferric iron permease that transports the produced Fe(III) into the cell.','2013-10-27','NSRP'),(17240,33574,'response to testosterone stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.','2013-10-27','NSRP'),(17241,33575,'protein glycosylation at cell surface','P','The addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid at the surface of a cell.','2013-10-27','NSRP'),(17242,33576,'protein glycosylation in cytosol','P','The addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid in the cytosol.','2013-10-27','NSRP'),(17243,33577,'protein glycosylation in endoplasmic reticulum','P','The addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid in the endoplasmic reticulum.','2013-10-27','NSRP'),(17244,33578,'protein glycosylation in Golgi','P','The addition of a carbohydrate or carbohydrate derivative unit to a protein amino acid in any compartment of the Golgi apparatus.','2013-10-27','NSRP'),(17245,33579,'protein galactosylation in endoplasmic reticulum','P','The addition of a galactose unit to a protein amino acid in the endoplasmic reticulum.','2013-10-27','NSRP'),(17246,33580,'protein galactosylation at cell surface','P','The addition of a galactose unit to a protein amino acid at the surface of a cell.','2013-10-27','NSRP'),(17247,33581,'protein galactosylation in Golgi','P','The addition of a galactose unit to a protein amino acid in any compartment of the Golgi apparatus.','2013-10-27','NSRP'),(17248,33582,'protein galactosylation in cytosol','P','The addition of a galactose unit to a protein amino acid in the cytosol.','2013-10-27','NSRP'),(17249,33583,'rhabdomere membrane','C','The portion of the plasma membrane surrounding the rhabdomere.','2013-10-27','NSRP'),(17250,33584,'tyrosine biosynthetic process from chorismate via L-arogenate','P','The chemical reactions and pathways resulting in the formation of tyrosine from other compounds, including chorismate, via the intermediate L-arogenate.','2013-10-27','NSRP'),(17251,33585,'L-phenylalanine biosynthetic process from chorismate via phenylpyruvate','P','The chemical reactions and pathways resulting in the formation of L-phenylalanine from other compounds, including chorismate, via the intermediate phenylpyruvate.','2013-10-27','NSRP'),(17252,33586,'L-phenylalanine biosynthetic process from chorismate via L-arogenate','P','The chemical reactions and pathways resulting in the formation of L-phenylalanine from other compounds, including chorismate, via the intermediate L-arogenate.','2013-10-27','NSRP'),(17253,33587,'shikimate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of shikimate, (3R,4S,5R)--3,4,5-trihydroxycyclohex-1-ene-1-carboxylate, the anion of shikimic acid.','2013-10-27','NSRP'),(17254,33588,'Elongator holoenzyme complex','C','A heterohexameric protein complex that is involved in modification of wobble nucleosides in tRNA, and exerts direct effects on transcriptional elongation and exocytosis. The complex can associate physically with hyperphosphorylated RNA polymerase II; it contains two discrete heterotrimeric subcomplexes.','2013-10-27','NSRP'),(17255,33590,'response to cobalamin','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cobalamin (vitamin B12) stimulus.','2013-10-27','NSRP'),(17256,33591,'response to L-ascorbic acid','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an L-ascorbic acid (vitamin C) stimulus.','2013-10-27','NSRP'),(17257,33592,'RNA strand annealing activity','F','Facilitates the base-pairing of complementary single-stranded RNA.','2013-10-27','NSRP'),(17258,33593,'BRCA2-MAGE-D1 complex','C','A heterodimeric protein complex formed of BRCA2 and MAGE-D1; may mediate the synergistic activities of the two proteins in regulating cell growth.','2013-10-27','NSRP'),(17259,33594,'response to hydroxyisoflavone','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroxyisoflavone stimulus.','2013-10-27','NSRP'),(17260,33595,'response to genistein','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a genistein stimulus.','2013-10-27','NSRP'),(17261,33596,'TSC1-TSC2 complex','C','A protein complex consisting of at least tumerin and hamartin; its formation may regulate hamartin homomultimer formation. The complex acts as a GTPase activating protein (GAP) for the small GTPase (Rheb), and inhibits the TOR signaling pathway.','2013-10-27','NSRP'),(17262,33597,'mitotic checkpoint complex','C','A multiprotein complex that functions as a mitotic checkpoint inhibitor of the anaphase-promoting complex/cyclosome (APC/C). In budding yeast this complex consists of Mad2p, Mad3p, Bub3p and Cdc20p, and in mammalian cells it consists of MAD2, BUBR1, BUB3, and CDC20.','2013-10-27','NSRP'),(17263,33598,'mammary gland epithelial cell proliferation','P','The multiplication or reproduction of mammary gland epithelial cells, resulting in the expansion of a cell population. Mammary gland epithelial cells make up the covering of surfaces of the mammary gland. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.','2013-10-27','NSRP'),(17264,33599,'regulation of mammary gland epithelial cell proliferation','P','Any process that modulates the frequency, rate or extent of mammary gland epithelial cell proliferation.','2013-10-27','NSRP'),(17265,33600,'negative regulation of mammary gland epithelial cell proliferation','P','Any process that stops, prevents or reduces the rate or extent of mammary gland epithelial cell proliferation.','2013-10-27','NSRP'),(17266,33601,'positive regulation of mammary gland epithelial cell proliferation','P','Any process that activates or increases the rate or extent of mammary gland epithelial cell proliferation.','2013-10-27','NSRP'),(17267,33602,'negative regulation of dopamine secretion','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of dopamine.','2013-10-27','NSRP'),(17268,33603,'positive regulation of dopamine secretion','P','Any process that activates or increases the frequency, rate or extent of the regulated release of dopamine.','2013-10-27','NSRP'),(17269,33604,'negative regulation of catecholamine secretion','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of a catecholamine.','2013-10-27','NSRP'),(17270,33605,'positive regulation of catecholamine secretion','P','Any process that activates or increases the frequency, rate or extent of the regulated release of a catecholamine.','2013-10-27','NSRP'),(17271,33606,'chemokine receptor transport within lipid bilayer','P','The directed movement of a chemokine receptor within a lipid bilayer.','2013-10-27','NSRP'),(17272,33607,'SOD1-Bcl-2 complex','C','A heterodimeric protein complex formed of superoxide dismutase 1 and Bcl-2. Complex formation is thought to link superoxide dismutase to an apoptotic pathway.','2013-10-27','NSRP'),(17273,33608,'formyl-CoA transferase activity','F','Catalysis of the reaction: formyl-CoA + oxalate = formate + oxalyl-CoA.','2013-10-27','NSRP'),(17274,33609,'oxalate metabolic process','P','The chemical reactions and pathways involving oxalate, the organic acid ethanedioate.','2013-10-27','NSRP'),(17275,33610,'oxalate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of oxalate, the organic acid ethanedioate.','2013-10-27','NSRP'),(17276,33611,'oxalate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of oxalate, the organic acid ethanedioate.','2013-10-27','NSRP'),(17277,33612,'receptor serine/threonine kinase binding','F','Interacting selectively and non-covalently with a receptor that possesses protein serine/threonine kinase activity.','2013-10-27','NSRP'),(17278,33613,'activating transcription factor binding','F','Interacting selectively and non-covalently with an activating transcription factor, any protein whose activity is required to initiate or upregulate transcription.','2013-10-27','NSRP'),(17279,33614,'chloroplast proton-transporting ATP synthase complex assembly','P','The aggregation, arrangement and bonding together of a proton-transporting ATP synthase in the chloroplast thylakoid membrane.','2013-10-27','NSRP'),(17280,33615,'mitochondrial proton-transporting ATP synthase complex assembly','P','The aggregation, arrangement and bonding together of a proton-transporting ATP synthase in the mitochondrial inner membrane.','2013-10-27','NSRP'),(17281,33616,'plasma membrane proton-transporting ATP synthase complex assembly','P','The aggregation, arrangement and bonding together of a proton-transporting ATP synthase in the plasma membrane.','2013-10-27','NSRP'),(17282,33617,'mitochondrial respiratory chain complex IV assembly','P','The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex IV (also known as cytochrome c oxidase) in the mitochondrial inner membrane.','2013-10-27','NSRP'),(17283,33618,'plasma membrane respiratory chain complex IV assembly','P','The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex IV (also known as cytochrome c oxidase) in the plasma membrane.','2013-10-27','NSRP'),(17284,33619,'membrane protein proteolysis','P','The proteolytic cleavage of a transmembrane protein leading to the release of its intracellular or ecto-domains.','2013-10-27','NSRP'),(17285,33620,'Mei2 nuclear dot','C','A nuclear body that forms during meiotic prophase in a fixed position in the horsetail nucleus; contains Mei2 and meiRNA. May play a role in the progression of meiosis I.','2013-10-27','NSRP'),(17286,33621,'nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts','P','The chemical reactions and pathways resulting in the selective degradation of meiosis-specific transcripts during vegetative growth, by a mechanism that requires determinant of selective removal (DSR) sequences in the targeted mRNAs and involves a YTH family protein.','2013-10-27','NSRP'),(17287,33622,'integrin activation','P','The aggregation, arrangement and bonding together of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, that lead to the increased affinity of the integrin for its extracellular ligands.','2013-10-27','NSRP'),(17288,33623,'regulation of integrin activation','P','Any process that modulates the frequency, rate, or extent of integrin activation.','2013-10-27','NSRP'),(17289,33624,'negative regulation of integrin activation','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of integrin activation.','2013-10-27','NSRP'),(17290,33625,'positive regulation of integrin activation','P','Any process that activates or increases the frequency, rate, or extent of integrin activation.','2013-10-27','NSRP'),(17291,33626,'positive regulation of integrin activation by cell surface receptor linked signal transduction','P','Any series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell that lead to the increased affinity of an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits, for its extracellular ligands.','2013-10-27','NSRP'),(17292,33627,'cell adhesion mediated by integrin','P','The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.','2013-10-27','NSRP'),(17293,33628,'regulation of cell adhesion mediated by integrin','P','Any process that modulates the frequency, rate, or extent of cell adhesion mediated by integrin.','2013-10-27','NSRP'),(17294,33629,'negative regulation of cell adhesion mediated by integrin','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin.','2013-10-27','NSRP'),(17295,33630,'positive regulation of cell adhesion mediated by integrin','P','Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin.','2013-10-27','NSRP'),(17296,33631,'cell-cell adhesion mediated by integrin','P','The attachment of one cell to another cell via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.','2013-10-27','NSRP'),(17297,33632,'regulation of cell-cell adhesion mediated by integrin','P','Any process that modulates the frequency, rate, or extent of cell-cell adhesion mediated by integrin.','2013-10-27','NSRP'),(17298,33633,'negative regulation of cell-cell adhesion mediated by integrin','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of cell-cell adhesion mediated by integrin.','2013-10-27','NSRP'),(17299,33634,'positive regulation of cell-cell adhesion mediated by integrin','P','Any process that activates or increases the frequency, rate, or extent of cell-cell adhesion mediated by integrin.','2013-10-27','NSRP'),(17300,33635,'modulation by symbiont of host response to abiotic stimulus','P','Any process in which an organism modulates a change in the state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an abiotic (non-living) stimulus. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17301,33636,'modulation by symbiont of host response to temperature stimulus','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17302,33637,'modulation by symbiont of host response to cold','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cold stimulus, a temperature stimulus below the optimal temperature for that organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17303,33638,'modulation by symbiont of host response to heat','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17304,33639,'modulation by symbiont of host response to water','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a water stimulus. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17305,33640,'modulation by symbiont of host response to osmotic stress','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17306,33641,'modulation by symbiont of host response to pH','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17307,33642,'modulation by symbiont of host response to gravitational stimulus','P','Any process in which an organism modulates a change in state or activity of a host cell or organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gravitational stimulus. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17308,33643,'host cell part','C','Any constituent part of a host cell. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17309,33644,'host cell membrane','C','Double layer of lipid molecules as it encloses host cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17310,33645,'host cell endomembrane system','C','A collection of membranous structures involved in transport within the host cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17311,33646,'host intracellular part','C','Any constituent part of the living contents of a host cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17312,33647,'host intracellular organelle','C','Organized structure of distinctive morphology and function, occurring within the host cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17313,33648,'host intracellular membrane-bounded organelle','C','Organized structure of distinctive morphology and function, as found in host cells, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17314,33650,'host cell mitochondrion','C','A semiautonomous, self replicating organelle as found in host cells that occurs in varying numbers, shapes, and sizes in the cell cytoplasm. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17315,33651,'host cell plastid','C','Any member of a family of organelles as found in the cytoplasm of host cells, which are membrane-bounded and contain DNA. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17316,33652,'host cell chloroplast','C','A chlorophyll-containing plastid as found within host cells with thylakoids organized into grana and frets, or stroma thylakoids, and embedded in a stroma. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17317,33653,'host cell chloroplast part','C','Any constituent part of a chloroplast as it is found in host cells and which are a chlorophyll-containing plastid with thylakoids organized into grana and frets, or stroma thylakoids, and embedded in a stroma. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17318,33654,'host cell chloroplast thylakoid membrane','C','Any sac-like membranous structures (cisternae) in a chloroplast found in host cells, combined into stacks (grana) and present singly in the stroma (stroma thylakoids or frets) as interconnections between grana. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17319,33655,'host cell cytoplasm part','C','Any constituent part of the host cell cytoplasm, all of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17320,33656,'modification by symbiont of host chloroplast','P','The process in which an organism effects a change in the structure or function of host cell chloroplasts. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17321,33657,'modification by symbiont of host chloroplast part','P','The process in which an organism effects a change in the structure or function of a component of the host cell chloroplast. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17322,33658,'modification by symbiont of host chloroplast thylakoid','P','The process in which an organism effects a change in the structure or function of the host cell chloroplast thylakoid. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17323,33659,'modification by symbiont of host mitochondrion','P','The process in which an organism effects a change in the structure or function of host cell mitochondria. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17324,33660,'negative regulation by symbiont of host resistance gene-dependent defense response','P','Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of the resistance gene-dependent defense response of the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17325,33661,'negative regulation by symbiont of defense-related host reactive oxygen species production','P','Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of the production of reactive oxygen species as part of the defense response of the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17326,33662,'modulation by symbiont of host defense-related protein level','P','The alternation by a symbiont of the levels of defense-related proteins in its host. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17327,33663,'negative regulation by symbiont of host defense-related protein level','P','Any process in which the symbiont stops or reduces of the levels of defense-related proteins in its host. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17328,33664,'positive regulation by symbiont of host defense-related protein level','P','Any process in which the symbiont activates, maintains or increases levels of defense-related proteins in its host. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17329,33665,'regulation of growth or development of symbiont in host','P','OBSOLETE. Any process by which the symbiont regulates the increase in its size or mass, or its progression from an initial condition to a later condition, within the cells or tissues of the host organism. This may (but not necessarily) include a filamentous growth form, and also can include secretion of proteases and lipases to break down. The host is defined as the larger of the organisms involved in the symbiotic interaction.','2013-10-27','NSRP'),(17330,33666,'positive regulation of growth or development of symbiont in host','P','OBSOLETE. Any process by which the symbiont activates, maintains or increases its size or mass or its progression from an initial condition to a later condition, within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction.','2013-10-27','NSRP'),(17331,33667,'negative regulation of growth or development of symbiont in host','P','OBSOLETE. Any process by which the symbiont stops, prevents or reduces its increase in size or mass or its progression from an initial condition to a later condition, within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction.','2013-10-27','NSRP'),(17332,33668,'negative regulation by symbiont of host apoptotic process','P','Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of programmed cell death in the host, where programmed cell death proceeds by apoptosis. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17333,33670,'regulation of NAD+ kinase activity','P','Any process that modulates the frequency, rate or extent of NAD kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an NAD molecule.','2013-10-27','NSRP'),(17334,33671,'negative regulation of NAD+ kinase activity','P','Any process that stops, prevents, or reduces the frequency, rate or extent of NAD kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an NAD molecule.','2013-10-27','NSRP'),(17335,33672,'positive regulation of NAD+ kinase activity','P','Any process that activates or increases the frequency, rate or extent of NAD kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an NAD molecule.','2013-10-27','NSRP'),(17336,33673,'negative regulation of kinase activity','P','Any process that stops, prevents, or reduces the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.','2013-10-27','NSRP'),(17337,33674,'positive regulation of kinase activity','P','Any process that activates or increases the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.','2013-10-27','NSRP'),(17338,33675,'pericanalicular vesicle','C','A membrane-bounded vesicle found near the apical, or pericanalicular, membrane of a hepatocyte; contains proteins involved in bile salt transport and other fluid and solute transport processes.','2013-10-27','NSRP'),(17339,33676,'double-stranded DNA-dependent ATPase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction requires the presence of double-stranded DNA, and it drives another reaction.','2013-10-27','NSRP'),(17340,33677,'DNA/RNA helicase activity','F','Catalysis of the reaction: NTP + H2O = NDP + phosphate; this reaction drives the unwinding of a DNA/RNA duplex, i.e. a double helix in which a strand of DNA pairs with a complementary strand of RNA.','2013-10-27','NSRP'),(17341,33678,'5\'-3\' DNA/RNA helicase activity','F','Catalysis of the unwinding of a DNA/RNA duplex in the direction 5\' to 3\'.','2013-10-27','NSRP'),(17342,33679,'3\'-5\' DNA/RNA helicase activity','F','Catalysis of the unwinding of a DNA/RNA duplex in the direction 3\' to 5\'.','2013-10-27','NSRP'),(17343,33680,'ATP-dependent DNA/RNA helicase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of a DNA/RNA duplex.','2013-10-27','NSRP'),(17344,33681,'ATP-dependent 3\'-5\' DNA/RNA helicase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of a DNA/RNA duplex in the direction 3\' to 5\'.','2013-10-27','NSRP'),(17345,33682,'ATP-dependent 5\'-3\' DNA/RNA helicase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of a DNA/RNA duplex in the direction 5\' to 3\'.','2013-10-27','NSRP'),(17346,33683,'nucleotide-excision repair, DNA incision','P','A process that results in the endonucleolytic cleavage of the damaged strand of DNA. The incision occurs at the junction of single-stranded DNA and double-stranded DNA that is formed when the DNA duplex is unwound.','2013-10-27','NSRP'),(17347,33684,'regulation of luteinizing hormone secretion','P','Any process that modulates the frequency, rate or extent of the regulated release of luteinizing hormone.','2013-10-27','NSRP'),(17348,33685,'negative regulation of luteinizing hormone secretion','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of luteinizing hormone.','2013-10-27','NSRP'),(17349,33686,'positive regulation of luteinizing hormone secretion','P','Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.','2013-10-27','NSRP'),(17350,33687,'osteoblast proliferation','P','The multiplication or reproduction of osteoblasts, resulting in the expansion of an osteoblast cell population. An osteoblast is a bone-forming cell which secretes an extracellular matrix. Hydroxyapatite crystals are then deposited into the matrix to form bone.','2013-10-27','NSRP'),(17351,33688,'regulation of osteoblast proliferation','P','Any process that modulates the frequency, rate or extent of osteoblast proliferation.','2013-10-27','NSRP'),(17352,33689,'negative regulation of osteoblast proliferation','P','Any process that stops, prevents or reduces the rate or extent of osteoblast proliferation.','2013-10-27','NSRP'),(17353,33690,'positive regulation of osteoblast proliferation','P','Any process that activates or increases the rate or extent of osteoblast proliferation.','2013-10-27','NSRP'),(17354,33691,'sialic acid binding','F','Interacting selectively and non-covalently with sialic acid, any of a variety of N- or O- substituted derivatives of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria.','2013-10-27','NSRP'),(17355,33692,'cellular polysaccharide biosynthetic process','P','The chemical reactions and pathways resulting in the formation of polysaccharides, polymers of many (typically more than 10) monosaccharide residues linked glycosidically, occurring at the level of an individual cell.','2013-10-27','NSRP'),(17356,33693,'neurofilament bundle assembly','P','The assembly of neurofilaments into bundles, in which the filaments are longitudinally oriented, with numerous crossbridges between them. Neurofilament bundles may be cross-linked to each other, to membrane-bounded organelles or other cytoskeletal structures such as microtubules.','2013-10-27','NSRP'),(17357,33694,'oxidoreductase activity, acting on the CH-NH group of donors, iron-sulfur protein as acceptor','F','Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH group acts as a hydrogen or electron donor and reduces an iron-sulfur protein.','2013-10-27','NSRP'),(17358,33695,'oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor','F','Catalysis of an oxidation-reduction (redox) reaction in which a CH2 group acts as a hydrogen or electron donor and reduces a quinone or similar acceptor molecule.','2013-10-27','NSRP'),(17359,33696,'negative regulation of extent of heterochromatin assembly','P','Any process that reduces the extent of heterochromatin formation; reduces the size of a chromosomal region converted to heterochromatin.','2013-10-27','NSRP'),(17360,33697,'positive regulation of extent of heterochromatin assembly','P','Any process that increases the extent of heterochromatin formation; increases the size of a chromosomal region converted to heterochromatin.','2013-10-27','NSRP'),(17361,33698,'Rpd3L complex','C','A histone deacetylase complex which deacetylates histones across gene coding regions. Composed of a catalytic histone deacetylase subunit, an Sds-3 family protein, a SIN3 family co-repressor, a WD repeat protein, and a zf- PHD finger (Clr6, Sds3, Pst1, Prw1, Png2 in Schizosaccharomyces pombe; Rpd3p, Sin3p, Ume1p, Pho23p, Sap30p, Sds3p, Cti6p, Rxt2p, Rxt3p, Dep1p, Ume6p and Ash1p in Saccharomyces cerevisiae).','2013-10-27','NSRP'),(17362,33699,'DNA 5\'-adenosine monophosphate hydrolase activity','F','Catalysis of the reaction: 5\'-AMP-DNA + H2O = AMP + DNA; nucleophilic release of a covalently linked adenylate residue from a DNA strand, leaving a 5\' phosphate terminus.','2013-10-27','NSRP'),(17363,33700,'phospholipid efflux','P','The directed movement of a phospholipid out of a cell or organelle.','2013-10-27','NSRP'),(17364,33701,'dTDP-galactose 6-dehydrogenase activity','F','Catalysis of the reaction: dTDP-D-galactose + 2 NADP+ + H2O = dTDP-D-galacturonate + 2 NADPH + 2 H+.','2013-10-27','NSRP'),(17365,33702,'(+)-trans-carveol dehydrogenase activity','F','Catalysis of the reaction: (1R,5S)-carveol + NAD(+) = (S)-carvone + H(+) + NADH.','2013-10-27','NSRP'),(17366,33703,'3beta-hydroxy-5beta-steroid dehydrogenase activity','F','Catalysis of the reaction: 3beta-hydroxy-5beta-pregnane-20-one + NADP(+) = 5beta-pregnan-3,20-dione + H(+) + NADPH.','2013-10-27','NSRP'),(17367,33704,'3beta-hydroxy-5alpha-steroid dehydrogenase activity','F','Catalysis of the reaction: 3beta-hydroxy-5alpha-pregnane-20-one + NADP(+) = 5alpha-pregnane-3,20-dione + H(+) + NADPH.','2013-10-27','NSRP'),(17368,33705,'GDP-4-dehydro-6-deoxy-D-mannose reductase activity','F','Catalysis of the reaction: GDP-6-deoxy-D-mannose + NAD(P)+ = GDP-4-dehydro-6-deoxy-D-mannose + NAD(P)H + H+.','2013-10-27','NSRP'),(17369,33706,'quinate/shikimate dehydrogenase activity','F','OBSOLETE. Catalysis of the reactions: L-quinate + NAD(P)+ = 3-dehydroquinate + NAD(P)H + H+, and shikimate + NAD(P)+ = 3-dehydroshikimate + NAD(P)H + H+.','2013-10-27','NSRP'),(17370,33707,'3\'\'-deamino-3\'\'-oxonicotianamine reductase activity','F','Catalysis of the reaction: 2\'-deoxymugineic acid + NAD(P)+ = 3\'\'-deamino-3\'\'-oxonicotianamine + NAD(P)H + H+.','2013-10-27','NSRP'),(17371,33708,'isocitrate-homoisocitrate dehydrogenase activity','F','Catalysis of the reactions: isocitrate + NAD+ = 2-oxoglutarate + CO2 + NADH, and (1R,2S)-1-hydroxybutane-1,2,4-tricarboxylate + NAD+ = 2-oxoadipate + CO2 + NADH + H+.','2013-10-27','NSRP'),(17372,33709,'D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity','F','Catalysis of the reaction: D-arabinitol + NADP+ = D-ribulose + NADPH + H+.','2013-10-27','NSRP'),(17373,33711,'4-phosphoerythronate dehydrogenase activity','F','Catalysis of the reaction: 4-phospho-D-erythronate + NAD(+) = (R)-3-hydroxy-2-oxo-4-phosphonooxybutanoate + H(+) + NADH.','2013-10-27','NSRP'),(17374,33712,'1,5-anhydro-D-fructose reductase (1,5-anhydro-D-mannitol-forming) activity','F','Catalysis of the reaction: 1,5-anhydro-D-mannitol + NADP(+) = 1,5-anhydro-D-fructose + H(+) + NADPH.','2013-10-27','NSRP'),(17375,33713,'choline:oxygen 1-oxidoreductase activity','F','Catalysis of the reaction: choline + O2 = betaine aldehyde + hydrogen peroxide.','2013-10-27','NSRP'),(17376,33714,'secondary-alcohol oxidase activity','F','Catalysis of the reaction: O(2) + secondary alcohol = H(2)O(2) + ketone.','2013-10-27','NSRP'),(17377,33715,'nucleoside oxidase activity','F','Catalysis of the reactions: inosine + O2 = 9-riburonosylhypoxanthine + 2 H2O; (1a) 2 inosine + O2 = 2 5\'-dehydroinosine + 2 H2O, and (1b) 2 5\'-dehydroinosine + O2 = 2 9-riburonosylhypoxanthine + 2 H2O.','2013-10-27','NSRP'),(17378,33716,'nucleoside oxidase (hydrogen peroxide-forming) activity','F','Catalysis of the reactions: adenosine + 2 O2 = 9-riburonosyladenine + 2 hydrogen peroxide; (1a) adenosine + O2 = 5\'-dehydroadenosine + hydrogen peroxide, and (1b) 5\'-dehydroadenosine + O2 = 9-riburonosyladenine + hydrogen peroxide.','2013-10-27','NSRP'),(17379,33717,'gluconate 2-dehydrogenase (acceptor) activity','F','Catalysis of the reaction: D-gluconate + acceptor = 2-dehydro-D-gluconate + reduced acceptor.','2013-10-27','NSRP'),(17380,33718,'pyranose dehydrogenase (acceptor) activity','F','Catalysis of the reactions: pyranose + acceptor = 2-dehydropyranose (or 3-dehydropyranose or 2,3-didehydropyranose) + reduced acceptor, and a pyranoside + acceptor = a 3-dehydropyranoside (or 3,4-didehydropyranoside) + reduced acceptor.','2013-10-27','NSRP'),(17381,33719,'2-oxo-acid reductase activity','F','Catalysis of the reaction: a (2R)-hydroxy-carboxylate + acceptor = a 2-oxo-carboxylate + reduced acceptor.','2013-10-27','NSRP'),(17382,33720,'(S)-mandelate dehydrogenase activity','F','Catalysis of the reaction: (S)-2-hydroxy-2-phenylacetate + acceptor = 2-oxo-2-phenylacetate + reduced acceptor.','2013-10-27','NSRP'),(17383,33721,'aldehyde dehydrogenase (NADP+) activity','F','Catalysis of the reaction: an aldehyde + NADP+ + H2O = an acid + NADPH + H+.','2013-10-27','NSRP'),(17384,33722,'malonate-semialdehyde dehydrogenase activity','F','Catalysis of the reaction: 3-oxopropanoate + NAD(P)+ + H2O = malonate + NAD(P)H + H+.','2013-10-27','NSRP'),(17385,33723,'fluoroacetaldehyde dehydrogenase activity','F','Catalysis of the reaction: fluoroacetaldehyde + NAD+ + H2O = fluoroacetate + NADH + 2 H+.','2013-10-27','NSRP'),(17386,33726,'aldehyde ferredoxin oxidoreductase activity','F','Catalysis of the reaction: an aldehyde + H2O + 2 oxidized ferredoxin = an acid + 2 H+ + 2 reduced ferredoxin.','2013-10-27','NSRP'),(17387,33727,'aldehyde dehydrogenase (FAD-independent) activity','F','Catalysis of the reaction: an aldehyde + H2O + acceptor = a carboxylate + reduced acceptor.','2013-10-27','NSRP'),(17388,33728,'divinyl chlorophyllide a 8-vinyl-reductase activity','F','Catalysis of the reaction: chlorophyllide a + NADP+ = divinyl chlorophyllide a + NADPH + H+.','2013-10-27','NSRP'),(17389,33729,'anthocyanidin reductase activity','F','Catalysis of the reaction: a flavan-3-ol + 2 NAD(P)+ = an anthocyanidin + 2 NAD(P)H + H+.','2013-10-27','NSRP'),(17390,33730,'arogenate dehydrogenase (NADP+) activity','F','Catalysis of the reaction: L-arogenate + NADP+ = L-tyrosine + NADPH + CO2.','2013-10-27','NSRP'),(17391,33731,'arogenate dehydrogenase [NAD(P)+] activity','F','Catalysis of the reaction: L-arogenate + NAD(P)+ = L-tyrosine + NAD(P)H + CO2.','2013-10-27','NSRP'),(17392,33732,'pyrroloquinoline-quinone synthase activity','F','Catalysis of the reaction: 6-(2-amino-2-carboxyethyl)-7,8-dioxo-1,2,3,4,7,8-hexahydroquinoline-2,4-dicarboxylate + 3 O(2) = 2 H(2)O + 2 H(2)O(2) + H(+) + pyrroloquinoline quinone.','2013-10-27','NSRP'),(17393,33734,'(R)-benzylsuccinyl-CoA dehydrogenase activity','F','Catalysis of the reaction: (R)-2-benzylsuccinyl-CoA + 2 electron-transferring flavoprotein = (E)-2-benzylidenesuccinyl-CoA + 2 reduced electron-transferring flavoprotein.','2013-10-27','NSRP'),(17394,33735,'aspartate dehydrogenase activity','F','Catalysis of the reaction: L-aspartate + H2O + NAD(P)+ = oxaloacetate + NH3 + NAD(P)H + H+.','2013-10-27','NSRP'),(17395,33736,'L-lysine 6-oxidase activity','F','Catalysis of the reaction: L-lysine + H(2)O + O(2) = allysine + H(2)O(2) + NH(4)(+).','2013-10-27','NSRP'),(17396,33737,'1-pyrroline dehydrogenase activity','F','Catalysis of the reaction: 1-pyrroline + NAD+ + 2 H2O = 4-aminobutanoate + NADH + 2 H+.','2013-10-27','NSRP'),(17397,33738,'methylenetetrahydrofolate reductase (ferredoxin) activity','F','Catalysis of the reaction: 5-methyltetrahydrofolate + oxidized ferredoxin = 5,10-methylenetetrahydrofolate + reduced ferredoxin.','2013-10-27','NSRP'),(17398,33739,'preQ1 synthase activity','F','Catalysis of the reaction: 7-aminomethyl-7-deazaguanine + 2 NADP(+) = 7-cyano-7-deazaguanine + 3 H(+) + 2 NADPH.','2013-10-27','NSRP'),(17399,33740,'hydroxylamine oxidoreductase activity','F','Catalysis of the reactions: hydroxylamine + NH3 = hydrazine + H2O, and hydrazine + acceptor = N2 + reduced acceptor.','2013-10-27','NSRP'),(17400,33741,'adenylyl-sulfate reductase (glutathione) activity','F','Catalysis of the reaction: AMP + glutathione disulfide + H(+) + sulfite = 5\'-adenylyl sulfate + 2 glutathione.','2013-10-27','NSRP'),(17401,33743,'peptide-methionine (R)-S-oxide reductase activity','F','Catalysis of the reaction: peptide-L-methionine + H(2)O + thioredoxin disulfide = peptide-L-methionine (R)-S-oxide + thioredoxin. Can act on oxidized methionine in peptide linkage with specificity for the R enantiomer. Thioredoxin disulfide is the oxidized form of thioredoxin.','2013-10-27','NSRP'),(17402,33744,'L-methionine-(S)-S-oxide reductase activity','F','Catalysis of the reaction: L-methionine + thioredoxin disulfide + H2O = L-methionine (S)-S-oxide + thioredoxin.','2013-10-27','NSRP'),(17403,33745,'L-methionine-(R)-S-oxide reductase activity','F','Catalysis of the reaction: L-methionine + thioredoxin disulfide + H2O = L-methionine (R)-S-oxide + thioredoxin.','2013-10-27','NSRP'),(17404,33746,'histone demethylase activity (H3-R2 specific)','F','Catalysis of the removal of a methyl group from arginine at position 2 of the histone H3 protein.','2013-10-27','NSRP'),(17405,33747,'versatile peroxidase activity','F','OBSOLETE. Catalysis of the reactions: Reactive Black 5 + hydrogen peroxide = oxidized Reactive Black 5 + 2 H2O, and donor + hydrogen peroxide = oxidized donor + 2 H2O.','2013-10-27','NSRP'),(17406,33748,'hydrogenase (acceptor) activity','F','Catalysis of the reaction: H2 + A = AH2.','2013-10-27','NSRP'),(17407,33749,'histone demethylase activity (H4-R3 specific)','F','Catalysis of the removal of a methyl group from arginine at position 3 of the histone H4 protein.','2013-10-27','NSRP'),(17408,33750,'ribosome localization','P','A process in which a ribosome is transported to, and/or maintained in, a specific location.','2013-10-27','NSRP'),(17409,33751,'linoleate diol synthase activity','F','Catalysis of the reaction: linoleate + O2 = (9Z,12Z)-(7S,8S)-dihydroxyoctadeca-9,12-dienoate.','2013-10-27','NSRP'),(17410,33752,'acetylacetone-cleaving enzyme activity','F','Catalysis of the reaction: pentane-2,4-dione + O2 = acetate + 2-oxopropanal.','2013-10-27','NSRP'),(17411,33753,'establishment of ribosome localization','P','The directed movement of the ribosome to a specific location.','2013-10-27','NSRP'),(17412,33754,'indoleamine 2,3-dioxygenase activity','F','Catalysis of the reaction: tryptophan + O2 = N-formylkynurenine. The product of the reaction depends on the substrate; D-tryptophan produces N-formyl-D-kynurenine, and L-tryptophan produces N-formyl-L-kynurenine.','2013-10-27','NSRP'),(17413,33755,'sulfur oxygenase/reductase activity','F','Catalysis of the reaction: 4 sulfur + 4 H2O + O2 = 2 hydrogen sulfide + 2 bisulfite + 2 H+.','2013-10-27','NSRP'),(17414,33756,'Oplophorus-luciferin 2-monooxygenase activity','F','Catalysis of the reaction: Oplophorus luciferin + O2 = oxidized Oplophorus luciferin + CO2 + hnu.','2013-10-27','NSRP'),(17415,33757,'glucoside 3-dehydrogenase activity','F','Catalysis of the reaction: sucrose + acceptor = 3-dehydro-alpha-D-glucosyl-beta-D-fructofuranoside + reduced acceptor.','2013-10-27','NSRP'),(17416,33758,'clavaminate synthase activity','F','Catalysis of the reactions: deoxyamidinoproclavaminate + 2-oxoglutarate + O2 = amidinoproclavaminate + succinate + CO2 + H2O; proclavaminate + 2-oxoglutarate + O2 = dihydroclavaminate + succinate + CO2 + 2 H2O; and dihydroclavaminate + 2-oxoglutarate + O2 = clavaminate + succinate + CO2 + 2 H2O.','2013-10-27','NSRP'),(17417,33759,'flavone synthase activity','F','Catalysis of the reaction: a flavanone + 2-oxoglutarate + O2 = a flavone + succinate + CO2 + H2O.','2013-10-27','NSRP'),(17418,33760,'2\'-deoxymugineic-acid 2\'-dioxygenase activity','F','Catalysis of the reaction: 2\'-deoxymugineate + 2-oxoglutarate + O(2) = CO(2) + H(+) + mugineate + succinate.','2013-10-27','NSRP'),(17419,33761,'mugineic-acid 3-dioxygenase activity','F','Catalysis of the reactions: mugineic acid + 2-oxoglutarate + O2 = 3-epihydroxymugineic acid + succinate + CO2.','2013-10-27','NSRP'),(17420,33762,'response to glucagon stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.','2013-10-27','NSRP'),(17421,33763,'proline 3-hydroxylase activity','F','Catalysis of the reaction: L-proline + 2-oxoglutarate + O2 = cis-3-hydroxy-L-proline + succinate + CO2.','2013-10-27','NSRP'),(17422,33764,'steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor','F','Catalysis of an oxidation-reduction (redox) reaction in which a CH-OH group acts as a hydrogen or electron donor and reduces NAD+ or NADP, and in which one substrate is a sterol derivative.','2013-10-27','NSRP'),(17423,33765,'steroid dehydrogenase activity, acting on the CH-CH group of donors','F','Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor, and in which one substrate is a sterol derivative.','2013-10-27','NSRP'),(17424,33766,'2-hydroxyquinoline 8-monooxygenase activity','F','Catalysis of the reaction: H(+) + NADH + O(2) + quinolin-2-ol = H(2)O + NAD(+) + quinoline-2,8-diol.','2013-10-27','NSRP'),(17425,33767,'4-hydroxyacetophenone monooxygenase activity','F','Catalysis of the reaction: 4\'-hydroxyacetophenone + H(+) + NADPH + O(2) = 4-hydroxyphenyl acetate + H(2)O + NADP(+).','2013-10-27','NSRP'),(17426,33768,'SUMO-targeted ubiquitin ligase complex','C','A nuclear ubiquitin ligase complex that specifically targets SUMOylated proteins; the complex is formed of homodimers or heterodimers of RNF4 family ubiquitin ligases and is conserved in eukaryotes.','2013-10-27','NSRP'),(17427,33769,'glyceollin synthase activity','F','Catalysis of the reactions: 2-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan + NADPH + H+ + O2 = glyceollin + NADP+ + 2 H2O, and 4-dimethylallyl-(6aS,11aS)-3,6a,9-trihydroxypterocarpan + NADPH + H+ + O2 = glyceollin + NADP+ + 2 H2O.','2013-10-27','NSRP'),(17428,33770,'2-hydroxyisoflavanone synthase activity','F','Catalysis of the reaction: apigenin + 2 NADPH + 2 H+ + O2 = 2-hydroxy-2,3-dihydrogenistein + 2 NADP+ + H2O.','2013-10-27','NSRP'),(17429,33771,'licodione synthase activity','F','Catalysis of the reaction: H(+) + liquiritigenin + NADPH + O(2) = H(2)O + licodione + NADP(+).','2013-10-27','NSRP'),(17430,33772,'flavonoid 3\',5\'-hydroxylase activity','F','Catalysis of the reactions: a flavanone + NADPH + H+ + O2 = a 3\'-hydroxyflavanone + NADP+ + H2O, and a 3\'-hydroxyflavanone + NADPH + H+ + O2 = a 3\',5\'-dihydroxyflavanone + NADP+ + H2O.','2013-10-27','NSRP'),(17431,33773,'isoflavone 2\'-hydroxylase activity','F','Catalysis of the reaction: an isoflavone + NADPH + H+ + O2 = a 2\'-hydroxyisoflavone + NADP+ + H2O.','2013-10-27','NSRP'),(17432,33774,'basal labyrinth','C','A region in the lower half of some cells formed from extensive infoldings of the basal plasma membrane; includes cytoplasm adjacent to the infolded membrane.','2013-10-27','NSRP'),(17433,33775,'deoxysarpagine hydroxylase activity','F','Catalysis of the reaction: 10-deoxysarpagine + H(+) + NADPH + O(2) = H(2)O + NADP(+) + sarpagine.','2013-10-27','NSRP'),(17434,33776,'phenylacetone monooxygenase activity','F','Catalysis of the reaction: H(+) + NADPH + O(2) + phenylacetone = benzyl acetate + H(2)O + NADP(+).','2013-10-27','NSRP'),(17435,33777,'lithocholate 6beta-hydroxylase activity','F','Catalysis of the reaction: H(+) + lithocholate + NADPH + O(2) = 6-beta-hydroxylithocholate + H(2)O + NADP(+).','2013-10-27','NSRP'),(17436,33778,'7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity','F','Catalysis of the reaction: 7alpha-hydroxycholest-4-en-3-one + H(+) + NADPH + O(2) = 7alpha,12alpha-dihydroxycholest-4-en-3-one + H(2)O + NADP(+).','2013-10-27','NSRP'),(17437,33779,'5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity','F','Catalysis of the reaction: 5beta-cholestane-3alpha,7alpha-diol + H(+) + NADPH + O(2) = 5beta-cholestane-3alpha,7alpha,12alpha-triol + H(2)O + NADP(+).','2013-10-27','NSRP'),(17438,33780,'taurochenodeoxycholate 6alpha-hydroxylase activity','F','Catalysis of the reactions: taurochenodeoxycholate + NADPH + H+ + O2 = taurohyocholate + NADP+ + H2O, and lithocholate + NADPH + H+ + O2 = hyodeoxycholate + NADP+ + H2O.','2013-10-27','NSRP'),(17439,33781,'cholesterol 24-hydroxylase activity','F','Catalysis of the reaction: cholesterol + H(+) + NADPH + O(2) = (24S)-24-hydroxycholesterol + H(2)O + NADP(+).','2013-10-27','NSRP'),(17440,33782,'24-hydroxycholesterol 7alpha-hydroxylase activity','F','Catalysis of the reaction: (24R)-cholest-5-ene-3beta,24-diol + H(+) + NADPH + O(2) = (24R)-7alpha,24-dihydroxycholesterol + H(2)O + NADP(+).','2013-10-27','NSRP'),(17441,33783,'25-hydroxycholesterol 7alpha-hydroxylase activity','F','Catalysis of the reactions: cholest-5-ene-3beta,25-diol + NADPH + H+ + O2 = cholest-5-ene-3beta,7alpha,25-triol + NADP+ + H2O, and cholest-5-ene-3beta,27-diol + NADPH + H+ + O2 = cholest-5-ene-3beta,7alpha,27-triol + NADP+ + H2O.','2013-10-27','NSRP'),(17442,33784,'senecionine N-oxygenase activity','F','Catalysis of the reaction: H(+) + NADPH + O(2) + senecionine = H(2)O + NADP(+) + senecionine N-oxide.','2013-10-27','NSRP'),(17443,33785,'heptose 7-phosphate kinase activity','F','Catalysis of the reaction: D-alpha,beta-D-heptose-7-phosphate + ATP = D-beta-D-heptose-1,7-bisphosphate + ADP.','2013-10-27','NSRP'),(17444,33786,'heptose-1-phosphate adenylyltransferase activity','F','Catalysis of the reaction: D-beta-D-heptose-1-phosphate + ATP = ADP-D-glycero-D-manno-heptose.','2013-10-27','NSRP'),(17445,33787,'cyanocobalamin reductase (cyanide-eliminating) activity','F','Catalysis of the reaction: cob(I)alamin + hydrogen cyanide + NADP(+) = cyanocob(III)alamin + H(+) + NADPH.','2013-10-27','NSRP'),(17446,33788,'leucoanthocyanidin reductase activity','F','Catalysis of the reaction: (2R,3S)-catechin + NADP+ + H2O = 2,3-trans-3,4-cis-leucocyanidin + NADPH + H+.','2013-10-27','NSRP'),(17447,33789,'phenylacetyl-CoA dehydrogenase activity','F','Catalysis of the reaction: 2 1,4-benzoquinone + H(2)O + phenylacetyl-CoA = 2 hydroquinone + phenylglyoxylyl-CoA.','2013-10-27','NSRP'),(17448,33790,'hydroxymethylfurfural reductase activity','F','Catalysis of the reaction: 5-hydroxymethylfurfural + NAD(P)H + H+ = 2,5-bis-hydroxymethylfuran + NAD(P)+.','2013-10-27','NSRP'),(17449,33791,'3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity','F','Catalysis of the reaction: (25R)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholestan-26-oyl-CoA + H2O + acceptor = (24R,25R)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestan-26-oyl-CoA + reduced acceptor.','2013-10-27','NSRP'),(17450,33792,'bile-acid 7alpha-dehydroxylase activity','F','Catalysis of the reactions: deoxycholate + FAD + H2O = cholate + FADH2, and lithocholate + FAD + H2O = chenodeoxycholate + FADH2.','2013-10-27','NSRP'),(17451,33793,'aureusidin synthase activity','F','Catalysis of the reactions: 2\',4,4\',6\'-tetrahydroxychalcone + O2 = aureusidin + H2O, and 2\',3,4,4\',6\'-pentahydroxychalcone + 1/2 O2 = aureusidin + H2O.','2013-10-27','NSRP'),(17452,33794,'sarcosine reductase activity','F','Catalysis of the reaction: acetyl phosphate + methylamine + thioredoxin disulfide = N-methylglycine + phosphate + thioredoxin.','2013-10-27','NSRP'),(17453,33795,'betaine reductase activity','F','Catalysis of the reaction: acetyl phosphate + trimethylamine + thioredoxin disulfide = N,N,N-trimethylglycine + phosphate + thioredoxin.','2013-10-27','NSRP'),(17454,33796,'sulfur reductase activity','F','Catalysis of the reduction of elemental sulfur or polysulfide to hydrogen sulfide.','2013-10-27','NSRP'),(17455,33797,'selenate reductase activity','F','Catalysis of the reaction: 2 e(-) + 2 H(+) + selenate = H(2)O + selenite.','2013-10-27','NSRP'),(17456,33798,'thyroxine 5-deiodinase activity','F','Catalysis of the reaction: 3,3\',5\'-triiodo-L-thyronine + iodide + A + H+ = L-thyroxine + AH2.','2013-10-27','NSRP'),(17457,33799,'myricetin 3\'-O-methyltransferase activity','F','Catalysis of the reaction: S-adenosyl-L-methionine + myricetin = S-adenosyl-L-homocysteine + laricitrin.','2013-10-27','NSRP'),(17458,33800,'isoflavone 7-O-methyltransferase activity','F','Catalysis of the reaction: S-adenosyl-L-methionine + a 7-hydroxyisoflavone = S-adenosyl-L-homocysteine + a 7-methoxyisoflavone.','2013-10-27','NSRP'),(17459,33801,'vitexin 2\'\'-O-rhamnoside 7-O-methyltransferase activity','F','Catalysis of the reaction: S-adenosyl-L-methionine + vitexin 2\'\'-O-beta-L-rhamnoside = S-adenosyl-L-homocysteine + 7-O-methylvitexin 2\'\'-O-beta-L-rhamnoside.','2013-10-27','NSRP'),(17460,33802,'isoliquiritigenin 2\'-O-methyltransferase activity','F','Catalysis of the reaction: S-adenosyl-L-methionine + isoliquiritigenin = 2\'-O-methylisoliquiritigenin + S-adenosyl-L-homocysteine + H(+).','2013-10-27','NSRP'),(17461,33803,'kaempferol 4\'-O-methyltransferase activity','F','Catalysis of the reaction: S-adenosyl-L-methionine + kaempferol = S-adenosyl-L-homocysteine + H(+) + kaempferide.','2013-10-27','NSRP'),(17462,33804,'glycine/sarcosine N-methyltransferase activity','F','OBSOLETE. Catalysis of the reactions: S-adenosyl-L-methionine + glycine = S-adenosyl-L-homocysteine + sarcosine, and S-adenosyl-L-methionine + sarcosine = S-adenosyl-L-homocysteine + N,N-dimethylglycine.','2013-10-27','NSRP'),(17463,33805,'sarcosine/dimethylglycine N-methyltransferase activity','F','OBSOLETE. Catalysis of the reactions: S-adenosyl-L-methionine + sarcosine = S-adenosyl-L-homocysteine + N,N-dimethylglycine, and S-adenosyl-L-methionine + N,N-dimethylglycine = S-adenosyl-L-homocysteine + betaine.','2013-10-27','NSRP'),(17464,33806,'fluorothreonine transaldolase activity','F','Catalysis of the reaction: L-threonine + fluoroacetaldehyde = acetaldehyde + 4-fluoro-L-threonine.','2013-10-27','NSRP'),(17465,33807,'icosanoyl-CoA synthase activity','F','Catalysis of the reaction: stearoyl-CoA + malonyl-CoA + 2 NAD(P)H + 2 H+ = icosanoyl-CoA + CO2 + 2 NAD(P)+.','2013-10-27','NSRP'),(17466,33808,'6\'-deoxychalcone synthase activity','F','Catalysis of the reaction: 3 malonyl-CoA + 4-coumaroyl-CoA + NADPH + H+ = 4 CoA + isoliquiritigenin + 3 CO2 + NADP+ + H2O.','2013-10-27','NSRP'),(17467,33809,'anthocyanin 6\'\'-O-malonyltransferase activity','F','Catalysis of the reaction: malonyl-CoA + an anthocyanidin 3-O-beta-D-glucoside = CoA + an anthocyanidin 3-O-(6-O-malonyl-beta-D-glucoside).','2013-10-27','NSRP'),(17468,33810,'anthocyanin 5-O-glucoside 6\'\'\'-O-malonyltransferase activity','F','Catalysis of the reaction: malonyl-CoA + pelargonidin 3-O-(6-caffeoyl-beta-D-glucoside) 5-O-beta-D-glucoside = CoA + 4\'\'\'-demalonylsalvianin.','2013-10-27','NSRP'),(17469,33811,'flavonol-3-O-triglucoside O-coumaroyltransferase activity','F','Catalysis of the reaction: 4-coumaroyl-CoA + a flavonol 3-O-[beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside] = CoA + a flavonol 3-O-[6-(4-coumaroyl)-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside].','2013-10-27','NSRP'),(17470,33812,'3-oxoadipyl-CoA thiolase activity','F','Catalysis of the reaction: succinyl-CoA + acetyl-CoA = CoA + 3-oxoadipyl-CoA.','2013-10-27','NSRP'),(17471,33813,'deacetylcephalosporin-C acetyltransferase activity','F','Catalysis of the reaction: acetyl-CoA + deacetylcephalosporin C = cephalosporin C + CoA.','2013-10-27','NSRP'),(17472,33814,'propanoyl-CoA C-acyltransferase activity','F','Catalysis of the reaction: 3alpha,7alpha,12alpha-trihydroxy-5beta-cholanoyl-CoA + propanoyl-CoA = CoA + 3alpha,7alpha,12alpha-trihydroxy-24-oxo-5beta-cholestanoyl-CoA.','2013-10-27','NSRP'),(17473,33815,'biphenyl synthase activity','F','Catalysis of the reaction: 3 malonyl-CoA + benzoyl-CoA = 4 CoA + 3,5-dihydroxybiphenyl + 4 CO2.','2013-10-27','NSRP'),(17474,33816,'diaminobutyrate acetyltransferase activity','F','Catalysis of the reaction: L-2,4-diaminobutyrate + acetyl-CoA = N(4)-acetyl-L-2,4-diaminobutyrate + CoA + H(+).','2013-10-27','NSRP'),(17475,33817,'beta-ketoacyl-acyl-carrier-protein synthase II activity','F','Catalysis of the reaction: (Z)-hexadec-11-enoyl-[acyl-carrier protein] + malonyl-[acyl-carrier protein] = (Z)-3-oxooctadec-13-enoyl-[acyl-carrier protein] + CO2 + [acyl-carrier protein].','2013-10-27','NSRP'),(17476,33818,'beta-ketoacyl-acyl-carrier-protein synthase III activity','F','Catalysis of the reaction: acetyl-CoA + malonyl-[acyl-carrier protein] = acetoacyl-[acyl-carrier protein] + CoA + CO2.','2013-10-27','NSRP'),(17477,33819,'lipoyl(octanoyl) transferase activity','F','Catalysis of the reaction: octanoyl-[acyl-carrier protein] + protein = protein N6-(octanoyl)lysine + acyl-carrier protein.','2013-10-27','NSRP'),(17478,33820,'DNA alpha-glucosyltransferase activity','F','Catalysis of the transfer of an alpha-D-glucosyl residue from UDP-glucose to a hydroxymethylcytosine residue in DNA.','2013-10-27','NSRP'),(17479,33821,'DNA beta-glucosyltransferase activity','F','Catalysis of the transfer of a beta-D-glucosyl residue from UDP-glucose to a hydroxymethylcytosine residue in DNA.','2013-10-27','NSRP'),(17480,33822,'glucosyl-DNA beta-glucosyltransferase activity','F','Catalysis of the transfer of a beta-D-glucosyl residue from UDP-glucose to a glucosylhydroxymethylcytosine residue in DNA.','2013-10-27','NSRP'),(17481,33823,'procollagen glucosyltransferase activity','F','Catalysis of the reaction: UDP-glucose + 5-(D-galactosyloxy)-L-lysine-procollagen = UDP + 1,2-D-glucosyl-5-D-(galactosyloxy)-L-lysine-procollagen.','2013-10-27','NSRP'),(17482,33824,'alternansucrase activity','F','Catalysis of the transfer of an alpha-D-glucosyl residue from sucrose to alternately the 6-position and the 3-position of the non-reducing terminal residue of an alpha-D-glucan, thus producing a glucan having alternating alpha-1,6- and alpha-1,3-linkages.','2013-10-27','NSRP'),(17483,33825,'oligosaccharide 4-alpha-D-glucosyltransferase activity','F','Catalysis of the transfer of the non-reducing terminal alpha-D-glucose residue from a 1,4-alpha-D-glucan to the 4-position of an alpha-D-glucan, thus bringing about the hydrolysis of oligosaccharides.','2013-10-27','NSRP'),(17484,33826,'xyloglucan 4-glucosyltransferase activity','F','Catalysis of the transfer of a beta-D-glucosyl residue from UDP-glucose on to a glucose residue in xyloglucan, forming a beta-1,4-D-glucosyl-D-glucose linkage.','2013-10-27','NSRP'),(17485,33827,'high-mannose-oligosaccharide beta-1,4-N-acetylglucosaminyltransferase activity','F','Catalysis of the transfer of an N-acetyl-D-glucosamine residue from UDP-N-acetyl-D-glucosamine to the 4-position of a mannose linked alpha-1,6 to the core mannose of high-mannose oligosaccharides produced by Dictyostelium discoideum.','2013-10-27','NSRP'),(17486,33828,'glucosylglycerol-phosphate synthase activity','F','Catalysis of the reaction: sn-glycerol 3-phosphate + ADP-glucose = 2-O-(beta-D-glucosyl)-sn-glycerol 3-phosphate + ADP + H(+).','2013-10-27','NSRP'),(17487,33829,'O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity','F','Catalysis of the transfer of a beta-D-GlcNAc residue from UDP-D-GlcNAc to the fucose residue of a fucosylated protein acceptor.','2013-10-27','NSRP'),(17488,33830,'Skp1-protein-hydroxyproline N-acetylglucosaminyltransferase activity','F','Catalysis of the reaction: UDP-N-acetylglucosamine + Skp1-protein-hydroxyproline = UDP + Skp1-protein-O-(N-acetyl-D-glucosaminyl)hydroxyproline.','2013-10-27','NSRP'),(17489,33831,'kojibiose phosphorylase activity','F','Catalysis of the reaction: kojibiose + phosphate = beta-D-glucose 1-phosphate + D-glucose.','2013-10-27','NSRP'),(17490,33832,'alpha,alpha-trehalose phosphorylase (configuration-retaining) activity','F','Catalysis of the reaction: alpha,alpha-trehalose + phosphate = alpha-D-glucose + alpha-D-glucose 1-phosphate.','2013-10-27','NSRP'),(17491,33833,'hydroxymethylfurfural reductase (NADH) activity','F','Catalysis of the reaction: 5-hydroxymethylfurfural + NADH + H+ = 2,5-bis-hydroxymethylfuran + NAD+.','2013-10-27','NSRP'),(17492,33834,'kaempferol 3-O-galactosyltransferase activity','F','Catalysis of the reaction: UDP-galactose + kaempferol = UDP + kaempferol 3-O-beta-D-galactoside.','2013-10-27','NSRP'),(17493,33835,'flavanone 7-O-glucoside 2\'\'-O-beta-L-rhamnosyltransferase activity','F','Catalysis of the reaction: UDP-L-rhamnose + a flavanone 7-O-glucoside = UDP + a flavanone 7-O-[beta-L-rhamnosyl-(1->2)-beta-D-glucoside].','2013-10-27','NSRP'),(17494,33836,'flavonol 7-O-beta-glucosyltransferase activity','F','Catalysis of the reaction: UDP-glucose + a flavonol = UDP + a flavonol 7-O-beta-D-glucoside.','2013-10-27','NSRP'),(17495,33837,'anthocyanin 3\'-O-beta-glucosyltransferase activity','F','Catalysis of the reaction: UDP-glucose + an anthocyanin = UDP + an anthocyanin 3\'-O-beta-D-glucoside.','2013-10-27','NSRP'),(17496,33838,'flavonol-3-O-glucoside glucosyltransferase activity','F','Catalysis of the reaction: UDP-glucose + a flavonol 3-O-beta-D-glucoside = UDP + a flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside.','2013-10-27','NSRP'),(17497,33839,'flavonol-3-O-glycoside glucosyltransferase activity','F','Catalysis of the reaction: UDP-glucose + a flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside = UDP + a flavonol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucosyl-(1->2)-beta-D-glucoside.','2013-10-27','NSRP'),(17498,33840,'NDP-glucose-starch glucosyltransferase activity','F','Catalysis of the reaction: NDP-glucose + (1,4-alpha-D-glucosyl)n = NDP + (1,4-alpha-D-glucosyl)n+1.','2013-10-27','NSRP'),(17499,33841,'6G-fructosyltransferase activity','F','Catalysis of the reaction: [1-beta-D-fructofuranosyl-(2->1)-]m+1 alpha-D-glucopyranoside + [1-beta-D-fructofuranosyl-(2->1)-]n+1 alpha-D-glucopyranoside = [1-beta-D-fructofuranosyl-(2->1)-]m alpha-D-glucopyranoside + [1-beta-D-fructofuranosyl-(2->1)-]n+1 beta-D-fructofuranosyl-(2->6)-alpha-D-glucopyranoside (m > 0; n >= 0).','2013-10-27','NSRP'),(17500,33842,'N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity','F','Catalysis of the reaction: UDP-N-acetyl-D-galactosamine + N-acetyl-beta-D-glucosaminyl group = UDP + N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl group.','2013-10-27','NSRP'),(17501,33843,'xyloglucan 6-xylosyltransferase activity','F','Catalysis of the transfer of an alpha-D-xylosyl residue from UDP-D-xylose to a glucose residue in xyloglucan, forming an alpha-1,6-D-xylosyl-D-glucose linkage.','2013-10-27','NSRP'),(17502,33844,'galactose-6-sulfurylase activity','F','Catalysis of the elimination of sulfate from the D-galactose 6-sulfate residues of porphyran, producing 3,6-anhydrogalactose residues.','2013-10-27','NSRP'),(17503,33845,'hydroxymethylfurfural reductase (NADPH) activity','F','Catalysis of the reaction: 5-hydroxymethylfurfural + NADPH + H+ = 2,5-bis-hydroxymethylfuran + NADP+.','2013-10-27','NSRP'),(17504,33846,'adenosyl-fluoride synthase activity','F','Catalysis of the reaction: S-adenosyl-L-methionine + fluoride = 5\'-deoxy-5\'-fluoroadenosine + L-methionine.','2013-10-27','NSRP'),(17505,33847,'O-phosphoserine sulfhydrylase activity','F','Catalysis of the reaction: O-phospho-L-serine + hydrogen sulfide = L-cysteine + phosphate.','2013-10-27','NSRP'),(17506,33848,'N2-(2-carboxyethyl)arginine synthase activity','F','Catalysis of the reaction: D-glyceraldehyde 3-phosphate + L-arginine = N(2)-(2-carboxyethyl)-L-arginine + H(+) + phosphate.','2013-10-27','NSRP'),(17507,33849,'chrysanthemyl diphosphate synthase activity','F','Catalysis of the reaction: 2 dimethylallyl diphosphate = (R,R)-chrysanthemyl diphosphate + diphosphate.','2013-10-27','NSRP'),(17508,33850,'Z-farnesyl diphosphate synthase activity','F','Catalysis of the reaction: geranyl diphosphate + isopentenyl diphosphate = 2-cis,6-trans-farnesyl diphosphate + diphosphate.','2013-10-27','NSRP'),(17509,33851,'lavandulyl diphosphate synthase activity','F','Catalysis of the reaction: 2 dimethylallyl diphosphate = diphosphate + lavandulyl diphosphate.','2013-10-27','NSRP'),(17510,33852,'thyroid-hormone transaminase activity','F','Catalysis of the reaction: 2-oxoglutarate + 3,5,3\'-triiodo-L-thyronine = 3,5,3\'-triiodothyropyruvate + L-glutamate.','2013-10-27','NSRP'),(17511,33853,'aspartate-prephenate aminotransferase activity','F','Catalysis of the reaction: L-arogenate + oxaloacetate = prephenate + L-aspartate.','2013-10-27','NSRP'),(17512,33854,'glutamate-prephenate aminotransferase activity','F','Catalysis of the reaction: 2-oxoglutarate + L-arogenate = L-glutamate + prephenate.','2013-10-27','NSRP'),(17513,33855,'nicotianamine aminotransferase activity','F','Catalysis of the reaction: 2-oxoglutarate + nicotianamine = 3\'\'-deamino-3\'\'-oxonicotianamine + L-glutamate.','2013-10-27','NSRP'),(17514,33856,'pyridoxine 5\'-phosphate synthase activity','F','Catalysis of the reaction: 1-deoxy-D-xylulose 5-phosphate + 3-amino-2-oxopropyl phosphate = 2 H(2)O + H(+) + phosphate + pyridoxine 5\'-phosphate.','2013-10-27','NSRP'),(17515,33857,'diphosphoinositol-pentakisphosphate kinase activity','F','Catalysis of the reaction: ATP + 1D-myo-inositol 5-diphosphate pentakisphosphate = ADP + 1D-myo-inositol bisdiphosphate tetrakisphosphate.','2013-10-27','NSRP'),(17516,33858,'N-acetylgalactosamine kinase activity','F','Catalysis of the reaction: ATP + N-acetyl-D-galactosamine = ADP + N-acetyl-alpha-D-galactosamine 1-phosphate.','2013-10-27','NSRP'),(17517,33859,'furaldehyde metabolic process','P','The chemical reactions and pathways involving furaldehyde, a furan ring-containing aldehyde compound which can be formed from the thermal decomposition of biomass.','2013-10-27','NSRP'),(17518,33860,'regulation of NAD(P)H oxidase activity','P','Any process that modulates the activity of the enzyme NAD(P)H oxidase.','2013-10-27','NSRP'),(17519,33861,'negative regulation of NAD(P)H oxidase activity','P','Any process that stops or reduces the activity of the enzyme NAD(P)H oxidase.','2013-10-27','NSRP'),(17520,33862,'UMP kinase activity','F','Catalysis of the reaction: ATP + UMP = ADP + UDP.','2013-10-27','NSRP'),(17521,33863,'ribose 1,5-bisphosphate phosphokinase activity','F','Catalysis of the reaction: D-ribose 1,5-diphosphate + ATP = 5-phospho-alpha-D-ribose 1-diphosphate + ADP + H(+).','2013-10-27','NSRP'),(17522,33864,'positive regulation of NAD(P)H oxidase activity','P','Any process that activates or increases the activity of the enzyme NAD(P)H oxidase.','2013-10-27','NSRP'),(17523,33865,'nucleoside bisphosphate metabolic process','P','The chemical reactions and pathways involving a nucleoside bisphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17524,33866,'nucleoside bisphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a nucleoside bisphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17525,33867,'Fas-activated serine/threonine kinase activity','F','Catalysis of the reaction: ATP + Fas-activated serine/threonine protein = ADP + Fas-activated serine/threonine phosphoprotein.','2013-10-27','NSRP'),(17526,33868,'Goodpasture-antigen-binding protein kinase activity','F','Catalysis of the reaction: ATP + Goodpasture antigen-binding protein = ADP + Goodpasture antigen-binding phosphoprotein.','2013-10-27','NSRP'),(17527,33869,'nucleoside bisphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a nucleoside bisphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17528,33870,'thiol sulfotransferase activity','F','Catalysis of the reaction: 3\'-phosphoadenylyl sulfate + a thiol = adenosine 3\',5\'-bisphosphate + an S-alkyl thiosulfate.','2013-10-27','NSRP'),(17529,33871,'[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity','F','Catalysis of the reaction: 3\'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine 3\',5\'-bisphosphate + [heparan sulfate]-glucosamine 3-sulfate; modifies selected glucosamine residues preceded by GlcA2S.','2013-10-27','NSRP'),(17530,33872,'[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity','F','Catalysis of the reaction: 3\'-phosphoadenylyl sulfate + [heparan sulfate]-glucosamine = adenosine 3\',5\'-bisphosphate + [heparan sulfate]-glucosamine 3-sulfate.','2013-10-27','NSRP'),(17531,33873,'petromyzonol sulfotransferase activity','F','Catalysis of the reaction: 3\'-phospho-5\'-adenylyl sulfate + 5alpha-cholane-3alpha,7alpha,12alpha,24-tetrol = 3alpha,7alpha,12alpha-trihydroxy-5alpha-cholan-24-yl sulfate + adenosine 3\',5\'-diphosphate + H(+).','2013-10-27','NSRP'),(17532,33874,'scymnol sulfotransferase activity','F','Catalysis of the reaction: 3\'-phospho-5\'-adenylyl sulfate + 5beta-scymnol = 5beta-scymnol sulfate + adenosine 3\',5\'-diphosphate + H(+).','2013-10-27','NSRP'),(17533,33875,'ribonucleoside bisphosphate metabolic process','P','The chemical reactions and pathways involving a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17534,33876,'glycochenodeoxycholate sulfotransferase activity','F','Catalysis of the reaction: 3\'-phospho-5\'-adenylyl sulfate + glycochenodeoxycholate = adenosine 3\',5\'-diphosphate + glycochenodeoxycholate 7-sulfate + H(+).','2013-10-27','NSRP'),(17535,33877,'succinyl-CoA:(R)-benzylsuccinate CoA-transferase activity','F','Catalysis of the reaction: (R)-2-benzylsuccinate + succinyl-CoA = (R)-2-benzylsuccinyl-CoA + succinate.','2013-10-27','NSRP'),(17536,33878,'hormone-sensitive lipase activity','F','Catalysis of the reactions: diacylglycerol + H2O = monoacylglycerol + a carboxylate; triacylglycerol + H2O = diacylglycerol + a carboxylate; and monoacylglycerol + H2O = glycerol + a carboxylate.','2013-10-27','NSRP'),(17537,33879,'acetylajmaline esterase activity','F','Catalysis of the reactions: 17-O-acetylajmaline + H2O = ajmaline + acetate, and 17-O-acetylnorajmaline + H2O = norajmaline + acetate.','2013-10-27','NSRP'),(17538,33880,'phenylacetyl-CoA hydrolase activity','F','Catalysis of the reaction: H(2)O + phenylglyoxylyl-CoA = CoA + H(+) + phenylglyoxylate.','2013-10-27','NSRP'),(17539,33881,'bile-acid-CoA hydrolase activity','F','Catalysis of the reaction: deoxycholoyl-CoA + H(2)O = CoA + deoxycholate + H(+).','2013-10-27','NSRP'),(17540,33882,'choloyl-CoA hydrolase activity','F','Catalysis of the reaction: choloyl-CoA + H2O = cholate + CoA.','2013-10-27','NSRP'),(17541,33883,'pyridoxal phosphatase activity','F','Catalysis of the reaction: pyridoxal 5\'-phosphate + H2O = pyridoxal + phosphate.','2013-10-27','NSRP'),(17542,33884,'phosphoethanolamine/phosphocholine phosphatase activity','F','OBSOLETE. Catalysis of the reactions: O-phosphoethanolamine + H2O = ethanolamine + phosphate, and phosphocholine + H2O = choline + phosphate.','2013-10-27','NSRP'),(17543,33885,'10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity','F','Catalysis of the reaction: (9S,10S)-10-hydroxy-9-(phosphonooxy)octadecanoate + H(2)O = (9S,10S)-9,10-dihydroxyoctadecanoate + phosphate.','2013-10-27','NSRP'),(17544,33886,'cellulose-polysulfatase activity','F','Catalysis of the hydrolysis of the 2- and 3-sulfate groups of the polysulfates of cellulose and charonin.','2013-10-27','NSRP'),(17545,33887,'chondro-4-sulfatase activity','F','Catalysis of the reaction: 4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine 4-sulfate + H(2)O = 4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine + H(+) + sulfate.','2013-10-27','NSRP'),(17546,33888,'chondro-6-sulfatase activity','F','Catalysis of the reaction: 4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine 6-sulfate + H(2)O = 4-deoxy-beta-D-gluc-4-enuronosyl-(1->3)-N-acetyl-D-galactosamine + H(+) + sulfate.','2013-10-27','NSRP'),(17547,33889,'N-sulfoglucosamine-3-sulfatase activity','F','Catalysis of the hydrolysis of the 3-sulfate groups of the N-sulfo-D-glucosamine 3-O-sulfate units of heparin.','2013-10-27','NSRP'),(17548,33890,'ribonuclease D activity','F','Catalysis of the exonucleolytic cleavage that removes extra residues from the 3\'-terminus of tRNA to produce 5\'-mononucleotides.','2013-10-27','NSRP'),(17549,33891,'CC-preferring endodeoxyribonuclease activity','F','Catalysis of the endonucleolytic cleavage to give 5\'-phosphooligonucleotide end-products, with a preference for cleavage within the sequence CC.','2013-10-27','NSRP'),(17550,33892,'deoxyribonuclease (pyrimidine dimer) activity','F','Catalysis of the endonucleolytic cleavage near pyrimidine dimers to products with 5\'-phosphate.','2013-10-27','NSRP'),(17551,33893,'ribonuclease IV activity','F','Catalysis of the endonucleolytic cleavage of poly(A) to fragments terminated by 3\'-hydroxy and 5\'-phosphate groups.','2013-10-27','NSRP'),(17552,33894,'ribonuclease P4 activity','F','Catalysis of the endonucleolytic cleavage of RNA, removing 3\'-extranucleotides from tRNA precursor.','2013-10-27','NSRP'),(17553,33895,'ribonuclease [poly-(U)-specific] activity','F','Catalysis of the endonucleolytic cleavage of poly(U) to fragments terminated by 3\'-hydroxy and 5\'-phosphate groups.','2013-10-27','NSRP'),(17554,33896,'ribonuclease IX activity','F','Catalysis of the endonucleolytic cleavage of poly(U) or poly(C) to fragments terminated by 3\'-hydroxy and 5\'-phosphate groups.','2013-10-27','NSRP'),(17555,33897,'ribonuclease T2 activity','F','Catalysis of the two-stage endonucleolytic cleavage to nucleoside 3\'-phosphates and 3\'-phosphooligonucleotides with 2\',3\'-cyclic phosphate intermediates.','2013-10-27','NSRP'),(17556,33898,'Bacillus subtilis ribonuclease activity','F','Catalysis of the endonucleolytic cleavage to 2\',3\'-cyclic nucleotides.','2013-10-27','NSRP'),(17557,33899,'ribonuclease U2 activity','F','Catalysis of the two-stage endonucleolytic cleavage to nucleoside 3\'-phosphates and 3\'-phosphooligonucleotides ending in Ap or Gp with 2\',3\'-cyclic phosphate intermediates.','2013-10-27','NSRP'),(17558,33900,'ribonuclease F activity','F','Catalysis of the endonucleolytic cleavage of RNA precursor into two, leaving 5\'-hydroxy and 3\'-phosphate groups.','2013-10-27','NSRP'),(17559,33901,'ribonuclease V activity','F','Catalysis of the hydrolysis of poly(A), forming oligoribonucleotides and ultimately 3\'-AMP.','2013-10-27','NSRP'),(17560,33902,'rRNA endonuclease activity','F','Catalysis of the hydrolysis of the phosphodiester linkage between guanosine and adenosine residues at one specific position in 28S rRNA from rat ribosomes.','2013-10-27','NSRP'),(17561,33903,'endo-1,3(4)-beta-glucanase activity','F','OBSOLETE. Catalysis of the endohydrolysis of 1,3- or 1,4-linkages in beta-D-glucans when the glucose residue whose reducing group is involved in the linkage to be hydrolysed is itself substituted at C-3.','2013-10-27','NSRP'),(17562,33904,'dextranase activity','F','Catalysis of the endohydrolysis of 1,6-alpha-D-glucosidic linkages in dextran.','2013-10-27','NSRP'),(17563,33905,'xylan endo-1,3-beta-xylosidase activity','F','Catalysis of the random hydrolysis of (1->3)-beta-D-glycosidic linkages in (1->3)-beta-D-xylans.','2013-10-27','NSRP'),(17564,33906,'hyaluronoglucuronidase activity','F','Catalysis of the random hydrolysis of 1,3-linkages between beta-D-glucuronate and N-acetyl-D-glucosamine residues in hyaluronate.','2013-10-27','NSRP'),(17565,33907,'beta-D-fucosidase activity','F','Catalysis of the hydrolysis of terminal non-reducing beta-D-fucose residues in beta-D-fucosides.','2013-10-27','NSRP'),(17566,33908,'beta-L-rhamnosidase activity','F','Catalysis of the hydrolysis of terminal, non-reducing beta-L-rhamnose residues in beta-L-rhamnosides.','2013-10-27','NSRP'),(17567,33909,'fucoidanase activity','F','Catalysis of the endohydrolysis of 1,2-alpha-L-fucoside linkages in fucoidan without release of sulfate.','2013-10-27','NSRP'),(17568,33910,'glucan 1,4-alpha-maltotetraohydrolase activity','F','Catalysis of the hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltotetraose residues from the non-reducing chain ends.','2013-10-27','NSRP'),(17569,33911,'mycodextranase activity','F','Catalysis of the endohydrolysis of 1,4-alpha-D-glucosidic linkages in alpha-D-glucans containing both 1,3- and 1,4-bonds.','2013-10-27','NSRP'),(17570,33912,'2,6-beta-fructan 6-levanbiohydrolase activity','F','Catalysis of the hydrolysis of (2->6)-beta-D-fructofuranan, to remove successive disaccharide residues as levanbiose, i.e. 6-(beta-D-fructofuranosyl)-D-fructose, from the end of the chain.','2013-10-27','NSRP'),(17571,33913,'glucan endo-1,2-beta-glucosidase activity','F','Catalysis of the random hydrolysis of (1->2)-glucosidic linkages in (1->2)-beta-D-glucans.','2013-10-27','NSRP'),(17572,33914,'xylan 1,3-beta-xylosidase activity','F','Catalysis of the hydrolysis of successive xylose residues from the non-reducing termini of (1->3)-beta-D-xylans.','2013-10-27','NSRP'),(17573,33915,'mannan 1,2-(1,3)-alpha-mannosidase activity','F','Catalysis of the hydrolysis of (1->2) and (1->3) linkages in mannan, releasing mannose.','2013-10-27','NSRP'),(17574,33916,'beta-agarase activity','F','Catalysis of the hydrolysis of (1->4)-beta-D-galactosidic linkages in agarose, giving the tetramer as the predominant product.','2013-10-27','NSRP'),(17575,33917,'exo-poly-alpha-galacturonosidase activity','F','Catalysis of the hydrolysis of pectic acid from the non-reducing end, releasing digalacturonate.','2013-10-27','NSRP'),(17576,33918,'kappa-carrageenase activity','F','Catalysis of the endohydrolysis of 1,4-beta-D-linkages between D-galactose 4-sulfate and 3,6-anhydro-D-galactose in kappa-carrageenans.','2013-10-27','NSRP'),(17577,33919,'glucan 1,3-alpha-glucosidase activity','F','Catalysis of the hydrolysis of terminal (1->3)-alpha-D-glucosidic links in 1,3-alpha-D-glucans.','2013-10-27','NSRP'),(17578,33920,'6-phospho-beta-galactosidase activity','F','Catalysis of the reaction: a 6-phospho-beta-D-galactoside + H2O = 6-phospho-D-galactose + an alcohol.','2013-10-27','NSRP'),(17579,33921,'capsular-polysaccharide endo-1,3-alpha-galactosidase activity','F','Catalysis of the random hydrolysis of (1->3)-alpha-D-galactosidic linkages in Aerobacter aerogenes capsular polysaccharide.','2013-10-27','NSRP'),(17580,33922,'peptidoglycan beta-N-acetylmuramidase activity','F','Catalysis of the hydrolysis of terminal, non-reducing N-acetylmuramic residues.','2013-10-27','NSRP'),(17581,33923,'glucan 1,6-alpha-isomaltosidase activity','F','Catalysis of the hydrolysis of (1->6)-alpha-D-glucosidic linkages in polysaccharides, to remove successive isomaltose units from the non-reducing ends of the chains.','2013-10-27','NSRP'),(17582,33924,'dextran 1,6-alpha-isomaltotriosidase activity','F','Catalysis of the hydrolysis of (1->6)-alpha-D-glucosidic linkages in dextrans, to remove successive isomaltotriose units from the non-reducing ends of the chains.','2013-10-27','NSRP'),(17583,33925,'mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity','F','Catalysis of the endohydrolysis of the N,N\'-diacetylchitobiosyl unit in high-mannose glycopeptides and glycoproteins containing the -[Man(GlcNAc)2]Asn-structure. One N-acetyl-D-glucosamine residue remains attached to the protein; the rest of the oligosaccharide is released intact.','2013-10-27','NSRP'),(17584,33926,'glycopeptide alpha-N-acetylgalactosaminidase activity','F','Catalysis of the reaction: D-galactosyl-3-(N-acetyl-alpha-D-galactosaminyl)-L-serine + H2O = D-galactosyl-3-N-acetyl-alpha-D-galactosamine + L-serine.','2013-10-27','NSRP'),(17585,33927,'glucan 1,4-alpha-maltohexaosidase activity','F','Catalysis of the hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltohexaose residues from the non-reducing chain ends.','2013-10-27','NSRP'),(17586,33928,'mannan 1,4-mannobiosidase activity','F','Catalysis of the hydrolysis of (1->4)-beta-D-mannosidic linkages in (1->4)-beta-D-mannans, to remove successive mannobiose residues from the non-reducing chain ends.','2013-10-27','NSRP'),(17587,33929,'blood-group-substance endo-1,4-beta-galactosidase activity','F','Catalysis of the endohydrolysis of (1->4)-beta-D-galactosidic linkages in blood group A and B substances.','2013-10-27','NSRP'),(17588,33930,'keratan-sulfate endo-1,4-beta-galactosidase activity','F','Catalysis of the endohydrolysis of (1->4)-beta-D-galactosidic linkages in keratan sulfate.','2013-10-27','NSRP'),(17589,33931,'endogalactosaminidase activity','F','Catalysis of the endohydrolysis of (1->4)-alpha-D-galactosaminidic linkages in poly(D-galactosamine).','2013-10-27','NSRP'),(17590,33932,'1,3-alpha-L-fucosidase activity','F','Catalysis of the hydrolysis of (1->3) linkages between alpha-L-fucose and N-acetylglucosamine residues in glycoproteins.','2013-10-27','NSRP'),(17591,33933,'branched-dextran exo-1,2-alpha-glucosidase activity','F','Catalysis of the hydrolysis of (1->2)-alpha-D-glucosidic linkages at the branch points of dextrans and related polysaccharides, producing free D-glucose.','2013-10-27','NSRP'),(17592,33934,'glucan 1,4-alpha-maltotriohydrolase activity','F','Catalysis of the hydrolysis of (1->4)-alpha-D-glucosidic linkages in amylaceous polysaccharides, to remove successive maltotriose residues from the non-reducing chain ends.','2013-10-27','NSRP'),(17593,33935,'oligoxyloglucan beta-glycosidase activity','F','Catalysis of the hydrolysis of (1->4)-beta-D-glucosidic links in oligoxyloglucans so as to remove successive isoprimeverose (i.e. alpha-xylo-1,6-beta-D-glucosyl-) residues from the non-reducing chain ends.','2013-10-27','NSRP'),(17594,33936,'polymannuronate hydrolase activity','F','Catalysis of the endohydrolysis of the D-mannuronide linkages of polymannuronate.','2013-10-27','NSRP'),(17595,33937,'3-deoxy-2-octulosonidase activity','F','Catalysis of the endohydrolysis of the beta-ketopyranosidic linkages of 3-deoxy-D-manno-2-octulosonate in capsular polysaccharides.','2013-10-27','NSRP'),(17596,33938,'1,6-alpha-L-fucosidase activity','F','Catalysis of the hydrolysis of (1->6) linkages between alpha-L-fucose and N-acetyl-D-glucosamine in glycopeptides such as immunoglobulin G glycopeptide and fucosyl-asialo-agalacto-fetuin.','2013-10-27','NSRP'),(17597,33939,'xylan alpha-1,2-glucuronosidase activity','F','Catalysis of the hydrolysis of alpha-D-(1->2)-(4-O-methyl)glucuronosyl links in the main chain of hardwood xylans.','2013-10-27','NSRP'),(17598,33940,'glucuronoarabinoxylan endo-1,4-beta-xylanase activity','F','Catalysis of the endohydrolysis of (1->4)-beta-D-xylosyl links in some glucuronoarabinoxylans.','2013-10-27','NSRP'),(17599,33941,'mannan exo-1,2-1,6-alpha-mannosidase activity','F','Catalysis of the hydrolysis of (1->2)-alpha-D- and (1->6)-alpha-D- linkages in mannan, releasing D-mannose.','2013-10-27','NSRP'),(17600,33942,'4-alpha-D-{(1->4)-alpha-D-glucano}trehalose trehalohydrolase activity','F','Catalysis of the hydrolysis of alpha-(1->4)-D-glucosidic linkage in 4-alpha-D-{(1->4)-alpha-D-glucanosyl}n trehalose to yield trehalose and alpha-(1->4)-D-glucan.','2013-10-27','NSRP'),(17601,33943,'galactan 1,3-beta-galactosidase activity','F','Catalysis of the hydrolysis of terminal, non-reducing beta-D-galactose residues in (1->3)-beta-D-galactopyranans.','2013-10-27','NSRP'),(17602,33944,'beta-galactofuranosidase activity','F','Catalysis of the hydrolysis of terminal non-reducing beta-D-galactofuranosides, releasing galactose.','2013-10-27','NSRP'),(17603,33945,'oligoxyloglucan reducing-end-specific cellobiohydrolase activity','F','Catalysis of the hydrolysis of cellobiose from the reducing end of xyloglucans consisting of a beta-(1->4) linked glucan carrying alpha-D-xylosyl groups on O-6 of the glucose residues. To be a substrate, the first residue must be unsubstituted, the second residue may bear a xylosyl group, whether further glycosylated or not, and the third residue, which becomes the new terminus by the action of the enzyme, is preferably xylosylated, but this xylose residue must not be further substituted.','2013-10-27','NSRP'),(17604,33946,'xyloglucan-specific endo-beta-1,4-glucanase activity','F','Catalysis of the reaction: xyloglucan + H2O = xyloglucan oligosaccharides. This reaction is the endohydrolysis of (1->4)-beta-D-glucosidic linkages in xyloglucan.','2013-10-27','NSRP'),(17605,33947,'mannosylglycoprotein endo-beta-mannosidase activity','F','Catalysis of the hydrolysis of the alpha-D-mannosyl-(1->6)-beta-D-mannosyl-(1->4)-beta-D-N-acetylglucosaminyl-(1->4)-beta-D-N-acetylglucosaminyl sequence of glycoprotein to alpha-D-mannosyl-(1->6)-D-mannose and beta-D-N-acetylglucosaminyl-(1->4)-beta-D-N-acetylglucosaminyl sequences.','2013-10-27','NSRP'),(17606,33948,'fructan beta-(2,1)-fructosidase activity','F','Catalysis of the hydrolysis of terminal, non-reducing (2->1) linked beta-D-fructofuranose residues in fructans.','2013-10-27','NSRP'),(17607,33949,'fructan beta-(2,6)-fructosidase activity','F','Catalysis of the hydrolysis of terminal, non-reducing (2->6) linked beta-D-fructofuranose residues in fructans.','2013-10-27','NSRP'),(17608,33950,'xyloglucan-specific exo-beta-1,4-glucanase activity','F','Catalysis of the reaction: xyloglucan + H2O = xyloglucan oligosaccharides. This reaction is the exohydrolysis of 1,4-beta-D-glucosidic linkages in xyloglucan.','2013-10-27','NSRP'),(17609,33951,'oligosaccharide reducing-end xylanase activity','F','Catalysis of the hydrolysis of 1,4-beta-D-xylose residues from the reducing end of oligosaccharides.','2013-10-27','NSRP'),(17610,33952,'iota-carrageenase activity','F','Catalysis of the endohydrolysis of 1,4-beta-D-linkages between D-galactose 4-sulfate and 3,6-anhydro-D-galactose-2-sulfate in iota-carrageenans.','2013-10-27','NSRP'),(17611,33953,'alpha-agarase activity','F','Catalysis of the endohydrolysis of 1,3-alpha-L-galactosidic linkages in agarose, yielding agarotetraose as the major product.','2013-10-27','NSRP'),(17612,33954,'alpha-neoagaro-oligosaccharide hydrolase activity','F','Catalysis of the hydrolysis of the 1,3-alpha-L-galactosidic linkages of neoagaro-oligosaccharides that are smaller than a hexamer, yielding 3,6-anhydro-L-galactose and D-galactose.','2013-10-27','NSRP'),(17613,33955,'mitochondrial DNA inheritance','P','The process in which copies of the mitochondrial genome are distributed into daughter mitochondria upon mitochondrial fission.','2013-10-27','NSRP'),(17614,33956,'beta-apiosyl-beta-glucosidase activity','F','Catalysis of the reaction: 7-[beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranosyloxy]isoflavonoid + H2O = a 7-hydroxyisoflavonoid + beta-D-apiofuranosyl-(1->6)-D-glucose.','2013-10-27','NSRP'),(17615,33957,'lambda-carrageenase activity','F','Catalysis of the endohydrolysis of beta-1,4-linkages in the backbone of lambda-carrageenan, resulting in the tetrasaccharide alpha-D-Galp2,6S2-(1->3)-beta-D-Galp2S-(1->4)-alpha-D-Galp2,6S2-(1->3)-D-Galp2S.','2013-10-27','NSRP'),(17616,33958,'DNA-deoxyinosine glycosylase activity','F','Catalysis of the hydrolysis of DNA and polynucleotides, releasing free hypoxanthine.','2013-10-27','NSRP'),(17617,33959,'deoxyribodipyrimidine endonucleosidase activity','F','Catalysis of the cleavage of the N-glycosidic bond between the 5\'-pyrimidine residue in cyclobutadipyrimidine (in DNA) and the corresponding deoxy-D-ribose residue.','2013-10-27','NSRP'),(17618,33960,'N-methyl nucleosidase activity','F','Catalysis of the reaction: 7-methylxanthosine + H(2)O = 7-methylxanthine + H(+) + ribofuranose.','2013-10-27','NSRP'),(17619,33961,'cis-stilbene-oxide hydrolase activity','F','Catalysis of the reaction: cis-stilbene oxide + H2O = (+)-(1R,2R)-1,2-diphenylethane-1,2-diol.','2013-10-27','NSRP'),(17620,33962,'cytoplasmic mRNA processing body assembly','P','The aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body.','2013-10-27','NSRP'),(17621,33963,'cholesterol-5,6-oxide hydrolase activity','F','Catalysis of the reactions: 5,6alpha-epoxy-5alpha-cholestan-3beta-ol + H2O = cholestane-3beta-5alpha,6beta-triol, and 5,6beta-epoxy-5beta-cholestan-3beta-ol + H2O = cholestane-3beta-5alpha,6beta-triol.','2013-10-27','NSRP'),(17622,33964,'glycosphingolipid deacylase activity','F','Catalysis of the hydrolysis of gangliosides and neutral glycosphingolipids, releasing fatty acids to form the lyso-derivatives.','2013-10-27','NSRP'),(17623,33965,'aculeacin-A deacylase activity','F','Catalysis of the hydrolysis of the amide bond in aculeacin A and related neutral lipopeptide antibiotics, releasing the long-chain fatty acid side-chain.','2013-10-27','NSRP'),(17624,33966,'N-substituted formamide deformylase activity','F','Catalysis of the reaction: N-benzylformamide + H2O = formate + benzylamine.','2013-10-27','NSRP'),(17625,33967,'box C/D snoRNA metabolic process','P','The chemical reactions and pathways involving box C/D type small nucleolar RNA.','2013-10-27','NSRP'),(17626,33968,'glutaryl-7-aminocephalosporanic-acid acylase activity','F','Catalysis of the reaction: (7R)-7-(4-carboxybutanamido)cephalosporanate + H2O = (7R)-7-aminocephalosporanate + glutarate.','2013-10-27','NSRP'),(17627,33969,'gamma-glutamyl-gamma-aminobutyrate hydrolase activity','F','Catalysis of the reaction: 4-(L-gamma-glutamylamino)butanoate + H(2)O = 4-aminobutanoate + L-glutamate.','2013-10-27','NSRP'),(17628,33970,'N-malonylurea hydrolase activity','F','Catalysis of the reaction: 3-oxo-3-ureidopropanoate + H(2)O = H(+) + malonate + urea.','2013-10-27','NSRP'),(17629,33971,'hydroxyisourate hydrolase activity','F','Catalysis of the reaction: 5-hydroxyisourate + H(2)O = 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1H-imidazole-5-carboxylate + H(+).','2013-10-27','NSRP'),(17630,33972,'proclavaminate amidinohydrolase activity','F','Catalysis of the reaction: amidinoproclavaminate + H(2)O = proclavaminate + urea.','2013-10-27','NSRP'),(17631,33973,'dCTP deaminase (dUMP-forming) activity','F','Catalysis of the reaction: dCTP + 2 H(2)O = diphosphate + dUMP + H(+) + NH(4)(+).','2013-10-27','NSRP'),(17632,33974,'nucleoside phosphoacylhydrolase activity','F','Catalysis of the hydrolysis of mixed phospho-anhydride bonds.','2013-10-27','NSRP'),(17633,33975,'(R)-2-haloacid dehalogenase activity','F','Catalysis of the reaction: (R)-2-haloacid + H2O = (S)-2-hydroxyacid + halide.','2013-10-27','NSRP'),(17634,33976,'2-haloacid dehalogenase (configuration-inverting) activity','F','Catalysis of the reactions: (S)-2-haloacid + H2O = (R)-2-hydroxyacid + halide, and (R)-2-haloacid + H2O = (S)-2-hydroxyacid + halide.','2013-10-27','NSRP'),(17635,33977,'2-haloacid dehalogenase (configuration-retaining) activity','F','Catalysis of the reactions: (S)-2-haloacid + H2O = (S)-2-hydroxyacid + halide, and (R)-2-haloacid + H2O = (R)-2-hydroxyacid + halide.','2013-10-27','NSRP'),(17636,33978,'phosphonopyruvate hydrolase activity','F','Catalysis of the reaction: 3-phosphonopyruvate + H(2)O = phosphate + pyruvate.','2013-10-27','NSRP'),(17637,33979,'box H/ACA snoRNA metabolic process','P','The chemical reactions and pathways involving box H/ACA type small nucleolar RNA.','2013-10-27','NSRP'),(17638,33980,'phosphonopyruvate decarboxylase activity','F','Catalysis of the reaction: 3-phosphonopyruvate + 2 H(+) = CO(2) + phosphonoacetaldehyde.','2013-10-27','NSRP'),(17639,33981,'D-dopachrome decarboxylase activity','F','Catalysis of the reaction: D-dopachrome + H(+) = 5,6-dihydroxyindole + CO(2).','2013-10-27','NSRP'),(17640,33982,'3-dehydro-L-gulonate-6-phosphate decarboxylase activity','F','Catalysis of the reaction: 3-dehydro-L-gulonate 6-phosphate + H(+) = L-xylulose 5-phosphate + CO(2).','2013-10-27','NSRP'),(17641,33983,'diaminobutyrate decarboxylase activity','F','Catalysis of the reaction: L-2,4-diaminobutyrate + H(+) = 1,3-diaminopropane + CO(2).','2013-10-27','NSRP'),(17642,33984,'indole-3-glycerol-phosphate lyase activity','F','Catalysis of the reaction: (1S,2R)-1-C-(indol-3-yl)glycerol 3-phosphate = indole + D-glyceraldehyde 3-phosphate.','2013-10-27','NSRP'),(17643,33985,'acidocalcisome lumen','C','The volume enclosed by the membranes of an acidocalcisome.','2013-10-27','NSRP'),(17644,33986,'response to methanol','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a methanol stimulus.','2013-10-27','NSRP'),(17645,33987,'2-hydroxyisoflavanone dehydratase activity','F','Catalysis of the reaction: 2,7,4\'-trihydroxyisoflavanone = daidzein + H2O.','2013-10-27','NSRP'),(17646,33988,'bile-acid 7alpha-dehydratase activity','F','Catalysis of the reaction: 7alpha,12alpha-dihydroxy-3-oxochol-4-en-24-oate = 12alpha-hydroxy-3-oxochola-4,6-dien-24-oate + H(2)O.','2013-10-27','NSRP'),(17647,33989,'3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity','F','Catalysis of the reaction: (24R,25R)-3alpha,7alpha,12alpha,24-tetrahydroxy-5beta-cholestanoyl-CoA = (24E)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA + H2O.','2013-10-27','NSRP'),(17648,33990,'ectoine synthase activity','F','Catalysis of the reaction: N(4)-acetyl-L-2,4-diaminobutyrate = ectoine + H(2)O.','2013-10-27','NSRP'),(17649,33991,'aldos-2-ulose dehydratase activity','F','Catalysis of the reactions: 1,5-anhydro-D-fructose = 2-hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one + H2O; (1a) 1,5-anhydro-D-fructose = 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose + H2O and (1b) 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose = 2-hydroxy-2-(hydroxymethyl)-2H-pyran-3(6H)-one.','2013-10-27','NSRP'),(17650,33992,'1,5-anhydro-D-fructose dehydratase activity','F','Catalysis of the reaction: 1,5-anhydro-D-fructose = 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose + H2O.','2013-10-27','NSRP'),(17651,33993,'response to lipid','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.','2013-10-27','NSRP'),(17652,33994,'glucuronan lyase activity','F','Catalysis of the reaction: (1->4)-beta-D-glucuronan = an oligosaccharide with 4-deoxy-beta-D-gluc-4-enuronosyl end + (1->4)-beta-D-glucuronan. This reaction is the eliminative cleavage of (1->4)-beta-D-glucuronans to give oligosaccharides with 4-deoxy-beta-D-gluc-4-enuronosyl groups at their non-reducing ends. Complete degradation of glucuronans results in the formation of tetrasaccharides.','2013-10-27','NSRP'),(17653,33995,'anhydrosialidase activity','F','Catalysis of the reaction: an N-acetylneuraminate glycoside = 2,7-anhydro-alpha-N-acetylneuraminate + an alpha-sialyl group. This reaction is the elimination of alpha-sialyl groups in N-acetylneuraminic acid glycosides, releasing 2,7-anhydro-alpha-N-acetylneuraminate.','2013-10-27','NSRP'),(17654,33996,'levan fructotransferase (DFA-IV-forming) activity','F','Catalysis of the reaction: beta-D-fructopyranosyl-(2->6)-[D-fructofuranosyl-(2->6)]n-D-fructofuranoside = beta-D-fructopyranosyl-(2->6)-[D-fructofuranosyl-(2->6)](n-1)-D-fructofuranoside + di-beta-D-fructofuranose 2,6\':2\',6-dianhydride. This reaction is the production of di-beta-D-fructofuranose 2,6\':2\',6-dianhydride (DFA IV) by successively eliminating the diminishing (2->6)-beta-D-fructan (levan) chain from the terminal D-fructosyl-D-fructosyl disaccharide.','2013-10-27','NSRP'),(17655,33997,'inulin fructotransferase (DFA-I-forming) activity','F','Catalysis of the reaction: [(2->1)-beta-D-fructosyl](n) = [(2->1)-beta-D-fructosyl](n-1) + alpha-D-fructofuranose-beta-D-fructofuranose 1,2\':1,2\'-dianhydride. This reaction is the production of alpha-D-fructofuranose beta-D-fructofuranose 1,2\':2,1\'-dianhydride (DFA I) by successively eliminating the diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal D-fructosyl-D-fructosyl disaccharide.','2013-10-27','NSRP'),(17656,33998,'inulin fructotransferase (DFA-III-forming) activity','F','Catalysis of the reaction: [(2->1)-beta-D-fructosyl](n) = [(2->1)-beta-D-fructosyl](n-1) + alpha-D-fructofuranose beta-D-fructofuranose 1,2\':2,3\'-dianhydride. This reaction is the production of alpha-D-fructofuranose beta-D-fructofuranose 1,2\':2,3\'-dianhydride (DFA III) by successively eliminating the diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal D-fructosyl-D-fructosyl disaccharide.','2013-10-27','NSRP'),(17657,33999,'chondroitin B lyase activity','F','Catalysis of the reaction: dermatan sulfate = n 4-deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate. This reaction is the eliminative cleavage of dermatan sulfate containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucurosonyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated dermatan-sulfate disaccharide (DeltaUA-GalNAC-4S). Chondroitin sulfate B is also known as dermatan sulfate.','2013-10-27','NSRP'),(17658,34000,'chondroitin-sulfate-ABC endolyase activity','F','Catalysis of the endolytic cleavage of beta-1,4-galactosaminic bonds between N-acetylgalactosamine and either D-glucuronic acid or L-iduronic acid to produce a mixture of Delta4-unsaturated oligosaccharides of different sizes that are ultimately degraded to Delta4-unsaturated tetra- and disaccharides.','2013-10-27','NSRP'),(17659,34001,'chondroitin-sulfate-ABC exolyase activity','F','Catalysis of the exolytic cleavage of disaccharide residues from the non-reducing ends of both polymeric chondroitin sulfates and their oligosaccharide fragments.','2013-10-27','NSRP'),(17660,34002,'(R)-limonene synthase activity','F','Catalysis of the reaction: geranyl diphosphate = (4R)-limonene + diphosphate.','2013-10-27','NSRP'),(17661,34003,'vetispiradiene synthase activity','F','Catalysis of the reaction: 2-trans,6-trans-farnesyl diphosphate = diphosphate + vetispiradiene.','2013-10-27','NSRP'),(17662,34004,'germacradienol synthase activity','F','Catalysis of the reaction: 2-trans,6-trans-farnesyl diphosphate + H2O = (1E,4S,5E,7R)-germacra-1(10),5-dien-11-ol + diphosphate.','2013-10-27','NSRP'),(17663,34005,'germacrene-A synthase activity','F','Catalysis of the reaction: 2-trans,6-trans-farnesyl diphosphate = (+)-(R)-germacrene A + diphosphate.','2013-10-27','NSRP'),(17664,34006,'amorpha-4,11-diene synthase activity','F','Catalysis of the reaction: 2-trans,6-trans-farnesyl diphosphate = amorpha-4,11-diene + diphosphate.','2013-10-27','NSRP'),(17665,34007,'S-linalool synthase activity','F','Catalysis of the reaction: geranyl diphosphate + H(2)O = (S)-linalool + diphosphate.','2013-10-27','NSRP'),(17666,34008,'R-linalool synthase activity','F','Catalysis of the reaction: geranyl diphosphate + H(2)O = (R)-linalool + diphosphate.','2013-10-27','NSRP'),(17667,34009,'isoprene synthase activity','F','Catalysis of the reaction: dimethylallyl diphosphate = diphosphate + isoprene.','2013-10-27','NSRP'),(17668,34010,'sulfolactate sulfo-lyase activity','F','Catalysis of the reaction: 3-sulfolactate = pyruvate + sulfite.','2013-10-27','NSRP'),(17669,34011,'L-cysteate sulfo-lyase activity','F','Catalysis of the reaction: L-cysteate + H(2)O = NH(4)(+) + pyruvate + sulfite.','2013-10-27','NSRP'),(17670,34012,'FAD-AMP lyase (cyclizing) activity','F','Catalysis of the reaction: FAD = AMP + riboflavin cyclic-4\',5\'-phosphate.','2013-10-27','NSRP'),(17671,34013,'aliphatic aldoxime dehydratase activity','F','Catalysis of the reaction: an aliphatic aldoxime = an aliphatic nitrile + H2O.','2013-10-27','NSRP'),(17672,34014,'response to triglyceride','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a triglyceride stimulus.','2013-10-27','NSRP'),(17673,34015,'L-ribulose-5-phosphate 3-epimerase activity','F','Catalysis of the reaction: L-ribulose 5-phosphate = L-xylulose 5-phosphate.','2013-10-27','NSRP'),(17674,34016,'polyenoic fatty acid isomerase activity','F','Catalysis of the reaction: all-cis-icosa-5,8,11,14,17-pentaenoate = (5Z,7E,9E,14Z,17Z)-icosapentaenoate.','2013-10-27','NSRP'),(17675,34017,'trans-2-decenoyl-acyl-carrier-protein isomerase activity','F','Catalysis of the reaction: trans-dec-2-enoyl-[acyl-carrier protein] = cis-dec-3-enoyl-[acyl-carrier protein].','2013-10-27','NSRP'),(17676,34018,'ascopyrone tautomerase activity','F','Catalysis of the reaction: 1,5-anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose = 1,5-anhydro-4-deoxy-D-glycero-hex-1-en-3-ulose.','2013-10-27','NSRP'),(17677,34019,'capsanthin/capsorubin synthase activity','F','OBSOLETE. Catalysis of the reactions: violaxanthin = capsorubin, and antheraxanthin = capsanthin.','2013-10-27','NSRP'),(17678,34020,'neoxanthin synthase activity','F','Catalysis of the reaction: all-trans-violaxanthin = all-trans-neoxanthin.','2013-10-27','NSRP'),(17679,34021,'response to silicon dioxide','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a silicon dioxide stimulus.','2013-10-27','NSRP'),(17680,34022,'3-(hydroxyamino)phenol mutase activity','F','Catalysis of the reaction: 3-hydroxyaminophenol = aminohydroquinone.','2013-10-27','NSRP'),(17681,34023,'5-(carboxyamino)imidazole ribonucleotide mutase activity','F','Catalysis of the reaction: 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole = 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate.','2013-10-27','NSRP'),(17682,34024,'glutamate-putrescine ligase activity','F','Catalysis of the reaction: L-glutamate + ATP + putrescine = gamma-L-glutamylputrescine + ADP + 2 H(+) + phosphate.','2013-10-27','NSRP'),(17683,34025,'D-aspartate ligase activity','F','Catalysis of the reaction: ATP + D-aspartate + [beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-D-Ala-D-Ala)]n = [beta-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-6-N-(beta-D-Asp)-L-Lys-D-Ala-D-Ala)]n + ADP + phosphate.','2013-10-27','NSRP'),(17684,34026,'L-amino-acid alpha-ligase activity','F','Catalysis of the reaction: ATP + an L-amino acid + an L-amino acid = ADP + phosphate + L-aminoacyl-L-amino acid.','2013-10-27','NSRP'),(17685,34027,'(carboxyethyl)arginine beta-lactam-synthase activity','F','Catalysis of the reaction: N(2)-(2-carboxyethyl)-L-arginine + ATP = AMP + deoxyamidinoproclavaminate + diphosphate + 2 H(+).','2013-10-27','NSRP'),(17686,34028,'5-(carboxyamino)imidazole ribonucleotide synthase activity','F','Catalysis of the reaction: 5-amino-1-(5-phospho-D-ribosyl)imidazole + ATP + bicarbonate = 5-carboxyamino-1-(5-phospho-D-ribosyl)imidazole + ADP + 3 H(+) + phosphate.','2013-10-27','NSRP'),(17687,34029,'2-oxoglutarate carboxylase activity','F','Catalysis of the reaction: 2-oxoglutarate + ATP + bicarbonate = ADP + 2 H(+) + oxalosuccinate + phosphate.','2013-10-27','NSRP'),(17688,34030,'ribonucleoside bisphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17689,34031,'ribonucleoside bisphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17690,34032,'purine nucleoside bisphosphate metabolic process','P','The chemical reactions and pathways involving a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17691,34033,'purine nucleoside bisphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17692,34034,'purine nucleoside bisphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17693,34035,'purine ribonucleoside bisphosphate metabolic process','P','The chemical reactions and pathways involving a purine ribonucleoside bisphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17694,34036,'purine ribonucleoside bisphosphate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a purine ribonucleoside bisphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17695,34037,'purine ribonucleoside bisphosphate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a purine ribonucleoside bisphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.','2013-10-27','NSRP'),(17696,34038,'deoxyhypusine synthase activity','F','Catalysis of the reaction: [eIF5A-precursor]-lysine + spermidine = [eIF5A-precursor]-deoxyhypusine + propane-1,3-diamine. Four sub-reactions have been identified,in which the intermediates remain tightly associated with the enzyme: spermidine + NAD+ = dehydrospermidine + NADH; dehydrospermidine + [enzyme]-lysine = N-(4-aminobutylidene)-[enzyme]-lysine + propane-1,3-diamine; N-(4-aminobutylidene)-[enzyme]-lysine + [eIF5A-precursor]-lysine = N-(4-aminobutylidene)-[eIF5A-precursor]-lysine + [enzyme]-lysine; N-(4-aminobutylidene)-[eIF5A-precursor]-lysine + NADH + H+ = [eIF5A-precursor]-deoxyhypusine + NAD+.','2013-10-27','NSRP'),(17697,34039,'8-oxo-7,8-dihydroguanine DNA N-glycosylase activity','F','Catalysis of the removal of 8-oxo-7,8-dihydroguanine bases by cleaving the N-C1\' glycosidic bond between the oxidized purine and the deoxyribose sugar.','2013-10-27','NSRP'),(17698,34040,'lipid-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + lipid(in) = ADP + phosphate + lipid(out).','2013-10-27','NSRP'),(17699,34041,'sterol-transporting ATPase activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: ATP + H2O + sterol(in) = ADP + phosphate + sterol(out).','2013-10-27','NSRP'),(17700,34042,'5-formyluracil DNA N-glycosylase activity','F','Catalysis of the removal of 5-formyluracil bases by cleaving the N-C1\' glycosidic bond between the oxidized pyrimidine and the deoxyribose sugar.','2013-10-27','NSRP'),(17701,34043,'5-hydroxymethyluracil DNA N-glycosylase activity','F','Catalysis of the removal of 5-hydroxymethyluracil bases by cleaving the N-C1\' glycosidic bond between the oxidized pyrimidine and the deoxyribose sugar.','2013-10-27','NSRP'),(17702,34044,'exomer complex','C','A protein complex that forms a coat structure on vesicles involved in exocytosis of proteins from the trans-Golgi network to the cell surface; in Saccharomyces, the complex contains Chs5p, Chs6p, and Chs6p paralogues.','2013-10-27','NSRP'),(17703,34045,'pre-autophagosomal structure membrane','C','A cellular membrane associated with the pre-autophagosomal structure.','2013-10-27','NSRP'),(17704,34046,'poly(G) RNA binding','F','Interacting selectively and non-covalently with a sequence of guanine residues in an RNA molecule.','2013-10-27','NSRP'),(17705,34047,'regulation of protein phosphatase type 2A activity','P','Any process that modulates the activity of the enzyme protein phosphatase type 2A.','2013-10-27','NSRP'),(17706,34048,'negative regulation of protein phosphatase type 2A activity','P','Any process that stops or reduces the activity of the enzyme protein phosphatase type 2A.','2013-10-27','NSRP'),(17707,34049,'positive regulation of protein phosphatase type 2A activity','P','Any process that activates or increases the activity of the enzyme protein phosphatase type 2A.','2013-10-27','NSRP'),(17708,34050,'host programmed cell death induced by symbiont','P','Cell death in a host resulting from activation of host endogenous cellular processes after direct or indirect interaction with a symbiont (defined as the smaller of two, or more, organisms engaged in symbiosis, a close interaction encompassing mutualism through parasitism). An example of direct interaction is contact with penetrating hyphae of a fungus; an example of indirect interaction is encountering symbiont-secreted molecules.','2013-10-27','NSRP'),(17709,34051,'negative regulation of plant-type hypersensitive response','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the hypersensitive response in a plant.','2013-10-27','NSRP'),(17710,34052,'positive regulation of plant-type hypersensitive response','P','Any process that activates or increases the frequency, rate or extent of the hypersensitive response in a plant.','2013-10-27','NSRP'),(17711,34053,'modulation by symbiont of host defense-related programmed cell death','P','Any process in which an organism modulates the frequency, rate or extent of defense-related programmed cell death in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17712,34054,'negative regulation by symbiont of host defense-related programmed cell death','P','Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of defense-related programmed cell death in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17713,34055,'positive regulation by symbiont of host defense-related programmed cell death','P','Any process in which an organism activates or increases the frequency, rate or extent of defense-related programmed cell death in the host organism. The host is defined as the larger of the organisms involved in a symbiotic interaction.','2013-10-27','NSRP'),(17714,34056,'estrogen response element binding','F','Interacting selectively and non-covalently with the estrogen response element (ERE), a conserved sequence found in the promoters of genes whose expression is regulated in response to estrogen.','2013-10-27','NSRP'),(17715,34057,'RNA strand-exchange activity','F','Facilitates the displacement of one strand of an RNA-RNA duplex and its replacement with a different strand of higher complementarity.','2013-10-27','NSRP'),(17716,34058,'endosomal vesicle fusion','P','The homotypic fusion of endocytic vesicles to form or add to an early endosome.','2013-10-27','NSRP'),(17717,34059,'response to anoxia','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating a decline in oxygen levels to trace amounts, <0.1%.','2013-10-27','NSRP'),(17718,34060,'cyanelle stroma','C','The space enclosed by the double membrane of a cyanelle.','2013-10-27','NSRP'),(17719,34061,'DNA polymerase activity','F','Catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1); the synthesis of DNA from deoxyribonucleotide triphosphates in the presence of a nucleic acid template and primer.','2013-10-27','NSRP'),(17720,34062,'RNA polymerase activity','F','Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); the synthesis of RNA from ribonucleotide triphosphates in the presence of a nucleic acid template.','2013-10-27','NSRP'),(17721,34063,'stress granule assembly','P','The aggregation, arrangement and bonding together of proteins and RNA molecules to form a stress granule.','2013-10-27','NSRP'),(17722,34064,'Tor2-Mei2-Ste11 complex','C','A protein complex that contains the transcription factor Ste11 and the RNA binding protein Mei2; involved in regulation of conjugation in fission yeast.','2013-10-27','NSRP'),(17723,34065,'replication fork processing at rDNA locus','P','The process in which a DNA replication fork that has stalled at the rDNA replication fork barrier (RFB) is repaired and replication is restarted.','2013-10-27','NSRP'),(17724,34066,'Ric1p-Rgp1p complex','C','A protein complex that acts as a nucleotide exchange factor for the GTPase Ypt6p, and is required for fusion of endosome-derived vesicles with the Golgi.','2013-10-27','NSRP'),(17725,34067,'protein localization to Golgi apparatus','P','A process in which a protein is transported to, or maintained in, a location within the Golgi apparatus.','2013-10-27','NSRP'),(17726,34068,'aminoglycoside nucleotidyltransferase activity','F','Catalysis of the reaction: nucleoside triphosphate + aminoglycoside = diphosphate + nucleotidylaminoglycoside.','2013-10-27','NSRP'),(17727,34069,'aminoglycoside N-acetyltransferase activity','F','Catalysis of the reaction: acetyl-CoA + aminoglycoside = CoA + N-acetylaminoglycoside.','2013-10-27','NSRP'),(17728,34070,'aminoglycoside 1-N-acetyltransferase activity','F','Catalysis of the reaction: acetyl-CoA + aminoglycoside = CoA + 1-N-acetylaminoglycoside. This is acetylation of the 1-amino group of the central deoxystreptamine ring.','2013-10-27','NSRP'),(17729,34071,'aminoglycoside phosphotransferase activity','F','Catalysis of the reaction: ATP + aminoglycoside = ADP + phosphoaminoglycoside.','2013-10-27','NSRP'),(17730,34072,'squalene cyclase activity','F','Catalysis of the reaction: squalene = triterpene.','2013-10-27','NSRP'),(17731,34073,'tetrahymanol cyclase activity','F','Catalysis of the reaction: squalene = tetrahymanol.','2013-10-27','NSRP'),(17732,34074,'marneral synthase activity','F','Catalysis of the reaction: oxidosqualene = marneral.','2013-10-27','NSRP'),(17733,34075,'arabidiol synthase activity','F','Catalysis of the reaction: oxidosqualene + H2O = arabidiol ((13R,14R,17E)-malabarica-17,21-diene-3beta,14-diol).','2013-10-27','NSRP'),(17734,34076,'cucurbitadienol synthase activity','F','Catalysis of the reaction: oxidosqualene = cucurbitadienol.','2013-10-27','NSRP'),(17735,34077,'butanediol metabolic process','P','The chemical reactions and pathways involving butanediol; the biologically relevant isomer is 2,3-butanediol, CH3CH(OH)CH(OH)CH3.','2013-10-27','NSRP'),(17736,34078,'butanediol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of butanediol; the biologically relevant isomer is 2,3-butanediol, CH3CH(OH)CH(OH)CH3.','2013-10-27','NSRP'),(17737,34079,'butanediol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of butanediol; the biologically relevant isomer is 2,3-butanediol, CH3CH(OH)CH(OH)CH3.','2013-10-27','NSRP'),(17738,34080,'CENP-A containing nucleosome assembly at centromere','P','The formation of nucleosomes containing the histone H3 variant CenH3 (also called CENP-A) to form centromeric chromatin; occurs outside the context of DNA replication.','2013-10-27','NSRP'),(17739,34081,'polyketide synthase complex','C','A protein complex that carries out enzymatic reactions involved in the biosynthesis of polyketides, any of a diverse group of natural products synthesized via linear poly-beta-ketones.','2013-10-27','NSRP'),(17740,34082,'type II polyketide synthase complex','C','A polyketide synthase complex that consists of several different polypeptide chains, each of which catalyzes a single reaction.','2013-10-27','NSRP'),(17741,34083,'type III polyketide synthase complex','C','A polyketide synthase complex that consists of two identical ketosynthase polypeptides.','2013-10-27','NSRP'),(17742,34084,'steryl deacetylase activity','F','Catalysis of the hydrolysis of an acetyl group or groups from an acetylated sterol.','2013-10-27','NSRP'),(17743,34085,'establishment of sister chromatid cohesion','P','The process in which the sister chromatids of a replicated chromosome become associated with each other during S phase.','2013-10-27','NSRP'),(17744,34086,'maintenance of sister chromatid cohesion','P','The process in which the association between sister chromatids of a replicated chromosome is maintained as chromosomes condense, attach to the spindle in a bipolar orientation, and congress to the metaphase plate.','2013-10-27','NSRP'),(17745,34087,'establishment of mitotic sister chromatid cohesion','P','The process in which the sister chromatids of a replicated chromosome become joined along the entire length of the chromosome during S phase during a mitotic cell cycle.','2013-10-27','NSRP'),(17746,34088,'maintenance of mitotic sister chromatid cohesion','P','The process in which the association between sister chromatids of a replicated chromosome is maintained as chromosomes condense, attach to the spindle in a bipolar orientation, and congress to the metaphase plate during a mitotic cell cycle.','2013-10-27','NSRP'),(17747,34089,'establishment of meiotic sister chromatid cohesion','P','The process in which the sister chromatids of a replicated chromosome become joined along the entire length of the chromosome during S phase during a meiotic cell cycle.','2013-10-27','NSRP'),(17748,34090,'maintenance of meiotic sister chromatid cohesion','P','The process in which the association between sister chromatids of a replicated chromosome is maintained as chromosomes condense, attach to the spindle in a bipolar orientation, and congress to the metaphase plate during a meiotic cell cycle.','2013-10-27','NSRP'),(17749,34091,'regulation of maintenance of sister chromatid cohesion','P','Any process that modulates the extent to which the association between sister chromatids of a replicated chromosome is maintained.','2013-10-27','NSRP'),(17750,34092,'negative regulation of maintenance of sister chromatid cohesion','P','Any process that decreases the extent to which the association between sister chromatids of a replicated chromosome is maintained.','2013-10-27','NSRP'),(17751,34093,'positive regulation of maintenance of sister chromatid cohesion','P','Any process that increases the extent to which the association between sister chromatids of a replicated chromosome is maintained.','2013-10-27','NSRP'),(17752,34094,'regulation of maintenance of meiotic sister chromatid cohesion','P','Any process that modulates the extent to which the association between sister chromatids of a replicated chromosome is maintained during a meiotic cell cycle.','2013-10-27','NSRP'),(17753,34095,'negative regulation of maintenance of meiotic sister chromatid cohesion','P','Any process that decreases the extent to which the association between sister chromatids of a replicated chromosome is maintained during a meiotic cell cycle.','2013-10-27','NSRP'),(17754,34096,'positive regulation of maintenance of meiotic sister chromatid cohesion','P','Any process that increases the extent to which the association between sister chromatids of a replicated chromosome is maintained during a meiotic cell cycle.','2013-10-27','NSRP'),(17755,34097,'response to cytokine stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.','2013-10-27','NSRP'),(17756,34098,'Cdc48p-Npl4p-Ufd1p AAA ATPase complex','C','A multiprotein ATPase complex required for the efficient dislocation of ER-lumenal degradation substrates, and their subsequent proteolysis by the proteasome. In budding yeast, this complex includes Cdc48p, Npl4p and Ufd1p proteins.','2013-10-27','NSRP'),(17757,34099,'luminal surveillance complex','C','A multiprotein complex that recognizes ERAD-luminal misfolded substrates and brings them to the ubiquitination/extraction machinery. In yeast, this complex consists of Yos9p, Kar2p and Hrd3p proteins.','2013-10-27','NSRP'),(17758,34101,'erythrocyte homeostasis','P','Any process of regulating the production and elimination of erythrocytes within an organism.','2013-10-27','NSRP'),(17759,34102,'erythrocyte clearance','P','The selective elimination of erythrocytes from the body by autoregulatory mechanisms.','2013-10-27','NSRP'),(17760,34103,'regulation of tissue remodeling','P','Any process that modulates the frequency, rate, or extent of tissue remodeling.','2013-10-27','NSRP'),(17761,34104,'negative regulation of tissue remodeling','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling.','2013-10-27','NSRP'),(17762,34105,'positive regulation of tissue remodeling','P','Any process that activates or increases the frequency, rate, or extent of tissue remodeling.','2013-10-27','NSRP'),(17763,34106,'regulation of erythrocyte clearance','P','Any process that modulates the frequency, rate, or extent of erythrocyte clearance.','2013-10-27','NSRP'),(17764,34107,'negative regulation of erythrocyte clearance','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of erythrocyte clearance.','2013-10-27','NSRP'),(17765,34108,'positive regulation of erythrocyte clearance','P','Any process that activates or increases the frequency, rate, or extent of erythrocyte clearance.','2013-10-27','NSRP'),(17766,34109,'homotypic cell-cell adhesion','P','The attachment of a cell to a second cell of the identical type via adhesion molecules.','2013-10-27','NSRP'),(17767,34110,'regulation of homotypic cell-cell adhesion','P','Any process that modulates the frequency, rate, or extent of homotypic cell-cell adhesion.','2013-10-27','NSRP'),(17768,34111,'negative regulation of homotypic cell-cell adhesion','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of homotypic cell-cell adhesion.','2013-10-27','NSRP'),(17769,34112,'positive regulation of homotypic cell-cell adhesion','P','Any process that activates or increases the frequency, rate, or extent of homotypic cell-cell adhesion.','2013-10-27','NSRP'),(17770,34113,'heterotypic cell-cell adhesion','P','The attachment of a cell to a cell of a different type via adhesion molecules.','2013-10-27','NSRP'),(17771,34114,'regulation of heterotypic cell-cell adhesion','P','Any process that modulates the frequency, rate, or extent of heterotypic cell-cell adhesion.','2013-10-27','NSRP'),(17772,34115,'negative regulation of heterotypic cell-cell adhesion','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.','2013-10-27','NSRP'),(17773,34116,'positive regulation of heterotypic cell-cell adhesion','P','Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.','2013-10-27','NSRP'),(17774,34117,'erythrocyte aggregation','P','The adhesion of one erythrocyte to one or more other erythrocytes via adhesion molecules.','2013-10-27','NSRP'),(17775,34118,'regulation of erythrocyte aggregation','P','Any process that modulates the frequency, rate, or extent of erythrocyte aggregation.','2013-10-27','NSRP'),(17776,34119,'negative regulation of erythrocyte aggregation','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of erythrocyte aggregation.','2013-10-27','NSRP'),(17777,34120,'positive regulation of erythrocyte aggregation','P','Any process that activates or increases the frequency, rate, or extent of erythrocyte aggregation.','2013-10-27','NSRP'),(17778,34121,'regulation of toll-like receptor signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17779,34122,'negative regulation of toll-like receptor signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17780,34123,'positive regulation of toll-like receptor signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17781,34124,'regulation of MyD88-dependent toll-like receptor signaling pathway','P','Any process that modulates the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17782,34125,'negative regulation of MyD88-dependent toll-like receptor signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17783,34126,'positive regulation of MyD88-dependent toll-like receptor signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17784,34127,'regulation of MyD88-independent toll-like receptor signaling pathway','P','Any process that modulates the frequency, rate, or extent of MyD88-independent toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17785,34128,'negative regulation of MyD88-independent toll-like receptor signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of MyD88-independent toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17786,34129,'positive regulation of MyD88-independent toll-like receptor signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of MyD88-independent toll-like receptor signaling pathway.','2013-10-27','NSRP'),(17787,34130,'toll-like receptor 1 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 1.','2013-10-27','NSRP'),(17788,34131,'regulation of toll-like receptor 1 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 1 signaling pathway.','2013-10-27','NSRP'),(17789,34132,'negative regulation of toll-like receptor 1 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 1 signaling pathway.','2013-10-27','NSRP'),(17790,34133,'positive regulation of toll-like receptor 1 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 1 signaling pathway.','2013-10-27','NSRP'),(17791,34134,'toll-like receptor 2 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 2.','2013-10-27','NSRP'),(17792,34135,'regulation of toll-like receptor 2 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 2 signaling pathway.','2013-10-27','NSRP'),(17793,34136,'negative regulation of toll-like receptor 2 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 2 signaling pathway.','2013-10-27','NSRP'),(17794,34137,'positive regulation of toll-like receptor 2 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 2 signaling pathway.','2013-10-27','NSRP'),(17795,34138,'toll-like receptor 3 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 3.','2013-10-27','NSRP'),(17796,34139,'regulation of toll-like receptor 3 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 3 signaling pathway.','2013-10-27','NSRP'),(17797,34140,'negative regulation of toll-like receptor 3 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 3 signaling pathway.','2013-10-27','NSRP'),(17798,34141,'positive regulation of toll-like receptor 3 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 3 signaling pathway.','2013-10-27','NSRP'),(17799,34142,'toll-like receptor 4 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 4.','2013-10-27','NSRP'),(17800,34143,'regulation of toll-like receptor 4 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 4 signaling pathway.','2013-10-27','NSRP'),(17801,34144,'negative regulation of toll-like receptor 4 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 4 signaling pathway.','2013-10-27','NSRP'),(17802,34145,'positive regulation of toll-like receptor 4 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 4 signaling pathway.','2013-10-27','NSRP'),(17803,34146,'toll-like receptor 5 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 5.','2013-10-27','NSRP'),(17804,34147,'regulation of toll-like receptor 5 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 5 signaling pathway.','2013-10-27','NSRP'),(17805,34148,'negative regulation of toll-like receptor 5 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 5 signaling pathway.','2013-10-27','NSRP'),(17806,34149,'positive regulation of toll-like receptor 5 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 5 signaling pathway.','2013-10-27','NSRP'),(17807,34150,'toll-like receptor 6 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 6.','2013-10-27','NSRP'),(17808,34151,'regulation of toll-like receptor 6 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 6 signaling pathway.','2013-10-27','NSRP'),(17809,34152,'negative regulation of toll-like receptor 6 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 6 signaling pathway.','2013-10-27','NSRP'),(17810,34153,'positive regulation of toll-like receptor 6 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 6 signaling pathway.','2013-10-27','NSRP'),(17811,34154,'toll-like receptor 7 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 7.','2013-10-27','NSRP'),(17812,34155,'regulation of toll-like receptor 7 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 7 signaling pathway.','2013-10-27','NSRP'),(17813,34156,'negative regulation of toll-like receptor 7 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 7 signaling pathway.','2013-10-27','NSRP'),(17814,34157,'positive regulation of toll-like receptor 7 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 7 signaling pathway.','2013-10-27','NSRP'),(17815,34158,'toll-like receptor 8 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 8.','2013-10-27','NSRP'),(17816,34159,'regulation of toll-like receptor 8 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 8 signaling pathway.','2013-10-27','NSRP'),(17817,34160,'negative regulation of toll-like receptor 8 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 8 signaling pathway.','2013-10-27','NSRP'),(17818,34161,'positive regulation of toll-like receptor 8 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 8 signaling pathway.','2013-10-27','NSRP'),(17819,34162,'toll-like receptor 9 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 9.','2013-10-27','NSRP'),(17820,34163,'regulation of toll-like receptor 9 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 9 signaling pathway.','2013-10-27','NSRP'),(17821,34164,'negative regulation of toll-like receptor 9 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 9 signaling pathway.','2013-10-27','NSRP'),(17822,34165,'positive regulation of toll-like receptor 9 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 9 signaling pathway.','2013-10-27','NSRP'),(17823,34166,'toll-like receptor 10 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 10.','2013-10-27','NSRP'),(17824,34167,'regulation of toll-like receptor 10 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 10 signaling pathway.','2013-10-27','NSRP'),(17825,34168,'negative regulation of toll-like receptor 10 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 10 signaling pathway.','2013-10-27','NSRP'),(17826,34169,'positive regulation of toll-like receptor 10 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 10 signaling pathway.','2013-10-27','NSRP'),(17827,34170,'toll-like receptor 11 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 11.','2013-10-27','NSRP'),(17828,34171,'regulation of toll-like receptor 11 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 11 signaling pathway.','2013-10-27','NSRP'),(17829,34172,'negative regulation of toll-like receptor 11 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 11 signaling pathway.','2013-10-27','NSRP'),(17830,34173,'positive regulation of toll-like receptor 11 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 11 signaling pathway.','2013-10-27','NSRP'),(17831,34174,'toll-like receptor 12 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 12.','2013-10-27','NSRP'),(17832,34175,'regulation of toll-like receptor 12 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 12 signaling pathway.','2013-10-27','NSRP'),(17833,34176,'negative regulation of toll-like receptor 12 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 12 signaling pathway.','2013-10-27','NSRP'),(17834,34177,'positive regulation of toll-like receptor 12 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 12 signaling pathway.','2013-10-27','NSRP'),(17835,34178,'toll-like receptor 13 signaling pathway','P','Any series of molecular signals generated as a consequence of binding to toll-like receptor 13.','2013-10-27','NSRP'),(17836,34179,'regulation of toll-like receptor 13 signaling pathway','P','Any process that modulates the frequency, rate, or extent of toll-like receptor 13 signaling pathway.','2013-10-27','NSRP'),(17837,34180,'negative regulation of toll-like receptor 13 signaling pathway','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of toll-like receptor 13 signaling pathway.','2013-10-27','NSRP'),(17838,34181,'positive regulation of toll-like receptor 13 signaling pathway','P','Any process that activates or increases the frequency, rate, or extent of toll-like receptor 13 signaling pathway.','2013-10-27','NSRP'),(17839,34182,'regulation of maintenance of mitotic sister chromatid cohesion','P','Any process that modulates the extent to which the association between sister chromatids of a replicated chromosome is maintained during a mitotic cell cycle.','2013-10-27','NSRP'),(17840,34183,'negative regulation of maintenance of mitotic sister chromatid cohesion','P','Any process that decreases the extent to which the association between sister chromatids of a replicated chromosome is maintained during a mitotic cell cycle.','2013-10-27','NSRP'),(17841,34184,'positive regulation of maintenance of mitotic sister chromatid cohesion','P','Any process that increases the extent to which the association between sister chromatids of a replicated chromosome is maintained during a mitotic cell cycle.','2013-10-27','NSRP'),(17842,34185,'apolipoprotein binding','F','Interacting selectively and non-covalently with an apolipoprotein, the protein component of a lipoprotein complex.','2013-10-27','NSRP'),(17843,34186,'apolipoprotein A-I binding','F','Interacting selectively and non-covalently with apolipoprotein A-I.','2013-10-27','NSRP'),(17844,34187,'apolipoprotein E binding','F','OBSOLETE. Interacting selectively and non-covalently with apolipoprotein E.','2013-10-27','NSRP'),(17845,34188,'apolipoprotein A-I receptor activity','F','Combining with apolipoprotein A-I and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.','2013-10-27','NSRP'),(17846,34189,'very-low-density lipoprotein particle binding','F','Interacting selectively and non-covalently with a very-low-density lipoprotein particle, a triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm.','2013-10-27','NSRP'),(17847,34190,'apolipoprotein receptor binding','F','Interacting selectively and non-covalently with an apolipoprotein receptor.','2013-10-27','NSRP'),(17848,34191,'apolipoprotein A-I receptor binding','F','Interacting selectively and non-covalently with an apolipoprotein A-I receptor.','2013-10-27','NSRP'),(17849,34192,'D-galactonate metabolic process','P','The chemical reactions and pathways involving D-galactonate, the anion of D-galactonic acid.','2013-10-27','NSRP'),(17850,34193,'L-galactonate metabolic process','P','The chemical reactions and pathways involving L-galactonate, the anion of L-galactonic acid.','2013-10-27','NSRP'),(17851,34194,'D-galactonate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of D-galactonate, the anion of D-galactonic acid.','2013-10-27','NSRP'),(17852,34195,'L-galactonate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of L-galactonate, the anion of L-galactonic acid.','2013-10-27','NSRP'),(17853,34196,'acylglycerol transport','P','The directed movement of an acylglycerol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. An acylglycerol is any mono-, di- or triester of glycerol with (one or more) fatty acids.','2013-10-27','NSRP'),(17854,34197,'triglyceride transport','P','The directed movement of triglyceride into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.','2013-10-27','NSRP'),(17855,34198,'cellular response to amino acid starvation','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids.','2013-10-27','NSRP'),(17856,34199,'activation of protein kinase A activity','P','Any process that initiates the activity of the inactive enzyme protein kinase A.','2013-10-27','NSRP'),(17857,34200,'D,D-heptose 1,7-bisphosphate phosphatase activity','F','Catalysis of the reaction: D-beta-D-heptose 1,7-bisphosphate + H2O = D-beta-D-heptose 1-phosphate + phosphate.','2013-10-27','NSRP'),(17858,34201,'response to oleic acid','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oleic acid stimulus.','2013-10-27','NSRP'),(17859,34202,'glycolipid-translocating activity','F','Catalysis of the movement of glycolipids from one membrane face to the other (glycolipid \'flippase\' activity).','2013-10-27','NSRP'),(17860,34203,'glycolipid translocation','P','The translocation, or flipping, of glycolipid molecules from one monolayer of a membrane bilayer to the opposite monolayer.','2013-10-27','NSRP'),(17861,34204,'lipid translocation','P','The translocation, or flipping, of lipid molecules from one monolayer of a membrane bilayer to the opposite monolayer.','2013-10-27','NSRP'),(17862,34205,'beta-amyloid formation','P','The generation of beta-amyloid by cleavage of the amyloid precursor protein (APP).','2013-10-27','NSRP'),(17863,34206,'enhanceosome','C','A protein-DNA complex formed by the association of a distinct set of general and specific transcription factors with a region of enhancer DNA. The cooperative assembly of an enhanceosome confers specificity of transcriptional regulation.','2013-10-27','NSRP'),(17864,34207,'steroid acetylation','P','The addition of an acetyl group to a steroid molecule. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.','2013-10-27','NSRP'),(17865,34208,'steroid deacetylation','P','The removal of an acetyl group from a steroid molecule. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.','2013-10-27','NSRP'),(17866,34209,'sterol acetylation','P','The addition of an acetyl group to a sterol molecule. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.','2013-10-27','NSRP'),(17867,34210,'sterol deacetylation','P','The removal of an acetyl group from a sterol molecule. An acetyl group is CH3CO-, derived from acetic [ethanoic] acid.','2013-10-27','NSRP'),(17868,34211,'GTP-dependent protein kinase activity','F','Catalysis of the reaction: ATP + a protein serine/threonine = ADP + protein serine/threonine phosphate, dependent on the presence of GTP.','2013-10-27','NSRP'),(17869,34212,'peptide N-acetyltransferase activity','F','Catalysis of the acetylation of an amino acid residue of a peptide or protein, according to the reaction: acetyl-CoA + peptide = CoA + N-acetylpeptide.','2013-10-27','NSRP'),(17870,34213,'quinolinate catabolic process','P','The chemical reactions and pathways resulting in the breakdown of quinolinate, the anion of quinolinic acid, also known as 2,3-pyridinedicarboxylic acid.','2013-10-27','NSRP'),(17871,34214,'protein hexamerization','P','The formation of a protein hexamer, a macromolecular structure consisting of six noncovalently associated identical or nonidentical subunits.','2013-10-27','NSRP'),(17872,34215,'thiamine:hydrogen symporter activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: thiamine(out) + H+(out) = thiamine(in) + H+(in).','2013-10-27','NSRP'),(17873,34216,'high-affinity thiamine:hydrogen symporter activity','F','Catalysis of the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: thiamine(out) + H+(out) = thiamine(in) + H+(in). In high affinity transport the transporter is able to bind the solute even if it is only present at very low concentrations.','2013-10-27','NSRP'),(17874,34217,'ascospore wall chitin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of ascospore wall chitin, a linear polysaccharide consisting of P-1,4-linked N-acetyl-D-glucosamine residues, found in the walls of ascospores.','2013-10-27','NSRP'),(17875,34218,'ascospore wall chitin metabolic process','P','The chemical reactions and pathways involving ascospore wall chitin, a linear polysaccharide consisting of P-1,4-linked N-acetyl-D-glucosamine residues, found in the walls of ascospores.','2013-10-27','NSRP'),(17876,34219,'carbohydrate transmembrane transport','P','The process in which a carbohydrate is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(17877,34220,'ion transmembrane transport','P','A process in which an ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(17878,34221,'fungal-type cell wall chitin biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cell wall chitin, a linear polysaccharide consisting of P-1,4-linked N-acetyl-D-glucosamine residues, found in the walls of fungal cells.','2013-10-27','NSRP'),(17879,34222,'regulation of cell wall chitin metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving chitin in a cell wall.','2013-10-27','NSRP'),(17880,34223,'regulation of ascospore wall chitin biosynthetic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ascospore wall chitin.','2013-10-27','NSRP'),(17881,34224,'cellular response to zinc ion starvation','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of zinc ions.','2013-10-27','NSRP'),(17882,34225,'regulation of transcription from RNA polymerase II promoter in response to zinc ion starvation','P','Modulation of the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a stimulus indicating the organism is deprived of zinc ions.','2013-10-27','NSRP'),(17883,34226,'lysine import','P','The directed movement of lysine, 2,6-diaminohexanoic acid, into a cell or organelle.','2013-10-27','NSRP'),(17884,34227,'tRNA thio-modification','P','The addition a sulfur atom to a nucleotide in a tRNA molecule.','2013-10-27','NSRP'),(17885,34228,'ethanolamine transmembrane transporter activity','F','Catalysis of the transfer of ethanolamine from one side of the membrane to the other. Ethanolamine (2-aminoethanol, monoethanolamine) is an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids, such as phosphatidylethanolamine.','2013-10-27','NSRP'),(17886,34229,'ethanolamine transport','P','The directed movement of ethanolamine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Ethanolamine (2-aminoethanol, monoethanolamine) is an amino alcohol that occurs widely in living organisms as a constituent of certain types of phospholipids, such as phosphatidylethanolamine.','2013-10-27','NSRP'),(17887,34230,'enkephalin processing','P','The formation of mature enkephalin, a pentapeptide hormone involved in regulating pain and nociception in the body by proteolytic processing of enkephalin propeptide.','2013-10-27','NSRP'),(17888,34231,'islet amyloid polypeptide processing','P','The formation of mature islet amyloid polypeptide (IAPP) by posttranslational processing of pro-islet amyloid polypeptide (pro-IAPP).','2013-10-27','NSRP'),(17889,34232,'ascospore wall chitin catabolic process','P','The chemical reactions and pathways resulting in the breakdown of ascospore wall chitin, a linear polysaccharide consisting of P-1,4-linked N-acetyl-D-glucosamine residues, found in the walls of ascospores.','2013-10-27','NSRP'),(17890,34233,'regulation of cell wall chitin catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of cell wall chitin.','2013-10-27','NSRP'),(17891,34234,'regulation of ascospore wall chitin catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of ascospore wall chitin.','2013-10-27','NSRP'),(17892,34235,'GPI anchor binding','F','Interacting selectively and non-covalently with any glycosylphosphatidylinositol anchor. GPI anchors serve to attach membrane proteins to the lipid bilayer of cell membranes.','2013-10-27','NSRP'),(17893,34236,'protein kinase A catalytic subunit binding','F','Interacting selectively and non-covalently with one or both of the catalytic subunits of protein kinase A.','2013-10-27','NSRP'),(17894,34237,'protein kinase A regulatory subunit binding','F','Interacting selectively and non-covalently with one or both of the regulatory subunits of protein kinase A.','2013-10-27','NSRP'),(17895,34238,'macrophage fusion','P','The binding and fusion of a macrophage to one or more other cells to form a multinucleated cell.','2013-10-27','NSRP'),(17896,34239,'regulation of macrophage fusion','P','Any process that modulates the frequency, rate or extent of macrophage fusion.','2013-10-27','NSRP'),(17897,34240,'negative regulation of macrophage fusion','P','Any process that stops, prevents, or decreases the frequency, rate or extent of macrophage fusion.','2013-10-27','NSRP'),(17898,34241,'positive regulation of macrophage fusion','P','Any process that activates or increases the frequency, rate or extent of macrophage fusion.','2013-10-27','NSRP'),(17899,34242,'negative regulation of syncytium formation by plasma membrane fusion','P','Any process that decreases the frequency, rate or extent of the formation of a syncytium, a mass of cytoplasm containing several nuclei enclosed within a single plasma membrane, by the fusion of the plasma membranes of two or more individual cells.','2013-10-27','NSRP'),(17900,34243,'regulation of transcription elongation from RNA polymerase II promoter','P','Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.','2013-10-27','NSRP'),(17901,34244,'negative regulation of transcription elongation from RNA polymerase II promoter','P','Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II.','2013-10-27','NSRP'),(17902,34245,'mitochondrial DNA-directed RNA polymerase complex','C','A DNA-directed RNA polymerase complex located in the mitochondrion. Mitochondrial RNA polymerase is composed of two subunits, a catalytic core, which resembles the enzymes from bacteriophage T7 and T3, and a specificity factor required for promoter recognition, which is similar to members of the eubacterial sigma factor family. In S. cerevisiae, these are encoded by the nuclear genes RPO41 and MTF1 and the specificity factor, required for promoter recognition and initiation, is not present in the elongating form.','2013-10-27','NSRP'),(17903,34246,'mitochondrial RNA polymerase binding promoter specificity activity','F','Interacting selectively and non-covalently with a mitochondrial RNA polymerase to form a holoenzyme complex and also, while present in the holoenzyme, interacting with promoter sequences in order to confer sequence specific recognition of mitochondrial promoter DNA sequence motifs.','2013-10-27','NSRP'),(17904,34247,'snoRNA splicing','P','The process of removing sections of a primary snoRNA transcript to remove sequences not present in the mature form of the snoRNA and joining the remaining sections to form the mature form of the snoRNA.','2013-10-27','NSRP'),(17905,34248,'regulation of cellular amide metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amides.','2013-10-27','NSRP'),(17906,34249,'negative regulation of cellular amide metabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving amides.','2013-10-27','NSRP'),(17907,34250,'positive regulation of cellular amide metabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amides.','2013-10-27','NSRP'),(17908,34251,'regulation of cellular amide catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of amides.','2013-10-27','NSRP'),(17909,34252,'negative regulation of cellular amide catabolic process','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of amides.','2013-10-27','NSRP'),(17910,34253,'positive regulation of cellular amide catabolic process','P','Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of amides.','2013-10-27','NSRP'),(17911,34254,'regulation of urea catabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of urea.','2013-10-27','NSRP'),(17912,34255,'regulation of urea metabolic process','P','Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving urea.','2013-10-27','NSRP'),(17913,34256,'chlorophyll(ide) b reductase activity','F','Catalysis of the reaction: 71-hydroxychlorophyll(ide) a + NAD(P)+ = chlorophyll(ide) b + NAD(P)H + H+.','2013-10-27','NSRP'),(17914,34257,'nicotinamide riboside transmembrane transporter activity','F','Catalysis of the transfer of nicotinamide riboside, which is a pyridine-3-carboxamide covalently bonded to a ribose sugar, from one side of a membrane to the other.','2013-10-27','NSRP'),(17915,34258,'nicotinamide riboside transport','P','The directed movement of a nicotinamide riboside, which is a pyridine-3-carboxamide covalently bonded to a ribose sugar, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(17916,34259,'negative regulation of Rho GTPase activity','P','Any process that stops or reduces the rate of activity of a GTPase of the Rho family.','2013-10-27','NSRP'),(17917,34260,'negative regulation of GTPase activity','P','Any process that stops or reduces the rate of GTP hydrolysis by a GTPase.','2013-10-27','NSRP'),(17918,34261,'negative regulation of Ras GTPase activity','P','Any process that stops or reduces the rate of activity of a GTPase of the Ras superfamily.','2013-10-27','NSRP'),(17919,34263,'autophagy in response to ER overload','P','The process in which cells digest parts of their own cytoplasm in response to the accumulation of misfolded proteins in the endoplasmic reticulum.','2013-10-27','NSRP'),(17920,34264,'isopentenyl adenine metabolic process','P','The chemical reactions and pathways involving the cytokinin 6-isopentenyladenine.','2013-10-27','NSRP'),(17921,34265,'isopentenyl adenine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of the cytokinin 6-isopentenyladenine.','2013-10-27','NSRP'),(17922,34266,'isopentenyl adenine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of the cytokinin 6-isopentenyladenine.','2013-10-27','NSRP'),(17923,34267,'discadenine metabolic process','P','The chemical reactions and pathways involving discadenine, (2S)-2-amino-4-{6-[(3-methylbut-2-en-1-yl)amino]-3H-purin-3-yl}butanoic acid.','2013-10-27','NSRP'),(17924,34268,'discadenine biosynthetic process','P','The chemical reactions and pathways resulting in the formation of discadenine, (2S)-2-amino-4-{6-[(3-methylbut-2-en-1-yl)amino]-3H-purin-3-yl}butanoic acid.','2013-10-27','NSRP'),(17925,34269,'discadenine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of discadenine, (2S)-2-amino-4-{6-[(3-methylbut-2-en-1-yl)amino]-3H-purin-3-yl}butanoic acid.','2013-10-27','NSRP'),(17926,34270,'CVT complex','C','A protein complex that is involved in the CVT pathway. In budding yeast, the CVT complex consists of multimers of preApe1p.','2013-10-27','NSRP'),(17927,34271,'phosphatidylinositol 3-kinase complex I','C','A protein complex that posseses phosphatidylinositol 3-kinase activity and is involved in autophagy. In budding yeast, this complex consists of Vps30p, Vps34p, Atg14p and Vps15p.','2013-10-27','NSRP'),(17928,34272,'phosphatidylinositol 3-kinase complex II','C','A protein complex that posseses phosphatidylinositol 3-kinase activity and is involved in vacuolar protein sorting (VPS) via endosomes. In budding yeast, this complex consists of Vps30p, Vps34p, VPS38 and Vps15p.','2013-10-27','NSRP'),(17929,34273,'Atg1p signaling complex','C','A protein complex that contains a protein kinase and is required for the autophagosome formation. In budding yeast this complex consists of the kinase Atg1p, Atg13p and Atg17p.','2013-10-27','NSRP'),(17930,34274,'Atg12-Atg5-Atg16 complex','C','A protein complex required for the expansion of the autophagosomal membrane. In budding yeast, this complex consists of Atg12p, Atg5p and Atg16p.','2013-10-27','NSRP'),(17931,34275,'kynurenic acid metabolic process','P','The chemical reactions and pathways involving kynurenic acid, 4-hydroxyquinoline-2-carboxylic acid.','2013-10-27','NSRP'),(17932,34276,'kynurenic acid biosynthetic process','P','The chemical reactions and pathways resulting in the formation of kynurenic acid, 4-hydroxyquinoline-2-carboxylic acid.','2013-10-27','NSRP'),(17933,34277,'ent-cassa-12,15-diene synthase activity','F','Catalysis of the reaction: ent-copalyl diphosphate = ent-cassa-12,15-diene + diphosphate.','2013-10-27','NSRP'),(17934,34278,'stemar-13-ene synthase activity','F','Catalysis of the reaction: 9-alpha-copalyl diphosphate = stemar-13-ene + diphosphate.','2013-10-27','NSRP'),(17935,34279,'syn-pimara-7,15-diene synthase activity','F','Catalysis of the reaction: 9-alpha-copalyl diphosphate = 9-beta-pimara-7,15-diene + diphosphate.','2013-10-27','NSRP'),(17936,34280,'ent-sandaracopimaradiene synthase activity','F','Catalysis of the reaction: ent-copalyl diphosphate = ent-sandaracopimara-8(14),15-diene + diphosphate.','2013-10-27','NSRP'),(17937,34281,'ent-isokaurene synthase activity','F','Catalysis of the reaction: ent-copalyl diphosphate = ent-isokaurene + diphosphate.','2013-10-27','NSRP'),(17938,34282,'ent-pimara-8(14),15-diene synthase activity','F','Catalysis of the reaction: ent-copalyl diphosphate = ent-pimara-8(14),15-diene + diphosphate.','2013-10-27','NSRP'),(17939,34283,'syn-stemod-13(17)-ene synthase activity','F','Catalysis of the reaction: 9-alpha-copalyl diphosphate = stemod-13(17)-ene + diphosphate.','2013-10-27','NSRP'),(17940,34284,'response to monosaccharide stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a monosaccharide stimulus.','2013-10-27','NSRP'),(17941,34285,'response to disaccharide stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disaccharide stimulus.','2013-10-27','NSRP'),(17942,34286,'response to maltose stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a maltose stimulus.','2013-10-27','NSRP'),(17943,34287,'detection of monosaccharide stimulus','P','The series of events in which a stimulus from a monosaccharide is received and converted into a molecular signal.','2013-10-27','NSRP'),(17944,34288,'detection of disaccharide stimulus','P','The series of events in which a stimulus from a disaccharide is received and converted into a molecular signal.','2013-10-27','NSRP'),(17945,34289,'detection of maltose stimulus','P','The series of events in which a maltose stimulus is received by a cell and converted into a molecular signal.','2013-10-27','NSRP'),(17946,34290,'holin activity','F','Catalysis of the temporally-regulated formation of a transmembrane protein hole that directly or indirectly allows murein hydrolyases to access their cell wall substrate.','2013-10-27','NSRP'),(17947,34291,'canonical holin activity','F','Catalysis of the temporally-regulated formation of a non-specific transmembrane protein hole that allows release of a fully-folded phage-encoded endolysin (murein-degradase) from the cell.','2013-10-27','NSRP'),(17948,34292,'pinholin activity','F','Catalysis of the temporally-regulated formation of a transmembrane protein hole that allows the passage of ions, causing a lethal, irreversible depolarization of the cell membrane.','2013-10-27','NSRP'),(17949,34293,'sexual sporulation','P','The formation of spores derived from the products of meiosis.','2013-10-27','NSRP'),(17950,34294,'sexual spore wall assembly','P','The aggregation, arrangement and bonding together of a set of components to form a sexual spore wall, the specialized envelope lying outside the cell membrane of a spore derived from a product of meiosis.','2013-10-27','NSRP'),(17951,34295,'basidiospore formation','P','The process in which spores form outside a specialized end cell known as a basidium. Basidia are characteristic of the basidiomycete fungi (phylum Basidiomycota), and give rise to spores that each contain a haploid nucleus that is the product of meiosis. The spores are usually attached to the basidium by short spikes called sterigmata (singular: sterigma). In most basidiomycetes there are four sterigmata (and four spores) to a basidium.','2013-10-27','NSRP'),(17952,34296,'zygospore formation','P','The process in which zygospores are formed. Zygospores are characteristic of the zygomycete fungi (phylum Zygomycota) thick-walled and darkly colored, and usually heavily ornamented as well, with many spines or ridges. It is formed between two specialized organs called suspensors, which are themselves usually heavily ornamented, one from each mating partner. The zygospore forms between them and then breaks away.','2013-10-27','NSRP'),(17953,34297,'oidium formation','P','The process in which oidia, a type of asexual spore found in fungi, are formed. Oidia are borne a few at a time on very simple hyphae that protrude a short distance into the substrate, and are usually presumed not to constitute the main reproductive strategy of the fungus.','2013-10-27','NSRP'),(17954,34298,'arthrospore formation','P','The formation of conidia by the conversion of a pre-existing hypha. An arthrospore is produced by the last cell on a hypha breaking off and dispersing. Usually the walls thicken and the cell(s) separates before swelling of each spore. Sometimes further septa form in each cell prior to disarticulation.','2013-10-27','NSRP'),(17955,34299,'reproductive blastospore formation','P','The formation of a spore following the marked enlargement of part of a cell before separation by a septum. Blastospores are a type of asexual spore found in some fungi, most notably the class Glomeromycota.','2013-10-27','NSRP'),(17956,34300,'sporangiospore formation','P','The process in which sporangiospores, a type of asexual spore found in fungi, are formed. Sporangiospores are formed within sac-like structure, the sporangium, following the division of the cytoplasm.','2013-10-27','NSRP'),(17957,34301,'endospore formation','P','The process in which a cell gives rise to an endospore, a dormant, highly resistant spore with a thick wall that forms within the mother cell. Endospores are produced by some low G+C Gram-positive bacteria in response to harsh conditions.','2013-10-27','NSRP'),(17958,34302,'akinete formation','P','The process in which an akinete, a thick-walled (encysted) dormant cell derived from the enlargement of a vegetative cell, is formed. Akinetes typically have granular cytoplasm, are more resistant to environmental extremes than vegetative cells, and are characteristic of several groups of Cyanobacteria.','2013-10-27','NSRP'),(17959,34303,'myxospore formation','P','The process in which differentiated, resting cells are formed, usually within a fruiting body by Myxobacteria. The myxospore is more resistant to high temperature, dessication, and UV than vegetative myxobacteria.','2013-10-27','NSRP'),(17960,34304,'actinomycete-type spore formation','P','The process in which differentiated, resting cells are formed from a substrate mycelium; characteristic of many members of the order Actinomycetales.','2013-10-27','NSRP'),(17961,34305,'regulation of asexual sporulation','P','Any process that modulates the frequency, rate or extent of spore formation from the products of mitosis.','2013-10-27','NSRP'),(17962,34306,'regulation of sexual sporulation','P','Any process that modulates the frequency, rate or extent of spore formation from the products of meiosis. An example of this is found in Saccharomyces cerevisiae.','2013-10-27','NSRP'),(17963,34307,'regulation of ascospore formation','P','Any process that modulates the frequency, rate or extent of ascospore formation. An example of this process is found in Saccharomyces cerevisiae.','2013-10-27','NSRP'),(17964,34308,'primary alcohol metabolic process','P','The chemical reactions and pathways involving primary alcohols. A primary alcohol is any alcohol in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.','2013-10-27','NSRP'),(17965,34309,'primary alcohol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of primary alcohols. A primary alcohol is any alcohol in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.','2013-10-27','NSRP'),(17966,34310,'primary alcohol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of primary alcohols. A primary alcohol is any alcohol in which a hydroxy group, -OH, is attached to a saturated carbon atom which has either three hydrogen atoms attached to it or only one other carbon atom and two hydrogen atoms attached to it.','2013-10-27','NSRP'),(17967,34311,'diol metabolic process','P','The chemical reactions and pathways involving a diol, a compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic.','2013-10-27','NSRP'),(17968,34312,'diol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a diol, any alcohol containing two hydroxyl groups attached to saturated carbon atoms.','2013-10-27','NSRP'),(17969,34313,'diol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a diol, any alcohol containing two hydroxyl groups attached to saturated carbon atoms.','2013-10-27','NSRP'),(17970,34314,'Arp2/3 complex-mediated actin nucleation','P','The actin nucleation process in which actin monomers combine to form a new branch on the side of an existing actin filament; mediated by the Arp2/3 protein complex and its interaction with other proteins.','2013-10-27','NSRP'),(17971,34315,'regulation of Arp2/3 complex-mediated actin nucleation','P','Any process that modulates the frequency, rate or extent of actin nucleation mediated by the Arp2/3 complex and interacting proteins.','2013-10-27','NSRP'),(17972,34316,'negative regulation of Arp2/3 complex-mediated actin nucleation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of actin nucleation mediated by the Arp2/3 complex and interacting proteins.','2013-10-27','NSRP'),(17973,34317,'nicotinic acid riboside kinase activity','F','Catalysis of the reaction: ATP + nicotinic acid riboside = ADP + nicotinic acid mononucleotide.','2013-10-27','NSRP'),(17974,34318,'alcohol O-acyltransferase activity','F','Catalysis of the transfer of an acyl group to an oxygen atom on an alcohol acceptor molecule.','2013-10-27','NSRP'),(17975,34319,'alcohol O-butanoyltransferase activity','F','Catalysis of the reaction: butanoyl-CoA + an alcohol = CoA + a butyl ester.','2013-10-27','NSRP'),(17976,34320,'alcohol O-hexanoyltransferase activity','F','Catalysis of the reaction: hexanoyl-CoA + an alcohol = CoA + a hexyl ester.','2013-10-27','NSRP'),(17977,34321,'alcohol O-octanoyltransferase activity','F','Catalysis of the reaction: octanoyl-CoA + an alcohol = CoA + an octyl ester.','2013-10-27','NSRP'),(17978,34322,'alcohol O-decanoyltransferase activity','F','Catalysis of the reaction: decanoyl-CoA + an alcohol = CoA + a decyl ester.','2013-10-27','NSRP'),(17979,34323,'O-butanoyltransferase activity','F','Catalysis of the transfer of a butyl group to an oxygen atom on the acceptor molecule.','2013-10-27','NSRP'),(17980,34324,'O-hexanoyltransferase activity','F','Catalysis of the transfer of a hexyl group to an oxygen atom on the acceptor molecule.','2013-10-27','NSRP'),(17981,34325,'O-decanoyltransferase activity','F','Catalysis of the transfer of a decyl group to an oxygen atom on the acceptor molecule.','2013-10-27','NSRP'),(17982,34326,'butanoyltransferase activity','F','Catalysis of the transfer of a butanoyl (CH3-[CH2]2-CO-) group to an acceptor molecule.','2013-10-27','NSRP'),(17983,34327,'hexanoyltransferase activity','F','Catalysis of the transfer of a hexanoyl (CH3-[CH2]4-CO-) group to an acceptor molecule.','2013-10-27','NSRP'),(17984,34328,'decanoyltransferase activity','F','Catalysis of the transfer of a decanoyl (CH3-[CH2]8-CO-) group to an acceptor molecule.','2013-10-27','NSRP'),(17985,34329,'cell junction assembly','P','A cellular process that results in the aggregation, arrangement and bonding together of a set of components to form a cell junction.','2013-10-27','NSRP'),(17986,34330,'cell junction organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell junction. A cell junction is a specialized region of connection between two cells or between a cell and the extracellular matrix.','2013-10-27','NSRP'),(17987,34331,'cell junction maintenance','P','The organization process that preserves a cell junction in a stable functional or structural state. A cell junction is a specialized region of connection between two cells or between a cell and the extracellular matrix.','2013-10-27','NSRP'),(17988,34332,'adherens junction organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.','2013-10-27','NSRP'),(17989,34333,'adherens junction assembly','P','The aggregation, arrangement and bonding together of a set of components to form an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.','2013-10-27','NSRP'),(17990,34334,'adherens junction maintenance','P','The maintenance of an adherens junction. An adherens junction is a cell junction at which the cytoplasmic face of the plasma membrane is attached to actin filaments.','2013-10-27','NSRP'),(17991,34335,'DNA supercoiling activity','F','OBSOLETE. Catalysis of the formation of positive or negative supercoils in a DNA molecule or region thereof; may be associated with a geometric or topological change in the DNA molecule.','2013-10-27','NSRP'),(17992,34336,'misfolded RNA binding','F','Interacting selectively and non-covalently with an RNA molecule that has assumed an incorrect conformation.','2013-10-27','NSRP'),(17993,34337,'RNA folding','P','The process of assisting in the covalent and noncovalent assembly of single or multimeric RNAs into the correct tertiary structure.','2013-10-27','NSRP'),(17994,34338,'short-chain carboxylesterase activity','F','Catalysis of the reaction: a carboxylic ester + H2O = an alcohol + a carboxylic anion, where the carboxylic chain has 8 or fewer carbon atoms.','2013-10-27','NSRP'),(17995,34339,'regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor','P','OBSOLETE. Any process in which a ligand-bound hormone receptor acts in the nucleus to modulate the frequency, rate or extent of transcription from an RNA polymerase II promoter.','2013-10-27','NSRP'),(17996,34340,'response to type I interferon','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a type I interferon stimulus. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.','2013-10-27','NSRP'),(17997,34341,'response to interferon-gamma','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon.','2013-10-27','NSRP'),(17998,34342,'response to type III interferon','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a type III interferon stimulus. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(17999,34343,'type III interferon production','P','The appearance of type III interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(18000,34344,'regulation of type III interferon production','P','Any process that modulates the frequency, rate, or extent of type III interferon production. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(18001,34345,'negative regulation of type III interferon production','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of type III interferon production. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(18002,34346,'positive regulation of type III interferon production','P','Any process that activates or increases the frequency, rate, or extent of type III interferon production. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(18003,34347,'type III interferon binding','F','Interacting selectively and non-covalently with a type III interferon. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(18004,34348,'type III interferon receptor activity','F','Combining with a type III interferon and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Type III interferons are members of the interferon-lambda gene family.','2013-10-27','NSRP'),(18005,34349,'glial cell apoptotic process','P','Any apoptotic process in a glial cell, a non-neuronal cell of the nervous system.','2013-10-27','NSRP'),(18006,34350,'regulation of glial cell apoptotic process','P','Any process that modulates the frequency, rate, or extent of glial cell apoptotic process.','2013-10-27','NSRP'),(18007,34351,'negative regulation of glial cell apoptotic process','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of glial cell apoptotic process.','2013-10-27','NSRP'),(18008,34352,'positive regulation of glial cell apoptotic process','P','Any process that activates or increases the frequency, rate, or extent of glial cell apoptotic process.','2013-10-27','NSRP'),(18009,34353,'RNA pyrophosphohydrolase activity','F','Catalysis of the removal of a 5\' terminal pyrophosphate from the 5\'-triphosphate end of an RNA, leaving a 5\'-monophosphate end.','2013-10-27','NSRP'),(18010,34354,'\'de novo\' NAD biosynthetic process from tryptophan','P','The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of tryptophan from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH.','2013-10-27','NSRP'),(18011,34355,'NAD salvage','P','Any process that generates nicotinamide adenine dinucleotide (NAD) from derivatives of it, without de novo synthesis; salvage is usually from the degradation products nicotinic acid (Na) and nicotinamide (Nam).','2013-10-27','NSRP'),(18012,34356,'NAD biosynthesis via nicotinamide riboside salvage pathway','P','The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD) from the vitamin precursor nicotinamide riboside.','2013-10-27','NSRP'),(18013,34357,'photosynthetic membrane','C','A membrane enriched in complexes formed of reaction centers, accessory pigments and electron carriers, in which photosynthetic reactions take place.','2013-10-27','NSRP'),(18014,34358,'plasma lipoprotein particle','C','A spherical particle with a hydrophobic core of triglycerides and/or cholesterol esters, surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Plasma lipoprotein particles transport lipids, which are non-covalently associated with the particles, in the blood or lymph.','2013-10-27','NSRP'),(18015,34359,'mature chylomicron','C','A chylomicron that contains apolipoprotein C2 (APOC2), a cofactor for lipoprotein lipase (LPL) activity, and has a mean diameter of 500 nm and density of 0.95g/ml. Mature chylomicron particles transport exogenous (dietary) lipids from the intestines to other body tissues, via the blood and lymph.','2013-10-27','NSRP'),(18016,34360,'chylomicron remnant','C','A lipoprotein particle that is derived from a mature chylomicron particle by the removal of triglycerides from the chylomicron core by lipoprotein lipase and the subsequent loss of surface components. It characteristically contains apolipoprotein E (APOE) and is cleared from the blood by the liver.','2013-10-27','NSRP'),(18017,34361,'very-low-density lipoprotein particle','C','A triglyceride-rich lipoprotein particle that is typically composed of APOB100, APOE and APOCs and has a density of about 1.006 g/ml and a diameter of between 20-80 nm. It is found in blood and transports endogenous products (newly synthesized cholesterol and triglycerides) from the liver.','2013-10-27','NSRP'),(18018,34362,'low-density lipoprotein particle','C','A lipoprotein particle, rich in cholesterol esters and low in triglycerides that is typically composed of APOB100 and APOE and has a density of 1.02-1.06 g/ml and a diameter of between 20-25 nm. LDL particles are formed from VLDL particles (via IDL) by the loss of triglyceride and gain of cholesterol ester. They transport endogenous cholesterol (and to some extent triglycerides) from peripheral tissues back to the liver.','2013-10-27','NSRP'),(18019,34363,'intermediate-density lipoprotein particle','C','A triglyceride-rich lipoprotein particle that typically contains APOB100, APOE and APOCs and has a density of 1.006-1.019 g/ml and a diameter of between 25-30 nm. IDL particles are found in blood and are formed by the delipidation of very-low-density lipoprotein particles (VLDL). IDL particles are removed from blood by the liver, following binding to the APOE receptor, or are converted to low-density lipoprotein (LDL).','2013-10-27','NSRP'),(18020,34364,'high-density lipoprotein particle','C','A lipoprotein particle with a high density (typically 1.063-1.21 g/ml) and a diameter of 5-10 nm that contains APOAs and may contain APOCs and APOE; found in blood and carries lipids from body tissues to the liver as part of the reverse cholesterol transport process.','2013-10-27','NSRP'),(18021,34365,'discoidal high-density lipoprotein particle','C','A newly formed high-density lipoprotein particle; consists of a phospholipid bilayer surrounded by two or more APOA1 molecules. The discoidal HDL particle is formed when lipid-free or lipid-poor APOA1 acquires phospholipids and unesterified cholesterol from either cell membranes or triglyceride-rich lipoproteins (undergoing lipolysis by lipoprotein lipase).','2013-10-27','NSRP'),(18022,34366,'spherical high-density lipoprotein particle','C','A mature high-density lipoprotein (HDL) particle, converted from discoidal HDL particles following the esterification of cholesterol in the particle by phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT).','2013-10-27','NSRP'),(18023,34367,'macromolecular complex remodeling','P','The acquisition, loss, or modification of macromolecules within a complex, resulting in the alteration of an existing complex.','2013-10-27','NSRP'),(18024,34368,'protein-lipid complex remodeling','P','The acquisition, loss or modification of a protein or lipid within a protein-lipid complex.','2013-10-27','NSRP'),(18025,34369,'plasma lipoprotein particle remodeling','P','The acquisition, loss or modification of a protein or lipid within a plasma lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the esterification of cholesterol by phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT).','2013-10-27','NSRP'),(18026,34370,'triglyceride-rich lipoprotein particle remodeling','P','The acquisition, loss or modification of a protein or lipid within a triglyceride-rich lipoprotein particle, including the hydrolysis of triglyceride by lipoprotein lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride from a triglyceride-rich lipoprotein particle.','2013-10-27','NSRP'),(18027,34371,'chylomicron remodeling','P','The acquisition, loss or modification of a protein or lipid within a chylomicron, including the hydrolysis of triglyceride by lipoprotein lipase and the subsequent loss of free fatty acid.','2013-10-27','NSRP'),(18028,34372,'very-low-density lipoprotein particle remodeling','P','The acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid.','2013-10-27','NSRP'),(18029,34373,'intermediate-density lipoprotein particle remodeling','P','The acquisition, loss or modification of a protein or lipid within an intermediate-density lipoprotein particle.','2013-10-27','NSRP'),(18030,34374,'low-density lipoprotein particle remodeling','P','The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.','2013-10-27','NSRP'),(18031,34375,'high-density lipoprotein particle remodeling','P','The acquisition, loss or modification of a protein or lipid within a high-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.','2013-10-27','NSRP'),(18032,34376,'conversion of discoidal high-density lipoprotein particle to spherical high-density lipoprotein particle','P','The process in which a discoidal high-density lipoprotein (HDL) particle acquires additional lipid or protein molecules, and cholesterol in the particle is converted to tightly bound cholesterol esters by the action of phosphatidylcholine-sterol O-acyltransferase (lecithin cholesterol acyltransferase; LCAT), resulting in the formation of a spherical HDL particle.','2013-10-27','NSRP'),(18033,34377,'plasma lipoprotein particle assembly','P','The aggregation and arrangement of proteins and lipids to form a plasma lipoprotein particle.','2013-10-27','NSRP'),(18034,34378,'chylomicron assembly','P','The aggregation and arrangement of proteins and lipids in the intestine to form a chylomicron.','2013-10-27','NSRP'),(18035,34379,'very-low-density lipoprotein particle assembly','P','The aggregation and arrangement of proteins and lipids in the liver to form a very-low-density lipoprotein particle.','2013-10-27','NSRP'),(18036,34380,'high-density lipoprotein particle assembly','P','The aggregation and arrangement of proteins and lipids to form a high-density lipoprotein particle.','2013-10-27','NSRP'),(18037,34381,'plasma lipoprotein particle clearance','P','The process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.','2013-10-27','NSRP'),(18038,34382,'chylomicron remnant clearance','P','The process in which a chylomicron remnant is removed from the blood via receptor-mediated endocytosis into liver cells and its constituent parts degraded.','2013-10-27','NSRP'),(18039,34383,'low-density lipoprotein particle clearance','P','The process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.','2013-10-27','NSRP'),(18040,34384,'high-density lipoprotein particle clearance','P','The process in which a high-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.','2013-10-27','NSRP'),(18041,34385,'triglyceride-rich lipoprotein particle','C','A plasma lipoprotein particle that has a hydrophobic core enriched in triglycerides surrounded by an amphipathic monolayer of phospholipids, cholesterol and apolipoproteins. Triglyceride-rich lipoproteinparticles transport lipids, which are non-covalently associated with the particles, in the blood.','2013-10-27','NSRP'),(18042,34386,'4-aminobutyrate:2-oxoglutarate transaminase activity','F','Catalysis of the reaction: 4-aminobutanoate + 2-oxoglutarate = succinate semialdehyde + L-glutamate.','2013-10-27','NSRP'),(18043,34387,'4-aminobutyrate:pyruvate transaminase activity','F','Catalysis of the reaction: 4-aminobutanoate + pyruvate = succinate semialdehyde + alanine.','2013-10-27','NSRP'),(18044,34388,'Pwp2p-containing subcomplex of 90S preribosome','C','A protein complex that forms a subcomplex of the 90S preribosome and can interact directly with the 5\' External Transcribed Spacer (ETS) of the full length pre-rRNA transcript. In S. cerevisiae, it sediments at 25-30 S and is composed of Pwp2p, Dip2p, Utp21p, Utp13p, Utp18p, and Utp6p.','2013-10-27','NSRP'),(18045,34389,'lipid particle organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lipid particle.','2013-10-27','NSRP'),(18046,34390,'smooth muscle cell apoptotic process','P','Any apoptotic process in a smooth muscle cell. Smooth muscle consists of non-striated, elongated, spindle-shaped cell found lining the digestive tract, uterus, and blood vessels.','2013-10-27','NSRP'),(18047,34391,'regulation of smooth muscle cell apoptotic process','P','Any process that modulates the frequency, rate, or extent of smooth muscle cell apoptotic process.','2013-10-27','NSRP'),(18048,34392,'negative regulation of smooth muscle cell apoptotic process','P','Any process that stops, prevents, or reduces the frequency, rate, or extent of smooth muscle cell apoptotic process.','2013-10-27','NSRP'),(18049,34393,'positive regulation of smooth muscle cell apoptotic process','P','Any process that activates or increases the frequency, rate, or extent of smooth muscle cell apoptotic process.','2013-10-27','NSRP'),(18050,34394,'protein localization to cell surface','P','A process in which a protein is transported to, or maintained in, a location within the external part of the cell wall and/or plasma membrane.','2013-10-27','NSRP'),(18051,34395,'regulation of transcription from RNA polymerase II promoter in response to iron','P','Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter in response to an iron stimulus.','2013-10-27','NSRP'),(18052,34396,'negative regulation of transcription from RNA polymerase II promoter in response to iron','P','Any process that stops, prevents or reduces the rate of transcription from an RNA polymerase II promoter in response to an iron stimulus.','2013-10-27','NSRP'),(18053,34397,'telomere localization','P','Any process in which a telomere is transported to, and/or maintained in, a specific location.','2013-10-27','NSRP'),(18054,34398,'telomere tethering at nuclear periphery','P','The process in which a telomere is maintained in a specific location at the nuclear periphery.','2013-10-27','NSRP'),(18055,34399,'nuclear periphery','C','The portion of the nuclear lumen proximal to the inner nuclear membrane.','2013-10-27','NSRP'),(18056,34400,'gerontoplast','C','A plastid found in senescing, formerly green tissues that is derived from a chloroplast that undergoes an organized developmental program of senescence.','2013-10-27','NSRP'),(18057,34401,'regulation of transcription by chromatin organization','P','Any cellular process that results in the specification, formation or maintenance of the physical structure of eukaryotic chromatin that modulates the rate, frequency or extent of DNA-dependent transcription.','2013-10-27','NSRP'),(18058,34402,'recruitment of 3\'-end processing factors to RNA polymerase II holoenzyme complex','P','The process in which proteins required for 3\'-end transcript processing become associated with the RNA polymerase II holoenzyme complex and the 3\' end of a transcript.','2013-10-27','NSRP'),(18059,34403,'alignment of 3\' and 5\' splice sites of mRNA','P','Recognition of both the 5\' and 3\'-splice sites and positioning them in the correct alignment with respect to each other so that the second catalytic step of nuclear mRNA splicing can occur.','2013-10-27','NSRP'),(18060,34404,'nucleobase-containing small molecule biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide.','2013-10-27','NSRP'),(18061,34405,'response to fluid shear stress','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.','2013-10-27','NSRP'),(18062,34406,'cell wall beta-glucan metabolic process','P','The chemical reactions and pathways involving beta-glucans, compounds composed of glucose residues linked by beta-D-glucosidic bonds, found in the walls of cells.','2013-10-27','NSRP'),(18063,34407,'cell wall (1->3)-beta-D-glucan metabolic process','P','The chemical reactions and pathways involving (1->3)-beta-D-glucans, compounds composed of glucose residues linked by (1->3)-beta-D-glucosidic bonds, found in the walls of cells.','2013-10-27','NSRP'),(18064,34408,'ascospore wall beta-glucan metabolic process','P','The chemical reactions and pathways involving beta-glucans, compounds composed of glucose residues linked by beta-D-glucosidic bonds, found in the walls of ascospores.','2013-10-27','NSRP'),(18065,34409,'ascospore wall (1->3)-beta-D-glucan metabolic process','P','The chemical reactions and pathways involving (1->3)-beta-D-glucans, compounds composed of glucose residues linked by (1->3)-beta-D-glucosidic bonds, found in the walls of ascospores.','2013-10-27','NSRP'),(18066,34410,'cell wall beta-glucan biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-glucans, compounds composed of glucose residues linked by beta-D-glucosidic bonds, found in the walls of cells.','2013-10-27','NSRP'),(18067,34411,'cell wall (1->3)-beta-D-glucan biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans, compounds composed of glucose residues linked by (1->3)-beta-D-glucosidic bonds, found in the walls of cells.','2013-10-27','NSRP'),(18068,34412,'ascospore wall beta-glucan biosynthetic process','P','The chemical reactions and pathways resulting in the formation of beta-glucans, compounds composed of glucose residues linked by beta-D-glucosidic bonds, found in the walls of ascospores.','2013-10-27','NSRP'),(18069,34413,'ascospore wall (1->3)-beta-D-glucan biosynthetic process','P','The chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans, compounds composed of glucose residues linked by (1->3)-beta-D-glucosidic bonds, found in the walls of ascospores.','2013-10-27','NSRP'),(18070,34414,'tRNA 3\'-trailer cleavage, endonucleolytic','P','Endonucleolytic cleavage of the 3\'-end of the pre-tRNA as part of the process of generating the mature 3\'-end of the tRNA.','2013-10-27','NSRP'),(18071,34415,'tRNA 3\'-trailer cleavage, exonucleolytic','P','Exonucleolytic cleavage of the 3\'-end of the pre-tRNA as part of the process of generating the mature 3\'-end of the tRNA.','2013-10-27','NSRP'),(18072,34416,'bisphosphoglycerate phosphatase activity','F','Catalysis of the reaction: 2,3-diphosphoglycerate + H2O = phosphoglycerate + phosphate.','2013-10-27','NSRP'),(18073,34417,'bisphosphoglycerate 3-phosphatase activity','F','Catalysis of the reaction: 2,3-diphosphoglycerate + H2O = 2-phospho-D-glycerate + phosphate.','2013-10-27','NSRP'),(18074,34418,'urate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of urate, the anion of uric acid, 2,6,8-trioxypurine.','2013-10-27','NSRP'),(18075,34419,'L-2-hydroxyglutarate oxidase activity','F','Catalysis of the reaction: L-2-hydroxyglutarate + O2 = 2-oxoglutarate + hydrogen peroxide.','2013-10-27','NSRP'),(18076,34420,'co-translational protein acetylation','P','The addition of an acetyl group to one or more amino acids in a protein, occurring before the protein has been completely translated and released from the ribosome.','2013-10-27','NSRP'),(18077,34421,'post-translational protein acetylation','P','The addition of an acetyl group to one or more amino acids in a protein, occurring after the protein has been completely translated and released from the ribosome.','2013-10-27','NSRP'),(18078,34422,'aleurone grain lumen','C','The volume enclosed by the membrane of an aleurone grain.','2013-10-27','NSRP'),(18079,34423,'autophagic vacuole lumen','C','The volume enclosed within the autophagic vacuole membrane.','2013-10-27','NSRP'),(18080,34424,'Vps55/Vps68 complex','C','A membrane-associated protein complex that is required for a late stage of endosomal transport. In budding yeast, this complex consists of Vps55p and Vps68p proteins.','2013-10-27','NSRP'),(18081,34425,'etioplast envelope','C','The double lipid bilayer enclosing the etioplast and separating its contents from the rest of the cytoplasm; includes the intermembrane space.','2013-10-27','NSRP'),(18082,34426,'etioplast membrane','C','Either of the lipid bilayers that surround a etioplast and form the etioplast envelope.','2013-10-27','NSRP'),(18083,34427,'nuclear-transcribed mRNA catabolic process, exonucleolytic, 3\'-5\'','P','The chemical reactions and pathways resulting in the breakdown of the mRNA transcript body that occurs when the 3\' end is not protected by a 3\'-poly(A) tail; degradation proceeds in the 3\' to 5\' direction.','2013-10-27','NSRP'),(18084,34428,'nuclear-transcribed mRNA catabolic process, exonucleolytic, 5\'-3\'','P','The chemical reactions and pathways resulting in the breakdown of the mRNA transcript body that occurs when the 5\' end is not protected by a 5\'-cap; degradation proceeds in the 5\' to 3\' direction.','2013-10-27','NSRP'),(18085,34429,'tectobulbar tract morphogenesis','P','Generation of a long process of a CNS neuron, that carries efferent (outgoing) action potentials from the cell body in the optic tectum towards target cells in the premotor reticulospinal system in the hindbrain.','2013-10-27','NSRP'),(18086,34430,'monolayer-surrounded lipid storage body outer lipid monolayer','C','The single layer of phopholipids surrounding a lipid storage body.','2013-10-27','NSRP'),(18087,34431,'bis(5\'-adenosyl)-hexaphosphatase activity','F','Catalysis of the reaction: P1-P6-bis(5\'-adenosyl) hexaphosphate + H2O = AMP + adenosine 5\'-pentaphosphate.','2013-10-27','NSRP'),(18088,34432,'bis(5\'-adenosyl)-pentaphosphatase activity','F','Catalysis of the reaction: P1-P6-bis(5\'-adenosyl) pentaphosphate + H2O = AMP + adenosine 5\'-tetraphosphate.','2013-10-27','NSRP'),(18089,34433,'steroid esterification','P','A lipid modification process in which a steroid ester is formed by the combination of a carboxylic acid (often a fatty acid) and a steroid molecule (e.g. cholesterol).','2013-10-27','NSRP'),(18090,34434,'sterol esterification','P','A lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and a sterol molecule (e.g. cholesterol).','2013-10-27','NSRP'),(18091,34435,'cholesterol esterification','P','A lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle.','2013-10-27','NSRP'),(18092,34436,'glycoprotein transport','P','The directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18093,34437,'glycoprotein transporter activity','F','Enables the directed movement of a glycoprotein, any protein that contains covalently bound glycose (i.e. monosaccharide) residues, into, out of or within a cell, or between cells.','2013-10-27','NSRP'),(18094,34438,'lipoprotein amino acid oxidation','P','The modification of a lipoprotein by oxidation of one or more amino acids in the protein.','2013-10-27','NSRP'),(18095,34439,'lipoprotein lipid oxidation','P','The modification of a lipoprotein by oxidation of the lipid group.','2013-10-27','NSRP'),(18096,34440,'lipid oxidation','P','The removal of one or more electrons from a lipid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen or by removal of hydrogen.','2013-10-27','NSRP'),(18097,34441,'plasma lipoprotein particle oxidation','P','The modification of a lipoprotein by oxidation of one or more amino acids or the lipid group, occurring in the blood plasma.','2013-10-27','NSRP'),(18098,34442,'regulation of lipoprotein oxidation','P','Any process that modulates the frequency, rate or extent of lipoprotein oxidation.','2013-10-27','NSRP'),(18099,34443,'negative regulation of lipoprotein oxidation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of lipoprotein oxidation.','2013-10-27','NSRP'),(18100,34444,'regulation of plasma lipoprotein particle oxidation','P','Any process that modulates the frequency, rate or extent of lipoprotein oxidation, occurring in the blood plasma.','2013-10-27','NSRP'),(18101,34445,'negative regulation of plasma lipoprotein particle oxidation','P','Any process that stops, prevents, or reduces the frequency, rate or extent of lipoprotein particle oxidation, occurring in the blood plasma.','2013-10-27','NSRP'),(18102,34446,'substrate adhesion-dependent cell spreading','P','The morphogenetic process that results in flattening of a cell as a consequence of its adhesion to a substrate.','2013-10-27','NSRP'),(18103,34447,'very-low-density lipoprotein particle clearance','P','The process in which a very-low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.','2013-10-27','NSRP'),(18104,34448,'EGO complex','C','A vacuolar membrane-associated protein complex that is required for activation of microautophagy during exit from rapamycin-induced growth arrest. In budding yeast, S. cerevisiae, this complex includes Gtr1p, Gtr2p, Meh1p, and Slm4p.','2013-10-27','NSRP'),(18105,34449,'GSE complex','C','A conserved protein complex required for protein sorting from endosome to the plasma membrane. In budding yeast, S. cerevisiae, this complex includes Gtr1p, Gtr2p, Slm4p, Meh1p and Ltv1p and it sorts Gap1p.','2012-03-14','NSRP'),(18106,34450,'ubiquitin-ubiquitin ligase activity','F','Catalysis of the reaction: ATP + ubiquitin + protein N-ubiquityl(n)lysine = AMP + diphosphate + protein N-ubiquityl(n+1)lysine. This reaction is the ligation of ubiquitin groups, via isopeptide bonds, to extend the length of the multiubiquitin chain attached to a substrate protein.','2013-10-27','NSRP'),(18107,34451,'centriolar satellite','C','A small (70-100 nm) cytoplasmic granule that contains a number of centrosomal proteins; centriolar satellites traffic toward microtubule minus ends and are enriched near the centrosome.','2013-10-27','NSRP'),(18108,34452,'dynactin binding','F','Interacting selectively and non-covalently with any part of a dynactin complex; dynactin is a large protein complex that activates dynein-based motor activity.','2013-10-27','NSRP'),(18109,34453,'microtubule anchoring','P','Any process in which a microtubule is maintained in a specific location in a cell.','2013-10-27','NSRP'),(18110,34454,'microtubule anchoring at centrosome','P','Any process in which a microtubule is maintained in a specific location in a cell by attachment to a centrosome.','2013-10-27','NSRP'),(18111,34455,'t-UTP complex','C','A protein complex that forms a subcomplex of the 90S preribosome and is required for the subsequent assembly of the rest of the preribosome. In S. cerevisiae, it is composed of Utp5p, Utp4p, Nan1p, Utp8p, Utp9p, Utp10 and Utp15p.','2013-10-27','NSRP'),(18112,34456,'UTP-C complex','C','A protein complex that forms a subcomplex of the 90S preribosome. In S. cerevisiae, it is composed of Rrp7p, Utp22p, Ckb1p, Cka1p, Ckb2p and Cka2p.','2013-10-27','NSRP'),(18113,34457,'Mpp10 complex','C','A protein complex that forms a subcomplex of the 90S preribosome. In S. cerevisiae, it is composed of Mpp10p, Imp3p and Imp4p.','2013-10-27','NSRP'),(18114,34458,'3\'-5\' RNA helicase activity','F','Catalysis of the unwinding of an RNA helix in the direction 3\' to 5\'.','2013-10-27','NSRP'),(18115,34459,'ATP-dependent 3\'-5\' RNA helicase activity','F','Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction drives the unwinding of an RNA helix in the direction 3\' to 5\'.','2013-10-27','NSRP'),(18116,34460,'uropod assembly','P','The assembly of a uropod by rearrangement of the cytoskeleton and overlying membrane.','2013-10-27','NSRP'),(18117,34461,'uropod retraction','P','The process in which a uropod detaches from the cell substrate and retracts the rear of a migrating cell.','2013-10-27','NSRP'),(18118,34462,'small-subunit processome assembly','P','The aggregation, arrangement and bonding together of proteins and RNA molecules to form a small-subunit processome.','2013-10-27','NSRP'),(18119,34463,'90S preribosome assembly','P','The aggregation, arrangement and bonding together of proteins and RNA molecules to form a 90S preribosome. The 90S preribosome represents the complex that forms on the primary rRNA transcript before it splits into the small subunit and large subunit portions.','2013-10-27','NSRP'),(18120,34464,'BBSome','C','A protein complex that associates with the primary cilium and is involved in cilium biogenesis; consists of seven conserved proteins: BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9.','2013-10-27','NSRP'),(18121,34465,'response to carbon monoxide','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbon monoxide (CO) stimulus.','2013-10-27','NSRP'),(18122,34466,'chromaffin granule lumen','C','The volume enclosed by the membrane of a chromaffin granule.','2013-10-27','NSRP'),(18123,34467,'esterosome lumen','C','The volume enclosed by the membrane of an esterosome.','2013-10-27','NSRP'),(18124,34468,'glycosome lumen','C','The volume enclosed by the membrane of a glycosome.','2013-10-27','NSRP'),(18125,34469,'Golgi stack lumen','C','The volume enclosed by any of the membranes of the thin, flattened cisternae that form the central portion of the Golgi complex.','2013-10-27','NSRP'),(18126,34470,'ncRNA processing','P','Any process that results in the conversion of one or more primary non-coding RNA (ncRNA) transcripts into one or more mature ncRNA molecules.','2013-10-27','NSRP'),(18127,34471,'ncRNA 5\'-end processing','P','Any process involved in forming the mature 5\' end of a non-coding RNA molecule.','2013-10-27','NSRP'),(18128,34472,'snRNA 3\'-end processing','P','Any process involved in forming the mature 3\' end of an snRNA molecule.','2013-10-27','NSRP'),(18129,34473,'U1 snRNA 3\'-end processing','P','Any process involved in forming the mature 3\' end of a U1 snRNA molecule.','2013-10-27','NSRP'),(18130,34474,'U2 snRNA 3\'-end processing','P','Any process involved in forming the mature 3\' end of a U2 snRNA molecule.','2013-10-27','NSRP'),(18131,34475,'U4 snRNA 3\'-end processing','P','Any process involved in forming the mature 3\' end of a U4 snRNA molecule.','2013-10-27','NSRP'),(18132,34476,'U5 snRNA 3\'-end processing','P','Any process involved in forming the mature 3\' end of a U5 snRNA molecule.','2013-10-27','NSRP'),(18133,34477,'U6 snRNA 3\'-end processing','P','Any process involved in forming the mature 3\' end of a U6 snRNA molecule.','2013-10-27','NSRP'),(18134,34478,'phosphatidylglycerol catabolic process','P','The chemical reactions and pathways resulting in the breakdown of phosphatidylglycerols, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of glycerol.','2013-10-27','NSRP'),(18135,34479,'phosphatidylglycerol phospholipase C activity','F','Catalysis of the reaction: a phosphatidylglycerol + H2O = 1,2-diacylglycerol + glycerol 3-phosphate.','2013-10-27','NSRP'),(18136,34480,'phosphatidylcholine phospholipase C activity','F','Catalysis of the reaction: phosphatidylcholine + H2O = 1,2-diacylglycerol + a choline phosphate.','2013-10-27','NSRP'),(18137,34481,'chondroitin sulfotransferase activity','F','Catalysis of the reaction: 3\'-phosphoadenosine 5\'-phosphosulfate + chondroitin = adenosine 3\',5\'-bisphosphate + chondroitin sulfate.','2013-10-27','NSRP'),(18138,34482,'chondroitin 2-O-sulfotransferase activity','F','Catalysis of the reaction: 3\'-phosphoadenosine 5\'-phosphosulfate + chondroitin = adenosine 3\',5\'-bisphosphate + chondroitin 2\'-O-sulfate. Results in sulfation of glucuronic acid and iduronic acid residues.','2013-10-27','NSRP'),(18139,34483,'heparan sulfate sulfotransferase activity','F','Catalysis of the reaction: 3\'-phosphoadenosine 5\'-phosphosulfate + heparan sulfate = adenosine 3\',5\'-bisphosphate + sulfated heparan sulfate.','2013-10-27','NSRP'),(18140,34484,'raffinose catabolic process','P','The chemical reactions and pathways resulting in the breakdown of raffinose, the trisaccharide beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside.','2013-10-27','NSRP'),(18141,34485,'phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity','F','Catalysis of the reaction: phosphatidylinositol-3,4,5-trisphosphate + H2O = phosphatidylinositol-3,4-bisphosphate + phosphate.','2013-10-27','NSRP'),(18142,34486,'vacuolar transmembrane transport','P','The process in which a solute is transported from one side of the vacuolar membrane to the other.','2013-10-27','NSRP'),(18143,34487,'vacuolar amino acid transmembrane transport','P','The process in which an amino acid is transported from one side of the vacuolar membrane to the other.','2013-10-27','NSRP'),(18144,34488,'basic amino acid transmembrane export from vacuole','P','The directed movement of basic amino acids out of the vacuole, across the vacuolar membrane.','2013-10-27','NSRP'),(18145,34489,'neutral amino acid transmembrane export from vacuole','P','The directed movement of neutral amino acids out of the vacuole, across the vacuolar membrane.','2013-10-27','NSRP'),(18146,34490,'basic amino acid transmembrane import into vacuole','P','The directed movement of basic amino acids into the vacuole across the vacuolar membrane.','2013-10-27','NSRP'),(18147,34491,'neutral amino acid transmembrane import into vacuole','P','The directed movement of neutral amino acids into the vacuole across the vacuolar membrane.','2013-10-27','NSRP'),(18148,34492,'hydrogenosome lumen','C','The volume enclosed by the hydrogenosome membrane.','2013-10-27','NSRP'),(18149,34493,'melanosome lumen','C','The volume enclosed by the melanosome membrane.','2013-10-27','NSRP'),(18150,34494,'microneme lumen','C','The volume enclosed by the microneme membrane.','2013-10-27','NSRP'),(18151,34495,'protein storage vacuole lumen','C','The volume enclosed by the protein storage vacuole membrane.','2013-10-27','NSRP'),(18152,34496,'multivesicular body membrane disassembly','P','The controlled breakdown of the membranes of multivesicular bodies.','2013-10-27','NSRP'),(18153,34497,'protein localization to pre-autophagosomal structure','P','Any process in which a protein is transported to, or maintained at, the pre-autophagosomal structure (PAS).','2013-10-27','NSRP'),(18154,34498,'early endosome to Golgi transport','P','The directed movement of substances from early endosomes to the Golgi.','2013-10-27','NSRP'),(18155,34499,'late endosome to Golgi transport','P','The directed movement of substances from late endosomes to the Golgi.','2013-10-27','NSRP'),(18156,34500,'rDNA separation','P','The cell cycle process in which rDNA repeat regions are physically detached from each other during chromosome separation.','2012-03-14','NSRP'),(18157,34501,'protein localization to kinetochore','P','Any process in which a protein is transported to, or maintained at, the kinetochore.','2013-10-27','NSRP'),(18158,34502,'protein localization to chromosome','P','Any process in which a protein is transported to, or maintained at, a specific location on a chromosome.','2013-10-27','NSRP'),(18159,34503,'protein localization to nucleolar rDNA repeats','P','Any process in which a protein is transported to, or maintained at, the rDNA repeats on a chromosome in the nucleolus.','2013-10-27','NSRP'),(18160,34504,'protein localization to nucleus','P','A process in which a protein is transported to, or maintained in, a location within the nucleus.','2013-10-27','NSRP'),(18161,34505,'tooth mineralization','P','The process in which calcium salts are deposited into calcareous tooth structures such as dental enamel, dentin and cementum.','2013-10-27','NSRP'),(18162,34506,'chromosome, centromeric core region','C','The innermost portion of the centromeric region of a chromosome, encompassing the core region of a chromosome centromere and the proteins that bind to it.','2013-10-27','NSRP'),(18163,34507,'chromosome, centromeric outer repeat region','C','The portion of the centromeric region of a chromosome that flanks the core region, encompassing repeated regions of a chromosome centromere and the proteins that bind to it.','2013-10-27','NSRP'),(18164,34508,'centromere complex assembly','P','The aggregation, arrangement and bonding together of proteins and centromeric DNA molecules to form a centromeric protein-DNA complex. Includes the formation of the chromatin structures which form a platform for the kinetochore, and assembly of the kinetochore onto this specialized chromatin. In fission yeast and higher eukaryotes this process also includes the formation of heterochromatin at the outer repeat (pericentric) regions of the centromere.','2013-10-27','NSRP'),(18165,34509,'centromeric core chromatin assembly','P','The assembly of chromatin into the specialized structure characteristic of the centromeric core region, defined by the presence of the variant histone CENP-A.','2012-03-14','NSRP'),(18166,34510,'centromere separation','P','The cell cycle process in which centromeres are physically detached from each other during chromosome separation.','2013-10-27','NSRP'),(18167,34511,'U3 snoRNA binding','F','Interacting selectively and non-covalently with U3 small nucleolar RNA.','2013-10-27','NSRP'),(18168,34512,'box C/D snoRNA binding','F','Interacting selectively and non-covalently with box C/D small nucleolar RNA.','2013-10-27','NSRP'),(18169,34513,'box H/ACA snoRNA binding','F','Interacting selectively and non-covalently with box H/ACA small nucleolar RNA.','2013-10-27','NSRP'),(18170,34514,'mitochondrial unfolded protein response','P','The series of molecular signals generated as a consequence of the presence of unfolded proteins in the mitochondrial matrix; results in transcriptional upregulation of nuclear genes encoding mitochondrial stress proteins.','2013-10-27','NSRP'),(18171,34515,'proteasome storage granule','C','A multisubunit proteasome complex that localizes in the cytoplasm as dot-like structures when cells are in a quiescent state.','2013-10-27','NSRP'),(18172,34516,'response to vitamin B6','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin B6 stimulus. Vitamin B6 encompasses pyridoxal, pyridoxamine and pyridoxine and the active form, pyridoxal phosphate.','2013-10-27','NSRP'),(18173,34517,'ribophagy','P','The process in which cells degrade mature ribosomes under conditions of starvation.','2013-10-27','NSRP'),(18174,34518,'RNA cap binding complex','C','Any protein complex that binds to a specialized RNA cap structure at any time in the lifetime of the RNA.','2013-10-27','NSRP'),(18175,34519,'cytoplasmic RNA cap binding complex','C','A protein complex found in the cytoplasm that binds the 5\' cap structure of an mRNA, and typically consists of the cap-binding protein eIF4E, the adaptor protein eIF4G, and a multi-factor complex comprising eIF1, eIF2, eIF3 and eIF5. This complex mediates recruitment of the 40S subunit to mRNA.','2013-10-27','NSRP'),(18176,34520,'2-naphthaldehyde dehydrogenase activity','F','Catalysis of the reaction: 2-naphthaldehyde + NAD+ + H2O = 2-naphthoate + NADH + H+.','2013-10-27','NSRP'),(18177,34521,'1-naphthoic acid dioxygenase activity','F','Catalysis of the reaction: 1-naphthoic acid + NADH + O2 + H+ = cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene + NAD+.','2013-10-27','NSRP'),(18178,34522,'cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity','F','Catalysis of the reaction: cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene = 1,2-dihydroxy-8-carboxynaphthalene + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18179,34523,'3-formylsalicylate oxidase activity','F','Catalysis of the reaction: 3-formylsalicylic acid + O2 + H2O = 2-hydroxyisophthalic acid + hydrogen peroxide.','2013-10-27','NSRP'),(18180,34524,'2-hydroxyisophthalate decarboxylase activity','F','Catalysis of the reaction: 2-hydroxyisophthalic acid = salicylate + CO2.','2013-10-27','NSRP'),(18181,34525,'1-naphthaldehyde dehydrogenase activity','F','Catalysis of the reaction: 1-naphthaldehyde + NAD+ + H2O = 1-naphthoic acid + NADH + H+.','2013-10-27','NSRP'),(18182,34526,'2-methylnaphthalene hydroxylase activity','F','Catalysis of the reaction: 2-methylnaphthalene + NADH + O2 + H+ = 2-hydroxymethylnaphthalene + NAD+ + H2O.','2013-10-27','NSRP'),(18183,34527,'1,2-dihydroxy-8-carboxynaphthalene dioxygenase activity','F','Catalysis of the reaction: 1,2-dihydroxy-8-carboxynaphthalene + O2 = 2-carboxy-2-hydroxy-8-carboxychromene.','2013-10-27','NSRP'),(18184,34528,'2-carboxy-2-hydroxy-8-carboxychromene isomerase activity','F','Catalysis of the reaction: 2-carboxy-2-hydroxy-8-carboxychromene = 2-hydroxy-3-carboxybenzalpyruvate.','2013-10-27','NSRP'),(18185,34529,'2-hydroxy-3-carboxy-benzalpyruvate hydratase-aldolase activity','F','Catalysis of the reaction: 2-hydroxy-3-carboxybenzalpyruvate + H2O = 3-formylsalicylic acid + pyruvate.','2013-10-27','NSRP'),(18186,34530,'4-hydroxymethylsalicyaldehyde dehydrogenase activity','F','Catalysis of the reaction: 4-hydroxymethylsalicylaldehyde + NAD+ + H2O = 4-hydroxymethylsalicylate + NADH + 2 H+.','2013-10-27','NSRP'),(18187,34531,'2-hydroxy-4-hydroxymethylbenzalpyruvate hydratase-aldolase activity','F','Catalysis of the reaction: 2-hydroxy-4-hydroxymethylbenzalpyruvate + H2O = pyruvate + 4-hydroxymethylsalicylaldehyde.','2013-10-27','NSRP'),(18188,34532,'2-hydroxy-7-hydroxymethylchromene-2-carboxylate isomerase activity','F','Catalysis of the reaction: 2-hydroxy-7-hydroxymethylchromene-2-carboxylate = 2-hydroxy-4-hydroxymethylbenzalpyruvate.','2013-10-27','NSRP'),(18189,34533,'1,2-dihydroxy-7-hydroxymethylnaphthalene dioxygenase activity','F','Catalysis of the reaction: 1,2-dihydroxy-7-hydroxymethylnaphthalene + O2 = 2-hydroxy-7-hydroxymethylchromene-2-carboxylate.','2013-10-27','NSRP'),(18190,34534,'1-methylnaphthalene hydroxylase activity','F','Catalysis of the reaction: 1-methylnaphthalene + NADH + H+ + O2 = 1-hydroxymethylnaphthalene + NAD+ + H2O.','2013-10-27','NSRP'),(18191,34535,'1,2-dihydroxy-8-methylnaphthalene dioxygenase activity','F','Catalysis of the reaction: 1,2-dihydroxy-8-methylnaphthalene + O2 = 2-hydroxy-8-methylchromene-2-carboxylate + H+.','2013-10-27','NSRP'),(18192,34536,'2-hydroxy-8-methylchromene-2-carboxylate isomerase activity','F','Catalysis of the reaction: 2-hydroxy-8-methylchromene-2-carboxylate = 2-hydroxy-3-methylbenzalpyruvate.','2013-10-27','NSRP'),(18193,34537,'2-hydroxy-3-methylbenzalpyruvate hydratase-aldolase activity','F','Catalysis of the reaction: 2-hydroxy-3-methylbenzalpyruvate + H2O = pyruvate + 3-methylsalicylaldehyde.','2013-10-27','NSRP'),(18194,34538,'3-methylsalicylaldehyde dehydrogenase activity','F','Catalysis of the reaction: 3-methylsalicylaldehyde + NAD+ = 3-methylsalicylate + NADH + H+.','2013-10-27','NSRP'),(18195,34539,'3,3\',5,5\'-tetrabromobisphenol A reductive dehalogenase activity','F','Catalysis of the reaction: 3,3\',5,5\'-tetrabromobisphenol A + 2 H+ + 2 e- = 3,3\',5-tribromobisphenol A + HBr.','2013-10-27','NSRP'),(18196,34540,'3-monobromobisphenol A reductive dehalogenase activity','F','Catalysis of the reaction: 3-monobromobisphenol A + 2 H+ + 2 e- = bisphenol A + HBr.','2013-10-27','NSRP'),(18197,34541,'dimethylarsinite methyltransferase activity','F','Catalysis of the reaction: dimethylarsenous acid + R2S-CH3 = trimethylarsine oxide + R2SH.','2013-10-27','NSRP'),(18198,34542,'trimethylarsine oxidase activity','F','Catalysis of the reaction: trimethylarsine oxide + 2 H+ + 2 e- = trimethylarsine + H2O.','2013-10-27','NSRP'),(18199,34543,'5-aminosalicylate dioxygenase activity','F','Catalysis of the reaction: 5-aminosalicylate + O2 = cis-4-amino-6-carboxy-2-oxo-hexa-3,5-dienoate.','2013-10-27','NSRP'),(18200,34544,'trans-ACOHDA hydrolase activity','F','Catalysis of the reaction: trans-4-amino-6-carboxy-2-oxo-hexa-3,5-dienoate + H2O = fumarylpyruvate + NH3.','2013-10-27','NSRP'),(18201,34545,'fumarylpyruvate hydrolase activity','F','Catalysis of the reaction: fumarylpyruvate + H2O = fumarate + pyruvate + H+.','2013-10-27','NSRP'),(18202,34546,'2,4-dichloroaniline reductive dehalogenase activity','F','Catalysis of the reaction: 2,4-dichloroaniline + 2 H+ + 2 e- = 4-chloroaniline + HCl.','2013-10-27','NSRP'),(18203,34547,'N-cyclopropylmelamine deaminase activity','F','Catalysis of the reaction: cyromazine + H2O = N-cyclopropylammeline + NH3.','2013-10-27','NSRP'),(18204,34548,'N-cyclopropylammeline deaminase activity','F','Catalysis of the reaction: N-cyclopropylammeline + H2O = N-cyclopropylammelide + NH3.','2013-10-27','NSRP'),(18205,34549,'N-cyclopropylammelide alkylamino hydrolase activity','F','Catalysis of the reaction: N-cyclopropylammelide + H2O = cyclopropylamine + cyanuric acid.','2013-10-27','NSRP'),(18206,34550,'dimethylarsinate reductase activity','F','Catalysis of the reaction: dimethylarsinate + 3 H+ + 2 e- = dimethylarsinous acid + H2O.','2013-10-27','NSRP'),(18207,34551,'mitochondrial respiratory chain complex III assembly','P','The aggregation, arrangement and bonding together of a set of components to form the cytochrome bc(1) complex (also known as ubiquinol-cytochrome c reductase), in the mitochondrial inner membrane.','2013-10-27','NSRP'),(18208,34552,'respiratory chain complex II assembly','P','The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex II.','2013-10-27','NSRP'),(18209,34553,'mitochondrial respiratory chain complex II assembly','P','The aggregation, arrangement and bonding together of a set of components to form respiratory chain complex II, in the mitochondrial inner membrane.','2013-10-27','NSRP'),(18210,34554,'3,3\',5-tribromobisphenol A reductive dehalogenase activity','F','Catalysis of the reaction: 3,3\',5-tribromobisphenol A + 2 H+ + 2 e- = 3,3\'-dibromobisphenol A + HBr.','2013-10-27','NSRP'),(18211,34555,'3,3\'-dibromobisphenol A reductive dehalogenase activity','F','Catalysis of the reaction: 3,3\'-dibromobisphenol A + 2 H+ + 2 e- = 3-monobromobisphenol A + HBr.','2013-10-27','NSRP'),(18212,34556,'nitrobenzoate nitroreductase activity','F','Catalysis of the reaction: o-nitrobenzoate + NADPH + H+ = o-hydroxylaminobenzoate + NADP+.','2013-10-27','NSRP'),(18213,34557,'2-hydroxylaminobenzoate reductase activity','F','Catalysis of the reaction: 2-hydroxylaminobenzoate + NAD(P)H = anthranilate + NAD(P)+ + H2O.','2013-10-27','NSRP'),(18214,34558,'technetium (VII) reductase activity','F','Catalysis of the reaction: pertechnetate ion + 3/2 H2 = technetium (IV) oxide + H2O + OH-.','2013-10-27','NSRP'),(18215,34559,'bisphenol A hydroxylase B activity','F','Catalysis of the reaction: bisphenol A + NADH + H+ + O2 = 1,2-bis(4-hydroxyphenyl)-2-propanol + NAD+ + H2O.','2013-10-27','NSRP'),(18216,34560,'bisphenol A hydroxylase A activity','F','Catalysis of the reaction: bisphenol A + NADH + H+ + O2 = 2,2-bis(4-hydroxyphenyl)-1-propanol + NAD+ + H2O.','2013-10-27','NSRP'),(18217,34561,'1,2-bis(4-hydroxyphenyl)-2-proponol dehydratase activity','F','Catalysis of the reaction: 1,2-bis(4-hydroxyphenyl)-2-propanol = 4,4\'-dihydroxy-alpha-methylstilbene + H2O.','2013-10-27','NSRP'),(18218,34562,'2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity','F','Catalysis of the reaction: 2,2-bis(4-hydroxyphenyl)-1-propanol + NADH + H+ + O2 = 2,3-bis(4-hydroxyphenyl)-1,2-propanediol + NAD+ + H2O.','2013-10-27','NSRP'),(18219,34563,'2,3-bis(4-hydroxyphenyl)-1,2-propanediol dioxygenase activity','F','Catalysis of the reaction: 2,3-bis(4-hydroxyphenyl)-1,2-propanediol + O2 = 4-hydroxyphenacyl alcohol + 4-hydroxybenzoate + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18220,34564,'4,4\'-dihydroxy-alpha-methylstilbene dioxygenase activity','F','Catalysis of the reaction: 4,4\'-dihydroxy-alpha-methylstilbene + O2 = 4-hydroxybenzaldehyde + 4-hydroxyacetophenone + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18221,34565,'1-nitro-1,2-dihydro-1,3,5-triazine hydrolase activity','F','Catalysis of the reaction: 1-nitro-1,2-dihydro-1,3,5-triazine + 2 H2O = 1-nitro-1,3,5-triazinane-2,4-diol.','2013-10-27','NSRP'),(18222,34567,'chromate reductase activity','F','Catalysis of the reaction: chromate = chromium (III).','2013-10-27','NSRP'),(18223,34568,'isoproturon dimethylaminedehydrogenase activity','F','Catalysis of the reaction: isoproturon + H2O = formaldehyde + monodemethylisoproturon + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18224,34569,'monodemethylisoproturon dehydrogenase activity','F','Catalysis of the reaction: monodemethylisoproturon + H2O = hydroxymonodemethylisoproturon + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18225,34570,'hydroxymonomethylisoproturon dimethylaminedehydrogenase activity','F','Catalysis of the reaction: hydroxymonodemethylisoproturon + H2O = formaldehyde + 4\'-(2-hydroxyisopropyl)phenylurea + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18226,34571,'4\'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity','F','Catalysis of the reaction: 4\'-(2-hydroxyisopropyl)phenylurea + H2O = 4\'-(2-hydroxyisopropyl)phenylaniline + carbamic acid.','2013-10-27','NSRP'),(18227,34572,'monodemethylisoproturon dimethylaminedehydrogenase activity','F','Catalysis of the reaction: monodemethylisoproturon + H2O = didemethylisoproturon + formaldehyde + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18228,34573,'didemethylisoproturon amidohydrolase activity','F','Catalysis of the reaction: didemethylisoproturon + H2O = carbamic acid + 4-isopropylaniline.','2013-10-27','NSRP'),(18229,34574,'didemethylisoproturon dehydrogenase activity','F','Catalysis of the reaction: didemethylisoproturon + H2O = 4\'-(2-hydroxyisopropyl)phenylurea + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18230,34575,'4-isopropylaniline dehydrogenase activity','F','Catalysis of the reaction: 4-isopropylaniline + H2O = 4\'-(2-hydroxyisopropyl)phenylaniline + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18231,34576,'N-isopropylacetanilide amidohydrolase activity','F','Catalysis of the reaction: N-isopropylacetanilide + OH- = N-isopropylaniline + acetate.','2013-10-27','NSRP'),(18232,34577,'N-isopropylacetaniline monooxygenase activity','F','Catalysis of the reaction: N-isopropylacetanilide + 1/2 O2 = acetanilide + acetone.','2013-10-27','NSRP'),(18233,34578,'limonene 8-hydratase activity','F','Catalysis of the reaction: limonene + H2O = alpha-terpineol.','2013-10-27','NSRP'),(18234,34579,'(1-methylpentyl)succinate synthase activity','F','Catalysis of the reaction: fumarate + n-hexane = (1-methylpentyl)succinate.','2013-10-27','NSRP'),(18235,34580,'4-methyloctanoyl-CoA dehydrogenase activity','F','Catalysis of the reaction: 4-methyloctanoyl-CoA = 4-methyloct-2-enoyl-CoA + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18236,34581,'4-methyloct-2-enoyl-CoA hydratase activity','F','Catalysis of the reaction: 4-methyloct-2-enoyl-CoA + H2O = 3-hydroxy-4-methyloctanoyl-CoA.','2013-10-27','NSRP'),(18237,34582,'3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity','F','Catalysis of the reaction: 3-hydroxy-4-methyloctanoyl-CoA = 4-methyl-3-oxooctanoyl-CoA + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18238,34583,'21U-RNA binding','F','Interacting selectively and non-covalently with a 21U-RNA, a 21-nucleotide RNA characterized by a uridine 5\'-monophosphate and a modified 3\' end resistant to periodate degradation. 21U-RNAs are derived from distinct, autonomously expressed loci within the genome.','2013-10-27','NSRP'),(18239,34584,'piRNA binding','F','Interacting selectively and non-covalently with a piRNA, a Piwi-associated RNA, a 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.','2013-10-27','NSRP'),(18240,34585,'21U-RNA metabolic process','P','The chemical reactions and pathways involving 21U-RNAs, a class of single-stranded RNA molecules of about 21 nucleotides in length characterized by a uridine 5\'-monophosphate and a modified 3\' end resistant to periodate degradation. 21U-RNAs are derived from distinct, autonomously expressed loci within the genome.','2013-10-27','NSRP'),(18241,34586,'21U-RNA catabolic process','P','The chemical reactions and pathways resulting in the breakdown of 21U-RNAs, a class of single-stranded RNA molecules of about 21 nucleotides in length characterized by a uridine 5\'-monophosphate and a modified 3\' end resistant to periodate degradation. 21U-RNAs are derived from distinct, autonomously expressed loci within the genome.','2013-10-27','NSRP'),(18242,34587,'piRNA metabolic process','P','The chemical reactions and pathways involving piRNAs, Piwi-associated RNAs, a class of 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.','2013-10-27','NSRP'),(18243,34588,'piRNA catabolic process','P','The chemical reactions and pathways resulting in the breakdown of piRNAs, Piwi-associated RNAs, a class of 24- to 30-nucleotide RNA derived from repeat or complex DNA sequence elements and processed by a Dicer-independent mechanism.','2013-10-27','NSRP'),(18244,34589,'hydroxyproline transport','P','The directed movement of hydroxyproline into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18245,34590,'L-hydroxyproline transmembrane transporter activity','F','Catalysis of the transfer of L-hydroxyproline from one side of a membrane to the other.','2013-10-27','NSRP'),(18246,34591,'rhoptry lumen','C','The volume enclosed by the rhoptry membrane.','2013-10-27','NSRP'),(18247,34592,'synaptic vesicle lumen','C','The volume enclosed by the synaptic vesicle membrane.','2013-10-27','NSRP'),(18248,34593,'phosphatidylinositol bisphosphate phosphatase activity','F','Catalysis of the reaction: phosphatidylinositol bisphosphate + H2O = phosphatidylinositol phosphate + phosphate.','2013-10-27','NSRP'),(18249,34594,'phosphatidylinositol trisphosphate phosphatase activity','F','Catalysis of the reaction: phosphatidylinositol trisphosphate + H2O = phosphatidylinositol bisphosphate + phosphate.','2013-10-27','NSRP'),(18250,34595,'phosphatidylinositol phosphate 5-phosphatase activity','F','Catalysis of the removal of the 5-phosphate group of a phosphatidylinositol phosphate.','2013-10-27','NSRP'),(18251,34596,'phosphatidylinositol phosphate 4-phosphatase activity','F','Catalysis of the removal of the 4-phosphate group of a phosphatidylinositol phosphate.','2013-10-27','NSRP'),(18252,34597,'phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity','F','Catalysis of the reaction: 1-phosphatidyl-myo-inositol 4,5-bisphosphate + H2O = 1-phosphatidyl-1D-myo-inositol 3-phosphate + phosphate.','2013-10-27','NSRP'),(18253,34598,'phosphothreonine lyase activity','F','Catalysis of the removal of the phosphate group from phosphothreonine by cleavage of the C-OP bond with the concomitant abstraction of the alpha proton, generating a double bond-containing product.','2013-10-27','NSRP'),(18254,34599,'cellular response to oxidative stress','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.','2013-10-27','NSRP'),(18255,34601,'oxoglutarate dehydrogenase [NAD(P)+] activity','F','Catalysis of the reaction: 2-oxoglutarate + CoA + NAD(P)+ = succinyl-CoA + CO2 + NAD(P)H.','2013-10-27','NSRP'),(18256,34602,'oxoglutarate dehydrogenase (NAD+) activity','F','Catalysis of the reaction: 2-oxoglutarate + CoA + NAD+ = succinyl-CoA + CO2 + NADH.','2013-10-27','NSRP'),(18257,34603,'pyruvate dehydrogenase [NAD(P)+] activity','F','Catalysis of the reaction: pyruvate + CoA + NAD(P)+ = acetyl-CoA + CO2 + NAD(P)H.','2013-10-27','NSRP'),(18258,34604,'pyruvate dehydrogenase (NAD+) activity','F','Catalysis of the reaction: pyruvate + CoA + NAD+ = acetyl-CoA + CO2 + NADH.','2013-10-27','NSRP'),(18259,34605,'cellular response to heat','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism.','2013-10-27','NSRP'),(18260,34606,'response to hermaphrodite contact','P','The response by the male to a hermaphrodite after initial contact following mate finding. The male stops forward locomotion, presses the ventral side of his tail against his partner\'s body, and begins moving backward along the hermaphrodite. Male response behavior is initiated when sensory neurons located in the rays of his tail contact a potential mate.','2013-10-27','NSRP'),(18261,34607,'turning behavior involved in mating','P','The sharp ventral turn performed by the male as he approaches either the hermaphrodite head or tail, whilst trying to locate his partner\'s vulva. Turning occurs via a sharp ventral coil of the male\'s tail.','2013-10-27','NSRP'),(18262,34608,'vulval location','P','Location, by the male, of his partner\'s vulva when backing along the ventral side of the hermaphrodite during mating. The male stops at the vulva, coordinates his movements to the hermaphrodite\'s, and positions his tail precisely over the vulva so that he may insert his spicules and ejaculate.','2013-10-27','NSRP'),(18263,34609,'spicule insertion','P','Insertion of the male copulatory spicules into the hermaphrodite. Spicule insertion behavior initiates when the male cloaca contacts the vulva. During most mating encounters, the spicule tips will prod the vulva continuously until they partially penetrate, which then causes the protractors to contract completely so that the spicules extend through the vulva.','2013-10-27','NSRP'),(18264,34610,'oligodeoxyribonucleotidase activity','F','Catalysis of the exonucleolytic cleavage of oligodeoxyribonucleotides to yield deoxyribonucleoside 5\'-phosphates.','2013-10-27','NSRP'),(18265,34611,'oligoribonucleotidase activity','F','Catalysis of the exonucleolytic cleavage of oligoribonucleotides to yield ribonucleoside 5\'-phosphates.','2013-10-27','NSRP'),(18266,34612,'response to tumor necrosis factor','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.','2013-10-27','NSRP'),(18267,34613,'cellular protein localization','P','Any process in which a protein is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.','2013-10-27','NSRP'),(18268,34614,'cellular response to reactive oxygen species','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals.','2013-10-27','NSRP'),(18269,34615,'GCH1 complex','C','A protein complex that possesses GTP cyclohydrolase I activity. In E. coli and human, the complex is a homodecamer, and monomers are catalytically inactive.','2013-10-27','NSRP'),(18270,34616,'response to laminar fluid shear stress','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls.','2013-10-27','NSRP'),(18271,34617,'tetrahydrobiopterin binding','F','Interacting selectively and non-covalently with a tetrahydrobiopterin, 5,6,7,8-tetrahydrobiopterin or a derivative thereof; tetrahydrobiopterins are enzyme cofactors that carry electrons in redox reactions.','2013-10-27','NSRP'),(18272,34618,'arginine binding','F','Interacting selectively and non-covalently with 2-amino-5-(carbamimidamido)pentanoic acid.','2013-10-27','NSRP'),(18273,34619,'cellular chaperone-mediated protein complex assembly','P','The aggregation, arrangement and bonding together of a set of components to form a protein complex, occurring at the level of an individual cell, mediated by chaperone molecules that do not form part of the finished complex.','2012-03-14','NSRP'),(18274,34620,'cellular response to unfolded protein','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.','2013-10-27','NSRP'),(18275,34621,'cellular macromolecular complex subunit organization','P','Any process carried out at the cellular level by which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a macromolecular complex.','2012-03-14','NSRP'),(18276,34622,'cellular macromolecular complex assembly','P','The aggregation, arrangement and bonding together of a set of macromolecules to form a complex, carried out at the cellular level.','2013-10-27','NSRP'),(18277,34623,'cellular macromolecular complex disassembly','P','The disaggregation of a macromolecular complex into its constituent components, carried out at the cellular level.','2012-03-14','NSRP'),(18278,34624,'DNA recombinase assembly involved in gene conversion at mating-type locus','P','The aggregation, arrangement and bonding together of strand exchange proteins (recombinases) into higher order oligomers on single-stranded DNA, involved in the conversion of the mating-type locus from one allele to another.','2013-10-27','NSRP'),(18279,34625,'fatty acid elongation, monounsaturated fatty acid','P','Elongation of a fatty acid chain into which one C-C double bond has been introduced.','2013-10-27','NSRP'),(18280,34626,'fatty acid elongation, polyunsaturated fatty acid','P','Elongation of a fatty acid chain into which two or more C-C double bonds have been introduced.','2013-10-27','NSRP'),(18281,34627,'\'de novo\' NAD biosynthetic process','P','The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of tryptophan or aspartate from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH.','2013-10-27','NSRP'),(18282,34628,'\'de novo\' NAD biosynthetic process from aspartate','P','The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of aspartate from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH.','2013-10-27','NSRP'),(18283,34629,'cellular protein complex localization','P','A protein complex localization process that takes place at the cellular level; as a result, a protein complex is transported to, or maintained in, a specific location within a cell.','2013-10-27','NSRP'),(18284,34630,'RITS complex localization','P','Any process in which a RITS complex is transported to, or maintained in, a specific location.','2013-10-27','NSRP'),(18285,34631,'microtubule anchoring at spindle pole body','P','Any process in which a microtubule is maintained in a specific location in a cell by attachment to a spindle pole body. Microtubules attach to spindle pole bodies at the minus end.','2013-10-27','NSRP'),(18286,34632,'retinol transporter activity','F','Enables the directed movement of retinol into, out of or within a cell, or between cells. Retinol is vitamin A1, 2,6,6-trimethyl-1-(9\'-hydroxy-3\',7\'-dimethylnona-1\',3\',5\',7\'-tetraenyl)cyclohex-1-ene, one of the three components that makes up vitamin A.','2013-10-27','NSRP'),(18287,34633,'retinol transport','P','The directed movement of retinol into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Retinol is vitamin A1, 2,6,6-trimethyl-1-(9\'-hydroxy-3\',7\'-dimethylnona-1\',3\',5\',7\'-tetraenyl)cyclohex-1-ene, one of the three components that makes up vitamin A.','2013-10-27','NSRP'),(18288,34634,'glutathione transmembrane transporter activity','F','Enables the directed movement of glutathione, the tripeptide glutamylcysteinylglycine, across a membrane into, out of or within a cell, or between cells.','2013-10-27','NSRP'),(18289,34635,'glutathione transport','P','The directed movement of glutathione, the tripeptide glutamylcysteinylglycine, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18290,34636,'strand invasion involved in gene conversion at mating-type locus','P','The process in which the nucleoprotein complex (composed of the broken single-strand DNA and the recombinase) searches and identifies a region of homology in intact duplex DNA at the mating-type locus. The broken single-strand DNA displaces the like strand and forms Watson-Crick base pairs with its complement, forming a duplex in which each strand is from one of the two recombining DNA molecules. This process occurs as part of gene conversion at the mating-type locus.','2013-10-27','NSRP'),(18291,34637,'cellular carbohydrate biosynthetic process','P','The chemical reactions and pathways resulting in the formation of carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y, carried out by individual cells.','2013-10-27','NSRP'),(18292,34638,'phosphatidylcholine catabolic process','P','The chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.','2013-10-27','NSRP'),(18293,34639,'L-amino acid efflux transmembrane transporter activity','F','Catalysis of the transfer of an L-amino acid from the inside of the cell to the outside of the cell across a membrane.','2013-10-27','NSRP'),(18294,34640,'establishment of mitochondrion localization by microtubule attachment','P','The directed movement of a mitochondrion by attachment to a microtubule, followed by elongation of the microtubule by tubulin polymerization.','2013-10-27','NSRP'),(18295,34641,'cellular nitrogen compound metabolic process','P','The chemical reactions and pathways involving various organic and inorganic nitrogenous compounds, as carried out by individual cells.','2013-10-27','NSRP'),(18296,34642,'mitochondrion migration along actin filament','P','The directed movement of a mitochondrion along a microfilament, mediated by motor proteins.','2013-10-27','NSRP'),(18297,34643,'establishment of mitochondrion localization, microtubule-mediated','P','The directed movement of the mitochondrion to a specific location, by a process involving microtubules.','2013-10-27','NSRP'),(18298,34644,'cellular response to UV','P','Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.','2013-10-27','NSRP'),(18299,34645,'cellular macromolecule biosynthetic process','P','The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass, carried out by individual cells.','2013-10-27','NSRP'),(18300,34646,'organelle-enclosing lipid monolayer','C','A lipid monolayer that surrounds and encloses an organelle.','2013-10-27','NSRP'),(18301,34647,'histone demethylase activity (H3-trimethyl-K4 specific)','F','Catalysis of the removal of a methyl group from trimethylated lysine at position 4 of the histone H3 protein.','2013-10-27','NSRP'),(18302,34648,'histone demethylase activity (H3-dimethyl-K4 specific)','F','Catalysis of the removal of a methyl group from dimethylated lysine at position 4 of the histone H3 protein.','2013-10-27','NSRP'),(18303,34649,'histone demethylase activity (H3-monomethyl-K4 specific)','F','Catalysis of the reaction: histone H3 N6-methyl-L-lysine (position 4) + O2 + FAD + H2O = histone H3 L-lysine (position 4) + H2O2 + formaldehyde + FADH2. This reaction is the removal of a methyl group from monomethylated lysine at position 4 of the histone H3 protein.','2013-10-27','NSRP'),(18304,34650,'cortisol metabolic process','P','The chemical reactions and pathways involving cortisol, the steroid hormone 11-beta-17,21-trihydroxypregn-4-ene-3,20-dione. Cortisol is synthesized from cholesterol in the adrenal gland and controls carbohydrate, fat and protein metabolism and has anti-inflammatory properties.','2013-10-27','NSRP'),(18305,34651,'cortisol biosynthetic process','P','The chemical reactions and pathways resulting in the formation of cortisol, the steroid hormone 11-beta-17,21-trihydroxypregn-4-ene-3,20-dione. Cortisol is synthesized from cholesterol in the adrenal gland and controls carbohydrate, fat and protein metabolism and has anti-inflammatory properties.','2013-10-27','NSRP'),(18306,34652,'extrachromosomal circular DNA localization involved in cell aging','P','A process in which extrachromosomal circular DNA molecules are transported to, or maintained in, a specific location in cells contributing to their aging.','2013-10-27','NSRP'),(18307,34653,'retinoic acid catabolic process','P','The chemical reactions and pathways resulting in the breakdown of retinoic acid, one of the three components that makes up vitamin A.','2013-10-27','NSRP'),(18308,34654,'nucleobase-containing compound biosynthetic process','P','The chemical reactions and pathways resulting in the formation of nucleobases, nucleosides, nucleotides and nucleic acids.','2013-10-27','NSRP'),(18309,34655,'nucleobase-containing compound catabolic process','P','The chemical reactions and pathways resulting in the breakdown of nucleobases, nucleosides, nucleotides and nucleic acids.','2013-10-27','NSRP'),(18310,34656,'nucleobase-containing small molecule catabolic process','P','The chemical reactions and pathways resulting in the breakdown of a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide.','2013-10-27','NSRP'),(18311,34657,'GID complex','C','A protein complex with ubiquitin ligase activity that is involved in proteasomal degradation of fructose-1,6-bisphosphatase (FBPase) and phosphoenolpyruvate carboxykinase during the transition from gluconeogenic to glycolytic growth conditions. In S. cerevisiae, the GID (Glucose Induced degradation Deficient) complex consists of Vid30p, Rmd5p, Vid24p, Vid28p, Gid7p, Gid8p, and Fyv10p.','2013-10-27','NSRP'),(18312,34658,'isopropylmalate transmembrane transporter activity','F','Catalysis of the transfer of isopropylmalate from one side of the membrane to the other.','2013-10-27','NSRP'),(18313,34659,'isopropylmalate transport','P','The directed movement of isopropylmalate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18314,34660,'ncRNA metabolic process','P','The chemical reactions and pathways involving non-coding RNA transcripts (ncRNAs).','2013-10-27','NSRP'),(18315,34661,'ncRNA catabolic process','P','The chemical reactions and pathways resulting in the breakdown of non-coding RNA transcripts (ncRNAs). Includes the breakdown of cryptic unstable transcripts (CUTs).','2013-10-27','NSRP'),(18316,34662,'CFTR-NHERF-ezrin complex','C','A protein complex that contains ezrin, Na+/H+ exchanger regulatory factor (NHERF, also called EBP50), and two copies of the cystic fibrosis transmembrane conductance regulator (CFTR). The CFTR molecules interact with NHERF via their cytoplasmic tail domains; the complex is thought to link the CFTR channel to the actin cytoskeleton and contribute to the regulation of channel activity.','2013-10-27','NSRP'),(18317,34663,'endoplasmic reticulum chaperone complex','C','A protein complex that is located in the endoplasmic reticulum and is composed of chaperone proteins, including BiP, GRP94; CaBP1, protein disulfide isomerase (PDI), ERdj3, cyclophilin B, ERp72, GRP170, UDP-glucosyltransferase, and SDF2-L1.','2013-10-27','NSRP'),(18318,34664,'Ig heavy chain-bound endoplasmic reticulum chaperone complex','C','A protein complex that is located in the endoplasmic reticulum (ER) and is formed by the association of an immunoglobulin heavy chain with the proteins of the ER chaperone complex; the latter include BiP, GRP94; CaBP1, protein disulfide isomerase (PDI), ERdj3, cyclophilin B, ERp72, GRP170, UDP-glucosyltransferase, and SDF2-L1.','2013-10-27','NSRP'),(18319,34665,'alpha1-beta1 integrin complex','C','An integrin complex that comprises one alpha1 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18320,34666,'alpha2-beta1 integrin complex','C','An integrin complex that comprises one alpha2 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18321,34667,'alpha3-beta1 integrin complex','C','An integrin complex that comprises one alpha3 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18322,34668,'alpha4-beta1 integrin complex','C','An integrin complex that comprises one alpha4 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18323,34669,'alpha4-beta7 integrin complex','C','An integrin complex that comprises one alpha4 subunit and one beta7 subunit.','2013-10-27','NSRP'),(18324,34670,'chemotaxis to arachidonic acid','P','The directed movement of a motile cell or organism in response to the presence of arachidonic acid.','2013-10-27','NSRP'),(18325,34671,'retinoic acid receptor signaling pathway involved in pronephros anterior/posterior pattern specification','P','The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands that results in the spatial identity of regions along the anterior-posterior axis of the pronephros.','2013-10-27','NSRP'),(18326,34672,'anterior/posterior pattern specification involved in pronephros development','P','The developmental process that results in the creation of defined areas or spaces within the pronephros along the anterior/posterior axis to which cells respond and eventually are instructed to differentiate.','2013-10-27','NSRP'),(18327,34673,'inhibin-betaglycan-ActRII complex','C','A protein complex that consists of inhibin, type III transforming growth factor beta receptor (also known as betaglycan), and the type II activin receptor ActRII. The complex is thought to negatively regulate the activity of activin B.','2013-10-27','NSRP'),(18328,34674,'alpha5-beta1 integrin complex','C','An integrin complex that comprises one alpha5 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18329,34675,'alpha6-beta1 integrin complex','C','An integrin complex that comprises one alpha6 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18330,34676,'alpha6-beta4 integrin complex','C','An integrin complex that comprises one alpha6 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18331,34677,'alpha7-beta1 integrin complex','C','An integrin complex that comprises one alpha7 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18332,34678,'alpha8-beta1 integrin complex','C','An integrin complex that comprises one alpha8 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18333,34679,'alpha9-beta1 integrin complex','C','An integrin complex that comprises one alpha9 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18334,34680,'alpha10-beta1 integrin complex','C','An integrin complex that comprises one alpha10 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18335,34681,'alpha11-beta1 integrin complex','C','An integrin complex that comprises one alpha11 subunit and one beta1 subunit.','2013-10-27','NSRP'),(18336,34682,'alphav-beta1 integrin complex','C','An integrin complex that comprises one alphav subunit and one beta1 subunit.','2013-10-27','NSRP'),(18337,34683,'alphav-beta3 integrin complex','C','An integrin complex that comprises one alphav subunit and one beta3 subunit.','2013-10-27','NSRP'),(18338,34684,'alphav-beta5 integrin complex','C','An integrin complex that comprises one alphav subunit and one beta5 subunit.','2013-10-27','NSRP'),(18339,34685,'alphav-beta6 integrin complex','C','An integrin complex that comprises one alphav subunit and one beta6 subunit.','2013-10-27','NSRP'),(18340,34686,'alphav-beta8 integrin complex','C','An integrin complex that comprises one alphav subunit and one beta8 subunit.','2013-10-27','NSRP'),(18341,34687,'alphaL-beta2 integrin complex','C','An integrin complex that comprises one alphaL subunit and one beta2 subunit.','2013-10-27','NSRP'),(18342,34688,'alphaM-beta2 integrin complex','C','An integrin complex that comprises one alphaM subunit and one beta2 subunit.','2013-10-27','NSRP'),(18343,34689,'alphaX-beta2 integrin complex','C','An integrin complex that comprises one alphaX subunit and one beta2 subunit.','2013-10-27','NSRP'),(18344,34690,'alphaD-beta2 integrin complex','C','An integrin complex that comprises one alphaD subunit and one beta2 subunit.','2013-10-27','NSRP'),(18345,34691,'alphaE-beta7 integrin complex','C','An integrin complex that comprises one alphaE subunit and one beta7 subunit.','2013-10-27','NSRP'),(18346,34692,'E.F.G complex','C','A protein complex that comprises three core spliceosomal proteins, designated E, F, and G. Formation of the E.F.G complex is essential but not sufficient for the formation of a stable U1 snRNP complex.','2013-10-27','NSRP'),(18347,34693,'U11/U12 snRNP','C','A ribonucleoprotein complex formed by the association of the U11 and U12 small nuclear ribonucleoproteins.','2013-10-27','NSRP'),(18348,34694,'response to prostaglandin stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin stimulus.','2013-10-27','NSRP'),(18349,34695,'response to prostaglandin E stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.','2013-10-27','NSRP'),(18350,34696,'response to prostaglandin F stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin F stimulus.','2013-10-27','NSRP'),(18351,34697,'response to prostaglandin I stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin I stimulus.','2013-10-27','NSRP'),(18352,34698,'response to gonadotropin stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.','2013-10-27','NSRP'),(18353,34699,'response to luteinizing hormone stimulus','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.','2013-10-27','NSRP'),(18354,34700,'allulose 6-phosphate 3-epimerase activity','F','Catalysis of the reaction: D-allulose 6-phosphate = D-fructose 6-phosphate.','2013-10-27','NSRP'),(18355,34701,'tripeptidase activity','F','Catalysis of the hydrolysis of a tripeptide.','2013-10-27','NSRP'),(18356,34702,'ion channel complex','C','A protein complex that spans a membrane and forms a water-filled channel across the phospholipid bilayer allowing selective ion transport down its electrochemical gradient.','2013-10-27','NSRP'),(18357,34703,'cation channel complex','C','An ion channel complex through which cations pass.','2013-10-27','NSRP'),(18358,34704,'calcium channel complex','C','An ion channel complex through which calcium ions pass.','2013-10-27','NSRP'),(18359,34705,'potassium channel complex','C','An ion channel complex through which potassium ions pass.','2013-10-27','NSRP'),(18360,34706,'sodium channel complex','C','An ion channel complex through which sodium ions pass.','2013-10-27','NSRP'),(18361,34707,'chloride channel complex','C','An ion channel complex through which chloride ions pass.','2013-10-27','NSRP'),(18362,34708,'methyltransferase complex','C','A protein complex that possesses methyltransferase activity.','2013-10-27','NSRP'),(18363,34709,'methylosome','C','A large (20 S) protein complex that possesses protein arginine methyltransferase activity and modifies specific arginines to dimethylarginines in the arginine- and glycine-rich domains of several spliceosomal Sm proteins, thereby targeting these proteins to the survival of motor neurons (SMN) complex for assembly into small nuclear ribonucleoprotein (snRNP) core particles. Proteins found in the methylosome include the methyltransferase JBP1 (PRMT5), pICln (CLNS1A), MEP50 (WDR77), and unmethylated forms of SM proteins that have RG domains.','2013-10-27','NSRP'),(18364,34710,'inhibin complex binding','F','Interacting selectively and non-covalently with an inhibin complex, a dimer of one inhibin-alpha subunit and one inhibin-beta subunit.','2013-10-27','NSRP'),(18365,34711,'inhibin binding','F','Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.','2013-10-27','NSRP'),(18366,34712,'inhibin alpha binding','F','Interacting selectively and non-covalently with inhibin alpha.','2012-03-14','NSRP'),(18367,34713,'type I transforming growth factor beta receptor binding','F','Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.','2013-10-27','NSRP'),(18368,34714,'type III transforming growth factor beta receptor binding','F','Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.','2013-10-27','NSRP'),(18369,34715,'pICln-Sm protein complex','C','A protein complex that contains pICln (CLNS1A) and several Sm proteins, including SmD1, SmD2, SmE, SmF, and SmG.','2013-10-27','NSRP'),(18370,34716,'Gemin3-Gemin4-Gemin5 complex','C','A protein complex that contains Gemin3 (DDX20), Gemin4, and Gemin5, and can bind to snRNAs; may be an intermediate in SMN complex assembly.','2013-10-27','NSRP'),(18371,34717,'Gemin6-Gemin7-unrip complex','C','A protein complex that contains Gemin6, Gemin7, and unrip (STRAP), and can bind to snRNAs; may play a role in snRNP assembly.','2013-10-27','NSRP'),(18372,34718,'SMN-Gemin2 complex','C','A protein complex that contains the survival motor neuron (SMN) protein and Gemin2; may form the stable core of the larger SMN complex.','2013-10-27','NSRP'),(18373,34719,'SMN-Sm protein complex','C','A protein complex formed by the association of several methylated Sm proteins with the SMN complex; the latter contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and unrip proteins; additional proteins, including galectin-1 and galectin-3, are also found in the SMN-SM complex. The SMN-Sm complex is involved in spliceosomal snRNP assembly in the cytoplasm.','2013-10-27','NSRP'),(18374,34720,'histone H3-K4 demethylation','P','The modification of histone H3 by the removal of a methyl group from lysine at position 4 of the histone.','2013-10-27','NSRP'),(18375,34721,'histone H3-K4 demethylation, trimethyl-H3-K4-specific','P','The modification of histone H3 by the removal of a methyl group from a trimetylated lysine at position 4 of the histone.','2013-10-27','NSRP'),(18376,34722,'gamma-glutamyl-peptidase activity','F','Catalysis of the cleavage of a gamma-linked glutamate bond.','2013-10-27','NSRP'),(18377,34723,'DNA replication-dependent nucleosome organization','P','The formation or destruction of chromatin structures on newly replicated DNA, coupled to strand elongation.','2013-10-27','NSRP'),(18378,34724,'DNA replication-independent nucleosome organization','P','The formation or destruction of chromatin structures, occurring outside the context of DNA replication.','2013-10-27','NSRP'),(18379,34725,'DNA replication-dependent nucleosome disassembly','P','The controlled breakdown of nucleosomes on newly replicated DNA, coupled to strand elongation.','2013-10-27','NSRP'),(18380,34726,'DNA replication-independent nucleosome disassembly','P','The controlled breakdown of nucleosomes outside the context of DNA replication.','2013-10-27','NSRP'),(18381,34727,'piecemeal microautophagy of nucleus','P','Degradation of a cell nucleus by microautophagy.','2013-10-27','NSRP'),(18382,34728,'nucleosome organization','P','A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of one or more nucleosomes.','2013-10-27','NSRP'),(18383,34729,'histone H3-K79 methylation','P','The modification of histone H3 by addition of a methyl group to lysine at position 79 of the histone.','2013-10-27','NSRP'),(18384,34730,'SmD-containing SMN-Sm protein complex','C','An SMN-Sm protein complex formed by the association of the methylated Sm proteins B/B\', D1, D2, D3, E, F, and G with the SMN complex.','2013-10-27','NSRP'),(18385,34731,'Lsm-containing SMN-Sm protein complex','C','An SMN-Sm protein complex formed by the association of the methylated Sm proteins B/B\', D3, E, F, and G, and Lsm10 and Lsm11, with the SMN complex. This complex forms Sm cores on U7 snRNA.','2013-10-27','NSRP'),(18386,34732,'transcription factor TFIIIB-alpha complex','C','A transcription factor TFIIIB-beta complex that contains the TATA-binding protein (TBP), B\'\' and a specialized homolog of the conserved subunit BRF referred to as BRFU or TFIIIB50, which found in human but not conserved in yeast; the complex is involved in the regulation of transcription from type 3 (upstream) RNA polymerase III promoters.','2013-10-27','NSRP'),(18387,34733,'transcription factor TFIIIB-beta complex','C','A transcription factor TFIIIB-beta complex that contains the TATA-binding protein (TBP), B\'\' and BRF, and is involved in the regulation of transcription from type 2 RNA polymerase III promoters.','2013-10-27','NSRP'),(18388,34734,'transcription factor TFIIIC1 complex','C','A transcription factor complex that forms part of the TFIIIC complex, observed in human. The complex is poorly characterized, but contains the 250-kDa form of HsBdp1, and is thought to include nuclear factor 1 (NF1). It stimulates binding by human TFIIIC2 and is required for transcription activity.','2013-10-27','NSRP'),(18389,34735,'transcription factor TFIIIC2 complex','C','A transcription factor complex that forms part of the TFIIIC complex, observed in human; composed of five subunits (GTF3C1/hTFIIIC220/TFIIICalpha, GTF3C2/hTFIIIC110/TFIIICbeta, GTF3C3/hTFIIIC102/TFIIICgamma, GTF3C4/hTFIIIC90/TFIIICdelta and GTF3C5/hTFIIIC63/TFIIICepsilon in human) that together recognize the type 2 RNA polymerase III promoter.','2013-10-27','NSRP'),(18390,34736,'cholesterol O-acyltransferase activity','F','Catalysis of the reaction: acyl-CoA + cholesterol = a cholesterol ester + CoA.','2013-10-27','NSRP'),(18391,34737,'ergosterol O-acyltransferase activity','F','Catalysis of the reaction: acyl-CoA + ergosterol = CoA + ergosterol ester.','2013-10-27','NSRP'),(18392,34738,'lanosterol O-acyltransferase activity','F','Catalysis of the reaction: acyl-CoA + lanosterol = CoA + lanosterol ester.','2013-10-27','NSRP'),(18393,34739,'histone deacetylase activity (H4-K16 specific)','F','Catalysis of the reaction: histone H4 N6-acetyl-L-lysine (position 16) + H2O = histone H4 L-lysine (position 16) + acetate. This reaction represents the removal of an acetyl group from lysine at position 16 of the histone H4 protein.','2013-10-27','NSRP'),(18394,34740,'TFIIIC-TOP1-SUB1 complex','C','A protein complex that contains TFIIIC, topoisomerase 1, and Sub1/PC4. Characterized in human, the complex is involved in regulating transcription from RNA polymerase III (Pol III) promoters. Topoisomerase 1 and Sub1 enhance the accuracy of transcription termination, and promote reinitiation by Pol III.','2013-10-27','NSRP'),(18395,34741,'APC-tubulin-IQGAP1 complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), alpha-tubulin, gamma-tubulin, and the Rac1 and Cdc42 effector IQGAP1; may play a role in cytoskeleton organization.','2013-10-27','NSRP'),(18396,34742,'APC-Axin-1-beta-catenin complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), Axin-1, and beta-catenin.','2012-03-14','NSRP'),(18397,34743,'APC-IQGAP complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC) and the Rac1 and Cdc42 effector IQGAP1; may play a role in cytoskeleton organization and cell migration.','2013-10-27','NSRP'),(18398,34744,'APC-IQGAP1-Cdc42 complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), the small GTPase Cdc42, and the Rac1 and Cdc42 effector IQGAP1; may play a role in cytoskeleton organization and cell migration.','2013-10-27','NSRP'),(18399,34745,'APC-IQGAP1-Rac1 complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), the small GTPase Rac1, and the Rac1 and Cdc42 effector IQGAP1; may play a role in cytoskeleton organization and cell migration.','2013-10-27','NSRP'),(18400,34746,'APC-IQGAP1-CLIP-170 complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), the small GTPase Cdc42, and CLIP-170; may play a role in cytoskeleton organization and cell migration.','2013-10-27','NSRP'),(18401,34747,'Axin-APC-beta-catenin-GSK3B complex','C','A protein complex that contains the tumor suppressor protein adenomatous polyposis coli (APC), Axin-1, beta-catenin, and glycogen synthase kinase 3 beta. Formation of this complex leads to phosphorylation of beta-catenin and down-regulation of beta-catenin activity.','2012-03-14','NSRP'),(18402,34748,'Par3-APC-KIF3A complex','C','A protein complex that contains Par3, the tumor suppressor protein adenomatous polyposis coli (APC), and the kinesin-related protein KIF3A; involved in establishing neuronal cell polarity.','2013-10-27','NSRP'),(18403,34749,'Scrib-APC complex','C','A protein complex that contains the Scribble protein (a cell polarity determinant) and the tumor suppressor protein adenomatous polyposis coli (APC); may be involved in the control of cell proliferation.','2013-10-27','NSRP'),(18404,34750,'Scrib-APC-beta-catenin complex','C','A protein complex that contains the Scribble protein (a cell polarity determinant), the tumor suppressor protein adenomatous polyposis coli (APC), and beta-catenin; may be involved in the control of cell proliferation.','2013-10-27','NSRP'),(18405,34751,'aryl hydrocarbon receptor complex','C','A protein complex that acts as an aryl hydrocarbon (Ah) receptor. Cytosolic and nuclear Ah receptor complexes have different subunit composition, but both contain the ligand-binding subunit AhR.','2013-10-27','NSRP'),(18406,34752,'cytosolic aryl hydrocarbon receptor complex','C','An aryl hydrocarbon receptor complex found in the cytosol, in which the ligand-binding subunit AhR is not bound to ligand; consists of AhR, two molecules of HSP90, the protein kinase c-Src, and the immunophilin XAP2/AIP.','2013-10-27','NSRP'),(18407,34753,'nuclear aryl hydrocarbon receptor complex','C','An aryl hydrocarbon receptor (AhR) complex found in the nucleus; ; consists of ligand-bound AhR and the aryl hydrocarbon receptor nuclear translocator (ARNT).','2013-10-27','NSRP'),(18408,34754,'cellular hormone metabolic process','P','The chemical reactions and pathways involving any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone, as carried out by individual cells.','2013-10-27','NSRP'),(18409,34755,'iron ion transmembrane transport','P','A process in which an iron ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18410,34756,'regulation of iron ion transport','P','Any process that modulates the frequency, rate or extent of the directed movement of iron ions (Fe) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18411,34757,'negative regulation of iron ion transport','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of iron ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18412,34758,'positive regulation of iron ion transport','P','Any process that activates or increases the frequency, rate or extent of the directed movement of iron ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18413,34759,'regulation of iron ion transmembrane transport','P','Any process that modulates the frequency, rate or extent of the directed movement of iron ions (Fe) from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18414,34760,'negative regulation of iron ion transmembrane transport','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of iron ions from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18415,34761,'positive regulation of iron ion transmembrane transport','P','Any process that activates or increases the frequency, rate or extent of the directed movement of iron ions from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18416,34762,'regulation of transmembrane transport','P','Any process that modulates the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.','2013-10-27','NSRP'),(18417,34763,'negative regulation of transmembrane transport','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.','2013-10-27','NSRP'),(18418,34764,'positive regulation of transmembrane transport','P','Any process that activates or increases the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.','2013-10-27','NSRP'),(18419,34765,'regulation of ion transmembrane transport','P','Any process that modulates the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.','2013-10-27','NSRP'),(18420,34766,'negative regulation of ion transmembrane transport','P','Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.','2013-10-27','NSRP'),(18421,34767,'positive regulation of ion transmembrane transport','P','Any process that activates or increases the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.','2013-10-27','NSRP'),(18422,34768,'(E)-beta-ocimene synthase activity','F','Catalysis of the reaction: geranyl diphosphate = (E)-beta-ocimene + diphosphate.','2013-10-27','NSRP'),(18423,34769,'basement membrane disassembly','P','The controlled breakdown of the basement membrane in the context of a normal process such as imaginal disc eversion.','2013-10-27','NSRP'),(18424,34770,'histone H4-K20 methylation','P','The modification of histone H4 by addition of one or more methyl groups to lysine at position 20 of the histone.','2013-10-27','NSRP'),(18425,34771,'histone H4-K20 monomethylation','P','The modification of histone H4 by addition of one methyl group to lysine at position 20 of the histone.','2013-10-27','NSRP'),(18426,34772,'histone H4-K20 dimethylation','P','The modification of histone H4 by addition of two methyl groups to lysine at position 20 of the histone.','2013-10-27','NSRP'),(18427,34773,'histone H4-K20 trimethylation','P','The modification of histone H4 by addition of three methyl groups to lysine at position 20 of the histone.','2013-10-27','NSRP'),(18428,34774,'secretory granule lumen','C','The volume enclosed by the membrane of a secretory granule.','2013-10-27','NSRP'),(18429,34775,'glutathione transmembrane transport','P','A process in which glutathione is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.','2013-10-27','NSRP'),(18430,34776,'response to histamine','P','Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.','2013-10-27','NSRP'),(18431,34777,'recycling endosome lumen','C','The volume enclosed by the membranes of a recycling endosome.','2013-10-27','NSRP'),(18432,34778,'2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity','F','Catalysis of the reaction: 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA = 4-isopropenyl-2-ketocyclohexane-1-carboxyl-CoA + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18433,34779,'4-isopropenyl-2-ketocyclohexane-1-carboxyl-CoA hydrolase activity','F','Catalysis of the reaction: 4-isopropenyl-2-ketocyclohexane-1-carboxyl-CoA + H2O = 3-isopropenylpimelyl-CoA.','2013-10-27','NSRP'),(18434,34780,'glyphosate dehydrogenase activity','F','Catalysis of the reaction: glyphosate + OH- = glyoxylate + aminomethylphosphonic acid + H+ + 2 e-.','2013-10-27','NSRP'),(18435,34781,'N-cyclohexylformamide amidohydrolase activity','F','Catalysis of the reaction: N-cyclohexylformamide + OH- = cyclohexylamine + formate.','2013-10-27','NSRP'),(18436,34782,'dimethylmalonate decarboxylase activity','F','Catalysis of the reaction: dimethylmalonate + H+ = isobutyrate + CO2.','2013-10-27','NSRP'),(18437,34783,'pivalate-CoA ligase activity','F','Catalysis of the reaction: pivalate + H+ + HSCoA + ATP = pivalyl-CoA + PPi + AMP.','2013-10-27','NSRP'),(18438,34784,'pivalyl-CoA mutase activity','F','Catalysis of the reaction: pivalyl-CoA = 3-methylbutyryl-CoA.','2013-10-27','NSRP'),(18439,34785,'salicylate 5-hydroxylase activity','F','Catalysis of the reaction: salicylate + O2 + NAD(P)H + H+ = gentisate + H2O + NAD(P)+.','2013-10-27','NSRP'),(18440,34786,'9-fluorenone-3,4-dioxygenase activity','F','Catalysis of the reaction: 9-fluorenone + O2 + 2 H+ + 2 e- = 1-hydro-1,1a-dihydroxy-9-fluorenone.','2013-10-27','NSRP'),(18441,34787,'1-hydro-1,1a-dihydroxy-9-fluorenone dehydrogenase activity','F','Catalysis of the reaction: 1-hydro-1,1a-dihydroxy-9-fluorenone + H2O = 2,3-dihydroxy-2\'-carboxybiphenyl + 3 H+ + 2 e-.','2013-10-27','NSRP'),(18442,34788,'2,3-dihydroxy-2\'-carboxybiphenyl 1,2-dioxygenase activity','F','Catalysis of the reaction: 2,3-dihydroxy-2\'-carboxybiphenyl + O2 = 2-hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate + H+.','2013-10-27','NSRP'),(18443,34789,'2-hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate hydrolase activity','F','Catalysis of the reaction: 2-hydroxy-6-oxo-6-(2-carboxyphenyl)-hexa-2,4-dienoate + H2O = cis-2-hydroxypenta-2,4-dienoate + phthalate + H+.','2013-10-27','NSRP'),(18444,34790,'3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity','F','Catalysis of the reaction: (+)-(3S,4R)-cis-3,4-dihydroxy-3,4-dihydrofluorene = 3,4-dihydroxyfluorene + 2 H+ + 2 e-.','2013-10-27','NSRP'),(18445,34791,'isobutylamine N-hydroxylase activity','F','Catalysis of the reaction: isobutylamine + NADPH + O2 = isobutylhydroxylamine + NADP+ + H2O.','2013-10-27','NSRP'),(18446,34792,'hypophosphite dioxygenase activity','F','Catalysis of the reaction: hypophosphite + 2-oxoglutarate + O2 = succinate + phosphite + CO2.','2013-10-27','NSRP'),(18447,34793,'cyclopropanecarboxylate-CoA ligase activity','F','Catalysis of the reaction: cyclopropanecarboxylate + CoASH = cyclopropanecarboxyl-CoA + OH-.','2013-10-27','NSRP'),(18448,34794,'cyclopropanecarboxyl-CoA decyclase activity','F','Catalysis of the reaction: cyclopropanecarboxyl-CoA = crotonoyl-CoA.','2013-10-27','NSRP'),